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"In w r it in g , th erefore , a h istory  cf d ise a se s , every 
p h ilo so p h ica l hypothesis which hath prepossessed  th e  w riter  in  
i t s  favour, ought to  he t o t a l ly  la id  a sid e , and then the m anifest 
and natural phenomena of d is e a se s , however minute, must he hoted  
w ith the utmost accuracy, im ita tin g  in  th is  th e great exactness  
of p a in ters , who in  th e ir  p ic tu re s  copy the sm allest spots or 
moles in  the o r ig in a ls ;  fo r  i t  i s  d i f f i c u l t  to  g ive  a d e ta il  
of the numerous errors th a t spring from h y p o th e s is  H
Thomas Sydenham ^
(From The Works c f  Thomas Sydenham, M.D*, 1850)
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X.
INTRODUCTION.
"The expression  "struma lymphomatosa", which I  r e c e n tly  in vented , I  take 
to  mean a p r o life r a t io n  o f  the lym phatic elem ents w ith  lymph f o l l i c l e s ,  a s w e ll  
as a cer ta in  a lte r a t io n  o f the parenchyma and o f the i n t e r s t i t i a l  t i s s u e ,  which 
can be seen in  the excised  struma t is s u e ."  (tra n s la ted  from the German).
H. Hashimoto. 1912.
The d isea se  defin ed  in  th ese  terms n early  h a lf  a century ago by the Japanese 
surgeon, H. Hashimoto, has ever s in ce  been attended by in t e r e s t  and controversy.
I t  has been known under various synonyms, in clu d in g  Hashimoto* s d ise a se ,
Hashimoto* s  th y r o id it is ,  struma lymphomatosa, lymphadenoid g o itr e , chronic lymphoid 
th y r o id it is , and more r ec e n tly  as auto-immune or auto-immunising th y r o id it is ,  
because o f  the d iscovery  of c ir c u la tin g  thyroid  auto-antibod ied  in  p a t ien ts  w ith  
the condition . This d isease  forms th e  study on which t h is  th e s is  i s  based.
Chapter I  o f the th e s is  i s  concerned w ith the background o f the present 
study. The h is to r ic a l  a sp ects , morbid anatomy, and p ast views regarding a e t io lo g y ,  
are reviewed, and an account o f  the recent immunological developments i s  a ls o  
given.
Chapter I I  of the t h e s is  d ea ls w ith  my observations in  30 p a tien ts  w ith  the  
disease and advantage has been taken o f modern methods o f in v e s t ig a t io n  to  study  
the c l in ic a l  fe a tu re s . The r o le  o f th e c ir c u la tin g  thyroid  au to -an tib od ies in  
the pathogenesis o f th e d isease  has been in v estig a ted  in  a study o f the nature o f  
skin reactions fo llo w in g  the in tra  dermal in je c t io n  o f  s t e r i l e  e x tr a c ts  o f human 
thyroid t is su e  in  p a tien ts  w ith  auto-immune th y r o id it is .  The biochem ical 
changes found in  th is  condition  a lso  form part o f the contents o f  th is  chapter  
and include observations o f the serum p ro te in s , serum f lo c c u la t io n  t e s t s ,  and 
erythrocyte sedim entation r a te . The mechanism o f th ese  changes i s  d iscu ssed  
and/
/and th e ir  d iagn ostic  s ig n if ic a n c e  eva lu ated . A d e ta ile d  in v e s t ig a t io n  o f  
iod ine metabolism has been undertaken and the abnorm alities in  the handling o f  
both stab le  iod in e  and rad io iod ine in  th is  d isea se  i s  d iscu ssed  in  t h is  Chapter. 
F in a lly , th e  d if f e r e n t ia l  d iagn osis  and treatm ent of the d isea se  are considered  
in  the l ig h t  o f  th ese  in v e s t ig a t io n s .
That auto-immune th y r o id it is  i s  r e la te d  to  both the hypothyroid and 
hyperthyroid s ta te  has long been suspected . Chapter I I I  o f  t h is  th e s is  i s  
concerned w ith  th is  problem and evidence i s  presented  th a t so -c a lle d  "primary1' 
hypothyroidism i s  a p a th o lo g ica l varian t o f auto-immune t h y r o id it is .  Thyroid 
auto-antibod ies have been stud ied  in  th y ro to x ico s is  in  r e la t io n  to  th e  c l in ic a l  
fea tu res, to  the outcome o f a n tith y ro id  therapy, and to  th e  fo c a l le s io n s  o f  
auto-immune th y r o id it is  in  the th yroid  gland a f t e r  operation .
Chapter IV d eals w ith  th e  wider im p lica tio n s o f auto-immune d isea se  
resu ltin g  from a study o f th e  c l in ic a l  a s so c ia tio n s  o f auto-immune th y r o id it is  
with d isea ses  in  which auto-immune mechanisms have been suspected , e .g .  the  
connective t is s u e  d iso rd ers , in  p a r ticu la r  rheumatoid a r t h r i t i s ,  th e haem olytic  
anaemias, and c irr h o s is  o f  the l iv e r .  An experiment designed to  measure the 
antibody-forming p o te n tia l in  p a tien ts  w ith  auto-immune d is e a se , i s  a ls o  
reported in  th is  chapter.
F in a lly , the im p lica tion s o f th ese  s tu d ies  are d iscu ssed  in  r e la t io n  to  the  
c lon a l s e le c t io n  theory o f antibody form ation and to  the concept o f  acquired  
immunological to lera n ce .
C H A P  T S  R I .
The Background to  th e  P resent Study.
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Introduction
The h is to r ic a l  a sp ects  o f  Hashimoto's th y r o id it is  are reviewed in  
S ection  1 . An account i s  g iven  o f Riedel* s  struma and o f  the e a r l ie r  
confusion between t h is  d isea se  and Hashimoto's th y r o id it is .  The even ts  
lead ing up to  the acceptance o f Hashimoto* s  th y r o id it is  a s  a separate  
c lin ic o -p a th o lo g ic a l e n t i t y  are o u tlin ed  and a b r ie f  d escr ip tio n  o f  
subacute th y r o id it is  (de Quervain) i s  a lso  g iven  in  t h is  se c tio n .
A b r ie f  account o f  th e morbid anatomy o f  the d isea se  i s  g iven  
(S ectio n  2 ) .
Past hypotheses to  exp la in  the a e t io lo g y  and pathogenesis o f  
Hashimoto's th y r o id it is  are reviewed in  S ectio n  3*
An o u tlin e  i s  given in  S ection  4  o f  the even ts lead in g  up to  the  
discovery o f  the th yroid  au to -an tib od ies in  p a t ie n ts  w ith the d ise a se , 
and a b r ie f  account i s  given  o f  experim ental th y r o id it is  in  anim als.
The nature o f the thyroid  an tigen s and th e ir  au to -an tib od ies i s  described  
together w ith  the methods cu rren tly  a v a ila b le  fo r  the d e tec tio n  o f  th ese  
au to-an tib od ies. The "leaJc" hyp othesis to  exp la in  the a e tio lo g y  o f  
the d isease  i s  c r i t i c a l l y  examined and an account i s  given o f  the  
concept o f "auto-immune" th y r o id it is  in  t h is  s e c t io n .
Section 1.
H is to r ic a l A sp ects.
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Section 1. H is to r ic a l A sp ects: review  o f  the o r ig in a l accounts o f M o d e l1 s  
struma and Hashimoto* s th y r o id it is  and the controversy regarding th e ir  
rela tio n sh ip s; d escr ip tio n  o f  de Quervain*s subacute th y r o id it is .
Original accounts o f M ed el*s struma and Hashimoto*s t h y r o id it is .
Struma fib ro sa  (M e d e l) .
In 1896 , Bernard M ed el ( 1) ,  then P rofessor  o f Surgery a t  Jena, 
described a p ecu liar  and h ith erto  unrecognised type o f chronic in f la mma tio n  
of the thyroid  gland, which he had observed in  2 p a t ie n ts , a man 42  years o f  
age and a woman 32 yea rs . The c h a r a c te r is t ic  fin d in g  in  both th ese  p a tien ts  
was the extreme induration  and f ix a t io n  o f the th yroid  gland. At operation , 
M edel found ex ten sive  in f i l t r a t io n  o f the v e s s e ls  and nerves o f the neck by 
a d iffu se  s c le r o s is  which perm itted on ly  p a r t ia l  r e se c tio n  o f  the thyroid  
isthmus. The h is to lo g ic a l  f in d in g s  in  the f i r s t  p a tien t were reported:
"The biopsy meanwhile showed th at there was no evidence o f  new growth. I t  
was an inflammatory process; in f i l t r a t io n  w ith  round c e l l s  was demonstrated; 
carcinoma and sarcoma were excluded; s y p h il is  was a lso  absent from the  
p a tien ts , and so was tu b ercu lo sis ."  (tra n sla ted  from the German). In  the  
second p a tien t m icroscopic examination revealed: "Interwoven in  the normal
thyroid t is s u e  there are c lu s te r s  o f round c e l l s ,  through which more or l e s s  
the normal thyroid  t is s u e  i s  destroyed." (tra n sla ted  from th e German).
In neither case report was there mention o f  f ib r o s is  on h is to lo g ic a l  
examination and, indeed, referr in g  to  the second ca se , M ed el remarked,
"When one sees the preparation one would not expect how hard the tumour i s ;  
one expected dense fib ro u s t is su e  to  be the co n stitu en t o f  the tumour and 
not, as has been sa id , enlarged round c e l l s " ,  (tra n sla ted  from the German).
S cru tin y/
Figure I*
Riedeli*s O riginal H is to lo g ic a l I l lu s tr a t io n  o f
Struma* fib rosa*

/S cru tin y  o f the o r ig in a l i l lu s t r a t io n s ,  o f which there are on ly  2 
(F ig . 1 .)  f u l l y  confirms t h is  statem ent. Indeed, the p au city  o f  p a th o lo g ica l 
d e ta il  makes i t  v ir tu a l ly  im possib le to  d e fin e , in  r e tro sp e c t , the d isease  
R iedel described in  th ese  2 p a t ie n ts .
In h is  second p u b lica tio n  in  1897 (2 ) R ied el presented a th ird  p a tien t  
in  whom the d isea se  occurred in  a man o f 29. Examination o f the thyroid  in  
th is  p a tien t showed th a t , " it  was made up o f sp ind le and round c e l l s ;  i t  
remained doubtful whether i t  was an inflammatory t is s u e  or neop lasia  
(fibrosarcom a); on ly  the fo llow -up  o f the c l in ic a l  course could decide; i t  
decided in  favour o f a chronic inflammation", (tra n sla ted  from th e German).
In 1910, R iedel (3 ) reported the benign course o f th is  patient* s i l l n e s s  and 
summarised h is  fin d in gs in  the previous 2 p a t ie n ts .
Although Riedel* s name i s  now firm ly  a sso c ia te d  by usage w ith  struma 
fib rosa  i t  i s  o f in te r e s t  th a t, in  1883, 11 years before R ied el*s f i r s t  
a r t ic le ,  Bowlby (4 ,5 )  described a le s io n  o f th e  thyroid  which he reported as  
an ' ' in f iltr a t in g  fibroma" and which probably corresponds to  the d isea se  
described by R ied e l. C erta in ly , m icroscopic examination in  Bowlby* s case  
was more in  keeping w ith  present-day concepts o f  struma fib r o sa , s in ce  the  
thyroid was found "to be e n t ir e ly  fib rou s throughout; there was no d isea se  o f  
the surrounding glands. The r a r ity  o f fibroma and the in f i l t r a t in g  manner o f  
the growths were the in te r e s t in g  po in ts" . Semple ( 6 ) had a lso  p rev iou sly  
described a somewhat s im ila r  case in  1885 ,  although the presence o f c er v ic a l  
lymphadenopathy r a is e s  the susp icion  th at the process was n e o p la s tic .
Following R ie d e l's  o r ig in a l account, Cordua (7) and others (8  -  13) 
reported sim ilar  ca ses , but d ea lt prim arily  w ith  the c l in ic a l  a sp ects  o f  the  
d isea se . /
/d is e a s e . S ila tsch ek  ( 14) and Spannaus ( 15) in  1910 described the  
p ath o log ica l changes in  more d e t a i l  and l ik e  D elore and Alamartine (13) 
found a d if fu se  s c le r o s is  com pletely o b lite r a tin g  the normal gland elem ents.
Struma Lvmphomatosa (Hashimoto) .
In 1912, H. Hashimoto ( 16) ,  a surgeon from Kyushi in  Japan, described  
4  p a tien ts , c l in ic a l ly  s im ila r  to  th ese  p rev io u sly  described by R ied e l, but 
in  whom the h is to lo g ic a l  p ic tu re  o f  the thyroid  was e n t ir e ly  d if fe r e n t .  
Hashimoto recorded the c l in ic a l  and p a th o lo g ica l fin d in g s  in  th ese  4  p a t ie n ts  
in  considerable d e ta i l  and concluded th a t he was d ea lin g  w ith an e n t ir e ly  
d ifferen t d isease  from th a t described  e a r lie r  by R ied e l. He named the  
disease "struma lymphomatosa" on account o f  the ex ten siv e  lymphoid i n f i l -  
: tr a tio n  which he found. The c la r i ty  o f  the d escr ip tio n s  can be judged by 
the ex ce llen ce  o f h is  summary o f  the c l in ic a l  and p a th o lo g ica l f in d in g s:
"If we summarise the c l in ic a l  ob servation s, u n t i l  now there are 
a ltogeth er  4  p a tien ts  who were o f the female sex  and more than 40  years o ld . 
They came from healthy fa m ilie s  and they d id  not l iv e  in  go itrou s areas.
The p a tien ts  p rev iou sly  were never sev ere ly  s ick  and f i r s t  o f a l l  th ey  had 
no serious in fe c t io u s  d isea se  which as a com plication o f  which thyroid  
disease and e sp e c ia lly  th y r o id it is  o ften  happens. S y p h ilis  and tu b ercu lo sis  
were excluded c l in ic a l ly .  The thyroid  enlargement was found in  a l l  cases  
by chance. There were no s ig n if ic a n t  symptoms on th a t ground and togeth er  
with a good general con d ition  and normal body temperature we did not f in d  a 
rapid enlargement o f the th yro id . Both lo b es  were a ffe c te d  -  severe  
pressure symptoms l ik e  dyspnoea or aphonia were never p resen t. The capsule 
of the tumour was apparently fr e e , but the con sisten ce was so dense th at one 
could /
Figure 2(a and b).
Hashimoto*s O riginal H is to lo g ic a l I l lu s t r a t io n  
of Struma Lymphomatosa
11.
Krklilrung; der Ahhlhluiigcn a u f Tnfel YI.
1 'i g u r  1. U o b c r s i o h t s b i  I d d c r  m i ic l i t ig o n  L y m p h f o l l i k e l -  
e n t w i c k l u n g  im  D a r o n c h y m .  (F a ll *2, M ikroplaner 35 mm . IlaulT. O rt. p i. 
Bulglango 40 cm. lliim atoxylin-K osinfiirbung .) a  Lym plifollikel m il Keim- 
cen tren . b  Jn to rslitium . c  Driisenlo11 ikc 1.
Hior s ieh t m an sclir klcinc Driiscnfollikcl, die im A llgem oinen m it w enig 
Colloid versehon s ind . Dio 11 undzclIcn in liIIra tion  ist dilTus verbreitot. In te r- 
s titium  is t dilTus liyportrophirt.
F i g u r  2. F o r t g e s c l i r i t t c u c  Y o r a n d e r u n g  d o s  I n l o r s t i l i u m s .  
(F a ll 2, D oppelfiirbung m it v a n  G ie s o n - lla m a lo x y lin .  Vorgt*. Zoiss Obj. AA, 
Ooul. 4 .) u  Lym plifollikel m it B lu tgefasscapillu rcn  (c) und K crn ilieilungs- 
figuren. b  B lu tgc lass. c  lly p c ilm p h irte s  liiterstitin tn , m il llundzc llcn  stark  
in filtr ir t. d  Y erandcrlo Follikel (Z ellgrenze unk la r, im Allgemoinen atropliiscli, 
fa s t frei von norm ulem  Colloid).
F i g u r  3. S t a r k  v e r a n d c r l e  D r i i s c n f o l l i k c l .  (F a ll 2 , Doppel- 
fa rb u n g  m it llamnloxylin-Kosiu*. Y ergr. Zeiss Obj. DD, O cul. 4 .)  a  An- 
scheinend  gescliichtcte Follikelcpitlielicn (Z ellgrenze undeu tlic li). b  Follikel- 
in h a lt  (verandcrte  E pitlic lzcllen , Leukoeyten und ilirc A bkom m lingo). c  Ein- 
gew anderte  Leukoeyten in dcr F ollikclw und. d  In lc rs tilium  m it U undzellen- 
in filtra tion .
F i g u r  4. C i r c u m s c r i p t  s t a r k  e n t w i c k e l t c s  i n t o r s t i t i e l l e s  
B i n d e g e w e b e .  (Im Innern atrop liirlo  Follikel cinscliliessend . F a ll 3, Doppel- 
fa rbung  m it lliim atoxylin-E osin . Ycrgr. Zeiss Obj. A A, O cul. 4 .)  a  S tark 
hypcrtrop liirtcs B indegew ebe. b Solir kleine, a troph irte  Follikel, fas t frei von 
Colloid, c  S tarke llundze llen in lillra tion . d  B lu lgefiisscapillare.
F i g u r  5 . F o r t g c s c l i r i t t c n o  Y o r a n d e r u n g .  (F a ll 4 , D oppelfarbung 
m it H am atoxylin-Eosin. V crgr. Zeiss Obj. AA, Ocul. 4 .)  a  Lym plifollikel mit 
K eim centrum . b D rusenfollikel (stark  afficirt, frei von norm alcm  Colloid, wenig 
schollige  Masse en tha llend ). c K iesenzcllen (K erne ra n d s tan d ig ). d  Ge- 
w uchertes In te rs titium  m it sch r s ta rk  in filtrirtcn  R undzellen .
12 .
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(enlarged to show detail)
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/cou ld  think about malignant tumour or R ied e l1 s t h y r o id it is .  The lymph 
glands were not palpable e ith e r  lo c a l ly  or in  other parts o f  the body.
We could fin d  nothing abnormal in  the in ter n a l organs. The operative  
fin d in gs did not show any s p e c ia l ly  marked growth in  the surrounding t is s u e s  
as in  R iedel*s th y r o id it is ,  which was emphasised by the author in  qu estion .
A p ost-op erative  huskiness remained more or l e s s  in  a l l  th e  ca ses  although  
i t  was of a very l ig h t  degree.
In the subsequent course a f t e r  the operation , oedema appeared in  the 
en tire  body, and disappeared w ith  continuous adm in istration  o f  th yroid  
extract” , (tra n sla ted  from the German).
The p r in c ip le  h is to lo g ic a l  fin d in g s in  a l l  4  p a tien ts  co n s isted  o f:
”( l )  numerous form ation o f  lymph f o l l i c l e s ,
(2) changes in  the l iv in g  epithelium  of the a c in i togeth er  w ith  th e ir
content.
(3) ex ten sive  new form ation o f connective t is s u e ,  and
(4 ) d iffu se  round c e l l  in f i l t r a t io n .” ; th ese  are i l lu s t r a t e d  in  F ig . 2 .
Subsequent confusion between Hashimotot s th y r o id it is  and R ied el*s struma.
1912 -  1931.
The events which follow ed the p u b lica tio n  o f Hashimoto*s account have 
been admirably reviewed by J o l l  (1 7 ) . According to th is  author, l i t t l e  
a tten tio n  appears to  have been paid to Hashimoto*s p u b lica tio n  d esp ite  the 
excellen ce o f the d escr ip tio n s . However, in  1914? Heineke ( 18 ) mentioned 
struma lymphomatosa and accepted i t  as a d e f in ite  e n t ity , although he 
described no case o f h is  own. Following t h is ,  nothing appears to  have been 
published on the subject u n t i l  1922, when Ewing ( 19) in  d iscu ssin g  4  p a tien ts  
with chronic th y r o id it is ,  came to  the conclusion  th at Hashimoto and R iedel 
had/
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/had described, “the ea r ly  and la te  sta g es  o f the same p a th o lo g ica l 
process". Ewing (20) la t e r  described both d ise a se s  under the name o f  
"benign granuloma" o f the th yro id , which had p rev iou sly  been used fo r  
struma fib ro sa  i t s e l f  (2 1 ) . With the so le  exception  o f H eist (22)
Ewing’ s views were w idely  accepted and during the next decade many cases  
with the c la s s ic a l  fea tu res  of Hashimoto*s th y r o id it is  were reported e ith e r  
as R iedel*s struma (23 ,24) or a s  one o f i t s  synonyms (25 -  31 )•  Further 
confusion in  the term inology arose w ith the p u b lica tio n s o f  W illiam son  
and Pearse (3 2 ,3 3 ) , who described a "lymphadenoid" g o itr e  which had a l l  the 
p ath olog ica l c h a r a c te r is t ic s  o f  the d isease  described e a r lie r  by Hashimoto.
C la r if ic a tio n  o f  Hashimoto * s th y r o id it is  by Graham and McCullagh 1931.
In 1931, Graham and McCullagh (34 ,33) c le a r ly  defined  the 2 d ise a se s , 
c r i t ic a l ly  compared them, and revived  Hashimoto*s o r ig in a l contention  th a t  
they were separate e n t i t i e s .  These authors based th e ir  argument mainly on 
the grounds th a t , "although R iedel*s struma i s  the supposedly la t e r  stage  
of the d ise a se , i t  n everth e less  occurred more commonly in  younger persons 
and a lso  was more freq u ently  a u n ila te r a l or lo c a lis e d  process."
Subsequent Controversy regarding R elationsh ip  between Hashimoto* s 
th y r o id it is  and R iedel*s struma.
Following th is  important a n a ly s is  a strong body o f evidence grew up 
in  favour o f the d u a lis t ic  concept o f the 2 d isea se s  (17 ,36  ~ 4 6 ); although  
many cases which were undoubtedly examples o f  Hashimoto*s th y r o id it is  
continued to  be reported as R iedel*s struma. For example, Renton e t  a l .  (47) 
in  a paper in  1937 on Riedel* s th y r o id it is  and i t s  treatment w ith radium 
made the surprising a sse r tio n , "that Riedel* s th y r o id it is  may be defined as 
b ein g /
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/being  ch aracterised  by lymphocytic in f i l t r a t io n ,  w ith or w ithout 
germ-centre form ation, and in creasin g  f ib r o s is  a f fe c t in g  the gland and o ften  
adjacent s tru ctu res , w ith  a lte r a t io n  and atrophy o f th yroid  ep ith eliu m , each 
in  varying degree". The d e f in it io n  c le a r ly  a p p lie s  to  Hashimoto‘ s 
th y r o id it is .  Opposing views to  those held  by G-raham and McCullagh were 
expressed by E isen  (48,49)* Boyden e t  a l  (5 0 ) , Vaux (5 1 ) , Merrington (52), 
and others (53*54), who continued to b e lie v e  th at Hashimoto had m erely  
described the e a r lie r  stage o f struma fib r o sa . E isen  (48 ,49 ) did not 
b e lie v e , however, th a t one d isease  n e c e s sa r ily  preceded or fo llow ed  the other, 
although he claimed to  have seen the tr a n s it io n  o f Hashimoto*s th y r o id it is  to  
Riedel*s struma in  one ca se .
In support of the d is t in c t io n  between th e 2 d isord ers, rep eat b io p sie s  
in  Hashimoto* s th y r o id it is  a t  in te r v a ls  ranging from severa l months (55) to  
23 years (56 ) did not rev ea l any evidence o f progression  to  Riedel* s struma 
(23 ,29 ,43 ,55  -  66) ,  a lth ou g i an increase in  the amount of fib ro u s  t is s u e  in  
the second biopsy specimen was observed in  severa l in sta n ces  ( 2 3 , 2 9 *4 3 *4 4 *60) .  
Moreover, as Hazard ( 67 ) has pointed out, the d isea se  now recognised  as  
R ied e l's  struma has many h is to lo g ic a l  d is s im ila r it ie s  w ith  Hashimoto* s 
th y r o id it is . These include: ( 1 ) the p r o life r a tio n  o f fib rou s t is s u e  which 
involves e ith e r  the whole or lo c a lis e d  portion  o f the gland and which causes 
lo s s  of the normal lobu lar structure; ( 2 ) the d estru ction  o f the capsule  
and extension o f  the f ib ro s in g  process in to  the p er i th yroid al t is s u e ;  ( 3) 
the presence o f neutrophil in f i l t r a t io n ;  and (4 ) the absence o f  any degree 
of lymphoid in f i l t r a t io n .
I t  must, however, be appreciated th at many of the p a th o lo g ica l 
d ifferen ces are q u an tita tive rather than q u a lita tiv e  ( 67) ; interm ediate  
ty p es /
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/ty p e s  have been recorded ( 52 , 57 , 68 \  and a few ca ses  have d e fied  p r e c ise  
c la s s if ic a t io n  ( 69) .
Since Graham and McCullagh*s c r i t i c a l  a n a ly s is  o f the two d ise a se s  
in  1931 (3 4 ,3 5 ) , su rp r isin g ly  few cases o f Riedel* s struma have been  
reported and th e number in  which s t r ic t  d e f in it io n  has been adhered to  i s  
extremely sm all (1 7 ,5 7 ,7 0 ,7 1 ) • Thus, in  1939, J o l l  ( 17) reported  5 cases  
in  a s e r ie s  of 5,650 thyroidectom ies and S c h il l in g  (57) in  1945 described  
one authentic case from 3 ,750  h o sp ita l adm issions fo r  thyroid  d ise a se .
Lindsay e t  a l .  (70) reported 2 cases o f R iedel*s struma in  a to t a l  o f 6,571 
thyroidectom ies over a 50-year period . Perhaps the la r g e s t  well-documented 
ser ie s  i s  th at o f Woolner e t  a l .  (71) in  1957, which described 20 cases  
observed a t  the Mayo C lin ic  in  a 36-year period , during which approxim ately  
42,000 thyroidectom ies had been performed. Thus, the r e la t iv e  r a r ity  o f  
Riedel* s struma makes i t  d i f f i c u l t  to  gain  an accurate c l in ic a l  p ic tu re  o f  
the d isea se .
C onsiderations of age and sex incidence have played a large  part in  the  
d is t in c t io n  between Hashimoto* s and Riedel* s d ise a se . I t  i s  g en era lly  agreed  
that both are more common in  fem ales, and th at t h i s  seems to  be p a r tic u la r ly  
true of Hashimoto*s th y r o id it is  (1 7 ,3 9 ,4 9 ,7 0  -  73)• In contrast to  e a r lie r  
reports (17 ,35 ,39 ) recent s tu d ies  have shown no apparent d ifferen ce  in  the  
age incidence o f the 2 d ise a se s . According to  J o l l  (17) the fea tu res  of 
Riedel*s struma which d if fe r e n t ia te d  i t  from Hashimoto*s th y r o id it is  
included the complaint of severe pressure symptoms in  the presence o f a 
g o itre , which although not unduly large was always stony hard and f ix e d  to  
surrounding cerv ica l stru ctu res . Further, the thyroid sw ellin g  in  Riedel* s  
struma was o ften  u n ila te r a l in  contrast to  the d if fu s e ly  enlarged g o itre  in  
struma/
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/strum a lymphomatosa, and hypothyroidism was in freq u en t. However, in  
the s e r ie s  of 20 p a tien ts  stud ied  by Woolner e t  a l .  (71) o b stru ctiv e  
fea tu res  were uncommon and frank hypothyroidism was observed in  4  o f  the  
p a tie n ts . In a l l  the p a tien ts  the g o itre  was "stony-hard" and in  hal£  
f ix a t io n  in  the neck was n o ticed . No c lea r  d is t in c t io n  from 
Hashimoto* s th y r o id it is  was p o ss ib le  and i t  may be as Herrington (52) has 
sta ted  th at "there i s  a s in g le  broad c l in ic a l  p ic tu re  common to  both  
(d is e a s e s ) , and attem pts to  draw a l in e  between them have not been con- 
: vincing."
Present-Day Concepts regarding R elationsh ip  between 
Hashimoto*s th y r o id it is  and R iedel*s struma.
Thus, the p rec ise  re la tio n sh ip  between Hashimoto* s  th y r o id it is  and 
Riedel* s  struma remains obscure, but i t  may be as R e ist (22) and Womack (74) 
have suggested th at the 2 d isea ses  are varying m an ifesta tion s o f the same 
p athological p rocess. This h o l i s t i c  concept has r e c e n tly  been supported 
by R iviere and Martino (75) who sta ted : 11 s t r i c t l y  speaking they did  not
co n stitu te  a ’disease* but a h is to lo g ic a l  s ta te  su scep tib le  to  m od ification  
with tim e, but not n e c e ssa r ily  so , and which expresses a u n ita iy  response  
against aggressions and th yro id al perturbations o f quite d if fe r e n t nature.
I t  seems, so to  say, th at they can be considered d if fe r e n t * facets*  o f the 
same condition ."  (tra n sla ted  from the French).
E lucidation  o f Riedel* s "r&tsel" or r id d le  as he so a p tly  described i t ,  
must remain unsolved u n t i l  more fa c t s  concerning the d isease  become a v a ila b le .
Subacute (G-ranulomatous) th y r o id it is .
The th ird  form of chronic th y r o id it is  which has been confused w ith  
b oth /
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/b o th  Hashimoto*s th y r o id it is  and R iedel*s struma, i s  subacute (granulomatous) 
th y r o id it is ,  which was f i r s t  described in  1904 by de Quervain (7 6 ) . The 
various synonyms used fo r  th is  form o f th y r o id it is  -  granulomatous th y r o id it is ,  
pseudo-tuberculous and tuberculous th y r o id it is ,  g ian t c e l l  th y r o id it is ,  
struma granulomatosa, g iant c e l l  th y r o id it is ,  pseudo-giant c e l l  th y r o id it is  
of de Quervain, and struma fib ro sa  -  g iant c e l l  v ar ian t, -  c a l l  a tte n tio n  
to the d is t in c t iv e  h is to lo g ic a l  fea tu res: the presence o f h is t io c y te s  and
th e ir  freq u en tly  fo c a l and pseudo-tuberculous arrangement, g ia n t c e l l s ,  and 
phagocytosis (7 7 ) . M icroscop ically  f ib r o s is  w ith  p r o life r a t io n  o f the  
stroma i s  a lso  noted and the a c in i are decreased in  s iz e  and number, w ith  
extravasation  o f th e ir  c o llo id  and a sso c ia ted  inflammatory r ea c tio n  w ith  
many polymorpho-nuclear leu co cy tes . ( 57*70 , 78 , 79) .
The granulomatous nature o f the d isea se  was taken as evidence o f i t s  
tuberculous nature by e a r lie r  workers (8 0 ) , but in  1930 J a ffe  (81 ) c le a r ly  
estab lish ed  i t  as being o f non -b acteria l o r ig in  and recognised  the tu b erc le­
lik e  stru ctu res as the r e s u lt  o f n o n -in fec tio u s in vo lu tion ary  changes. A 
virus in fe c t io n  was suggested ( 56 , 82) on the b a s is  of a h igh incid ence of 
upper resp iratory  tr a c t  in fe c t io n  (85 ) ,  although Lindsay and D a iley  ( 78 ) 
were unable to  demonstrate in c lu s io n  b od ies. R ecently Eylan e t  a l .  (84 ) 
demonstrated p o s it iv e  com plem ent-fixation an tib od ies aga in st mumps v irus in  
10 of 11 p a tien ts  w ith subacute th y r o id it is  during an outbreak o f mumps in  
Isr a e l, thus providing evidence of a causal a sso c ia tio n .
C rile  (85) and S talker and Walther ( 85) consider subacute th y r o id it is  
as the commonest form of th y r o id it is  in  the United S ta te s , but i t  i s  
generally  regarded as rare in  th is  country (8 2 ,8 6 ) . Although de Quervain
w
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/ i n  1936, w ith G-iordanengo (87 ) ,  c le a r ly  e sta b lish e d  subacute th y r o id it is  
as a separate c lin ic o -p a th o lo g ic a l e n t it y  la te r  workers (88) confused i t  
w ith both Hashimoto*s th y r o id it is  and R iedel*s struma. However, consid­
e r a t io n  o f the c l in ic a l  fea tu res  serves to  d if fe r e n t ia te  i t  from the 
other 2 types o f th y r o id it is .  Thus, the onset i s  o ften  acute w ith  a sore  
th roat, pain and tenderness o f the gland, m alaise and fe v e r , and the course 
i s  u su a lly  subacute or chronic and alm ost in v a r ia b ly  s e l f - l im i t in g  w ith no 
subsequent derangement o f thyroid  fu n ctio n . The concept expressed by 
de Quervain and G-iordanengo in  th e ir  paper in  19% has been accepted by 
most workers (70 ,77  -  8 0 ,8 3 ,8 5 ) , although sev era l cases have been reported  
under other d esignation s (4 3 ,9 0  -  93 ).
CONCLUSIONS.
In summary, i t  can be concluded from a study o f the l it e r a tu r e  th at 
there i s  good evidence fo r  the acceptance o f  3 d is t in c t  types o f chronic 
th y r o id it is :  ( 1) struma lymphomatosa (Hashimoto), ( 2 ) struma fib ro sa  (R ie d e l) ,
and ( 3) subacute (granulomatous) th y r o id it is  (de Quervain).
The re la tio n sh ip  between Hashimoto* s th y r o id it is  and Riedel* s struma 
remains obscure, but the comparative r a r ity  o f the la t t e r  makes the 
d iffe r e n t ia t io n  of l i t t l e  p r a c tic a l moment. Subacute (granulomatous) 
th y r o id it is  i s  probably o f  v ir a l a e t io lo g y , and i t s  c l in ic a l  and p ath o log ica l 
featu res make i t  qu ite d is t in c t iv e  and e a s i ly  d if fe r e n t ia te d  from the other  
2 d isea se s .
Section 2.
MQyhia Anatomy feeview^«
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Several su ccin ct accounts o f  the morbid anatomy o f Hashimoto* s 
th y r o id it is  have been given in  recen t years (1 -  5) and th e fo llo w in g  
review  i s  la r g e ly  based on the opin ions expressed in  th ese  papers.
1. Macroscopic Changes.
The g o itre  in  Hashimoto* s th y r o id it is  i s  u su a lly  o f moderate 
s iz e ;  su rg ica l specimens varying in  weight from 24 (6) to  225 (7) g.> 
w ith means o f 45*7 (6 ) ,  66 .8  ( 7 ) ,  100 ( 8 ) ,  and 130 (9) g** in  sev era l 
large  s e r ie s .  The g o itr e  i s  u su a lly  uniform ly enlarged, although i t  
may be s l ig h t ly  asym m etrical, and the pyramidal lobe i s  o ften  
conspicuous ( 2 ) .  O ccasionally  the enlargement i s  u n ila te r a l, and 
when so the r ig h t lobe i s  u su a lly  greater  than the l e f t  (3 ) .  The 
gland i s  c h a r a c te r is t ic a lly  firm  or "rubbery hard" ( 9 ) ,  pale  in  
colour, and w ith a smoothly b osse la ted  or lob u la ted  surface ( 9) .  
O ccasionally  the go itre  may be nodular ( 1 , 7 ) ,  although g en era lly  
adenomatous formation i s  inconspicuous (1 0 ) .  The capsule i s  
gen era lly  th ick , w e ll preserved, and d is t in c t ,  and o cca sio n a lly  may 
be s l ig h t ly  adherent to  the trachea and c e r v ic a l stru ctu res ( 3) .
The adjacent c erv ica l lymph nodes are freq u en tly  enlarged (11) .  The 
cut surface has been described as varying in  colour from "salmon- 
pink" ( 9) to  "yellow ish white w ith a brownish tinge" ( 2 ) .  C o llo id  
i s  absent ( 3) and the gland i s  d ivided up in  a lobu lar manner by 
d iv id ing  fibrous septa ( 9)* The surface i s  r e la t iv e ly  f r ia b le , but 
in  the la te r  stages of the d isease with increasin g f ib r o s is  i t  may 
b e /
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/b e  o f a " r e s i l ie n t  toughness" ( 2 ) .
2 .  M icroscopic Changes.
These h is to lo g ic a l  changes can b est be considered under f iv e  
headings: ( l )  Lymphoid elem ents, (2) F ib r o s is , (3 ) V e s ic le s ,
(4 ) Epithelium , (5 ) Blood V esse ls .
(1) Lymphoid Elements. The c h a r a c te r is t ic  fin d in g  in  
Hashimoto*s th y r o id it is  i s  d if fu se  in f i l t r a t io n  w ith lymphocytes 
and plasma c e l l s  ( 2 ) .  Lymph f o l l i c l e s  w ith germinal cen tres may 
be ev id en t, and d if f e r  in  no way from the lymph f o l l i c l e s  found 
elsewhere in  the body ( 9) .  Parmley and H ellw ig (6) have estim ated  
th at the lymphocytic in f i l t r a t io n  accounts fo r  approxim ately one 
th ird  the s iz e  of the g o itr e , and Furr and C rile  (12) have s ta ted  
th a t i t  i s  e sp e c ia lly  marked in  g o itr e s  o f short duration. 
O ccasionally  i t  may be so dense a s  to  be mistaken fo r  lymphosarcoma 
(4 ) .  Monocytes are present in  sm all numbers ( 1) ,  but polymorpho- 
m uclear leu cocy tes are rare ( 5 ) .  Foreign body g iant c e l l s  are 
seen in  10 per cen t, o f glands according to  J o l l  ( 2 ) ,  but are 
never as  numerous as  in  subacute th y r o id it is  ( 13) .
(2) F ib r o s is . Fibrous t is s u e  i s  present in  variab le  amount in  
Hashimoto* s th y r o id it is ;  c la s ic a l ly  i t  i s  f in e  in  tex tu re  and 
arranged in  whorls about the thyroid  lo b u le s . In 10 per cen t, 
o f glands f ib r o s is  i s  abundant ( 3) and may o cca s io n a lly  cause 
complete replacement of a thyroid lobu le  ( 1) .
(3) V e s ic le s . The th yroid  v e s ic le s  are reduced in  s iz e  and may 
be round, oval, or ir reg u la r . Hashimoto* s o r ig in a l measurements 
o f /
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/ o f  the diameter o f th e thyroid  v e s ic le s  la y  between 30 and 
3 6 0 p (l4 ). The c o llo id  contained in  the a c in i i s  reduced in  
amount and may be absent; i t  freq u en tly  shows considerab ly  
v a r ia b il ity  in  i t s  s ta in in g  p rop erties and i s  o ften  in te n se ly  
sta in in g  and e ith e r  granular or homogeneous (13)« O ccasionally  
the c o llo id  may show peripheral vacuolation  (13) and may contain  
fo re ign  body giant c e l l s  (3,4>13)«
(4 ) Epithelium . E p ith e lia l  changes are common in  Hashimoto*s 
th y r o id it is .  They were a ttr ib u ted  to  degenerative p rocesses by 
Hashimoto ( 14) and to hyperplasia  secondary to  thyroid  d estru ctio n  
by la te r  workers (3>15>16). Renton e t  a l .  (17) found i t  d i f f i c u l t  
to  reco n c ile  the h yp erp lastic  appearance o f the epithelium  w ith  
the c l in ic a l  fea tu res  o f hypothyroidism.
In ad d ition  to  th e ir  h yp erp lastic  appearance some o f the acinar  
c e l l s  show a d is t in c t iv e  oxyph ilic  a lte r a t io n  o f the cytoplasm .
These c e l l s  are often  la rg er  than normal, contain  abundant cytoplasm, 
and have hyperchromatic n u cle i of variab le  s iz e  and shape.
H ellw ig ( 18) considered th ese c e l l s  s im ila r  to  the changes seen in  
the epithelium  of the breast in  chronic m a s t it is , and Womach ( 19) 
thought th at they bore a resemblance to  the c e l l s  p rev iou sly  
described by Httrthle (20) in  the dog. In 1948* Lennox (21) 
id e n t if ie d  them w ith the c e l l s  described by Askanazy (22) in  
thyrotoxic glands. Thus, these p ecu liar  e p ith e l ia l  c e l l s  have been 
variou sly  described as Htirthle (20) or Askanazy (22) c e l l s ,  and 
from consideration  o f th e ir  appearance have been considered as  
d e g e n e r a t i v e  ( 1 0 ) , /
FIGURES 1 -  8 
H isto lo g ica l Appearances in  Hashimoto^
T h y ro id itis
Hashimoto^ T h y ro id itis
Showing chronic inflammatoiy c e l l  in f i l t r a t io n ,  lo s s  o f  
normal f o l l ic u la r  arch itectu re w ith  form ation o f numerous 
sm all f o l l i c u le s .  ( Haemat o xy lin  and eosin  x  60)o
FIG-. 2. Hashimotof s T h yro id itis.
Showing lymphoid f o l l i c l e s  w ith germinal c en tres , and 
giant c e l l s  in  thyroid f o l l i c l e s .  There i s  a lso  
generalised  in f i l t r a t io n  with round c e l l s ,  and the a c in i 
are sm all. ( Haematoxylin and eosin  x  140).
27 .
FIG-. 3« Hashimoto^ Thyroiditis.
Shornng d iffu se  rou n d -cell inflammatory c e l l  
in f i l t r a t io n  and A skanazy-cell change. A lymph 
f o l l i c l e  w ith  a large germinal centre can be seen, 
and th ere are also  m ultinucleated g ian t c e l l s  and 
a distended lymphatic present in  t h i s  sec tio n . 
(Haematoxylin and eo sin  x 112).
28.
FIG-, ifri. Hashimoto1 s T hyroid iti s
Showing diffuse chronic inflammatory cell infiltration 
with foci of more dense aggregation. The acini are small 
and there is virtually no colloid storage. Colloidophagy 
is evident in the lumen of the acini. There are also 
dense strands of fibrous tissue (left of centre) and a 
general increase in connective tissue between individual 
acini. (iiaematoxylin and eosin x 1 50).
29.
FIG-. 5« Hashimoto1 s T h yro id itis.
Showing d iffu se  chronic rou n d -cell in f i l t r a t io n ,  
small a c in i, and colloidophagy. Epithelium i s  
in  the form cf Askanazy c e l l s .  (Haematoxylin and 
eosin  x  A30).
30.
FIG-. 6. Hashimoto^ T h y ro id itis .
Showing d iffu se  in f i l t r a t io n  w ith  plasma c e l l s  and 
lymphocytes. A l l  epithelium  i s  in  the form o f sm all 
a c in i and so lid  clumps, and shows A skanazy-cell change. 
There i s  v ir tu a lly  no c o llo id  in  any o f the a c in i.
(Haematoxylin and eo sin  x 500) .
31.
FIG-. 7* Hashimoto^ T h yro id itis .
Showing very dense chronic inflammatory c e l l  in f i l t r a t io n  
and a group of a c in i showing tendency o f epithelium  to  
form s o lid  clumps. The e p ith e l ia l  c e l l s  are enlarged  
ir reg u la r ly  and have the ty p ica l appearances of Askanazy- 
c e l l s .  Colloidophagy i s  seen in  one of the small a c in i.  
(Haemat oxy lin  and eo sin  x 500) .
32.
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FIG, 8, Hashimoto1 s T hyroid iti s
Showing d iffu se  rou n d -cell in f i l t r a t io n  and Askanazy- 
c e l l  change in  the thyroid  epithelium . The m ajority  
of the rou nd -cells  are plasma c e l l s .
(Haematoxylin and eosin x 425).
/d egen era tive  (10 ) ,  in v o lu tio n a l ( 23) ,  or exhausted ( 3) forms o f  
thyroid ep ithelium .
(5 ) V e sse ls . Apart from a th e r o sc le r o tic  changes no s p e c if ic  
abnorm alities have been recorded in  th e blood v e s s e ls  in  Hashimoto* s 
th y r o id it is  (1 -  3 , 13) *
In summary, the h is to lo g ic a l  f in d in g s  in  Hashimoto* s th y r o id it is  
are characterised  by: d if fu se  lymphocytic and plasma c e l l  in f i l t r a t io n ,
ly m p h -fo llic le  form ation, small a c in i devoid o f  c o l lo id ,  h yp erp lastic  
epithelium  showing A skanazy-cell change, and f ib r o s is ,  present in  
variab le degree. Some o f th ese  fea tu res  are i l lu s t r a t e d  in  F ig s . 1 -  8..
H is to lo g ic a l C r iter ia  of Hashimoto*s th y r o id it is .
Considerable confusion has e x is te d  in  the past regarding the  
h is to lo g ic a l  c r ite r ia  o f Hashimoto* s t h y r o id it is .  Thus, some workers 
( 2 , 7 , 24) have r e s tr ic te d  the term to  those glands showing d if fu se  
changes of c h a r a c ter is t ic  type, whereas others (3 ,23 ,25)  have extended  
the d escr ip tio n  to  include a fo c a l le s io n  o f  the same typ e.
Furthermore, some p a th o lo g ists  do not accept glands w ith d if fu se  
changes which lack  one o f the e s s e n t ia l  c h a r a c te r is t ic s  o f the d ise a se ,  
3uch as A skanazy-cell change or plasma c e l l  in f i l t r a t io n ,a s  examples 
o f Hashimoto*s th y r o id it is .  Thus, C rile  (26 ) and others (2 ,4 , 3 , 9 ) ,  
have emphasised the importance o f the e p i t h e l ia l  changes, and C rile  
and Hazard ( 27) and G ribetz e t  a l .  (28) have referred  to  g o itr e s  
occurring in  adolescen ts and young g ir l s  which showed d iffu se  
lymphocytic in f i l t r a t io n  w ith l i t t l e  or no A skanazy-cell change as  
"lymphocytic” or "lymphoid” th y r o id it is .  Paine e t  a l .  (29) contend 
th a t /
/ th a t  Hashimoto1 s th y r o id it is  should on ly  be made in  the absence 
o f p la sm a-ce ll in f i l t r a t io n  and use th e  term "chronic n on -sp ecific"  
th y r o id it is  when th ese  c e l l s  are p resen t. There i s ,  however, no 
h is to r ic a l  ju s t i f ic a t io n  fo r  th is  view, s in ce  Hashimoto ( 14) s ta ted  
th at the ro u n d -ce lls  present "included a number o f  plasma c e lls"  
(tra n sla ted  from the German). In  recen t years there has been a 
tendency to include such varian ts under the general d esign ation  o f  
Hashimoto's th y r o id it is  (11) .
The h is to lo g ic a l  c r i t e r ia  adopted in  the present t h e s is  are 
those o f J o l l  ( 2 ) .  In th is  author's opin ion , the c h a r a c te r is t ic  
m icroscopic fea tu re  i s  the uniform ity o f  the changes and the d if fu se  
nature o f the lymphocytic in f i l t r a t io n ,  although, a s he observed, 
t h is  did not "preclude considerable d iffe re n c e s  in  d e t a i l  according  
to  the stage reached by the d isease" . Later in  Chapter I I I  o f the  
th e s is ,  evidence w i l l  be brought forward to  suggest th at th e  fo c a l  
lymphoid le s io n s  o f  chronic th y r o id it is  can be accepted a s  an ea r ly  
stage o f the d if fu se  d isea se  process.
Section 3.
A etio logy  and P athogenesis (R eview).
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I t  i s  perhaps not su rp risin g  th at e a r l ie r  w r iters  should have 
considered an in fe c t iv e  b a s is  fo r  the a e t io lo g y  o f Hashimoto's 
th y r o id it is ,  s in ce  h is t o lo g ic a l ly  the d isea se  has many c h a r a c te r is t ic s  
o f an inflammatory con d ition . Both Brttnger ( 1 ) and Eason (2) 
regarded the presence of lymph f o l l i c l e s  a s  evidence o f an inflammat- 
:ory rea c tio n , although Hashimoto ( 3) o r ig in a lly  compared struma 
lymphomatosa w ith M iku licz's  d ise a se . Since i t  was known th a t  
th y r o id it is  was never primary, f o c i  o f in fe c t io n  were sought in  th e  te e th
(4 ) ,  t o n s i ls  (5 ) ,  and upper resp ira to ry  passages (6 ,7 )*  Bohan (4 ) 
fo r  in stan ce iso la te d  organisms in  d en ta l in fe c t io n  which when 
in jec ted  in to  rab b its produced H ashim oto-like chaages in  the th yro id . 
Meeker (5) described a p a tien t w ith  a p e r s is te n t  p o ster io r  branch ial 
body and suggested th a t in fe c t io n  might have reached the th yroid  in  
th is  way. Although unable to  demonstrate the presence o f  tu b erc le  
b a c i l l i  Wegelin ( 8 ) did not d ism iss th e  p o s s ib i l i t y  th a t tu b ercu lo s is  
might be an a e t io lo g ic a l  fa c to r . L ikew ise, s y p h il is  was incrim inated  
by W illiamson and Pearse ( 9) in  1929, although Ewing (10) had 
p reviou sly  considered Hashimoto* s th y r o id it is  to  be a "benign 
granulomatous" in fe c t io n . That the thyroid  gland was r e s is ta n t  to  
b a c te r ia l in fe c t io n  was demonstrated by Womack ( 11) who in je c te d  pure 
cu ltu res o f  strep to co cc i and staph ylococci d ir e c t ly  in to  the  
superior thyroid  artery  in  dogs and showed th a t abscess form ation  
ra re ly  fo llow ed . The p o s s ib i l i t y  o f a v ir a l  in fe c t io n  was not so 
r ea d ily  d ism issed , and indeed a few cases have been reported in  
which/
37 .
/w hich th e  concurrence o f a v iru s in fe c t io n  w ith  a tender g o itr e  
has occurred and progressed over severa l years to  c la s s ic a l  
Hashimoto*s th y r o id it is  (1 2 ,1 3 ,1 9 ) .  I t  was g en era lly  agreed, 
however, th at tu b ercu lo s is , s y p h il is ,  and in fe c t io n  w ith  pyogenic 
organisms could be excluded.
Graham ( 14) thought th at Hashimoto* s th y r o id it is  was a " lo ca l  
expression  o f a c o n s titu tio n a l disorder" and C r ile  (15) emphasised 
the evidence fo r  th is  view . Vaux ( 16) considered th a t the changes 
in  the thyroid  were comparable to  the changes seen in  other organs. 
L ev itt ( 17) a lso  b e liev ed  i t  was a c o n s titu tio n a l d isorder s in ce  
corresponding changes were o cca sio n a lly  found in  th e adrenals (18,19)  
adenohypophysis (20) and ovaries (21 )•  In  one o f th e f a t a l  ca ses  
reported by Lindsay e t  a l .  (22 ) ,  there was an extrem ely large  
hyp erp lastic  thymus gland and abundant lymphoid t is s u e  in  a l l  
portions o f the body. S k i l le m  e t  a l .  (2 3 ) ,  how ever,believed i t  
to  be due to  "primary th yroid  fa ilu r e " .
There was considerable sp ecu la tion  as to  the cause o f the 
lymphoid in f i l t r a t io n  in  Hashimoto*s th y r o id it is .  The production o f  
a "lymphogenic" substance by the thyroid  ( 9) ,  and a d e fic ie n c y  o f  
the " e ffe c t iv e  lymphoid-moderating hormones" ( 24 ) ,  were both  
p ostu la ted . Goldberg and Dawson ( 23 ) adduced evidence to  suggest 
th at i t  might be an expression  o f  r e la t iv e  ischaem ia. Davison  
L ett on ( 26 ) regarded i t  a s  an exaggeration o f th a t normally 
occurring in  thyrotoxic g lands. Ferguson (27) b e liev ed  th a t the  
lymphoid in f i l t r a t io n  was the r e s u lt  o f ir r i t a t io n  by hydrolyzed  
l ip id  m ateria ls from c o l lo id . More r e c e n tly , H ellw ig and h is  co­
workers/
/co-w orkers (28  -  32) suggested th a t i t  might be exp lained  on the  
b a s is  o f colloidophagy. By the use o f su p ra -v ita l s ta in s  Chesky 
e t  a l .  ( 32) were able to  show th at macrophages, which had in g ested  
c o llo id  in  the v e s ic le s ,  on re -en ter in g  the stroma, d is in teg ra ted  
and lib er a te d  c o llo id  which acted  as  an ir r i ta n t  focu s fo r  lympho- 
:c y t ic  in f iltr a t io n *  This was a ttr ib u ted  by th ese  authors to  
ex cessiv e  thyroid stim u latin g  hormone (TSH) production -  a view  
a lso  la te r  supported by Purr and C rile  ( 24 ) • This hypothesis was 
supported by the experim ental work o f H ellw ig (28 -  31) , who 
produced lymphocytic in f i l t r a t io n  by TSH stim u la tio n , and by the  
work of Rawson e t  a l .  (33) who showed th a t normally TSH was 
n eu tra lised  only  by thyroid  t is s u e  or lymphocytes. Cheney and 
Mezey ( 18) and Parmley and H ellw ig ( 21) suggested th a t excess  TSH 
production might be mediated through reduction  in  ovarian fu n ctio n  
a t the time of th e menopause. The r o le  o f TSH in  the a e t io lo g y  
of Hashimoto's d isease  i s  s t i l l  un certa in . No d ir e c t  measurements 
have as y e t been made (34)» The su ggestion  th at there i s  normally 
an increase in  TSH production a f te r  the menopause has, however, 
not been confirmed (35)*
Boyden e t  a l .  (37) ,  a f t e r  considering the views o f Warthin (38) 
on the h is to lo g ic a l  e f f e c t  o f adm inistration  o f  iod ine in  exophthalmic 
g o itr e , concluded th a t "the p a th o log ica l changes p ecu lia r  to  the  
d isease  are la r g e ly  the r e su lt  o f an over-response on the part of  
the thyroid to prolonged iod ide adm inistration" -  a view which was 
a lso  held  by Dunhill ( 39) •  P o l l i s  (4 0 ) produced lymphocytic 
in f i l t r a t io n /
39.
/ i n f i l t r a t i o n  in  the th yroid  o f hampsters by ex cess iv e  io d id e  
adm in istration . S tatland  e t  a l , (41 ) ,  however, poin ted  out th a t  
most p a tien ts  w ith Hashimoto's th y r o id it is  have not rece ived  
previous iod ide  therapy; and Lennox (4 2 ) found no r e la t io n  between 
the o x y p h ilia  o f  thyroid epithelium  and previous io d in e  m edication. 
Furthermore, the h is to lo g ic a l  appearance o f  iod ide-induced  g o itr e  
in  man i s  e n t ir e ly  d if fe r e n t  from th a t in  Hashimoto's th y r o id it is .  
Iodide g o itr e s  show parenchymatous hypertrophy w ith  variab le  amounts 
o f c o llo id  storage, but no lymphocytic in f i ltr a t io n *  (43)•
A vitam in d e fic ien cy  was suggested by th e work o f McCarrison 
(4 4  -  46 ) .  He reported lymphocytic in f i l t r a t io n ,  f ib r o s is  and 
atrophy in  the thyroids of r a ts  fed  on a d ie t  d e f ic ie n t  in  vitam ins 
and manganese for  periods ranging from 2-g- to  6 months. T his work 
was corroborated by B asten ie (47) • On the other hand, Rinehart 
(4 8 ) found no le s io n s  l ik e  those o f Hashimoto's th y r o id it is  in  
an imals on d ie t s  d e f ic ie n t  in  many vitam ins. Lederer e t  a l .  (4 9 ) 
reported a p a tien t w ith  Hashimoto' s th y r o id it is  who had long-stand in g  
vitam in B d e fic ien cy . Lupulescou (50 ) observed th a t in  human 
p ella g ra , "one f in d s  a t autopsy a lte r a t io n s  ( in  the th y ro id ), l ik e  
chronic thyroid atrophy" (tra n sla ted  from th e French). However, 
no d e f in ite  c l in ic a l  r e la t io n sh ip  to  vitamin': d e fic ien cy  has been  
found in  the E nglish  l it e r a tu r e  on Hashimoto's th y r o id it is  (22,41 )•
I t  i s  o f in te r e s t  th a t out o f the mass o f inform ation and 
sp ecu lation  regarding the a e tio lo g y  and pathogenesis o f  the d isea se  
on ly /
/on 3y  Ferguson (27) and H ellw ig e t  a l .  (28-32) poin ted  out th e  
p o ss ib le  s ig n ifica n ce  o f leakage o f c o l lo id  a s  an a e t io lo g ic a l  
fa c to r  and were thus a n tic ip a tin g  the immunological a sp ects  o f  
con d ition .
the
Section 4.
Thyroid Auto-immunity (Review).
Recent in te r e s t  in  th yro id  auto-immunity springs la r g e ly  from 
the d iscovery  o f R o itt e t  a l .  ( 1) in  1956 th a t a h igh  proportion o f  
p a tien ts  w ith  Hashimoto's th y r o id it is  have c ir c u la tin g  thyroid  
au to-an tib od ies in  th e ir  blood serum. These observations have 
sin ce  been confirmed by th ese  (2 -  4 ) and other (5 -  16) workers 
and have been the subject o f  sev era l recent review s (17 “ 20 ) .
Before o u tlin in g  th ese  d isco v er ie s  short accounts w i l l  f i r s t  be 
given o f the e a r lie r  work on thyroid  Immunology and on the more 
recent s tu d ies  on experim ental th y r o id it is  in  anim als.
E a r lier  L itera tu re .
During the f i r s t  decade o f th is  century sev era l workers (21 -  25) 
demonstrated th a t th y r o id -sp e c if ic  agg lu tin in ^  could be produced by 
in je c t io n  o f crude thyroid e x tr a c ts , although Schulhof ( 26) and 
Rosen and Marine (2?) were la te r  unable to  repeat th ese  ob servation s. 
In  1942 Lerman (28) made the fa sc in a tin g  observation th a t prolonged  
immunisation w ith iso logou s (human) th yroglob u lin  in  the rabbit 
u ltim a te ly  le d  to  hypothyroidism. In  a s e r ie s  o f b r i l l ia n t  
experiments Professor Hektoen and h is  co-workers (29  -  51) in  Chicago 
demonstrated th a t th y r o id -sp e c if ic  an tib od ies could r e a d ily  be 
produced byimmunisation w ith  thyroglob u lin . These workers ( 31) 
showed th a t the an tib od ies produced had a variab le  degree o f  cross­
rea ction  w ith mammal ian  thyrogLobulins from other sp e c ie s , although  
in  general th e antib od ies were s p e c ie s - s p e c if ic .  These observations  
were la te r  confirmed by severa l other workers (32  -  36 ) .
Experimental Th.vroidi.tis
P rofessor Witebsky and h is  co llab ora tors in  B uffa lo  chose 
thyroglobulin  a s a r e a d ily  a v a ila b le  p ro te in  fo r  th e ir  s tu d ie s  o f  
org a n -sp ec ific  au to -an tib od ies (8 ,3 7 -3 9 ) • They (8 ) f i r s t  demon- 
sstra ted  th a t th y r o id -sp e c if ic  au to -an tib od ies could be produced 
in  ra b b its , dogs, or gu in ea-p igs, by in je c t io n  o f a combination o f  
crude homologous th yroid  e x tra c ts  w ith  Freund adjuvants (4 0 ) 
contain ing mineral o i l ,  A r la ce l and k i l le d  m ycobacteria; la t e r  
th ey  showed th a t homologous an tib od ies to  th yroid  could be produced 
by using refin ed  (90$ pure) th yroid  e x tr a c ts  ( 8 ) .  W itebsky e t  a l .  
(8) proved th at th ese an tib od ies were true au to -an tib od ies by showing 
th at th ey  could be produced by immunisation w ith  the an im al's own 
thyroid . I t  was a lso  found th a t mycobacteria could be om itted from 
the adjuvants and s t i l l  a llow  antibody form ation ( 8 ) .
Some years elapsed before th ese  workers noted th at a f t e r  2 to  
3 months some o f the immunised animals showed h is to lo g ic a l  evidence ' 
of thyroid  damage (8 ,41) • This con sisted  o f in f i l t r a t io n  w ith  
lymphoid c e l l s ,  and eo sin o p h ils  surrounding thyroid  v e s ic le s ,  which 
in  extreme cases contained l i t t l e  or no c o l lo id  ( 8 ) .  The o v e r a ll  
p ictu re  resembled th at seen in  Hashimoto's th y r o id it is ;  an 
observation which f i r s t  appears to  have been made by Dr. R iggs 
working in  P rofessor W itebsky's laboratory (4 2 ) • However, nothing  
comparable to A skanazy-cell change was reported and g o itr e s  were 
not produced. T h y ro id itis  was a lso  observed in  aw-i ma.1 « immunised 
w ith  cro ss-rea ctin g  heterologous thyroid  an tigen s (43)* These 
f in d in g s /
/f in d in g s  have since been confirmed by Milcu e t  a l .  (2*4) in  the  
rab b it, and L ilie n  (45) and Jones and R o itt  (4 6 ) in  the r a t .
Terplan e t  a l .  (47) concluded th a t th e th yroid  a u to -a n tib od ies  
r esu lt in g  from immunisation w ith  crude or re fin ed  thyroid  e x tr a c ts  
reacted  w ith components o f  the thyroid  t is s u e  in  s i t u  and r e su lted  
in  subsequent damage to  the th yro id . However, th ese  workers could  
f in d  no s t r i c t  c o rre la tio n  between the t i t r e  o f humoral antibody  
and the presence and extent o f the th yroid  le s io n . Furthermore, 
Jones and R o itt (4 6 ) noted th a t in  the ra t reg ress io n  o f the le s io n s  
occurred i f  the immunisation procedure was d iscontin ued .
O utline o f the Events lead ing  up to  the H ypothesis th a t Hashimoto* s 
th y r o id it is  i s  a d isease  o f Auto-immunisation.
Various workers (48  -  51) had demonstrated abnormal serum 
f lo c c u la t io n  t e s t s  and ra ised  gamma-globulin le v e l s  in  Hashimoto's 
th y r o id it is .  The known a sso c ia tio n  o f ra ised  gamma-gLobulins w ith  
c irc u la tin g  an tib od ies ( 52) and the in f i l t r a t io n  o f  the d iseased  
thyroid  w ith lymphocytes and plasma c e l l s ,  which are known to  produce 
a n tib od ies, suggested to  Dr. Doniach and her co lleagu es (1 ,2 )  th at  
Hashimoto's th y r o id it is  might be explained on the b a s is  o f auto­
immunisation. In support of t h is  hypothesis th ese  workers were 
able to  obtain  e a s i ly  demonstrable p r e c ip ita te s  by making an ex tract  
o f human thyroid gland and adding i t  to  the serum o f p a t ien ts  w ith  
Hashimoto's th y r o id it is .  They fu rth er  demonstrated th a t the 
precipitin reaction  occurred w ith e ith e r  crude or re fin ed  ex tra cts  o f  
humar/
/human thyroid  gland (2 ) ,  suggesting  immunisation a g a in st th yro- 
: g lob u lin . They a lso  showed th at th e  antibody was a lso  o rg a n -sp ec ific  
and did not rea c t w ith  e x tra c ts  o f thyroid  gland from any o f  6 
mammalian sp ec ie s  in clu d in g  the ra b b it , r a t ,  sheep, p ig , cow, and 
horse. White (53) la b e lle d  the p r e c ip ita tin g  antibody o f  a p a tien t  
with Hashimoto's th y r o id it is  w ith f lu o r e sc in  and was subsequently  
ab le  to  demonstrate s ta in in g  o f the c o llo id  in  the th yro id , thus 
providing convincing evidence o f the auto-immune nature o f the rea c tio n .
The "Leak" H ypothesis
I t  has been mentioned in  the previous sec tio n  o f  t h is  Chapter 
th at c o llo id  may a ct as an " ir r ita n t11, and the demonstration th a t  
the th yroglob u lin  component o f  th e c o llo id  i s  a n tig en ic  could be 
adduced as evidence to  support th e concept o f Doniach and R o itt (2) 
th a t Hashimoto's th y r o id it is  might be the consequence o f  auto­
an tibod ies a c tin g  on the thyroid gland, These workers argued th at  
a rea ction  o f th is  type once in i t ia t e d  might be expected to  become 
se lf-p erp etu a tin g , since damage to  the thyroid  would cause r e le a se  o f  
more antigen  and hence enhance th e le v e l  o f c irc u la tin g  antibody which 
in  turn would r e s u lt  in  fu rther thyroid  damage. The confinement o f  
thyroglobulin  in  the thyroid a c in i during f o e t a l  l i f e  was considered  
by R o itt e t  a l .  (54) to  p o ss ib ly  lead  to  a fa i lu r e  o f  establishm ent 
o f  immunological to leran ce so th at escape of thyroglobulin  in  adu lt 
l i f e  would s e t  in  motion a s e lf -d e s tr u c t iv e  auto-immune r ea c tio n .
Certain fa c t s  were aga in st the view th at stru c tu ra l and hence 
immunological a lte r a tio n  of the thyroglobulin  present in  th e  d iseased  
gland/
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/g la n d  was respon sib le  fo r  the in i t ia t io n  o f the auto-immune p rocess. 
F ir s t ly ,  Doniach and R o itt (2) demonstrated th a t the antibody reacted  
ju st a s  stron g ly  w ith th yroglobu lin  obtained from normal glands as  
i t  did  from g o itr e s  w ith  Hashimoto's th y r o id it is ;  secondly, Rose 
and Witebsky (41) demonstrated in  th e ir  ra b b its  th a t a n tib od ies  
produced by autologous immunisation reacted  w ith  e x tr a c ts  made from 
the anim al's own th yroid .
Problems a sso c ia ted  w ith  the Acceptance o f  the 
"Leak" H ypothesis.
Im p lic it  in  the acceptance o f the "leak" hyp othesis to  exp la in  
the pathogenesis o f Hashimoto's th y r o id it is  i s  th a t there i s  an 
i n i t i a l  r e le a se  o f thyroid antigen or a n tig en s. Stuart and A llan  
(55) working in  Edinburgh stud ied  the basement membrane changes by  
a s ilv e r -s ta in in g  method. These workers concluded th at fa i lu r e  o f  
the in te g r ity  o f the basement membrane was p a r tic u la r ly  widespread  
and severb in  Hashimoto's th y r o id it is  and th at a d ir e c t r e la tio n sh ip  
e x isted  between the ir r e g u la r it ie s  observed and the le v e l  o f  
thyroglobulin  auto-antibod ies and the degree o f rou n d -cell i n f i l t r a t -  
sion . Although th ese observations may serve as  an anatom ical b a s is  
fo r  thyroid  auto-antibody form ation, i t  i s  eq u a lly  p o ss ib le  th at the  
changes described are the consequence rather than the cause o f the  
d isea se .
Leakage o f an tigen  could conceivably be brought about by simple 
mechanical rupture o f  f o l l i c l e s ,  due to  in crease  in  s iz e  o f  the  
g o itr e , although, a s  w i l l  be d iscu ssed  la te r ,  thyroid  au to-an tib od ies  
a r e /
/a r e  a lso  found in  a s so c ia tio n  w ith  the shrunken glands in  primary 
hypothyroidism (4 ,1 1 ,9 ,1 2 ,1 4 ) . E xcessive TSH stim u la tio n  by i t s  
h yp erp lastic  e f f e c t  might help  to  m aintain r e le a se  o f an tigen , bu t, 
as has been p rev iou sly  d iscu ssed , i t  i s  d i f f i c u l t  to  conceive how 
t h is  by i t s e l f  could in i t i a t e  the p rocess. Because o f the adjuvant 
e f f e c t  a ttr ib u ted  to  v iru ses  in  the causation  o f a u to -a lle r g ic  
d isea ses  (57) Doniach e t  a l .  (58) considered the p o s s ib i l i t y  o f a 
v ir a l  in fe c t io n  in i t ia t in g  the auto-immune p rocess. So fa r ,  no 
sa t is fa c to r y  evidence has been produced in  favour o f t h is  view .
The subsequent experience o f R o itt  and Doniach (4 ) suggested  
th a t the thyroid  an tib od ies may not in  them selves be the d ir e c t  
cy to to x ic  agent, but may merely r e f le c t  the underlying p a th o lo g ica l 
p rocess. P assive  transm ission  o f the d isea se  by in fu s io n  o f  
Hashimoto-sera containing high antibody t i t r e s  has not so fa r  been  
su ccessfu l (4)> and Irvine (59) and P u lv er ta ft e t  a l .  ( 60 ) have been  
unable to  demonstrate any e f f e c t  o f  th yro id  au to-an tib od ies on e ith e r  
the growth dm morphology o f try p sin ised  thyroid  c e l l s  in  t is s u e  
cu ltu re . A cy to to x ic  fa c to r  has, however, been demonstrated by 
th ese  workers in  a high proportion o f sera from p a tien ts  w ith  
Hashimoto's d isease  (59 ,61-63) but i t s  s ig n ifica n ce  re lev a n t to  the  
pathogenesis o f the d isea se  has not been so fa r  f u l ly  a sse ssed .
That the auto-immune p rocess, once in i t ia t e d ,  i s  not n e c e ssa r ily  
se lf-p erp etu a tin g  i s  c lea r  from stu d ies  in  subacute th y r o id it is  
(4 , 6 , 12 , 14 , 64 ) .  In t h is  d isea se  the appearance o f  au to-an tib od ies  
i s  temporary and presumably a sso c ia ted  w ith  the v ir a l  in fe c t io n  and 
subsequent/
/subsequent thyroid  damage does not occur, although from th e  
h is to r y  Hashimoto’ s th y r o id it is  may have supervened on subacute 
th y r o id it is  in  the p a tien t reported by D icourt e t  a l .  ( 65 ) .  I t  
i s  th erefore c lea r  th a t a t  the moment the "leak” hypothesis i s  
in s u f f ic ie n t  to  exp la in  the pathogenesis o f Hashimoto’ s th y r o id it is ,  
although auto-imm unisation can c le a r ly  be demonstrated.
M u lt ip lic ity  o f Antigen Antibody R eactions.
Further work in  the immunology o f auto-immune th y r o id it is  has 
le d  to  the knowledge th at th e an tigen s involved  are m u ltip le  
(4>5,7>11 j1 2 ) . E arly experience w ith the com plem ent-fixation (CF) 
technique le d  T rotter e t  a l .  (7) to  suggest th at a d if fe r e n t  rea c tio n  
might be involved  in  t h is  rea c tio n  as compared w ith  the p r e c ip it in  
t e s t .  T his suggestion  was confirmed by Goudie e t  a l .  (5 ) who 
demonstrated CF an tib od ies in  a l l  o f  16 untreated  p a t ien ts  and in  
15 o f 16 trea ted  p a tien ts  w ith  auto-immune th y r o id it is ,  whereas the 
p r e c ip it in  t e s t  was p o s it iv e  in  only 20 o f  the 32 p a t ie n ts . The 
antigen  used by Goudie e t  a l .  ( 5 ) in  the CF rea c tio n  was an ex tra ct  
o f thyrotoxic gland a s  T rotter e t  a l .  (7) had been unable to  d e tec t  
CF antibod ies using ex tra cts  made from a normal gland. The 
im p lica tion s o f th ese e a r lie r  s tu d ies  was th a t th e  an tigen s involved  
in  the p r e c ip it in  and CF rea ctio n s were qu ite d is t in c t  and a lso  
th a t the CF antigen  might be s p e c if ic  fo r  th y r o to x ic o s is . However, 
both White (53) and Anderson e t  a l , ( 9 )  were subsequently ab le  to  
d etect th e antigen  resp on sib le  fo r  the CF t e s t  in  normal glands and 
sim ple/
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Table I#
Methods fo r  D etec tio n  o f Thyroid A uto -an tibod ies
Antigen Methods o f D etec tion  o f Auto-Ant ib o d ie s
Thyr ©globulin
in
C olloid
P re c ip i ta t io n  .
Tanned R ed -ce ll haem agglu tina tion  • 
R ad ioactive  C o -p re c ip ita tio n  , 
Coon’s flu o re scen t Antibody 
Technique on Fixed Sections# 
Passive Cutaneous Anaphylaxis in  
Guinea Pigs*.
Skin T ests  *
"Ifi.crosomal” 
Antigen in  
Acinar C ells
Com plem ent-Fixation.
Coon’s F luorescen t Antibody technique 
in  Unfixed Sections#
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/s im p le  g o itr e s , and in  the glands o f go itrou s c r e t in s .
Nature o f the Thyroid A ntigen s.
Subsequent s tu d ie s  have confirmed th a t th ere are a t  le a s t  2 
separate antigen-antibody systems involved  in  th yro id  auto-immunity 
( 4 ,2 0 , ) .  In  the f i r s t  o f th ese  the an tigen  i s  presumed to  be 
thyroglobulin  which i s  stored  in  the c o l lo id , and the second has 
been shown by u ltr a -c e n tr ifu g a tio n  o f  th yro id  t is s u e  e x tr a c ts  to  be 
lo ca ted  in  the "microsomes" o f  the acinar c e l l s  (4 ,1 1 ) .  R arely  
p r e c ip ita tin g  sera may d ev ia te  complement when rea c tin g  w ith  
thyroglobulin  (1 1 ,67 )•
Methods a v a ila b le  fo r  the D etection  o f Thyroid A u to-an tib od ies.
Several methods are now a v a ila b le  fo r  th e d e tec tio n  o f th ese  
au to-an tib od ies and th ese  have been summarised according to  R o itt  
and Doniach (20) in  Table 1 • In p ra ctice  the p r e c ip it in  and tanned 
r e d -c e l l  haem agglutination (TRC) t e s t s  are most commonly used fo r  
d etectio n  o f thyroglobulin  au to-an tibod ies and CF t e s t  fo r  microsomal 
auto-an tib od ies; the p r in c ip le s  o f th ese  techniques w i l l  now 
b r ie f ly  be described.
1 . P r e c ip it in  T est fo r  Thyroglobulin A u to-antib od ies.
I t  has been known fo r  a long number o f years th a t cer ta in  
an tib od ies react w ith  th e ir  s p e c if ic  antigen  to  form la rg e  p r e e ip it -  
:a tin g  prote in  aggregates. Thus, p r e c ip ita tin g  an tib o d ies  may be 
demonstrated by e ith e r  mixing the serum d ir e c t ly  w ith  the antigen  or 
by employing the a g a r -d iffu s io n  methods o f  Oudin (68) or Ouchterlony 
(69) .  P r e c ip ita tin g  au to-an tib od ies are most conveniently  te s te d  
f o r /
FIGURE I.
I l lu s tr a t io n  df a P o s itiv e  JPreoipitin t e s t  fry 
the A gar-d iffu sion  Method o f Ouofaterlony.
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Ouchterlony P la te , Antigen has been placed in  the cen tra l w e ll  
and a p o s it iv e  p r e c ip ita tin g  serum in  the w e ll on the l e f t ,  and 
a control serum on the r ig h t. Both the antigen and the two 
sera have d iffu sed  in to  the agar, and on the l e f t  a w hite l in e  
of p r e c ip ita te  has formed at the l in e  of in ter fa c e , in d ic a tin g  
a p o s it iv e  t e s t .  The agar has remained c lea r  on the r ig h t.
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/ f o r  by the Ouchterlony technique and an example o f  a p o s it iv e  t e s t  
i s  i l lu s tr a te d  in  F ig , 1 • The amount o f antibody detected  by the  
p r e c ip it in  t e s t  i s  o f the order o f 5 “g. per ml* o f serum, but 
q u a n tities  exceeding 15 mg. per ml. o f serum have been recorded (20) • 
The p r ec ip ita tin g  a n tib od ies to  th yroglob u lin  are o f e ith e r  the 7S 
or 18S type (70 ,71) or a mixture o f both (7 2 ) , and q u a n tita tiv e  
p r e c ip it in  curves have been o f the "rabbit** (53) or " horse-floccu la tion "  
type (73)* O ccasionally  a c le a r  l in e  develops in  the agar in  p lace  
o f an opaque l in e ;  Goudie e t  a l .  (74) in terp reted  t h is  as in d ic a tin g  
non-aggregating antigen-antibody complexes. In  general p r e c ip ita t in g  
auto-antibod ies to  thyroglobulin  are true au to -an tib od ies in  th e  
sense th at th ey  rea c t w ith  autologous th yroglob u lin , but excep tion s  
have been recorded (75) •
2 . Tanned Red-Cell Haemagglutination T est (TRC) fo r  
Thyroglobulin A uto-antib od ies.
The p r in c ip le  o f th is  t e s t  i s  r e la t iv e ly  sim ple. R ed -ce lls  
are f i r s t  trea ted  w ith tannic a c id  so th at they become adhesive and are 
then coated w ith thyroglobulin; when serum contain ing th yroglob u lin  
auto-antibod ies i s  added agg lu tin a tio n  of the r e d -c e l ls  occurs. The 
t e s t  i s  more s e n s it iv e  than the p r e c ip it in  t e s t  and o cca sio n a lly  
d e tec ts  t i t r e s  o f antib od ies exceeding severa l m illio n  d ilu tio n  in  
auto-immune th y r o id it is  (7 6 ) . In  general th ere i s  good agreement 
between the p r e c ip it in  and TRC t e s t ,  although some overlap does occur 
(7 6 ) .
The standard technique o f Boyden (77) has r e c e n tly  been m odified
h y /
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FIG. 2
PREVALENCE OF VARIOUS THYROID AUTO-ANTIBODY TESTS IN 
THYROID DISEASE AS COMPILED FROM LITERATURE
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I t  i s  to  be noted that the le v e l s  of auto-antibody t i t r e s  
in d ica tin g  a p o s it iv e  C.F. or T.R.C. t e s t  v a r ie s  w ith  
d ifferen t authors. The prevalence of th ese  two auto­
antibody t e s t s  in  the various d isea se s  i s  th erefore  only  
approximate.
/b y  the in trod uction  o f a s ta b le  preparation o f  form alised  sheep 
c e l l s  (7 8 ) .
3* Complement-Fixation (CF) T est fo r  D etection  o f  
"Microsomal" A u to-an tib od ies.
The d e tec tio n  o f "microsomal" au to-an tib od ies i s  based on th e  
standard com plem ent-fixation t e s t ,  such as  used in  the Wasserman 
rea ctio n . The antigen-antibody complexes combine w ith complement 
and th is  f ix a t io n  can be d etected  by the a d d itio n  o f  an in d ica to r  
system o f se n s it iz e d  sheep r e d -c e l ls  which are ly sed  in  th e presence  
o f complement. The absence of l y s i s  in d ic a te s  th e presence o f  
complement. Like the TEC t e s t  the CF rea c tio n  i s  q u a n tita tiv e  and 
t i t r e s  exceeding 1/20 d ilu t io n  are common in  auto-immune 
th y r o id it is  (4 )•
The other methods a v a ila b le  fo r  d e tec tio n  o f thyroid  auto­
an tibod ies include Coon*s flu o rescen t technique (53*74)* ra d io a c tiv e  
co -p rec ip ita tio n  (73)*and p assive  cutaneous anaphylaxis ( 8 0 ,8 l ) ,  but 
th ese are of research rather than p r a c tic a l in t e r e s t ,  and w i l l  not be 
considered fu rth er .
Prevalence o f Thyroid A uto-antibodies in  Various Thyroid D isea ses.
The r e s u lt s  o f se r o lo g ic a l stu d ies  obtained by a number o f  
workers (4*6,9*11*12,14*16,82-90) in  the p r in c ip a l th yroid  d iseased  
have been summarised in  F ig . 2 . I t  can be seen th at the 3 1ypes 
of thyroid  auto-antibody t e s t s  are more freq u en tly  p o s it iv e  in  
Hashimoto’ s th y r o id it is  than in  any other form o f thyroid  d ise a se . 
Furthermore i t  can be seen th a t the p r e c ip it in  t e s t  i s  l e s s  
freq u en tly /
/fr e q u e n tly  p o s it iv e  than e ith e r  the TRC or CF t e s t  and th a t i t  i s  
seldom p o s it iv e  in  s in p le  non -tox ic  g o itr e  or th yroid  neoplasm, 
con d ition s which are most l ik e ly  to  be confused w ith  Hashimoto’ s 
th y r o id it is .  Indeed, in  go itrou s th yroid  d ise a se , excluding  
th y ro to x ico s is , the fin d in g  o f a p o s it iv e  p r e c ip it in  t e s t  i s ,  in  
the words o f one American review er (91) > "enough to  serve as a 
confirm atory t e s t  in  the d iagn osis o f lymphadenoid g o iter" .
In th is  h o sp ita l, th yroid  b iopsy  in  25 consecutive p a t ie n ts  
w ith g o itre  and a p o s it iv e  p r e c ip it in  t e s t  showed the ty p ic a l  
appearances o f Hashimoto's th y r o id it is  in  a l l  but one p a tien t who 
had Sjftgren's syndrome. The thyroid in  t h i s  p a tien t revea led  
d iffu se  A skanazy-cell change, but v ir tu a l ly  no ro u n d -cell i n f i l t r a t ­
i o n .  The d iagn ostic  value o f the p r e c ip it in  t e s t  has lik ew ise  
been confirmed by Doniach (92) •
Concept o f Auto-immune th y r o id it is .
Because the d iagn osis of Hashimoto's th y r o id it is  i s  now made 
in  the v a st m ajority o f  cases on the b a s is  o f s e r o lo g ic a l t e s t s ,  
the terms "auto-immunising" ( 16) th y r o id it is  and "auto-immune" (4 ) 
th y r o id it is  have been introduced to  describe the co n d ition . The 
term "auto-immunising" th y r o id it is  does not appear e n t ir e ly  s a t i s ­
f a c t o r y  as i t  i s  somewhat ambiguous and might be taken to  imply 
th at auto-immunisation i s  the so le  fa c to r  resp on sib le  in  the 
pathogenesis o f th e d isea se . On th e  other hand, i t  appears both  
ju s t i f ia b le  and convenient to  adopt the term "auto-immune" th y r o id it is  
and th is  has been done in  the present t h e s is .
C H A P T E R  I I
Aii-hft—•$ aumiwfl T favroid itis: 
C lin ica l and Experimental S tu d ies .
Seotion 1.
D iscu ssion  o f the C lin ic a l Features o f Auto-immune 
T h y ro id itis  based on a Study o f 50 P a t ie n ts .
U n til the fin d in g  of ra ised  gamma-globulins (1 -6 ) and th yro id  
auto-antibod ies (7 -9 ) auto-immune th y r o id it is  was thought to  be a 
r e la t iv e ly  rare d isease  and was o f in te r e s t  mainly to  surgeons and 
p a th o lo g is ts . For, although the d isea se  might sometimes have been  
suspected on c l in ic a l  grounds, the d iagn osis could on ly  be confirmed 
by h is to lo g ic a l  examination and su rg ica l in terv en tio n  was not always 
j u s t i f ie d .  Consequently, previous c l in ic a l  s tu d ies  (10-14) have 
been based on a r b itr a r ily  se le c te d  s e r ie s  drawn from su r g ica l or 
p ath o log ica l m ateria l, in  which the d iagn osis was o ften  r e tr o sp e c t iv e .
The in trod u ction  o f t e s t s  fo r  th yroid  au to -a n tib o d ies , in  
p a rticu la r  the p r e c ip it in  t e s t ,  has enabled the d iagn osis  to  be made 
in  many p a tien ts  a t an ea r ly  stage o f the d ise a se , thus making p o ss ib le  
a more adequate study o f the c l in ic a l  fea tu res  and progress o f the  
d isea se  without unnecessary su rg ica l in terv en tio n . However, only  
2 stu d ies  dealing w ith  the c l in ic a l  a sp ects o f auto-immune th y r o id it is  
have been reported since the in trod uction  o f the thyroid  auto-antibody  
t e s t s :  f i r s t l y ,  Hubble (15) who, in  h is  Honeyman-Gillespie Lecture
in  1958, d iscussed  th e c l in ic a l  fea tu res  in  18 p a tien ts ;  and 
secondly, Doniach e t  a l .  (6) who, in  1960, summarised th e ir  c l in ic a l  
experience based on a study o f 106 p a t ie n ts .
The purpose o f  the present se c tio n  o f the th e s is  i s  to  provide 
a d e ta iled  account o f the c l in ic a l  fea tu res  o f auto-immune th y r o id it is  
as revealed  by modern d iagn ostic  methods. The r e s u lt s  o f t h is  study  
have/
/have been presented fo r  convenience in  the form o f  a d iscussion *
The fin d in g s in  the in d iv id u a l p a t ie n ts  o f the study are summaris e d  
in  the Appendices.
P a tien ts  Studied  
The study comprises 50 p a tien ts  w ith auto-immune th y r o id it is .  
A ll the p a tien ts  were seen and p erso n a lly  examined by me a t  the 
Endocrine C lin ic  in  the U n iversity  Department o f M edicine, Western 
Infirm ary, where they  had been referred  to ,  e ith e r  by th e ir  own 
doctor (41 p a t ie n ts ) , or by a ph ysician  or surgeon in  the h o sp ita l  
(9  p a t ie n ts ) .
D iagnostic  C r iter ia  
The d iagn osis of auto-immune th y r o id it is  was based on the  
presence o f a g o itr e , e ith e r  d iffu se  or nodular, in  a euthyroid  
or hypothyroid p a tien t; and confirmed in  every  p a tien t by a p o s it iv e  
p r e c ip it in  t e s t  (38  p a t ie n ts ) , by h is to lo g ic a l  examination of the  
thyroid  (16  p a t ie n ts ) ,o r  both (4  p a t ie n ts ) . The h is to lo g ic a l  
c r ite r ia  were those of J o l l  (17) • Further supportive evidence o f  
auto-immune th y r o id it is  was provided by: a p o s it iv e  CF t e s t  (45
p a t ie n ts ) , high gamm a-globulin le v e l s  (23  p a t ie n ts ) ,  abnormal serum 
f lo c c u la tio n  t e s t s  (31 p a t ie n ts ) , abnormal routine rad io iod ine t e s t s  
(37 p a t ie n ts ) , and by follow -up s tu d ie s . S p ecia l care was taken to  
exclude subacute th y r o id it is ,  which may o cca sio n a lly  be a sso c ia ted  
with temporary p o s it iv e  thyroid  auto-antibody t e s t s  ( 16) ,  both  
c l in ic a l ly  and by radioiod ine t e s t s .  P a tien ts  with th y ro to x ico s is  
or with hypothyroidism without a g o itre  ( i . e .  primary hypothyroidism) 
were excluded from the study.
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Methods
The c l in ic a l  h is to ry  in  each p a tien t included the r e s u lt s  o f  
an enquiry regarding age, presenting  symptoms, and the on set and 
duration o f  the g o itr e . In  ad d ition , a h is to r y  o f mumps or contact 
w ith mumps, or f e b r i le  i l l n e s s  a t  the onset o f th e g o itr e  was sought. 
Enquiry was a lso  made concerning a fam ily  h is to r y  o f th yro id  d isea se  
and of the typ e, i f  known. Local symptoms, such as pain  or 
dysphagia a sso c ia ted  w ith th e g o itr e  was noted and enquiry was a lso  
made regarding system ic symptoms.
The c l in ic a l  fea tu res  o f  th e g o itre  were recorded; s iz e  
( s l ig h t ly  enlarged -  approxim ately 50 g . ,  m oderately enlarged -  
approximately 75 g*> and considerably  enlarged -  100 g . or more), 
type (d iffu se  or nodular), con sisten cy  (" s o ft”, "firm”, or "hard”)? 
f ix a t io n , tenderness, b ru it , and a sso c ia ted  lymphadenopathy.
The c l in ic a l  s ta tu s  o f the p a tien t was a ssessed  by th e  methods 
described by Wayne ( 18) .  By th ese  methods a score i s  a l lo t t e d  to  
the relevant symptoms and s ig n s and the sum o f  the scores i s  
described as the "diagnostic index". Thus, in  the assessm ent o f  
hypothyroidism, scores l e s s  than 5 in d ica te  the euthyroid range, 
scores between 5 and 15 the equivocal range, and scores exceeding  
15 the d e f in ite ly  hypothyroid range.
Evidence o f system ic d isea se  was a lso  sought in  every p a tien t  
idio had a carefu l p h ysica l examination. In  the fem ale p a tien ts  the  
age of the menarche, menstrual ir r e g u la r it ie s ,  number o f pregnancies 
in clu d ing  m iscarriages, and the age o f the menopause was noted , and 
compared w ith those found in  a con tro l s e r ie s  o f 70 h o sp ita l p a tien ts  
matched/
* I  am g ra te fu l to  Dr. R.R. Macdonald o f the U n iversity  
Department o f  O b stetr ics fo r  carrying out the cer v ic a l 
mucus t e s t s .
** I  am g ra te fu l to  Dr. J.R . Anderson, Dr. R.B. Goudie, and
Miss K athleen G. Gray, B .S c . fo r  the r e s u lt s  o f  th e th yroid  
auto-antibody t e s t s .
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/matched fo r  age. Evidence of h y p e r oestrogenian was sought in  
12 post-menopausal female p a tien ts  w ith auto-immune th y r o id it is  by 
the ’’ferning*1 t e s t  of the c e r v ic a l mucus (19)» *
The p r e c ip it in  t e s t **was performed by the Ouchterlony technique  
o f double d iffu s io n  in  agar, as described by Anderson e t  a l .  (20 ) .  
A fter  f i l i n g  the serum and antigen  w e lls , the p la te s  were kept a t  
room temperature and examined 14 days la t e r .  The thyroid  an tigen  
was prepared from sa lin e  ex tra cts  o f thyroid  t is s u e  obtained a t  
operation from p a tien ts  w ith th y ro to x ico s is  and simple c o l lo id  g o itr e  
or from normal thyroid s obtained sh o rtly  a f te r  death. The r e s u lt s  
o f the p r e c ip it in  t e s t  were recorded as  e ith e r  n egative  ( - )  or 
p o s it iv e  (+ ) .
The CP t e s t  was performed as a 3 -tube t e s t  a s  described by 
Anderson e t  a l .  (20 ) .  Anticomplementary (AC) a c t iv i t y  was te s te d  fo r  
in  the f i r s t  tube, and in  the second and th ird  tube r e s p e c t iv e ly  the  
sera was te s ted  undiluted and in  a 1 in  4  d ilu t io n . The complement 
in  these t e s t s  con sisted  o f guinea-pig serum and the an tigen  was 
prepared from th yrotox ic  gland e x tr a c ts .
The tubes were incubated a t  37 degrees C* fo r  one hour and then  
0*5 ml. o f a suspension o f sheep red c e l l s  s e n s it is e d  w ith  fou r  
min i mal haem olytic doses o f  immune horse-serum, was added to  each  
tube to  determine th e presence o f res id u a l complement. The r e s u lt s  
of the t e s t  were then recorded as fo llo w s: in h ib it io n  o f  l y s i s  in
Tube 1 in d icated  AC a c t iv ity ;  in h ib it io n  o f l y s i s  in  Tube 2 a  
p o s it iv e  (+) t e s t ;  and in h ib it io n  o f ly s is  in  Tube 3 as a stron g ly  
p o s it iv e  (++) rea c tio n . The s p e c if ic i t y  o f  the CP rea ctio n  fo r  
th y ro id /
TABLE I.
Prevalence of Auto-immune T h y ro id itis  r e la t iv e  
to  Number o f Thyroid Operations.
Table I.
Prevalence of Auto-immune Thyroditis Relative 
to Number of Tbyroid Operations,
Author Year R ef. No. T o ta l No. of 
Thyroid o p e ra tio n s
No. w ith  
Auto-immune 
T h y ro d it is
P re v a le n c e
(JO
G reat B r i ta in
Renton e t a l . 1938 27 418 7 1 .7
J o l l 1939 17 5,650 51 0 .9
Keynes e t  a l . 1939 28 1,600 25 1 .5
L e v itt 1951 29 2,114 30 1 .4
H e p tin s ta l l  and E a s tc o t t 195** 30 600 16 2 .7
U nited S ta te s
McSwain and lloore 1943 31 1,999 15 0 .7 5
F ic a r ra 1946 32 1,938 9 0 .4
M arshall e t  a l . 1948 25 25,000 78 0 .3
L asser and G reyzel 1949 1,595 9 0 .5
Chesky e t  a l . 1951 26 2,051 14 0 .1
S tn tla n d  e t  a l . 1951 11 3,676 51 1 .4
Lindsay e t  a l . 1952 12 6,571 170 2 .6
Werner 1955 34 4,750 47 1 .0
Walt e t  a l . 1957 35 13,600 160 1 .2
Woolner e t  a l . 1959 14 42,000 145 0 .4
/th y ro id  t is s u e  ex tra ct was confirmed by t e s t in g  a g a in st other t is s u e  
e x tra c ts  ( i . e .  l iv e r ,  kidney and adrenal) and was carr ied  out in  a l l  
p a tien ts  who had d ise a se s  l ik e ly  to  g ive r i s e  to  CP iso a n tib o d ie s  (2 1 ) .
The p r e c ip it in  and CP t e s t s  were performed on each p a t ien t a t  
the time o f h is  or her f i r s t  appearance a t  the c l in ic  and were sub­
se q u e n t ly  repeated a t varying in te r v a ls  during th e  period  o f fo llo w -  
up. A ll  sera were examined w ith in  one week o f c o l le c t io n .
Basal m etabolic ra te  (BMR) determ inations were performed by the  
method described by Crooks e t  a l .  (22) using  the standards o f  
Robertson and Reid (23)*
The serum c h o le s ter o l was estim ated by the method o f  Sackett (24) 
and electrocardiogram s (EC&s) included 13 lea d s (standard, un ipolar, 
and p reco rd ia l).
Prevalence
Assessment of the prevalence o f  auto-immune th y r o id it is  i s  b e se t  
w ith the d i f f ic u l t y  o f changing opinions among p a th o lo g is ts  
regarding the c la s s i f i c a t io n  o f th y r o id it is  and o f the p rese lec ted  
nature o f h o sp ita l m ateria l. The prevalence among thyroid  operations  
has in  general been low, varying between 0 .3  ( 23) and M  (30) per 
cen t. (Table 1 ) . Experience in  the present study su ggests th a t the  
d isease  i s  not as rare as most o f th ese  f ig u re s  from su rg ica l s e r ie s  
would imply, and the d isea se  accounted, fo r  approxim ately 4*5 per 
cent, o f a l l  thyroid  d isord ers. However, th is  fig u re  might w e ll be 
m isleading as i t  undoubtedly r e f le c t s  a personal in te r e s t  in  the  
d isease  and the range o f in v e s tig a tio n s  th a t were undertaken.
C learly there i s  a need fo r  a f i e ld  survey o f  random samples o f  the  
population.
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FIGURE 1
H osp ita l Admissions fo r  Auto-immune T h y ro id itis
Western Infirm ary. Glasgow. 1950 -  1960.
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F ig . I,
HO SPITAL ADMISSIONS FO R AUTO-IM MUNE THYROIDITIS 
W es te rn  I n f i rm a ry ,  Glasgow 1 9 5 0 - 1 9 6 0
No; of
thyroid ops. 109
ROUTINE IMMUNOLOGICAL 
TESTS INTRODUCED
1950y e a r I9 6 0
DIAGNOSIS CONFIRMED HISTOLOGICALLY 
f | DIAGNOSIS MADE ON BASIS OF IMMUNOLOGICAL STUDIES
Hetz e t  a l .  ( 36) have suggested th a t th ere  has been a true  
in crease  in  the prevalence o f auto-immune th y r o id it is  in  recen t y ea rs . 
However, Lindsay e t  a l .  (12) found no s ig n if ic a n t  a lte r a t io n  in  the 
incidence during each o f 3 decades from 1920 to  1950 in  a s e r ie s  o f  
6,371 thyroidectom ies. In  the author* s opin ion the apparent r i s e  
in  the prevalence o f auto-immune th y r o id it is  can be adequately  
explained on the b a s is  o f improved d ia g n o sis . Thus, in  F ig . 1 i t  
can be seen th at th e increased  number o f h o sp ita l adm issions to  the  
Western Infirm ary coincided  w ith th e a v a i la b i l i t y  o f  the rou tin e  
ser o lo g ic a l t e s t s .
G-eographical Prevalence
Most reports on auto-immune th y r o id it is  have come from the
United Kingdom and North America, but the d isea se  has been reported
from most countries w ith adequate medical s e r v ic e s . However, J o l l  ( 17)
considered th at the d isease  was rare in  mountainous reg io n s, where
go itre  was common and th y ro to x ico s is  rare. This had p rev iou sly  been
noted by de Quervain in  Berne (37) and by Hass ( 38) in  Munich.
Lehman (39) reported th at 21 o f h is  23 p a tien ts  l iv e d  in  non-endemic
areas; and of J o ll* s  51 p a tien ts  (17) ,  only 5 came from d is t r ic t s
where g o itre  was regarded as endemic. Both Emerson (4 0 ) and Lindsay
e t  a l .  ( 12) found a h is to iy  o f  residence in  an endemic area w ith
e s s e n t ia l ly  the same frequency as in  the general o u t-p a tien t popul-
p a tien ts  o f
:a tio n . Only tw o/ the present s e r ie s  gave a past h is to r y  o f  residence  
in  an endemic reg ion .
No conclusions can be drawn regarding the prevalence o f auto­
immune/
FIGURE 2
Autoimmune T h y ro id itis  : Age and Sex D is tr ib u tio n
Nu
mb
er
 o
f 
Pa
tie
nt
s
72.
F ig . 2 .
AUTO -IM M UNE THYROIDITIS 
AGE AND SEX DISTRIBUTION
Male
Female
Age Years
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/auto-immune th y r o id it is  in  r e la t io n  to  the endem icity o f  g o itr e ,  
hut i t  would be o f  considerable th e o r e t ic a l in te r e s t  to  know whether 
such a rec ip roca l re la t io n sh ip  as suggested by J o l l  (17) a c tu a lly  
e x is t s  or not.
R acia l Prevalence 
Auto-immune th y r o id it is  has been g en era lly  regarded as uncommon 
in  the negro races in  the United S ta tes  (4 1 ) and S te in  (4 2 ) formed 
the im pression th at i t  occurred l e s s  freq u en tly  in  Jewish p atien ts*
No d e f in ite  conclusions can be drawn from the present study regarding  
the r a c ia l  prevalence o f the d isea se , s in ce  a l l  the p a t ie n ts  were 
e ith e r  o f Scots or I r is h  descent w ith  the excep tion  o f one who was 
Jewish.
S o c ia l Prevalence 
There was nothing in  the present study to  confirm McCarrison’s  
suggestion  (4 3 ) th at a poor d ie tary  intake a sso c ia ted  w ith  a low  
s o c ia l s ta tu s may be an a e t io lo g ic a l  fa c to r . This i s  in  agreement 
w ith J o l l  ( 17) who found the d isease  eq u a lly  d is tr ib u ted  among a l l  
c la s s e s .
Age and Sex D istr ib u tio n  
The age d is tr ib u tio n  in  the present s e r ie s  (F ig . 2) conforms to  
th at reported in  the litera tu re*  The age range was from 28 to  70 
years, w ith a mean age o f 32*5 y ears. The mean age o f published  
s e r ie s  l i e s  between 30 (44) and 53 years (42 ) ,  and the age range from 
7 i  (33) to  78 years (45)* J o l l  ( 17) considered the d isea se  a r a r ity  
in  childhood, but severa l in stan ces o f i t s  occurrence in  ch ild ren  and 
young/
FIGURE 3 
Sex D istr ib u tio n  in  Thyroid D isease
FIGURE 4
Age of Onset o f G oitre in  46 Female 
P a tien ts  w ith  Auto-immune T h y ro id itis
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/young ad u lts have been reported (3* ”11 ,14* 4 2 ,46—31) • such case
has been seen in  the present study.
The s tr ik in g  preponderance o f autordmmune th y r o id it is  in  fem ales  
i s  confirmed; 46  o f th e  50 p a tien ts  were fem ales ( 92 $ ) . Apart 
from simple non-toxic g o itre  no other type o f  thyroid  d isea se  demon- 
: stra ted  as marked a p red isp o sitio n  fo r  a f fe c t in g  the female a s  auto­
immune th y r o id it is  (P ig . 3)»
A re la tio n sh ip  between the d isease  and th e  ovarian hormones has 
been suggested on the b a s is  of the high prevalence o f  fem ales w ith  the 
d ise a se . Parmley and H ellw ig (52) were impressed w ith  the h igh  
incidence o f menstrual ir r e g u la r it ie s  among th e ir  p a t ie n ts  and Lindsay 
e t  a l .  (12) and Hendrick (53) observed th a t the onset o f the i l l n e s s  
orig in ated  most freq u en tly  during the ch ild -b earin g  y ea rs . The only  
p r ec ip ita tin g  fa c to r  e l i c i t e d  by S k il le m  e t  a l .  ( 3) was the s t r e s s  o f  
pregnancy although nothing to  support t h is  was found by Purr and C r ile  
(13) in  th e ir  p a tien ts .
The wide d is tr ib u tio n  o f the age a t  the onset o f the g o itr e  in  
the present se r ie s  (F ig . 4 ) would appear to  preclude any d ir e c t  
re la tio n sh ip  w ith the ovarian hormones; and only one p a tien t had 
n oticed  the onset of her g o itre  during a pregnancy. However, the  
p o s s ib i l i t y  remains th at the ex cessiv e  demands on the thyroid  during 
the sexual l i f e  o f the female may predispose the th yroid  to  
d estruction  by chronic th y r o id it is .  For t h is  reason, th e age o f  the  
menarche, menstrual ir r e g u la r it ie s ,  number o f pregnancies in c lu d in g  
m iscarriages, and the age o f the menopause, in  the p a tien ts  w ith  auto­
immune th y r o id it is  were compared w ith  a con tro l h o sp ita l group matched 
f o r /
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TABLE I I .
Reproductive H istory in  Female P a tien ts  ndth Auto­
immune T h y ro id itis ,
Table II.
Age
(Yrs.)
Menstrual
History
Reproductive
History
Reproductive History in Female Patients 
With Auto-iranune Thyroiditis.
Auto-immune Thyroditis
Total Number 46 70
Mean 51.9 56.1
Range 28-70 31-74
Mean age at menarche (yrs.) 13.8 14.0
History of Mc-norrhagia 4 6
History of Oligomenorrhoea 3 0
Mean age at menopause (yrs.) 45.9 46.1
No. married 40 (872) 52 (652)
No. of births/person 2.7 2.5
No. of abortions/person 0.5 0 .4
Infertile 7 (17. 52) 8 (15. 42)
Female Hospital Controls
/ f o r  age (see  Appendices fo r  fu rth er  d e t a i l s ) .  I t  can be seen  
from Table I I  that no s ig n if ic a n t  d ifferen ces  were found; t h i s  i s  
in  agreement w ith the observations o f S tatland  e t  a l .  (11) and 
Woolner e t  a l .  (1 4 ) . Furthermore, no evidence o f  ex ce ss iv e  oestrogen  
secretio n  secretio n  was found in  12 post-m enopausal p a t ie n ts  o f th e  
present study as judged by "ferning" o f the c e r v ic a l mucus (5 4 ) .  
Moreover, thyroid  le s io n s  resem bling auto-immune th y r o id it is  have not 
so fa r  been produced experim entally  by e ith e r  excess or d e fic ie n c y  
of oestrogen hormones (55 )•
From th ese  stu d ies  i t  i s  c lea r  th a t the ovarian hormones cannot 
be incrim inated d ir e c t ly  in  the pathogenesis o f auto-immune 
th y r o id it is ;  i t  i s  p o ss ib le  th at female proneness to  the d isea se  may 
be g e n e tic a lly  determined.
C lin ic a l P ictu re
Presenting Symptoms
The presence of a g o itr e , e ith e r  a lon e (15 p a t ie n ts ) ,  or 
associa ted  w ith recent in crease  in  s iz e  (11 p a t ie n ts ) ,  m ild pressure  
e f fe c t s  (4  p a t ie n ts ) , or w ith  symptoms o f  hypothyroidism (7  p a t ie n ts ) ,  
was the most common cause o f the p a tien t seeking m edical ad v ice .
This i s  in  agreement w ith  the experience o f  J o l l  (17) and other  
workers (1 1 ,1 2 ). One p a tien t had a "painful" g o itre  and 5 
presented w ith thyrotoxic m an ifesta tion s. Seven p a t ie n ts  complained 
of symptoms of hypothyroidism and were unaware o f the presence o f a 
g o itre , which was found in c id e n ta lly  on p h ysica l examination.
CHiu-c a l fin d in gs relevan t to  the g o itre
OBset and duration. The onset o f the g o itre  in  auto-immune 
th y r o id it is /
FIGURE 5
Duration of Goitre in  Auto-immune T h y ro id it is  
FIGURE 6
C lin ica l Assessment o f G oitre S ize  in  Auto­
immune T h y r o id it is .
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/ t h y r o id i t i s  i s  in s id io u s  in  most p a t ie n ts  and without system ic  
upset (1 4 ) . O ccasionally , however, th e  on set o f th e  g o itr e  may 
he a sso c ia ted  w ith fev er ish n ess  and lo c a l  discom fort in  the gland 
(16) and th is  was present in  2 p a t ien ts  o f  the present s e r ie s .
The p o s s ib i l i t y  o f a v iru s in fe c t io n  has been suggested by Doniach 
e t  a l .  ( 16) but in  n e ith er  o f  th ese 2 p a t ie n ts  was th ere a h is to r y  
of contact w ith mumps, which i s  a known cause o f th y r o id it is  (56 ) .  
Furthermore, h is to lo g y  o f the thyroid  in  one o f  th ese  p a t ie n ts  
revealed  uncomplicated auto-immune th y r o id it is .
The duration o f the g o itre  in  the present s e r ie s  varied  between  
6 weeks and 37 years (F ig . 5 );  and 12 p a tien ts  had had a g o itr e  o f  
a year or l e s s .  These fin d in g s  are in  general agreement w ith  those  
of C rile  (5 7 ) , although a higher proportion o f p a t ie n ts  w ith  g o itr e s  
of short duration have been reported by other workers (1 2 ,1 4 ) . 
O ccasionally the go itre  may reach a considerable s iz e  w ith in  a few  
weeks or months ( 14*58) and th is  was seen in  4  p a t ien ts  o f th e  
present s e r ie s .  Twelve per cen t, o f the p a t ien ts  stu d ied  by Purr and 
C rile  ( 13) had had a g o itre  of 20 years or more; but th is  was seen  
in  only one patien t o f the present s e r ie s ,  who had had her g o itr e  
fo r  37 years. H is to lo g ic a l examination o f the th yroid  in  t h is  
p atien t suggested th at auto-immune th y r o id it is  had been superimposed 
on a simple c o llo id  g o itr e . However, a p r e -e x is t in g  g o itr e  i s  
probably unusual in  auto—immune th y r o id it is ,  except perhaps in  endemic 
areas ( 17) .
(3) S iz e . Prom F ig . 6 i t  can be seen th a t in  the present s e r ie s
th er e /
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/th e r e  was a wide v a r ia tio n  o f  the s iz e  o f th e  g o itr e , although  
moderatly enlarged (75 g .)  g o itr e s  were most common. T his i s  in  
agreement w ith the recorded w eights in  su r g ica l specimens ( s e e  
Chapter I ,  S ection  2 , p .21 ) .
(4 ) Type. D iffu se  enlargement o f the th yroid  was present in  
28 p a tien ts  o f  the present s e r ie s ,  and in  6 p a t ien ts  th e pyramidal 
lobe was palpable. G enerally true adenomatous form ation in  auto­
immune th y r o id it is  i s  inconspicuous (59 ) > although one p a t ie n t  in  
the present s e r ie s  had numerous d isc r e e t  nodules o f normal c o l lo id -  
contain ing a c in i en c irc led  by whorls o f  fib rou s t is s u e  present in  
the thyroid . The apparent n od u larity  in  the rem aining p a t ie n ts
can probably be a ttr ib u ted  to  the exaggeration o f  the normal lo b u la ted  
surface.
(5) C onsistency. The most c h a r a c te r is tic  fea tu re  o f  the g o itr e  
in  auto-immune th y r o id it is  i s  i t s  "firm ness” on p a lp a tion . A l l  but 
4  p a tien ts  o f the present study had "firm" g o itr e s ;  two o f  th ese  4  
p a tien ts  had "hard"' g o itr e s  and in  the remaining 2 the th yro id  was 
"soft" in  con sisten cy .
(6 ) F ixation . In none o f the p a tien ts  o f the present study was 
there f ix a t io n  o f the thyroid  to  skin or neck stru ctu res on c l in ic a l  
examina tio n . This i s  in  contrast to  th e f ix a t io n  freq u en tly  present 
in  thyroid neoplasm. However, extension  beyond the capsule in to  
the surrounding t is s u e s  was present in  one p a tien t w ith  a fib ro u s  
variant o f  auto-immune th y r o id it is .
(7) Tenderness. This was present in  12#  o f  the p a t ien ts  stu d ied
by Lindsay e t  a l .  ( 12) but was not observed in  any o f  the p a tien ts  
in  th is  study.
(8) B ru it. A thyroid  b r u it  was recorded in  one p a t ie n t .
( 9) A ssociated  lvmphadenopathy. The c e r v ic a l lymph nodes are  
frequently  found to  be hypertrophied a t  operation  (6 0 ) , presumably 
because they are producing thyroid  a u to -an tib od ies (60) • Occasion­
a l l y  th ese  nodes are palpable (44) &ucL th is  was observed in  one 
p a tien t in  th is  study. In  th is  p a tien t the "sen tinel"  or "Delphic" 
lymph node o f  Cope (6 l)  was a ls o  thought to  be p resen t. Werner (34) 
has s tressed  the d iagn ostic  value o f the fin d in g  o f t h is  node, but 
t h is  has not been confirmed in  the present study.
Symptoms a sso c ia ted  w ith  the g o itre
Mild pressure symptoms, in clu d in g  dysphagia, are not in frequ en t 
in  auto-immune th y r o id it is  ( 11 , 12 , 4 4 , 62 ) .  Sensation s o f  " tightness"  
or "choking" were present in  11 p a tien ts  o f  t h is  study and 6 had 
s l ig h t  dysphagia. One p a tien t complained o f pain in  her th yro id , 
and 3 others adm itted to  having occasion al "discom fort". Hoarseness 
was a ttr ib u ted  to  hypothyroidism in  12 p a t ie n ts , but was a lso  present 
in  7 p a tien ts  who were euthyroid. One o f  th ese  euthyroid p a t ie n ts  
a lso  had dysphonia and a temporary vocal cord p a r a ly s is . This 
la t t e r  featu re has p rev iou sly  been reported in  auto-immune 
th y r o id it is  (13,57) and i s  presumably due to  involvement o f  the  
recurrent laryngeal nerve in  the d isea se  p rocess. Cough and s tr id o r  
were present in  one p a tien t who had a very large  g o itr e . However, 
none o f the p a tien ts  had a m ediastin al syndrome, such as reported  
by S h oll and Black (63 ) .
Systemic Symptoms
Hypothyroidism. Vague systemic complaints, such as lack of 
fe e lin g /
/ f e e l in g  o f  w ell-b e in g  and la s s itu d e , have been freq u en tly  recorded  
by many authors in  the past (11 , 13*17*31 ,4 4 ,5 2 ,5 7 ) , i t  i s 
that they now can be a ttr ib u ted  to  thyroid  in s u f f ic ie n c y . Hypo- 
:thyroidism  has been reported in  10 per cen t, or l e s s  o f  su r g ica l  
p a tien ts  (1 1 ,1 2 ,2 5 ,3 9 ,6 4 ,6 5 ) , but was present in  18 p a t ie n ts  ( 36#) 
of the present study. However, o f the 28 euthyroid and 4  
eq u ivoca lly  hypothyroid p a t ie n ts , 10 had ra ised  serum c h o le s te r o l  
va lu es, 8 had lowered b a sa l m etabolic r a te s ,  and 7 had abnormal 
electrocardiogram s co n sisten t w ith hypothyroidism . Furthermore, 
the mean serum protein-bound iod in e (PBl) was s ig n if ic a n t ly  lower 
in  the euthyroid p a t ie n ts  with auto-immune th y r o id it is  than in  a 
con tro l group (see  S ection  4 , P»175)* Thus, c la s s i f i c a t io n  
according to  c l in ic a l  s ta tu s  i s  arb itra ry , sin ce  varying degrees o f  
thyroid  in su ff ic ie n c y  sire present and there i s  no c lea r -c u t d iv is io n  
between the euthyroid and hypothyroid s ta te .
(2) Thyrotoxico s i 3 . The p o ssib le  r o le  o f th y ro to x ico s is  in  the  
pathogenesis of auto-immune th y r o id it is  has been given much a tte n t io n  
in  the past ( 12 , 65- 67 ) ,  and Graham and McCullagh (68) b e liev ed  th a t  
" i f  i t  could be found in  the past h is to r y  the b a s ic  le s io n s  fo r  the  
changes in  the thyroid  would have been found". A h is to r y  suggestive  
of th yro to x ico sis  was e l i c i t e d  in  8 p a t ie n ts , but in  on ly  3 was i t  
convincing. This i s  in  agreement w ith  th e fin d in g  o f  Bason ( 69 ) 
and i t  may be th at th ese p a tien ts  represent the end r e s u lt  o f  a 
"burnt-out" th y ro to x ico s is .
Mild thyrotoxic symptoms have a lso  been observed a t  the onset 
of auto-immune th y r o id it is  (65 ,70-72) and Lindsay e t  a l .  ( 12 ) 
reported /
TABLE I I I
R esu lts  o f P r e c ip ita tio n  and Complement -  F ix a tio n  
(C .F .) T ests in  Auto-immune T h y ro id itis .
FIGURE 7 
Clear Line B re o ip itin  Tesb
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Table III*
Results of Precipitation and Complement-Fixation (CF) Tests 
in Auto-immune Thyroditis.
Authors Year Ref. No. Total No. 
of Cases
Positive Thyroid 
Precipitin
Auto-antibody Tests 
CF
Roitt and Doniach 1958 75 106 71 98
Anderson et al. 1959 20 60 42 52
Belyavin and Trotter 1959 76 64 27 15
Blizzard et al. 1959 77 3 1
Hubble 1959 15 18 15
Present Series 50 38 46
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A c lea r  l in e  i s  seen in  the agar on the l e f t  
and a p o s it iv e  p rec ip ita te  fo r  comparison on the r ig h t.
/rep orted  an incidence o f  12 per cen t, in  th e ir  s e r ie s  o f  170 
p a tie n ts . Five p a tien ts  in  the present study presented  in  t h is  way, 
but were subsequently shown to  be euthyroid . The d ia g n o stic  and 
th eo r e tic a l im p lications o f  th ese  fin d in g s  w i l l  be d iscu ssed  la t e r  
in  greater d e ta i l  in  Chapter I I I .
Bye Signs
McSwain and Moore (31) and others (42 ,73 ) have reported  m ild  
degrees o f exophthalmos in  p a tien ts  w ith auto-immune t h y r o id it is .  
Exophthalmos was present in  9 of  the 50 p a t ie n ts  o f  th e  present 
study; an incidence which does not d if f e r  s ig n if ic a n t ly  (P < 0 .1 )  
from th a t described by Wayne (74) using the same c r i t e r ia  in  7 o f  
90 h o sp ita l co n tro ls . One p a tien t was, however, o f  considerab le  
in te r e s t  s in ce  she had exophthalmic ophthalmoplegia and was hypo- 
: thyroid .
The C lin ic a l S ig n ifica n ce  o f the Thyroid A uto-antib od ies
The r e s u lt s  o f the p r e c ip it in  and CF t e s t s  obtained in  the  
present study are summarised in  Table I I I  and compared w ith the  
r e s u lt s  obtained by other workers (15,20,75*77)* The o v e ra ll  
r e s u lt s  are in  su rp r isin g ly  c lo se  agreement, considering the 
varia tion s in  techniques used and the choice o f m a ter ia l. P o s it iv e  
p r e c ip it in  t e s t s  were found in  38 p a tien ts  in  the present study, 
inclu d ing one p a tien t who had had a su b tota l thyroidectom y performed 
5 years prev iou sly . A c lea r  l in e  developed in  the agar in stea d  o f  
the usual dense white p r e c ip ita te  (F ig . 7) in  1 p a tien t w ith  a 
" p o sitiv e” p r e c ip it in  t e s t .  G-oudie e t  a l .  (78) in terp reted  t h is  a s
in d ica tin g  the formation o f non-aggregating antigen  antibody  
com plexes/
FIGURE 8 
D oub le-line P r e c ip it in  Test
TABLE IV
R ela tion  between the P r e c ip itin  T est and the C lin ic a l  
Features in  Auto-immune T h y ro id itis .
FIG. 8
\
L eft Right
A double p r e c ip itin  t e s t  i s  seen on the l e f t ,  
w ith a s in g le - l in e  p rec ip ita te  f  or comparison on the right,
Table IV.
R elation between the P re c ip it in  T est and the 
C lin ica l Features in  Auto-immune T h y ro id it is .
P re c ip it in  Test ( - ) (+)
Total No. of P a tie n ts  
Sex ra tio n  (m/ f )
Age (y rs)
mean
range
12
l / l l
52.9  
37 -  70
38
3/35
52.5  
28 -  67
Age a t  onset o f g o itre (y rs )  
mean 
range
46.0  
15 -  70
47 .6  
28 -  68
Assessed g o itre  s ize  (g .)  
mean 
range
104
50 -  300
102 
50 -  200
Duration o f g o itre  (y rs) 
mean 
range
4.5
4m -  37
3.5  
6 wks. -  19
Nodular g o itre 8 14
C lin ic a l s ta tu s
euthyroid 
equivocally  hypothyroid 
hypothyroid
10
0
2
17
3
14
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/com plexes and suggested th a t t h is  might a lso  hold  fo r  the double- 
l in e  p r e c ip ita te  (F ig . 8) which was seen in  another p a t ie n t . No 
untoward c l in ic a l  fea tu res  were noted in  e ith e r  o f  th ese  p a t ie n ts  
and the h is to lo g y  o f  the thyroid  in  the p a tien t w ith  the c le a r - l in e  
p rec ip ita te  was unremarkable.
No co rre la tio n  was found between the r e s u lt s  o f  the p r e c ip it in  
t e s t  and the c l in ic a l  fea tu res  o f  th e d isea se  (Table IV) • However, 
p a tien ts  w ith negative p r e c ip it in  t e s t s  had a higher prevalence  
(P < 0 .1 )  o f nodular g o itr e s  and hypothyroidism was more frequent 
(P < 0 .5 )  in  p a tien ts  w ith p o s it iv e  p r e c ip it in  t e s t s .
No d e f in ite  co rre la tio n  oould be e sta b lish ed  between th e presence  
or absence o f a p o s it iv e  p r e c ip it in  t e s t  and the natural progress o f  
the d ise a se . Thus, sev era l p a tien ts  w ith p o s it iv e  p r e c ip it in  t e s t s  
were observed fo r  periods ranging from 4  to  18 months (mean 12 .6  
months) without any appreciable change in  the s iz e  o f  the g o itr e  
and without the development o f hypothyroidism (A ppendices). On 
the other hand, 2 p a tien ts  w ith negative p r e c ip it in  t e s t s  became 
hypothyroid 6 and 18 months r e sp e c t iv e ly  a f t e r  th e ir  f i r s t  v i s i t  to  
the c l in ic .  These fin d in g s  are in  agreement w ith  those o f R o itt  
and Doniach (75)> and lend support to  the view th at th e p r e c ip ita t in g  
auto-antibod ies are not in  them selves the d ir e c t cy to to x ic  agent.
The CF t e s t  was p o s it iv e  (+) in  3 p a t ie n ts  (6%) and stro n g ly  
p o s it iv e  (++) in  43 (86$); 2 p a t ie n ts  (4$) had negative  t e s t s ,  and 
2 had AC rea c tio n s. In  general, p a t ie n ts  w ith  a p o s it iv e  p r e c ip it in  
t e s t  a lso  had a p o s it iv e  CF t e s t ,  but there were 2 exceptions -  one 
w ith a negative CF t e s t ,  and another w ith  an AC rea c tio n . Since  
m ost/
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FIGURE 9
Composite Family H istory of Thyroid D isease in  50 
P a tien ts  w ith  Auto-immune T hyroid itis*
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F ig . 9.
COMPOSITE FAMILY HISTORY OF THYROID D ISEA SE IN 
5 0  PATIENTS WITH AUTO-IMMUNE THYROIDITIS
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/m ost p a tien ts  had a p o s it iv e  CF t e s t  no con clu sion s can be drawn 
regarding i t s  co rre la tio n  w ith the c l in i c a l  fe a tu re s  o f  the d is e a se .  
The fin d in g s are , however, co n s isten t w ith  2 separate immune 
systems in  auto-immune t h y r o id it is .
Only one p a tien t had both a n ega tive  p r e c ip it in  and CF t e s t .  
This p a tien t had a fib ro u s variant o f auto-immune t h y r o id it is .  Low 
t i t r e s  o f thyroid  au to-an tib od ies have been reported in  4  p a t ie n ts  
with t h is  cond ition  by R o itt  end Doniach (75) • I t  i s  o f  in t e r e s t  
th at in  the p a tien t in  th is  study high l e v e l s  o f  gamma-globulins 
and abnormal serum f lo c c u la t io n  t e s t s  were present and i t  i s  
p o ss ib le  th at a c o llo id  antibody d is t in c t  from th yroglob u lin  might 
have been detected  as described by Balfour e t  a l .  (79) •
F am ilia l and G enetic A spects
I t  has long been recognised  th at d if fe r e n t  th yroid  d is e a se s ,  
such a s  primary hypothyroidism, th y r o to x ic o s is , and n on -tox ic  
g o itr e , may a r ise  in  the same fam ily  (80) • Dunning (81 ) has 
reported 3 p a tien ts  w ith auto-immune th y r o id it is  in  one fa m ily , and 
Lindsay e t  a l .  (12) found an increased  prevalence o f  a fa m ily  
h isto ry  o f g o itre  in  p a tien ts  with auto-immune th y r o id it is .  A 
f amily h is to r y  o f thyroid  d isea se  was obtained in  a much h igher  
(P< 0 .05) proportion o f th e p a tien ts  (8  o f 50) in  the presen t study  
than in  a control group (2 o f 70); no common a s so c ia t io n  was 
found w ith any p a rticu la r  th yroid  d isea se  (F ig . 9 ) ,  although fem ale  
r e la t iv e s  were, as expected , predominantly a ffe c te d  (s e e  
Appendices fo r  fu rther d e t a i l s ) .
C ircu la tin g /
/C ircu la tin g  th yroid  au to-an tib od ies were demonstrated by  
H all e t  a l .  (82) in  22 o f  39 s ib lin g s  o f 11 p a t ie n ts  w ith  auto­
immune thyroid  d isease  and th is  f in d in g  was in terp re ted  by th ese  
authors a s  in d ica tin g  th a t the p r e d isp o s itio n  to  develop th yro id  
auto—an tib od ies i s  in h er ited  as  a dominant c h a r a c te r is t ic . R o itt  
and Doniach (83) s im ila r ly  stud ied  64  c lo se  r e la t iv e s  o f p a t ie n ts  
w ith auto—immune th y r o id it is  and found th a t o f 33 w ith  cl i n i c a l  
evidence o f  thyroid  d isea se  91 per cen t, had th yroid  a u to -a n tib o d ie s . 
In the remaining 61 r e la t iv e s  th yro id  au to -a n tib o d ies  were 
demonstrated in  30 per cen t. In the present study p r e c ip it in  and 
CF t e s t s  were performed in  17 female r e la t iv e s  o f 8 p a t ie n ts  w ith  
auto-immune th y r o id it is  (Appencffces). None o f the sera had 
demonstrable p r e c ip it in s , but 6 had p o s it iv e  CF t e s t s ;  an in cid en ce  
which i s  much higher (;P<i0.02) than th at in  a s e r ie s  o f  fem ale  
h o sp ita l con tro ls  (27 o f 243) stud ied  in  th e same laboratory by the  
same methods ( 98) .
A ssociated  I l ln e s s e s  
In  the past most su rg ica l s tu d ies  have revea led  l i t t l e  evidence  
o f previous serious i l l - h e a l t h  in  p a t ien ts  w ith  auto-immune 
th y r o id it is  (10 ,11 ,17*53); although is o la te d  cases were reported  in  
a sso c ia tio n  w ith  a wide v a r ie ty  o f d isord ers, in c lu d in g  dissem inated  
tu b ercu losis  (84)* rheumatoid a r t h r i t i s  ( 63 )* i r i t i s  ( 84 ) ,  Vitamin B 
d efic ien cy  ( 85) ,  pemphigus (86) and pseudo-xanthoma elasticu m  (4 4 ) .  
However, Furr and C rile  ( 13) observed a frequent a s so c ia t io n  w ith  
other ailm en ts , in  p a r ticu la r  w ith  hypertensive and ischaem ic  
h e a r t/
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A ssociated  I l ln e s s e s  in  Auto-immune T h y ro id itis
in  the Present Study,
Table V.
Associated Illnesses in Auto-immune Thyroiditis.
D isease No. o f Cases D isease No. o f  Cases
Rheumatoid a r t h r i t i s 7 G as tr ic  carcinoma 1
Acquired haem olytic anaemia 1 T ubercu lo sis 1
D iabetes m e lli tu s 2 S y p h ilis 1
H ypertension 1 U rtic a r ia 1
Angina 2 Hay fev e r 3
M itra l s te n o s is 1 Vasomotor rh inorrhoea 2
Chronic B ro n ch itis 4 Drug a l le rg y  ( p e n ic i l l in ) 1
Duodenal u lc e r 1 Unexplained hepato-splenom egaly 1
/h e a r t  d isea se  and " a r th r it is  o f undetermined a e tio lo g y " . Beare 
( 87) found a considerable proportion o f h is  p a t ien ts  gave an antecedent 
h is to r y  o f rheumatic fe v e r , rheumatoid a r t h r i t i s ,  n e p h r it is , and 
skin  a lle r g y . In  a study o f 24 p a t ien ts  reported by Luxton and 
Cooke (2) 6 p a t ie n ts  had splenomegaly and 2 had a h is t o lo g ic a l ly -  
proven c ir r h o s is  o f the l iv e r .
Recent study o f the r o le  o f auto-imm unisation in  the pathogenesis  
of severa l d isea se s  has aroused in te r e s t  in  the c l in ic a l  a sso c ia tio n s  
o f auto-immune th y r o id it is .  The co -ex isten ce  o f auto-immune 
th y r o id it is  w ith other d isea ses  o f suspected auto-immune a e tio lo g y  
has been reported . Thus, auto-immune th y r o id it is  has been asso c­
i a t e d  w ith p rogressive h e p a t it is  (2 , 88- 90) ,  nephrosis (91)» acquired  
haemoHytic anaemia ( 92- 93) > primary adrenal atrophy (94) f and the  
connective t is s u e  d ise a se s  (93)* The a sso c ia ted  i l ln e s s e s  in  the 
50 p a tien ts  o f  the present study are summarised in  Table V. I t  can 
be seen th a t an unexpectedly high incidence o f rheumatoid a r t h r it is  
was found (7  o f 30 p a t ie n ts ) , and the s ig n ifica n ce  o f t h is  w i l l  be 
d iscussed  fu rther in  Chapter IV o f the th e s is .  One o f the p a tien ts  
had a Coombs-negative acquired haem olytic anaemia; another w ith a 
past h is to r y  o f  g a s tr ic  carcinoma had an unexplained hepato-spleno­
megaly. Two p a tien ts  developed d iab etes during the course o f th e ir  
i l l n e s s ,  but p r e c ip ita tin g  pancreatic auto-antibod ies o f the type 
described by Thai e t  a l .  (96) were found in  n e ith er . The a sso c ia tio n  
of auto—immune th y r o id it is  w ith  Paget* s  d isease  o f the bone was 
brought forward by Luxton (97)» but none o f the p a tien ts  o f  the  
present study had e ith e r  r a d io lo g ic a l ( i . e .  X-ray o f the sk u ll, 
p e l v i s , /
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/p e l v i s ,  lum bo-sacral spine and tib ia $  or biochem ical ( i . e .  ra ised  
serum a lk a lin e  phosphatase le v e ls )  evidence o f  the d ise a se .
B lizzard  e t  a l .  (77) noted th a t p e n ic illin -h y p e r  s e n s i t iv i t y  i s  more 
frequent in  p a t ie n ts  w ith  auto-immune th y r o id it is ,  but the prevalence  
of a l le r g ic  m an ifesta tion s in  the p a tien ts  o f the present study m s  
no higher than would be expected in  a random sample o f  the general 
population o f s im ila r  age and sex  d is tr ib u tio n  (99)*
SUMMARY
The c l in i c a l  fe a tu re s  of auto-immune th y r o id it is  have been  
d iscu ssed  in  th e b a s is  o f a study o f 30 p a tien ts  w ith  the d ise a se .
The priud ip lb  conclusions were as fo llo w s
(1) Auto-immune th y r o id it is  can no longer be regarded as  a 
rare thyroid  d isea se ; i t  accounted fo r  4*5 per cent o f  a l l  
th yro id  d isorders in  the present study.
(2) The d isea se  predominantly a f f e c t s  middle-aged fem ales, 
but the onset does not appear to  be d ir e c t ly  re la ted  to ovarian  
fu n ctio n .
(3) The commonest p resen tation  i s  a complaint o f neck sw e llin g . 
The g o itr e  i s  u su a lly  o f in s id io u s  onset and may be a sso c ia ted  
w ith  mild pressure symptoms. I t  i s  u su a lly  moderately enlarged
-  .  u  _  w
d if fu se  or nodular.
(4 ) C la s s if ic a t io n  according to  c l in ic a l  s ta tu s  i s  arb itrary . 
E ighteen per cen t, o f the p a tien ts  in  the present study were 
obviou sly  hypothyroid, but many o f the c l in ic a l ly  euthyroid  
p a tien ts  had laboratory evidence of hypothyroidism.
(5 ) Auto-immune th y r o id it is  may occa sio n a lly  represent the 
en d -resu lt o f a Mburnt-outH th y ro to x ico sis  and 6 per cen t, o f the  
p a tie n ts  in  the present study gave a convincing h is to r y  o f  
th y ro to x ico s is  in  the p a st.
(6 ) No co rre la tio n  was found between the c l in ic a l  fea tu res  
and progress o f  the d isease  and the r e s u lt s  o f  the p r e c ip it in  and 
CP thyroid  auto-antibody t e s t s ;  th is  i s  co n sisten t w ith the  
v iew /
/v ie w  th a t th ese  au to -an tib od ies are not the d ir e c t  c y to to x ic  
agen t.
(7 ) A fam ily  h is to r y  o f th yroid  d isease  and an increased  
prevalence o f th yroid  au to -an tib od ies in  r e la t iv e s  o f  p a t ie n ts  
w ith  auto-immune th y r o id it is  suggest th at a g en etic  fa c to r  i s  
in vo lved  in  the pathogenesis o f the d ise a se .
(8) A v a r ie ty  o f  i l ln e s s e s  was a sso c ia ted  w ith auto-immune 
th y r o id it is  in  the present study, but on ly  rheumatoid a r t h r i t i s  
had an unexpectedly high prevalence (7  o f 3 0 ) .
Section 2.
A S k in  T est in  Auto-Tromme T h y r o id it is .
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TABLE X.
C lin ic a l and Immuno-pathologioal Features of the Three 
Types of Skin R eactions.
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Tablie I*
C lin ic a l  and Immuno-pathological F ea tu res  o f the Three Types o f  Skin R eac tions.
Type o f  Skin Inmediate ArthuB Delayed
Macroscopic
appearance
Wheal and Erythema Erythema and Ind u ra tio n Erythema and Indu ration
Time o f onset 
and o f maximal 
in te n s i ty
0 - 6 0  minutes 6 - 2 4  hours 18 -  40 hours
M icroscopic
appearances
V ascu lar p e rm eab ility  
and oedema, due to  
re le a se  o f histam ine 
o r  a l l i e d  H-substance
Polym orphonuclear reac tio n  
w ith f ib r in o id  n ec ro s ic , 
haemorrhage and oedema. 
O ccasional e o sin o p h ilic  
i n f i l t r a t i o n
Mononuclear 
re a c tio n  w ith 
occasiona l f ib r in o id  
n e cro sis
A ssociated
c l in ic a l
cond ition
Hay fe v e r ,  asthma Serum sickness T ubercu losis , b ru c e l lo s is ,  
h is to p lasm o sis , lympho­
granuloma, poison ivy-and 
n ic k e l d e rm a titis
S e n s itiz in g
m a te ria l P o llen s
Soluble p ro te in s  and 
carbohydrates
B ac te r ia , v iru s e s ,  p lan t 
m a te r ia ls ,  simple 
chem icals
Antibody
P resen t in  serum as 
reag in . Non- 
p re c ip ita b le  and 
h e a t - la b ile
P r e c ip ita t in g  
antibody p resen t 
in  serum
Absent in  serum, b e lieved  
to  be "cell-bound"
T ran sfe r o f 
s e n s i t iv i ty
With serum-
P rau sn itz -K u stn er
re a c tio n
With serum
Not w ith serum, bu t 
with o e lls
Pharmacology A ntih istam ines
in h ib i t
A ntihi8tam ines 
do not in h ib i t
A ntih istam ines 
do no t in h ib i t
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INTRODUCTION.
The c r e d it  fo r  f i r s t  rep orting  the value o f sk in  t e s t s  must go 
to  B lack ley  ( 1 ) ,  who, in  1873* showed, th a t grass p o llen  rubbed, in to  
a scratch  on the sk in  o f  a hay-fever p a tien t caused lo c a l  sw e llin g , 
erythema, and ir r i t a t io n .  Some 30 years la te r  Dunbar (2 ) confirmed 
t h is  observation  and in  1913 Cooke (3) introduced the intraderm al 
method o f sk in  t e s t in g . Since th ese e a r l ie r  observations sk in  
reaction s have been demonstrated to  a wide v a r ie ty  o f substances  
and appear to  f a l l  in to  3 main types: f i r s t l y ,  the immediate type
o f sk in  response; secondly, the Arthus phenomenon; and th ir d ly ,  
delayed-type h y p e r se n s it iv ity . The relevant d e ta i l s  o f  th ese  3 
1ypes o f  sk in  responses are summarised in  Table 1 and w i l l  now b r ie f ly  
be ou tlin ed .
Immediate-type Response 
The immediate type o f skin response i s  ch aracterised  by a wheal 
and f la r e  appearing u su a lly  w ith in  one hour o f in je c t io n  o f the  
a lle r g in ;  i t  i s  commonly a sso c ia ted  w ith the c l in ic a l  syndromes o f  
h ay-fever and asthma and c la s s ic a l ly  provoked by p lan t p o llen s . 
H is to lo g ic a lly , the le s io n  i s  ch aracterised  by vascular perm eability  
and oedema due to  the r e le a se  o f histam ine or a l l i e d  H-substance as  
i t  can be in h ib ited  by an tih istam in es. C ircu latin g  antibody i s  
present in  t h i s  type of rea c tio n  and i s  known as rea g in : the response
can only be transm itted  by serum using the Prausnitz-K ustner rea ctio n .
Arthus Phenomenon 
The Arthus phenomenon was f i r s t  described in  the rabbit in  1903
(4 ) /
/(it.)* The sk in  response i s  u su a lly  o f maximum in t e n s i t y  between  
6 and 24 hours and i s  ch aracterised  h is to lo g ic a l ly  b y  an in ten se  
polymorphonuclear inflam m ation accompanied by haemorrhages, oedema, 
and f ib r in o id  n ech o s is . The Arthus rea c tio n  i s  in v a r ia b ly  a s so c -  
: ia te d  w ith c ir c u la t in g  p r e c ip it in s , and can be transm itted  by serum 
or plasma by technique o f d ir e c t  or reversed  p assiv e  cutaneous 
anaphylaxis in  th e gu in ea-p ig  (5 ) .  The Arthus rea c tio n  i s  rare in  
c l in ic a l  p r a c tic e , but i s  seen a f t e r  repeated in je c t io n s  o f fo re ig n  
serum.
Delayed H y p ersen sitiv ity  R eactions 
Skin rea c tio n s  o f th e delayed type are c la s s ic a l ly  seen in  the  
tubercu lin  r ea c tio n , but a lso  occur in  a wide v a r ie ty  o f  b a c te r ia l ,  
v ir a l ,  and sp iroch aeta l in fe c t io n s  and w ith contact w ith cer ta in  p lant 
substances and other chemical compounds (6) • The term "delayed” 
stems from the la te n t  period , u su a lly  24  to  48 hours, which e la p ses  
from the time o f a p p lica tio n  o f the antigen  u n t i l  the appearance o f  
the sk in  r ea c tio n . H is to lo g ic a lly , th is  type o f response i s  
ch aracterised  by a mononuclear in f i l t r a t io n  w ith  l i t t l e  or no t is s u e  
d estru ction . Unlike the other 2 typ es o f skin responses i t  i s  not 
a sso c ia ted  w ith  humoral an tib od ies and p assive  transm ission cannot be 
achieved using e ith e r  serum or plasma. "Cell-bound" an tib od ies are, 
however, present in  delayed h y p e r se n s it iv ity  and p assive  tran sfer  
can be carried  out using  c e l l s  o f  the leucocyte s e r ie s  (7) • Delayed-  
type responses have been demonstrated in  vascu lar t is s u e s  such as  
the cornea ( 8 ) .
Skin T ests  to  Homologous or Autologous A ntigens 
D espite the wide a p p lic a tio n  o f sk in - te s t in g , l i t t l e  study has 
been done in  sk in  s e n s i t iv i t y  to  homologous or autologous t is s u e  
antigens* In  1948 McPherson and Woods (9) using b e e f i r i s —pigment 
ex tra cts  a s  antigen  demonstrated sk in  rea ctio n s in  p a t ie n ts  w ith  
sympathetic ophthalm ia. Several workers have f a i le d  to  demonstrate 
cutaneous a lle r g y  to  syn ov ia l f lu id  in  rheumatoid a r t h r it is  (10) 
and to  e x tr a c ts  o f colon  in  u lc e ra tiv e  c o l i t i s  (1 1 ) , but apart 
from th ese  s tu d ie s  no other in v e s t ig a tio n s  o f  s im ila r  nature have 
been carr ied  out in  humans.
Cutaneous s e n s i t iv i t y  to  homologous t e s t ic u la r  e x tra c ts  was 
observed by Freund e t  a l .  (12) in  experim ental asperm atogenesis in  
guinea-pigs; and delayed sk in  to  sp in a l cord an tigen  rea c tio n s  have 
been reported by Waksman and Morrison (13) in  experim ental encephalo- 
:m y e lit is  in  r a b b its . In  experim ental th y r o id it is  in  ra b b its  
Witebsky e t  a l .  ( 14) carried  out skin t e s t s  and "in sev era l in sta n ces  
p o s it iv e  rea c tio n s  were observed w ith  the thyroid  e x tr a c ts . The 
reaction s belonged to  th e delayed typ e, being strongest about 3 days 
a fte r  in je c t io n " . No other d e ta ils  were, however, given.
P ersonal Observations 
The present in v e s t ig a t io n  was undertaken in  order to  determine 
whether sk in  rea c tio n s  might fo llo w  the intradermal in je c t io n s  of 
thyroid an tigen s in  p a t ie n ts  w ith auto-immune th y r o id it is .  In  
order to  a s se s s  the d ia g n o stic  value o f any such reaction s skin  
t e s t s  were a lso  carried  out in  p a tien ts  w ith other thyroid  d isea ses  
and in  co n tro l su b jec ts .
TABLE I I .
R esu lts  off ffreo ip itin  T ests  and Skin R eactions  
to  S t e r i le  Thyroid E xtract in  56 P atien t s .
TABLE II,
Results of P re c ip itin  Tests and Skin Reactions to 
S te r i le  Thyroid E xtract in 56 P a tien ts .
Diagnosis Case No. T rec ip itin
Test
Skin Reaction
1 -  6 + + +
Auto-immune 9 + +
10 + -
T hyro id itis 11 - +
12 + “
Primaiy 13, 14 + + +
Hypo­ 15 + -
thyroidism 16, 17 - +
18 -  21 —
T hyrotoxicisis 22 +
23 -  31
Simple Non­
toxic G oitre 32 -  35 ■”
Thyroid
Cancer 36 “
U nclassified 37 - +
Controls 38 +
39 -  56 "
Skin Reactions (- )  negative; (+) weakly p o sitiv e ; 
(++) strongly  p o s itiv e .
Skin T ests
Sub.iects, Skin t e s t s  were performed on 56 p a t ie n ts , o f whom 37 
(3  males and 34 fem a les), aged 20 to  68 years, had thyroid  d ise a se , 
and 19 (3  males and 16 fem a les), aged 41 to  82 years, served as  
co n tro ls . The 37 p a t ie n ts  w ith thyroid d isea se  included 12 
p a tien ts  w ith auto-immune th y r o id it is ,  9 w ith primary hypothyroidism  
10 w ith th y r o to x ic o s is , 4  w ith simple g o itr e , and one w ith  thyroid  
carcinoma. The c l in i c a l  and h is to lo g ic a l  c r it e r ia  fo r  d iagn osis  
o f auto-immune th y r o id it is  were as described in  the previous se c tio n  
One p a tien t d id  not r e a d ily  f i t  in to  any o f the d iagn ostic  groups 
and was recorded as  11 u n c la s s if ie d " . (Table I I ) . This p a tien t
(case 37) had been trea ted  fo r  35 years w ith thyroid e x tr a c t . She 
was euthyroid when I  saw her but she gave a h isto ry  ty p ic a l of 
hypothyroidism before treatm ent. The c l in ic a l  d e ta i l s  o f the 56 
p a tien ts  stud ied  are summarised in  the appendices.
Antigen fo r  sk in  t e s t in g .* A s t e r i le  sa lin e  ex tract was prepared 
from the su rg ica l e x c ise d  thyroid o f a thyrotoxic p a tien t by the 
method p rev io u sly  described  by G-oudie e t  a l .  (15) • The ex tra ct  
was then passed through a S e itz  f i l t e r ,  dispensed in  volumes o f 0 .5  
to  1 .0  m l., and stored  a t  -15 degrees C. Samples were cultured  
under both aerob ic and anaerobic cond itions a t 20 degrees C. and 
37 degrees C. fo r  7 days to ensure s t e r i l i t y .
Skin t e s t s .  The t e s t s  were carried  out on th e volar asp ect o f the 
forearms. T hirty—f iv e  p a tien ts  received  3 intraderm al in je c t io n s  $ 
(a)/
* I  am g r a te fu l to  Dr. R.B. G-oudie fo r  th e preparation o f th is  
an tigen .
TABLE III.
R elation sh ip  o f  P rec ip ita tin g  A nti thyroid  A ntibod ies  
to  R esu lts  of Skin T ests w ith  S a lin e  Extract o f Thyroid
T issu e.
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TABLE I I I .
R elationship  of P re c ip ita tin g  .Antithyroid A ntibodies to R esu lts 
o f Skin Tests w ith Saline E xtract o f Thyroid T issu e .
P re c ip it in  Test Skin reac tio n  (no . of cases)
Negative Weakly P o sitiv e S trongly  P o s itiv e
+ 4 . 1 10
- 3b 5 0
/ ( a )  conta in ing  0 .2  m l. of an tigen , (b) con ta in in g  0 .2  m l. o f  
an tigen  to  which had been added 0*05 nil. o f  a suspension o f  co rtiso n e
a ceta te  ('C ortelan*)*  and (c )  contain ing 0 .2  m l. o f  s t e r i l e  0 .9 %
sa lin e  so lu tio n  and 0 .0 5  ml* o f  cortison e  acetate*  This procedure 
was based on th e m od ifica tion  o f the tu b ercu lin  t e s t  described  by 
C itron and Scadding ( 16) •  The remaining 21 p a t ien ts  rece iv ed  the  
f i r s t  in je c t io n  on ly . The t e s t s  were read a f t e r  24 hours, s in ce  
the rea c tio n  was u su a lly  maximal a t  t h i s  tim e. The r e s u lt s  were 
c la s s i f i e d  a s  n egative  (no r ea c tio n  or an area o f erythema o f l e s s  
than one centim etre diam eter), weakly p o s it iv e  (an area o f erythema 
one centim etre or more in  d iam eter), or s tro n g ly  p o s it iv e  (an area o f  
erythema one centim etre or more in  diam eter w ith cen tra l induration) • 
Because the o u tlin e  o f th e sk in  rea c tio n  was ir r e g u la r , th e  s iz e  o f
the response was recorded a s  th e mean o f th e maximum and minimum
diam eters.
Thyroid A uto-antibody t e s t s .  P r e c ip it in  and CP t e s t s  were performed 
by the methods described E a r l ie r ,: and were carried  out in  a l l  p a t ie n ts  
on the serum obtained b efore akin te s t in g  and a lso  in  46  p a t ie n ts  
one to  24  weeks a f t e r  th e sk in  t e s t .
R esu lts
The r e s u lt s  o f the sk in  rea c tio n s  in  r e la t io n  to  th e p r e c ip it in  
and CF t e s t s  in  56 p a t ie n ts  te s te d  are summarised in  Tables I I  and 
I I I  resp ectiv e ly *  Table U lsh ow s th a t o f the 15 p a t ien ts  toith 
p o s it iv e  p r e c ip it in  t e s t s ,  10 had stro n g ly  p o s it iv e  sk in  t e s t s  and 
1 had a weakly p o s it iv e  reaction * Of the remaini ng 4  p r e c ip it in  
p o s it iv e /
TABLE IV.
R esu lts cf Complement-Fixation (C .ff.) T ests to  S te r i le  
Thyroid E xtract in  56 P a tien ts .
TABLE V.
R elationsh ip  o f Complement-fixing (O .P .) Anti thyroid  
Antibodies to  R esult of Skin T ests with S a line  Extract
o f Thyroid T issue.
TABLE IV.
Results of Conplement-Fixation (CF) Tests to 
S terile Thyroid Extract in 56 Patients.
Diagnosis Case No. C.F. Test Skin Reaction
1 + + +
Auto-immune 2 - 8 + + + +
9 + +
Thyroiditis 10 + + -
11 + + +
12 + + -
14 _ + +
Primazy 15 , 20, 21 - -
13 + + +
hypothyroidism 18, 19 + -
16, 17 + + +
Thyrotoxicosis 22 + + +
23 - -
24 -  26 + -
27 -  31 + + -
Simple Non-
Toxic Goitres 32 -  35 - -
Thyroid
Cancer 36 - -
Unclassified 37 - +
Controls 38 + +
39, 40 + -
41 + + -
42 -  56 — —
Footnotes Skin Reaction: (-) negative; (+) weakly positive;
(++) strongly positive.
TABLE V.
R elationship o f Complement-fixing (CF) A ntithyroid A ntibodies 
to R esult o f Skin Tests with Saline Extract o f  Thyroid T issu e .
•F. Test
+  +
+
Skin Reactions (no. o f cases)
legative
8
7
24
Weakly P o sitiv e
4
2
1
Strongly P o s it iv e
7
2
1
/p o s i t iv e  p a t ie n ts  w ith  negative sh in  rea c tio n s , 3 are o f  sp ec ia l  
in t e r e s t .  One p a tien t w ith  h is to lo g ic a l ly  proven auto-immune 
th y r o id it is  (ca se  10) had an atypicalpH-dependent p r e c ip it in  rea c tio n  
(17) • The second (case  15) who had primary hypothyroidism, had a 
sk in  rea c tio n  which was delayed fo r  48  hours. Because o f the  
c r it e r ia  la id  down, t h is  response was c la s s i f i e d  as  n eg a tiv e . The 
th ird  p a tien t (case  22) was unequivocally  th y ro to x ic .
Of the 41 p a t ie n ts  w ith  negative p r e c ip it in  t e s t s ,  36 had 
negative  sh in  rea c tio n s  and 5  had weakly p o s it iv e  sk in  rea c tio n s  
(Table I I I ) .  The d e ta ils  o f t h is  la t t e r  group are a s  fo llo w s .
One p a tien t (case  11) had had a p a r t ia l  thyroidectom y performed 
tw ice prev iou sly , and auto-immune th y r o id it is  was diagnosed h i s t o l -  
:o g ic a lly  on the second occasion . A fter  th e  second operation the  
p a tien t became hypothyroid and was treated  w ith thyroxine. Cases 
16 and 17 had primary hypothyroidism; case 37 was u n c la s s if ie d  but 
gave a p ast h is to r y  o f hypothyroidism; and case 38, a fem ale o f  
82 years w ith pern icious anaemia, was one o f the con tro l s e r ie s .
A l e s s  c le a r  a s so c ia tio n  was found between the r e s u lt s  o f  the
IV and
skin  rea c tio n s  and the CF auto-antibody t e s t s  (Tables//"). Thus, 2 
of tire 26 p a tien ts  w ith  negative CF t e s t s  had p o s it iv e  sk in  rea ctio n s  
and one o f th ese  (case  14) w ith  primary hypothyroidism and a p o s it iv e  
p r e c ip it in  t e s t  had a stron g ly  p o s it iv e  skin rea c tio n . Moreover, 
of the 30 p a tien ts  w ith p o s it iv e  (+ and ++) CF t e s t s  only 15 had 
p o s it iv e  sk in  t e s t s .
The e f f e c t  o f adding cortison e to  the inoculum was v a r iab le .
There was a tendency fo r  th e skin  rea ctio n  to  be enhanced, as  
showxv'
FIGURE 1,
Comparison o f Mean Diameters o f Skin R eactions to
In .jeotion s o f Thyroid Extract w ith  and w ith out 
C ortisone A ceta te .
FIGURE 2.
Examples cf Strongly P o s it iv e  Skin R eaction s.
FIGURE 3.
Example cf a Weakly P o s it iv e  Skin R eaction.
FIGURE 4  (a and b) 
h is to lo g ic a l  Features o f a strongly  P o s it iv e  Skin R eaction .
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FIG, 1
Comparison of Mean Diam eters o f Skin R eactions to  
I n je c t io n s  o f Thyroid Extract w ith  and without 
C ortisone A cetate,
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THYROID & CORTISONE REACTION.cm.
(a) Strongly p o s it iv e  w ith  antigen  alone,
(h) StrongLy p o s it iv e  w ith  antigen  p lu s c o r t iso n e .
(c) E ffect o f co n tro l in je c t io n  o f co rtiso n e  a c e ta te  in  s a lin e .
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FIG. 2
Examples of a Strongly P o s it iv e  Skin R eaction
FIG-. 3.
Example of a Weakly P o s it iv e  Skin R eaction.
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FIG-. 1+ (a) Low Power view  of dermis, showing d iffu se  
in f i l t r a t io n  with inflammatory c e l l s .  (Haematoxylin and e o s in  x  90 )
PIG-, 4(b) High power view  of derm is, showing dense in f la mmatory  
c e l l  in f i l t r a t io n ,  haemorrhages, t is s u e  n e c r o s is , and f ib r in o u s  
exudates. Inflammatory c e l l s  c o n s is t  mainly o f polymorpho-nuc 1 ear 
leucocytes, many o f which are dead or have pyknotic n u c le i.  
(Haematoxylin and eo sin  x 520) .
/shown in  P ig . 1 where the mean diam eters o f the r ea c tio n  to  thyroid  
ex tra ct alone have been p lo tte d  aga in st the measurements obtained  
when co rtison e  was added. In  2 su b jects  (ca ses  12 and 22) a 
weakly p o s it iv e  rea c tio n  was produced w ith thyroid  ex tra ct and 
co r tiso n e , whereas there was a negative rea ctio n  w ith thyroid  a lone. 
In no in stan ce  d id  the intradermal in je c t io n  o f cortison e a ceta te  
and sa lin e  produce a sk in  rea c tio n .
An example o f a stron g ly  p o s it iv e  response i s  shown in  P ig . 2 
and o f a weakly p o s it iv e  rea c tio n  in  P ig . 3* When indurated, the  
le s io n s  were o ften  p a in fu l and tender. The diameters o f the  
indurated areas varied  between 2*3 and 7*23 cm. (average 4 -3  cm .), 
and in  th ose rea c tio n s  where erythema alone was present the diameters 
of the le s io n s  were between 1 .7  and 3*5 cm. (average 2 .5  cm .). 
R esolu tion  was rap id , being complete in  most in stan ces in  48  to  72 
hours. In no case was there v e s ica tio n , suppuration, or u lcera tio n , 
and no lo c a l  sequelae were observed. An immediate erythematous 
f la r e  which faded ra p id ly  was noted in  severa l p a tien ts  inclu d ing  
co n tro ls . T his bore no re la tio n sh ip  to  the c l in ic a l  or ser o lo g ic a l  
f in d in g s , or to  th e  type o f skin rea ctio n  a t  48 hours, and was not 
amenable to  p a ssiv e  tra n sfer  by the Prausnitz-Kustner rea ctio n  in  
4  p a t ien ts  stu d ied .
Biopsy o f  a stron g ly  p o s it iv e  sk in  rea ction  showed extensive  
oedema Mid haemorrhage in to  the dermis and su b cutis. There was 
marked em igration o f  polymorph neutroph ils, many o f which were 
n ecro tic , togeth er  w ith  a few eosin op h il leu cocytes (F ig . 4) • 
H is to lo g ic a lly , weakly p o s it iv e  and negative sk in  reaction s were much 
l e s s  e x te n s iv e /
/ l e s s  ex ten siv e  but th ey  were q u a lita t iv e ly  g&nrfiiw to  the stron gly  
p o s it iv e  rea c tio n  seen  in  fig u re  4 .  The intraderm al in je c t io n  of 
0*2 ml. o f  s a lin e  so lu tio n , or o f  an equal volume o f  an 
in d iv id u a l’ s  own plasma, produced a s im ila r  h is to lo g ic a l  rea c tio n  
to  th a t fo llo w in g  th e  in je c t io n  o f antigen  in  a con tro l subject 
w ith a negative sk in  t e s t .
D iscussion
Stron gly  p o s it iv e  sk in  reaction s characterised  by both erythema 
and in dur a tio n  a f t e r  intraderm al in je c t io n s  o f  human th yroid  t is s u e  
extract were seen  on ly  in  p a tien ts  w ith thyroid  d isea se  who had 
p r e c ip ita tin g  th yroid  auto-antibody in  the serum. A weakly p o s it iv e  
reaction  w ith  erythema on ly  was a lso  seen in  one such p a t ie n t. 
Presumably the sk in  rea c tio n  in  a l l  th ese  p a tien ts  was a m anifest­
a t i o n  o f a lo c a l  an tigen  antibody rea ctio n  occurring between the 
thyroglob u lin  in  th e  inoculum and the c irc u la tin g  p r e c ip it in s . This 
in terp re ta tio n  may a ls o  hold fo r  the 5 p a tien ts  who gave a weakly 
p o s it iv e  r ea c tio n  but who had no demonstrable p rec ip itin s  in  the  
serum; 4  o f th ese  had a form o f thyroid  d isease  in  which p r e c ip it in s  
are known to  occur and the f i f t h  (case 38) p o ss ib ly  had la te n t  fo c a l  
Hashimoto—l ik e  changes in  the thyroid s in ce  she was a euthyroid , 
e ld er ly  fem ale w ith  a p o s it iv e  thyroid CP t e s t  ( 18) • The lack  o f  
a sso c ia tio n  between the sk in  rea ctio n  and p rec ip ita tin g  antibody in  
th ese p a t ie n ts  may thus be due to  the known in s e n s it iv it y  o f the  
p r e c ip it in  rea c tio n . C ircu la tin g  an tibod ies might have been 
demonstrated in  th ese  p a t ien ts  by the TRC method, s in ce  t h is  i s  
more/
/more s e n s it iv e  in  d e tec tin g  thyroglobulin  au to-an tib od ies.
The a s so c ia t io n  between the skin  reaction s and the CP auto- 
/IV  and
an tib od ies (Tables^) was l e s s  c lea r  than w ith the p r e c ip it in  t e s t ,  
and makes i t  unl i ke ly  that a n t i—microsomal auto—an tib od ies were 
invo lved . Thus i t  i s  probable, but not cer ta in , th at the 
changes seen  are those o f an Arthus phenomenon. P rec ip ita tin g  
antibody i s  e s s e n t ia l  fo r  th is  phenomenon; a s  shown above, th is  
type of antibody was present in  a l l  the p a tien ts  w ith stron g ly  
p o s it iv e  sk in  rea c tio n s  and i t  may w e ll have been present even though 
undetected in  those p a t ie n ts  showing a weakly p o s it iv e  rea c tio n .
The r e la t iv e ly  slow  development, the macroscopic appearance, and 
the h is to lo g ic a l  fea tu res  of the sk in  response are in  keeping w ith  
the Arthus phenomenon, but the v a lid ity  of the h is to lo g ic a l  evidence 
i s  doubtful s in ce  th e  con tro l s tu d ies  using e ith er  sa lin e , autologous 
plasma, or th yro id  t is s u e  ex tract produced a q u a lita t iv e ly  s im ilar , 
but l e s s  marked, m icroscopic le s io n . Attempts to transmit 
s e n s i t iv i t y  p a s s iv e ly  to  the rabbit have been unsuccessful (19)> 
although Ovary e t  a l .  (20) and L essof e t  a l .  (21) have demonstrated 
p assive  cutaneous anaphylaxis in  the guinea-pig with p rec ip ita tin g  
a n ti-th y ro g lo b u lin  sera but not w ith complement-fixing thyroid  sera .
As shown in  F ig . 1 , the add ition  o f cortisone to  the intradermal 
in je c t io n  enhanced the sk in  rea ctio n . Citron and Scadding (16) 
observed a si mi la r* e f f e c t  in  tuberculin  sk in  te s t in g , and they  
suggested th a t cortiso n e  prolonged the reten tion  of the inoculum 
at the s i t e  o f  in je c t io n , thus increasing the s e n s it iv ity  o f the 
t e s t .
T h is /
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/T h is  exp lanation  might a lso  apply to  the r e s u lt s  in  the 
present in v e s t ig a t io n ;  p a r tic u la r ly  those o f  the 2 p r e c ip it in  
p o s it iv e  p a t ie n ts  in  cases 11 and 20 in  whom weakly p o s it iv e  sflHym 
rea c tio n s  developed when cortison e was included in  the in je c t io n .
This study was the f i r s t  in  which lo c a l reaction s were observed 
a f te r  the intraderm al in je c t io n  o f  thyroid extract in  p a tien ts  w ith  
spontaneous th yroid  d isea se  although, as previously  mentioned, 
Witebsky e t  a l .  (14-) had noted a delayed type of sk in  rea ctio n  in  
ra b b its  immunised w ith homologous thyroid t is s u e . Witebsky (22) 
and Barwell and White (23) have sin ce  confirmed my fin d in g s.
However, Witebsky (2 2 ) , and a lso  the Lancet (2Jt|«), and S co ttish  
Medical Journal (2 5 ) , have in c lin ed  to  the view that the reaction s  
are m an ifestation s o f " c e l l  bound" or delayed h y p ersen sit iv ity , 
although there i s  nothing in  the present study which supports such 
an in ter p r e ta tio n .
Although th e intraderm al t e s t  may help  to e lu c id ate  the auto­
immune phenomena o f human thyroid d isease i t  should not be used as  
a d iagn ostic  t e s t .  The p r e c ip it in  t e s t  i s  equally e f fe c t iv e ,  and 
there i s  a small but appreciable r isk  o f transm itting homologous 
serum jaundice by th e in je c t io n  o f  human thyroid extract ( 26) .  
Furthermore, such an in je c t io n  in  a suscep tib le  ind ividual may 
induce th yro id  antibody fo im ation . P r e c ip it in  t e s t s  were performed 
one to  four weeks a f t e r  sk in  te s t in g  in  46 p a tien ts , and in  6 o f 
th ese w ith th yroid  d isea se  changes were observed in  the p r e c ip itin  
rea c tio n . Three p a tien ts  w ith auto-immune th y r o id it is  (ca ses  1 , 4 #  
8) the rea c tio n  became weaker or n egative. In one p atien t with  
thyrot oxico s i  s /
/th y r o to x ic o s is  (ca se  30 ) a weak p r e c ip it in  r ea c tio n  developed 3 
weeks a f t e r  the sk in  t e s t ,  but t h is  was no lon ger p resen t 2 weeks 
la te r . Case 15 w ith  primary hypothyroidism  and case  22 w ith  
th y ro to x ico sis  both had weakly p o s it iv e  p r e c ip it in  r ea c tio n s  which 
became stronger a f t e r  the sk in  t e s t .  U nfortunately , the  
s ig n ifica n ce  o f the changes in  the p r e c ip it in  r e a c tio n  in  th ese  
p a tien ts  i s  doubtfu l s in c e  adequate s e r ia l  s tu d ies  to  a sc e r ta in  th e  
constancy o f th e  r e a c tio n  b efore sk in  te s t in g  were not made.
SUMMARY
Intradermal t e s t s ,  using  a sa lin e  ex tract of human thyroid  
t is s u e  as a n tigen , were carr ied  out on 56 subjects o f whom 37 had 
thyroid d ise a se . The sk in  reaction s were c la s s i f ie d  as stron g ly  
p o s it iv e  or weakly p o s i t iv e .  There was a c lo se  co rre la tio n  between 
the presence o f c ir c u la t in g  thyroid  p r e c ip it in s  and stron g ly  p o s it iv e  
skin r e a c tio n s .
In  gen era l, p o s it iv e  sk in  rea ctio n s were observed in  p a tien ts  
with auto-immune t h y r o id it is  or w ith  primary hypothyroidism. With 
one exception  p o s it iv e  rea ctio n s d id  not occur in  in d iv id u a ls  w ithout 
c l in ic a l  evidence o f th yro id  d isea se . The sk in  rea ctio n  was 
compatible w ith  an Arthus phenomenon, and the ad d ition  o f cortison e  
acetate  to  the inoculum tended to  increase the s iz e  o f the rea c tio n .
These fin d in g s  show th a t thyroid antigen i s  capable o f producing 
an abnormal t is s u e  rea c tio n  in  cer ta in  p a tien ts  with auto-immune 
thyroid d ise a se . The demonstration o f t is s u e  damage a t the s i t e  of 
in ocu la tion  o f  the th yroid  an tigen  might be in terpreted  as in d ica tin g  
that some o f the changes seen in  the thyroid in  auto—immune 
th y r o id it is  might be the r e s u lt  o f an antigen antibody rea c tio n .
No evidence has been found th a t " c e l l  bound" or delayed hypersensit— 
s iv i ty  i s  present in  auto-immune th y r o id it is .
S ection  3 . 
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H is to r ic a l A spects 
In  1952 Fromm e t  a l .  ( 1) described  ra ised  gamma-globulins in  
4 p a t ie n ts  w ith  auto-immune t h y r o id it is .  Abnormal c o l lo id a l  gold  
curves were reported  in  2 p a t ie n ts  w ith auto-immune th y r o id it is  
by Cooke and V/ilder ( 2 ) -  an observation  which was la te r  extended  
by Skirpan e t  a l .  ( 3) .  These authors stu d ied  th e  c o l lo id a l  gold  
curves and serum c h o le s te r o l le v e l s  in  19 p a t ie n ts  w ith auto-immune 
th y r o id it is  and found abnormal c o l lo id a l  gold  t e s t s  in  15; they  
concluded th at the c o l lo id a l  gold t e s t  seemed 11 to  be more 
s e n s it iv e  than serum c h o le s te r o l determ inations in  e s ta b lish in g  a 
d ia g n o sis  o f th yro id  fa i lu r e  w ithout g o itre" .
In  1936 Luxton and Cooke (4 ) reported  th a t in  21 o f 24 
p a t ie n ts  su ffe r in g  from auto-immune t h y r o id it is  the c o l lo id a l  gold  
and thymol tu r b id ity  t e s t s  y ie ld e d  abnormal r e s u lt s  which rev erted  to  
normal a f t e r  treatm ent w ith th yro id  ex tra c t in  from 4  to  26 months. 
They considered  th a t th ese  f lo c c u la t io n  t e s t s  might prove of value  
in  the d ia g n o sis  of g o itr e , as they had "not seen p o s it iv e  r e s u lt s  
in  s im p le ,to x ic ,o r  malignant g o itr e s" .
Luxton and Cooke (4 ) a lso  stu d ied  th e  serum albumin and 
g lo b u lin  le v e l s  in  20 p a t ie n ts  w ith  auto-iramune th y r o id it is ;  6 
showed an in crea se  in  g lo b u lin . They a lso  carr ied  out e le c tr o ­
p h o resis  o f the serum p ro te in s  in  6 p a t ie n ts  and found high gamma­
g lo b u lin  le v e l s  in  6 .
Changes in  the e le c tr o p h o r e tic  p a ttern  o f the serum p ro te in s
w ere/
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/ware observed in  16 o f  20 p a t ie n ts  w ith  auto-immune t h y r o id i t i s  
studied by S k ille r n  e t  a l .  (5 ) in  1936; th ese  c o n s is te d  o f  
decreases in  the serum albumin to  low or low-normal l e v e l s  and 
e lev a tio n  o f the gamm a-globulins. Treatment w ith  d e s iec a te d  
thyroid  induced a decrease in  the gamma-globulins a lth ough  not 
u su a lly  to  normal l e v e l s ,  and an in crea se  in  the value o f  th e  serum 
albumin. S k ille r n  e t  a l .  (3 ) a lso  found abnormal c o l lo id a l  go ld  
curves in  20 o f 25 p a t ie n ts ,  abnormal thymol tu r b id ity  t e s t s  in  7 
o f 12 p a t ie n ts , and abnormal z in c  su lph ate tu r b id ity  l e v e l s  in  6 
of 12 p a t ie n ts . These changes were a ttr ib u te d  by th ese  authors to  
the e f f e c t s  o f thyroxine d e f ic ie n c y .
In  1957 R o itt  and Doniach (6 ) c o r r e c t ly  a s so c ia te d  th e  b iochem ical
disturbances w ith  the auto-immune p ro cess . E m pirical l i v e r  fu n c tio n
t e s t s  and d if f e r e n t ia l  serum p r o te in  d eterm inations were ca rr ied  out
by Doniach and Hudson (7 ) in  11 p a t ie n ts  w ith  auto-immune t h y r o id i t i s ,
in  21 p a tien ts  w ith  sim ple n on -tox ic  g o itr e ,  4  p a t ie n ts  w ith  th y ro -
:to x ic o s is ,  and 8 p a t ie n ts  w ith  primary or secondary hypothyroidism
who acted as  c o n tr o ls . R aised gamma-globulins were found in  alm ost
a l l  the p a tien ts  w ith  auto-immune t h y r o id i t i s ,  a lthough th e  t o t a l
serum albumin and g lo b u lin  le v e l s  were normal. The c o l lo id a l  go ld ,
thymol tu r b id ity , and z in c  su lph ate tu r b id ity  t e s t s  a ls o  y ie ld e d
abnormal r e s u lt s  in  alm ost a l l  th e p a t ie n ts  w ith  auto-immune th y ro id -
: i t i s .  in  gen era l, th ese  t e s t s  gave concordant r e s u lt s  although.
"in a few p a tie n ts  the c o l lo id a l  go ld  r e s u l t s  d isagreed  w ith  other
flo ccu la tio n  rea c tio n s  and w ith  the r e s u l t s  o f e lec tro p h o res is"  •
Normal gamma-globulins and serum f lo c c u la t io n  t e s t s  were found in  
th e /
/th e  21 p a t ien ts  w ith  sim ple g o itr e  and in  $ p a t ie n ts  s u ffe r in g  from  
thyroid neoplasms. On t h i s  ev idence Doniach and Hudson (7 ) concluded  
that "paper e lec tr o p h o re s is  in  com bination w ith  f lo c c u la t io n  t e s t s  
provide d ia g n o stic  h e lp  and d is t in g u is h  lymphadenoid g o itr e  from  
simple non-tox ic  g o itr e  and from carcinoma o f  th e  th y ro id 11.
Doniach and Hudson (7 ) a ls o  s tu d ied  th e  serum f lo c c u la t io n  t e s t s  
and serum p ro te in  changes in  a p o s t-o p e r a tiv e  group o f  25 p a t ie n ts  
su ffering  from auto-immune t h y r o id i t i s .  They found th a t  th e  serum 
proteins were normal in  most p a t ie n ts  a lth ough "there was a la g  o f  
several months b efore  t h i s  r e v e r sa l took p la ce" . S im ila r ly  th e  
serum f lo c c u la t io n  t e s t s  were found to  retu rn  to  normal a f t e r  removal 
of th e  g o itr e .
In  1953 Greene e t  a l .  (8 ) rep orted  t h e ir  experien ce  w ith  serum 
f lo ccu la tio n  t e s t s  and e le c tr o p h o r e s is  o f  th e  serum p r o te in s  in  
thyroid d ise a se s . These authors found th e  c o l lo id a l  gold  curve 
abnormal in  8 7 .5 $  o f th e ir  p a t ie n ts  w ith  auto-immune t h y r o id i t i s  a s  
compared w ith  31 • 3% in  o th er  th y ro id  d is e a s e s , and concluded th a t  
th is  t e s t  was "a f a i r l y  good, but not in v a r ia b ly  r e l ia b le  c r i t e r io n  
of Hashimoto* s  d ise a se  when o th er cau ses o f  abnorm ality have been  
excluded". Greene e t  a l .  (8 ) a ls o  found r a ise d  gamma-globulin  
le v e ls  and decreased serum albumin v a lu es  on e le c tr o p h o r e s is  o f  th e  
sera o f  8 p a t ie n ts  w ith  auto-immune t h y r o id i t i s ,  and su ggested  th a t  
the albumin/gamma-globulin ' r a t io  might be a  u s e fu l  d ia g n o st ic  
cr iter io n  fo r  th e  d is e a s e . The r e s u l t s  o f  th e  f in d in g s  in  a p o s t­
operative group o f  p a t ie n ts  w ith  auto-immune t h y r o id i t i s  confirm ed  
the previous observation  o f  Doniach and Hudson (7 ) th a t  thyroidectom y  
causes the e lec tr o p h o re tic  p a ttern  to  retu rn  to  normal.
ghnfm*n e t  a l .  (9 ) could  f in d  no s p e c i f ic  abnorm ality i n  th e  
e lectrop h oretic  p a ttern  i n  51 p a t ie n ts  whom th ey  stu d ied ; th u s ,
20 had e leva ted  gamma-globulins, 6 r a is e d  b e ta -g lo b u lin s , 23 r a ise d  
alpha-2 and 10 r a ise d  alpha-1 g lo b u lin s , and th e  serum album in was 
lowered in  6 . Moreover, th ese  workers could  f in d  no c o r r e la t io n  
between the gamma-globulin le v e l s  and th e  t i t r e s  o f  TEC a u to -a n tib o d ie s  
and concluded th a t "such a n a ly ses  are o f no r e a l  c l i n i c a l  va lu e" •
P erson a l O bservations  
Although c o n s is te n t ab n orm alities  have been d escr ib ed  i n  auto­
immune th y r o id it is  by a number o f  w orkers, i t  i s  d i f f i c u l t  to  ev a lu a te  
th e ir  extent because in  most o f  the s tu d ie s  th e  number o f  p a t ie n ts  
has been small and th e  con tro l data inadequate fo r  s t a t i s t i c a l  
assessm ent. The purpose, th er e fo re , o f  th e  p resen t s e c t io n  o f  th e  
th e s is  i s  to  study th e  serum p r o te in  abnormal! t i e s  in  t h i s  d ise a se  
and to compare them w ith  th e changes occurring in  o th er  th y ro id  
d iseases which may o ccasion  d ia g n o stic  d i f f i c u l t y ,  n o ta b ly  sim ple  
non-toxic g o itre  and th yro id  neoplasm. S in ce many p a t ie n ts  w ith  
auto-immune t h y r o id it is  are hypothyroid and s in c e  a  few  p resen t w ith  
the c l in ic a l  fe a tu re s  o f th y r o to x ic o s is  th e  serum p r o te in  changes in  
primary hypothyroidism, and th y r o to x ic o s is  have been s tu d ie d . A lso , 
since changes in  th e  serum p r o te in s  are R e fle c te d  in  th e  standard  
serum flo c c u la tio n  t e s t s  and the d ia g n o stic  use  o f  th e  l a t t e r  has  
been advocated (4 » 7 ,1 0 ) , t h i s  group o f  t e s t s  has a ls o  been  ev a lu a ted . 
Opportunity has a lso  been taken to  a sse ss  th e  value o f th e  e ry th ro ­
cyte sed iaen ta tio n  ra te  ( r a t)  in  th e  d iagnosis o f auto-immune 
th y ro id it is ,/
TABLE I.
R esu lts  of D eteim in ation s and E le c tr o -p h o r e s is  o f  
of the Serum P ro te in s  in  Thyroid D ise a se .
TABLE I I .
R esu lts  o f Serum F lo c c u la t io n  T ests  and E rythrocyte  
Sedim entation R ates in  Thyroid D ise a se .
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TABLE I .
R esults of Determinations and Electrophoresis of the Serum Proteins
in  Thyroid Disease.
C lin ical
Group.
Total No. 
of 
Cases
Albumin 
(g./lOO ml.) 
Mean S.D.
Globulin 
(g./lOO ml.) 
Mean S.D. Mean
0C1
S.D.
Globulin Fractic 
oC 2 
Mean S.D.
ns ml. 
0
Mean S.D.
.
Mean
r
S.D.
Normals. 26 5-2 -  0 .4 1.9 -  0 .3 0.20 -  0.05 0.43 -  0.09 O.55 -  0.11 0.74 -  0.15
Auto-immune
T h y ro id itis .
41 4 .2 1 +
 
O ■U 2.4 -  0.6 0.20 -  0.09 0.44 t  0.13 0.57 -  0.12 1.25 +- O.5O
Primary
•Hypothyroidism.
40 4 .3 -  0.4 2.0 -  0.5 0.18 *  0.07 0.40 -  0.18 O.65 -  0.24 0.83 *  J .23
Simple Goitre 33 4-9 1 0.5 1.9 1 0 .3 0.20 -  0.12 0.40 -  0.09 0.51 -  0.10 0.79 -  0 .I4
Thyrotoxicosis. 37 4.1 -  0.4 1.9 -  0.4 0.18 -  0.04 0.37 -  0.17 O.52 -  0.13 0.82 -  0.19
Thyrotoxicosis with 
Exophthalmic 
Ophthalmoplegi a .
16 4.1 -  0.4 1.9 ± 0.4 0.20 i  0.06 0.43 -  0.16 0.50 i  0.08 0.82 -  0.19
Treated
Thyrotoxicosis.
16 4-7 1+ 0 -Ch. 1.8 -  0.2 0.19 -  0 .0 4 0 .3 7 -  O .1 5 0 .5 0 -  0 .0 7 0 . 7 7 -  0 .1 9
Thyroid Neoplasm. 15 4-5 -  0.6 1.9 -  0.2 0.21 -  0.05 O.50 -  0.10 O.46 -  0.06 O.78 -  0.10
i
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TABLE I I .
R e su lts  o f  Serum F lo c c u la tio n  T e s ts  and E ry th rocy te  Sedim entation R ates 
i n  Thyroid D isease .
C l in ic a l
Thymol T u rb id ity , 
(normal 0 - 2  u n i t s ) .
Thymol F lo c cu la tio n , 
(normal 0 u n i ts ) .
Cephalin  C h o leste ro l 
(normal 0 ) .
Group. 0 - 2 3 - 5 5
T ota l
Ho.
51
Abnormal 0 1 -  2 3 - 4
Total
No.
*
Abnormal 0
+ and 
++ +++
Total
No.
i
Abnormal
Auto-immune
T h y r o id i t is . 11 16 14 41 73 .2 18 8 15 41 56.1 8 6 8 22 63.6
Prim ary
H ypothyroidism . 42 13 0 55 23.6 48 5 2 55 12.7 26 5 1 32 18.8
Simple G o itre . 118 9 0 127 7.1 125 2 0 127 1.6 44 15 1 60 26.7
T h y ro to x ic o s is . 153 13 0 166 7 .8 150 12 0 162 7-4 56 31 12 99 43.4
T h y ro to x ic o s is  w ith
Exophthalm ic
O phthalm oplegia.
15 0 0 15 0 14 1 0 15 6.7
2 1 0 3 33.3
T rea ted
T h y ro to x ic o s is . 11 3 0 16 18.8 15
1 0 16 6.3 4 2 1 8 37.5
Thyroid Neoplasm 15 1 0 16 6 .3 15 1 0 16 6.3 2 0 0 2 0
--------------
C l in ic a l
Group. 0 -  1
C o llo id a l Gold 
(normal 0 — 1 u n its )*
2 - 3  4 - 5  Tr *Abnormal 5 - 1 2
Zina Sulphate T u rb id ity  
(normal 5 - 1 2  u n i ts ) .
12 -  25 25 *Abnorm al
(normel 0 -  
Mean Benge
E.3.B .
12 n o . / f i r s t  h r .)
Total i  
No. Abnormal.
Auto-ianune
T h y ro id i t is . 13 6 21 40 67.5 5 16 7 28 82.1 ro -U 1 C
O 41 68.3
Prim ary
H ypothyroidism. 19 15 7 41 53.7 11 12 0 23 5 2 .2 19 3 - 5 5 4j 62.8
Simple G o itre . 50 33 21 104 51-9 28 15 1 44 36.4 7 1 - 2 0 106 6. 7
T h y ro to x ic o s is . 58 46 34 138 58 .O 36 21 0 57 36.9 6 1 -  IS 134 7-5 j
T h y ro to x ico sis  » i th
Exophthalmic
Ophthalm oplegia.
7 4 3 14 5 0 .0 6 6 0 12 5 0 .0
T reated
T h y ro to x ico s is .
7 6 3 16 56.3 6 2 0 8 25 .O
Thyroid Neoplasm 5 4 3 12 58-3 7 3 0 10
3 0 .0 26 5 - 6 8 15 6 6 .7  j
/ t h y r o id i t i s ,  s in ce  t h i s  has been found e ith e r  normal (11 ,12) or 
m oderately e lev a ted  (7 ,13-15)*
M aterials and Methods 
Serum p ro te in  an a lyses were carried  out in  28 normal co n tro ls  and 
182 p a t ie n ts  w ith  thyroid  d isease  l i s t e d  in  Table 1 (see  Appendices 
fo r  fu rth er  d e t a i l s ) .  The la t t e r  included: 41 p a tien ts  w ith auto­
immune t h y r o id it is ,  40 p a tien ts  w ith primary hypothyroidism, 33 
p a tie n ts  w ith simple non-toxic g o itr e , 69 p a tien ts  with th y ro to x ico s is , 
in clu d in g  16 p a tien ts  w ith  exophthalmic ophthalmoplegia and 16 
euthyroid p a t ien ts  a f te r  various forms of therapy, and 15 p a tien ts  
w ith  thyroid  neoplasm. Serum flo c c u la tio n  t e s t s  were a lso  carried  
out in  a to t a l  o f 420 p a tien ts  w ith thyroid d isease (Table H )  who 
included: 41 w ith auto-immune th y r o id it is , 55 with primary hypo­
thyroidism , 127 w ith simple non-toxic g o itre , 181 with th y ro to x ico s is  
in c lu d in g  15 w ith exophthalmic ophthalmoplegia, and 16 euthyroid  
a f te r  treatm ent, and 16 p a tien ts  with thyroid neoplasm (see  
Appendices fo r  fu rther d e ta i l s ) .  The ESR was carried  out in  a to ta l  
W  339 p a tien ts  w ith thyroid d isease . (Table H ) .
The diagnosis of auto-immune th y r o id it is , simple non-toxic  
g o itre  and thyroid neoplasm, was based on the c r ite r ia  described  
in  th is  Chapter of the th e s is . The d iagnosis o f th yro tox icosis  
(16 ,17) and primaiy hypothyroidism (17) were based on the methods 
described elsewhere. P atien ts with systemic d isea se , which might 
have been associated  with changes in  the serum p rote in s, were 
excluded from the study.
Serum protein  estimations/^
/Serum prote in  estim ation s were carried  out by the b iu ret  
method of G-ornall e t  a l .  ( 18) .  F i l t e r  paper e lec tro p h o resis  was 
performed on serum using the h orizon ta l s tr ip  method; a f te r  s ta in in g , 
qu an tita tive  evaluation  of the p ro te in  p attern  was carried  out using  
an "E.E.L." scanner. The percentage value thus found was expressed  
as g . per 100 ml. o f serum from the to t a l  value of the seium g lob u lin .
The serum f lo c c u la t io n  t e s t s  were carried  out by the standard 
laboratory methods and included thymol tu rb id ity  ( 19) and f lo c c u la t io n  
( 20) ,  z inc sulphate tu rb id ity  ( 21) ,  cephalin ch o le ster o l (22 ), and 
c o llo id a l gold ( 23) r ea c tio n s . The ESR was performed by the method 
o f Westergren ( 24) .
T ests  fo r  thyroid  auto-antibod ies were carried  out by both  
p r e c ip it in  and CF methods as described in  Section  1 of th is  Chapter.
R esu lts
The r e s u lt s  o f the serum p rote in  determ inations are summarised 
in  Table 1 and th e serum flo c c u la t io n  t e s t s  and the ESR in  Table I I .  
Auto-immune th y r o id it is .  The mean serum albumin in  the p a tien ts  with  
auto-immune th y r o id it is  was 4*2 g. per 100 ml. (SD -  0 . 4 ) which was 
s ig n if ic a n t ly  lower (P {0 .0 0 1 ) than the mean value of 5*2 g . per 
100 ml. (SD -  0 .4 )  found in  the normal su b jec ts . The mean serum 
glob u lin  o f 2 .4  g . per 100 ml. (SD -  0 .6 )  in  the former was s ig n i f i c -  
:a n tly  higher (P ^  0.001) than the normal mean value of 1 .9  g. per 
100 ml. (SD -  0 .3 )*  This increase in  to ta l  g lobu lins was e n t ir e ly  
due/
* I  am g ra te fu l to  Dr. E.BHendry and h is  s t a f f  o f the Biochem istry  
Department o f the Western Infirmary fo r  carrying out a l l  the serum 
p ro te in  estim ation s and serum flo c c u la t io n  t e s t s  reported in  th is  
se c tio n .
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/d u e to  an in crease  in  the gamma-globulin fr a c tio n  (P^O .OOl).
Twenty*-two o f the 36 p a tien ts  (61 per c e n t.)  in  whom e lec trop h oresis  
was performed had gamma-globulin values which exceeded the h igh est  
value (l.O g . per 100 m l.) found in  the normal group (see  Appendices). 
There was a h ig h ly  s ig n if ic a n t  co rre la tio n  between the g o itre  s iz e  
and the le v e ls  o f gamma-globulin (r  = 0 .3k , P ^ 0 .0 0 1 ) .
The various serum flo c c u la t io n  t e s t s  were abnormal in  36 to  82 
per cen t, o f p a tien ts  w ith auto-immune th y r o id it is  (Table I I )  and 
the mean ESR (23 mm. in  the f i r s t  hour) was r a ise d . The ESR exceeded 
the upper l im it  o f  the normal range (12 mm. in  the f i r s t  hour) in  27 
o f the p a tien ts  (6 8 .3  per c e n t . ) .  There was a co rre la tio n  between 
the thymol tu rb id ity  r e s u lt s  and the le v e ls  o f gamma-globulins 
(r  = 0 .385 , P = 0 .0 2 ) .
Primary Hypothyroidism. The mean serum albumin in  the p a tien ts  w ith  
primary hypothyroidism was 4*3 6* per 100 ml. (SD i  0 .4 ) ,  which was 
s ig n if ic a n t ly  lower (P {0 .0 0 1 )  than the normal mean value o f 5*2 g. 
per 100 ml. (SD -  0 .4 ) .  The to t a l  serum g lob u lin , on the other hand, 
was on ly  s l ig h t ly  increased , although there was a suggestive increase  
in  the beta  and gamma (p ^ O .1) g lob u lin s. The trends were
present to  a greater extent in  p a tien ts  w ith a p o s it iv e  p r e c ip it in  
t e s t ,  but the sm all number (8 p a tien ts) does not permit s t a t i s t i c a l  
a n a ly s is . Seven of the 40 p a tien ts  (17 per c en t.)  had a serum gamma­
globu lin  value which exceeded 1 .0  g. per 100 ml.
The various serum flo c c u la tio n  t e s t s  were p o s it iv e  in  12 .7  to  
53*7 per cent, o f the p a tien ts  (Table I I )  and the mean ESR (19 d®1* i n 
th e /
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/ t h e  f i r s t  hour) was increased . The ESR exceeded the upper l im it  
o f the normal range in  27 of 45 p a tien ts  (62 .8  per c e n t . ) .  The 
fin d in g  o f a ra ised  ESR in  some cases o f primary hypothyroidism i s  
in  agreement w ith  the observations o f MacAlpine (25) and L illin g to n  
e t  a l .  (2 6 ) .
Simple Non-toxic G-oitre. The mean serum albumin was 4*9 6* per 
100 ml. (SD -  0 .5 )  in  p a tien ts  w ith simple non-toxic g o itr e , which 
was sL igh tly , but s ig n if ic a n t ly , lower (P ^ 0 .0 2 ) than the mean value 
o f the control s e r ie s .  The to t a l  g lobu lins and the d ifferen t  
g lob u lin  fr a c tio n s  did n ot, however, d if fe r  s ig n if ic a n t ly  from the 
normal. Only 2 o f the 55 p a tien ts  (6 per c e n t.)  had gamma-globulin 
l e v e l s  exceeding 1 .0  g. per 100 ml.
The serum flo c c u la tio n  t e s t s  were abnormal in  only a few 
p a tien ts  w ith the exception o f the cephalin c h o le s ter o l, zinc  
sulphate turbidity^ and c o llo id a l gold tests^which were abnormal in  
2 6 .7  per c e n t .,  56 .4  per c e n t .,  and 51*9 per c e n t ., r e sp e c tiv e ly  
(Table I I ) • The ESR (mean 7 mm. in  the f i r s t  hour) la y  w ith in  the  
normal range in  the m ajority o f the p a tien ts  although in  11 ( .6 .7  per 
c e n t.)  i t  was s l ig h t ly  e levated .
T h yrotox icosis . The mean serum albumin (4*1 g. per 100 ml. SD -  0 .4 )  
was more markedly/ (P ^ .001) in  th is  d isease  than in  any other thyroid  
disorder (Table I ) . The to ta l  serum g lobu lins were normal; but 
there was a s l ig h t  increase in  the gamma-globulins (P ^ O .1 ). Four 
of the 57 p a tien ts  (11 per c en t.)  had gamma-globulin values exceeding  
1 .0  g. per 100 ml.
The serum f lo c c u la t io n  t e s t s  were abnormal in  a high proportion  
of th e /
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/ o f  the p a tien ts ; in  p a rticu la r  the zinc sulphate tu rb id ity  ( 36*9 
per c e n t .) ,  the cephalin  c h o le s ter o l (43*4  per cent.)^and c o llo id a l  
gold (58 .0  per c e n t.)  t e s t s  (Table I I ) .
The ESR (mean = 6 mm. in  the f i r s t  hour) was w ith in  the normal 
range in  the m ajority of the p a t ie n ts , although in  19 ( 7 »5 per c e n t.)  
i t  was s l ig h t ly  ra ised .
P a tien t3 w ith th y ro to x ico s is  com plicated by severe exophthalmos 
had sim ila r  abnorm alities to  those found in  uncomplicated th y ro to x ic-  
:o s is  and do not m erit separate consideration .
The th y ro to x ico s is  was treated  by e ith e r  an tith yro id  drugs or by
131I  therapy and th is  tended to reverse the serum p rote in  abnorm alities; 
the mean serum albumin in  the group of treated  and euthyroid p a tien ts  
being 4 .7  g* per 100 ml. (SD -  0 .4 )  as compared w ith 4*1 g* per 100 ml. 
(SD -  0 .4 )  in  the untreated group.
Thyroid neoplasm. These p a tien ts  had an abnormally (P ^ 0 .001) 
decreased serum albumin (mean 4*5 g* per 100 ml. SD -  0 .6 ) ,  whereas 
the to t a l  serum g lob u lin s were normal. However, the alpha-2 g lob u lin s  
were increased  (P ^ 0 .0 5 ) and the beta g lobu lins decreased (P ^ O .O l).
None o f the p a tien ts  w ith thyroid neoplasm had gamma-globulin le v e ls  
exceeding 1 .0  g . per 100 ml.
The thymol tu rb id ity  and flo c c u la tio n  t e s t s  and the cephalin  
c h o le stero l were normal in  most ca ses , although the zinc sulphate 
tu rb id ity  and c o llo id a l  gold t e s t s  gave abnormal r e s u lt s  in  30 and
58 .3  per cen t, r e sp e c t iv e ly  (Table H ) . The mean ESR (26  mm. in  the 
f i r s t  hour) was increased  and exceeded the upper lim it  o f the normal 
range in  9 (6 6 .7  per c en t.)  of the p a t ie n ts .
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D iscussion
An increase in  the gamma-globulin fr a c tio n  o f  the serum p rote in s  
in  auto-immune th y r o id it is  has been reported by other workers 
(1 >4>5*7-9); and in  th is  study the le v e l s  found have been compared 
s t a t i s t i c a l l y  w ith  those in  other thyroid d ise a se s . When system ic  
disorders a sso c ia ted  w ith  serum p rote in  abnorm alities are excluded  
the fin d in g  o f an e levated  gamma-globulin i . e .  exceeding 1 .0  g . per 
100 ml. can be considered as strong supportive evidence o f auto-immune 
th y r o id it is .  On the other hand a normal le v e l  of gamma-globulin 
does not exclude the d iagn osis sin ce  in  about h a lf  o f  the p a tien ts  
in  the present study the gamma-globulin le v e l  was below 1 .0  g. per 
100 ml. A s l ig h t  in crease  in  the gamma-globulins was a lso  found in  
p a tien ts  w ith primary hypothyroidism and th is  was p a r tic u la r ly  marked 
in  those w ith p r e c ip ita tin g  an tib od ies to  thyroglobulin . This i s  
co n s isten t w ith the view th a t th e r is e  in  the gamma-globulins i s  
asso c ia ted  w ith the auto-immune response and not w ith hypothyroidism  
per se (2 7 ) .
Doniach e t  a l .  (28) have reported th at the le v e ls  o f p r e c ip it in s  
in  auto-immune th y r o id it is  are in  the region  o f 700 mg. per 100 ml. 
although higher le v e l s  up to  1890 mg. per 100 ml. have been reported  
(2 9 ) . The fin d in g  o f a mean r is e  of 510 mg. per 100 ml. in  p a tien ts  
with auto-immune th y r o id it is  i s  co n sisten t w ith most, i f  not a l l ,  
o f the in crease  in  the gamma-globulin concentration being due to  the  
c irc u la tin g  p r e c ip it in s . However, Humphrey and h is  co lleagues  
(30 ,51) have shown th at the r i s e  in  gamma-globulins to  an antigen ic  
stim u lu s/
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/s tim u lu s  may a lso  be p a r tly  a ttr ib u ted  to  the syntheses o f non­
s p e c if ic  antibody.
The fin d in g  o f a low serum albumin in  a l l  forms o f thyroid  
d isease  e lim in ates th is  determ ination as a d iagn ostic  t e s t  fo r  auto­
immune th y r o id it is .  The low le v e l s  found in  auto-immune th y r o id it is  
and primary hypothyroidism may be a sso c ia ted  w ith diminished albumin 
syn th esis  by the l iv e r  due to  o ccu lt or overt hypothyroidism ( 32) ,  
and K line (33) has demonstrated dim inution in  the lib e r a t io n  o f  
n itrogen  and amincu-acids from l iv e r  s l i c e s  o f hypothyroid r a ts .  The 
s tr ik in g  decrease in  serum albumin in  th y ro to x ico s is  confirms previous 
observations (32  , 34, 35) and i s  probably accounted fo r  by an 
increased  breakdown o f albumin in  the peripheral t is s u e s  (36), although  
impairment o f hepatic  syn th esis  has a lso  been invoked (32 ,35) • The 
low le v e l s  o f serum albumin may be a r e f le c t io n  o f the poor in take o f  
p rotein  in  th ese  p a tien ts  (3 7 ) , but the low le v e ls  in  simple non-toxic  
g o itre  i s  not as y e t explained.
As p rev iou sly  mentioned, severa l authors (4 ,7 ,1 0 )  have advocated  
the use o f serum f lo c c u la t io n  t e s t s  in  the d iagn osis o f auto-immune 
th y r o id it is .  In the present study the cephalin c h o le s ter o l, 
c o llo id a l gold , and zinc sulphate tu rb id ity  t e s t s  were found o f l i t t l e  
p ra c tica l value sin ce  they were freq u ently  p o s it iv e  in  p a tien ts  w ith  
simple non-toxic g o itre  and thyroid neoplasm. On the other hand the 
thymol tu rb id ity  and thymol f lo c c u la tio n  t e s t s  were found to  be more 
s p e c if ic . Although negative in  about a quarter o f the p a tien ts  w ith  
auto—immune th y r o id it is  these t e s t s  were ra re ly  p o s it iv e  in  simple 
non-toxic g o itre  and thyroid  neoplasm, conditions most l ik e ly  to  be 
confused w ith  auto-immune th y r o id it is .
F in a l ly , /
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/F in a l ly ,  the value o f the ESR determ ination should not be 
underestimated; th is  was normal in  93 per cent o f p a t ien ts  w ith simple 
non-toxic g o itre  and e levated  in  68 per cent o f  p a tien ts  w ith auto­
immune th y r o id it is .
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SUMMARY
Serum p rote in  e lec tro p h o res is , f lo c c u la tio n  t e s t s ,  and ESR 
determ inations, were stud ied  in  28 health y contro l su b jec ts , 41 
p a tien ts  w ith  auto-immune th y r o id it is ,  and a large number o f  
p a tien ts  w ith various other forms o f thyroid  d ise a se . The s tr ik in g  
f in d in g s  were the ra ised  gamma-globulin le v e l  in  auto-immune 
th y r o id it is  and the decreased serum albumin le v e l  in  th y ro to x ico s is . 
I t  i s  concluded th at a ra ised  gamma-globulin, abnormal thymol 
tu rb id ity  and flo c c u la tio n  t e s t s ,  and an e levated  ESR, are o f  
d iagn ostic  value in  auto-immune th y r o id it is .
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Section A.
Iodine Metabolism in  
Anto-inmane T h y ro id itis .
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INPRODUCTION
In  recen t years 3 developments have f a c i l i t a t e d  the study o f  
iod in e  metabolism and thyroid  fu n ction  in  man: f i r s t l y ,  the use o f
ra d io iso top es o f iod in e; secondly, the p er fec tio n  o f accurate methods 
fo r  the separation , id e n t if ic a t io n , and chemical determ ination o f the 
extrem ely sm all amounts o f iod inated  compounds in  the thyroid  and 
ex tra -th yro id a l t is s u e s ;  and th ird ly , the d iscovery o f the a n ti thyroid  
drugs, which, by in te r fe r in g  w ith cer ta in  s p e c if ic  step s in  the 
b io sy n th esis  o f the thyroid  hormones, have enabled a more d e ta iled  
study o f thyroid  fu n ction . Much o f t h is  work has been reviewed  
( 1 - 7 )  and need not be r e iter a te d  here; only th ese  aspects d ea lin g  
w ith q u an tita tive  measurements o f iod ine metabolism w i l l  be o u tlin ed .
Stable Iodine Metabolism
In a b r i l l ia n t  th e o r e tic a l review on the q u an titative a sp ects  o f  
iod in e  metabolism in  man Riggs (8) sta ted  that: ”A sharp d is t in c t io n
must be drawn between the kind o f inform ation obtained w ith tra cer  
doses o f ra d io a ctiv e  iodine and the kind o f  inform ation obtained w ith  
chemical methods o f a n a ly s is . Tracer stu d ies are id e a l fo r  the 
measurement o f  the proportion o f the iod ine in  the body which fo llo w s  
a p a rticu la r  m etabolic pathway and fo r  the study o f the ra te  o f  
turnover o f  iodine w ith in  the various compartments. By them selves, 
however, tra cer  s tu d ies  cannot in d ica te  the a ctu a l amounts o f  iod in e  
which are being m etabolised” , Koutras e t  a l .  ( 9) have c le a r ly  
demonstrated th at the rad io iod ine uptake depends not only on the le v e l  
o f /
/ o f  thyroid  a c t iv i t y ,  but a lso  on the concentration o f iod in e  in  
th e plasma {pnjj; and lik ew ise  th at the PBI^*  ^ not only  depends on
the amount o f hormone being produced, but a lso  on the ra te  o f  turnover 
of the iso to p e  by the thyroid  and th s s iz e  o f the in tra th y ro id a l 
exchangeable iodine (IEI) p o o l.
Measurement o f  PH and Absolute Iodine Uptake (AIU).
In normal circum stances the le v e l  of PH i s  too sm all to  be
measured d ir e c t ly  by chemical methods (1 0 ) . Stanley (11) in  19^9
was the f i r s t  to  use an in d ir ec t method o f  measuring both the PH
and th e absolute (s ta b le )  uptake o f iod ine by the thyroid (AIU)
based on the p r in c ip le  of iso to p ic  d ilu tio n . Since the thyroid  and
kidney cannot d is tin g u ish  between rad ioactive  and sta b le  iod in e
atoms, the s p e c if ic  a c t iv i t y  o f the iod ine ( i . e .  the proportion o f
the rad ioactive  to  th e to t a l  iod in e atoms) going in to  the thyroid
i s  the same as the s p e c if ic  a c t iv i t y  o f the inorganic iod in e present
in  plasma and urine. The s ta b le  amount o f iod ine accumulated by
the thyroid  i s  expressed as AIU, the uptake o f  rad ioiod ine during the
131same period o f time as I  , the le v e l  o f plasma and urinary
131 131inorganic and radioiod ine as PH and PII , and UII and UH ,
r e sp e c tiv e ly , then:
PII UII AIU
Therefore, PH  = x UII
A lte r n a tiv e ly  the AIU can he derived from knowledge o f the 
volume o f  plasma cleared  o f i t s  iod ine content in  un it time ( i .e .  
the thyroid clearance) and the concentration o f iod ine in  th is  
volume o f  plasma. Thus:-
AIU = thyroid  clearance x P H .
Several workers (10, 12-17) have used methods based on th ese  
p r in c ip le s  fo r  stu d ies  o f sta b le  iod ine metabolism, although  
German workers (18-20) have preferred sa liv a  to  urine. These 
authors have claimed th at sa liv a ry  iod in e i s  e n t ir e ly  inorganic, 
whereas urinary iod in e  a lso  contains some inorganic compounds. 
However, w ith the exception o f rare cases o f dehalogenase d e fec t  
(21 , 2 2 )|ad m in istra tion  o f organic iod in e compounds (23), 
nephrosis (24), and in  some thyrotoxic p a tien ts  ( 25), the iodine  
normally present in  the urine i s  almost e n t ir e ly  in  th e  inorganic  
form ( 7 ) .  Furthermore, c o lle c t io n  o f urine i s  both e a s ie r  and 
more accurate than th at o f sa liv a  and i s  on the whole p referab le .
Measurement o f USI 
S im ilar ly  on the b a s is  o f iso to p ic  d ilu tio n , the IKI can be 
measured (2 6 ) . A fter  the adm inistration  o f a tracer  dose o f  
rad io iod in e , the s p e c if ic  a c t iv i t y  o f hormone in  the blood—stream  
w i l l  gradually approach th a t in  the thyroid gland. When the two 
s p e c if ic  a c t iv i t i e s  become equal: then,
PBI in  th e thyroid (IEI) _ PBI in  the blood  
PBI1^1 in  the thyroid  PBI1^1 in  the blood .
From t h is  equation i t  can be seen th at organic iod ine in  the 
th y ro id /
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/th y ro id  (PBI in  the thyroid) or 3EI can be derived:
_ PBI (blood) x  PBI131 ( thyroid)
PBI131 (blood)
Measurement o f Serum PBI 
Estim ation of the amount o f iod ine (c h ie f ly  in  the form o f  
thyroxine) which i s  bound to  plasma prote in s (PBI) i s  a lso  
necessary  i f  a complete p ictu re  o f  iod in e  metablism i s  to  be 
obtained. I t  i s  probably the b est t e s t  o f thyroid  fu n ction  
cu rren tly  a v a ila b le  (5) and has an o v e ra ll accuracy o f over 90 per 
cent (27) • The p r in c ip le  step s in  the estim ation  o f  the serum PBI 
include: ( 1) separation o f  PBI from inorganic io d in e , ( 2 ) p rote in
d ig e s tio n  and is o la t io n  o f  bound iod in e in  a form su ita b le  fo r  
estim ation , and ( 3) co lorim etric  determ ination using the iod ide  
ca ta lysed  c e r ic -a r se n ite  rea ctio n . A lkaline ashing and d ig estio n  
w ith d i s t i l la t io n  have been w idely used fo r  p rote in  d ig e stio n , but 
are te c h n ic a lly  d i f f i c u l t .  Zak e t  a l .  (28) s im p lified  th is  la t t e r  
procedure by using a ch lo r ic  acid  d ig estio n  method. FarreH and 
Richmond (29) have m odified the ch lo r ic  ac id  d ig estio n  method, 
improved the i n i t i a l  separation  o f inorganic iodine from p ro te in -  
bound iod in e by using an anion-echange r e s in  column, and s im p lified  
the f in a l  co lorim etric  measurement by applying a brucine c a ta ly t ic  
in h ib ito r . F arrelland Macgregor (30) and Richmond e t  a l .  (31) 
have reported co n sisten t and r e lia b le  r e s u lt s  using th is  method.
Measurement o f Butanol-extrable Iodine (BKE).
Although the PBI i s  gen era lly  regarded as a measure o f the
c ir c u la t in g /
156.
/c ir c u la t in g  thyroid hormone, i t  i s  n everth e less  the r e s u lt  o f 2 
parameters o f thyroid  hormone production, namely the ra te  o f  
form ation and the ra te  o f peripheral degradation. Furthermore, 
included in  the estim ation  o f the to t a l  PBI are other iod in ated  
p rote in  complexes. Since both thyroxine and triiodothyronin e are 
soluble in  butanol ( 32) j the butanol extractab le  protein-bound iod in e  
(EEl) g iv es  a more accurate determ ination o f the c irc u la tin g  
thyroxine le v e l  (33)* A sim ila r  ex traction  procedure can a lso  be 
used to  recover lab elled -th yrox in e  from the t o t a l  PBI (3 4 ) .
A f u l l  p ic tu re  o f iod ine metabolism can only be obtained by 
simultaneous measurement o f the various aspects o f thyroid fu n ction ;  
a p oin t f i r s t  emphasised by Riggs (8 ): "Chemical methods on the
other hand g ive valuable inform ation concerning the q u a n tities  o f 
iod in e  w ith which the body d ea ls , but by them selves provide no more 
than a dim o u tlin e  o f the dynamics o f  iod ine metabolism. Only by 
the combined use o f rad ioactive  iod in e tracers and o f chemical 
methods can a c lea r  p ictu re  o f the o v e r -a ll  metabolism o f  io di ne be 
obtained."
H is to r ic a l A spects o f Iodine Metabolism in  Auto-immune T h y ro id itis .
In 1949, Werner (35) f i r s t  observed that the radioiod ine  
uptake may be e ith e r  low or normal in  auto-immune th y ro id itis#  This
fin d in g  was confirmed by others (36“4 8 ) , although in  severa l 
p a tien ts  without c l in ic a l  evidence o f th y ro to x ico sis  the thyroid  
uptake was noted to  be in  the th yrotoxic  range (3 6 ,3 9 ,4 0 ,4 2 ,4 4 ,4 5 , 
4 7 ,4 8 ) .
In general a poor co rre la tio n  was found between the thyroid gland 
uptake o f  radioiod ine and the c l in ic a l  sta tu s; and S k ille r a  e t  a l .  
(4 0 ) , Doniach and Hudson (4 7 ) , and Murray and McG-irr (4 8 ) ,  
concluded th at the measurement o f the thyroid  gland uptake alone  
was o f no d iagn ostic  value in  th is  d isea se .
Goodwin e t  a l .  (49) observed a high P B I ^  (2 .3 ^ /d .o se /litr e )  
in  one p a tien t w ith auto-immune th y r o id it is , but Werner ( 36) appears 
to  have been the f i r s t  to  draw a tten tio n  to  th is  anomaly. Beare (42)
A  " Z A
recorded a PBI value in  the thyrotoxic range (0.66fo d o s e / l i t r e )  
in  a p a tien t who was hypothyroid, and Doniach and Hudson ((47)  
observed high values in  4  o f th e ir  p a t ie n ts . Doniach and Hudson (47) 
in terp reted  th ese fin d in g s as in d ica tin g  th at "in lymphadenoid g o itre  
there i s  a sm all in tra th yro id a l iodine pool w ith a high s p e c if ic  
a c t iv ity " ;  and in  support o f  th is  these authors found a much shorter  
b io lo g ic a l h a l f - l i f e  o f a tra cer  dose o f radioiod ine (2*8 to  12 days) 
in  4  p a tien ts  with auto-immune th y r o id it is  as compared w ith 30 to  180 
days in  10 p a tien ts  w ith simple non-toxic g o itr e . Other workers 
(6 ,7 ,4 8 )  accepted t h is  in terp reta tio n , although Hubble (45) 
suggested that i t  might a lso  be due to  the formation o f  an abnormal 
iod inated  p rote in  such as had been described by Owen and McConahey 
(4 3 ) .  These authors showed th at more than 10 per cent o f the t o t a l  
PBI1^1 was b u tan o l-in so lu b le  in  30 o f 38 p a tien ts  w ith auto-immune 
th y r o id it is ,  and th at in  approximately one-th ird  o f the p a tien ts  the  
butanol in so lu b le  fr a c tio n  exceeded the value o f radio-thyroxine.
Owen/
/Owen and McConahey (43 ) were, however, unable to  id e n t ify  the 
nature o f the b u tan o l-in extrab le  iod o-p rote in  as only  tra cer  doses 
o f rad ioiod ine were given  and the concentration o f rad io iod ine in  
the serum was inadequate fo r  d e ta iled  a n a ly s is . B utan ol-in solu b le  
iod o-p rote in s have a lso  been reported by others in  both sta b le  (4 0 , 41 ) 
and radioiod ine (47) fr a c tio n s  o f the PBI. Chromatographic 
in v e s tig a tio n s  in  auto-immune th y r o id it is  have demonstrated the  
form ation o f  abnormal iod inated  prote in s in  the thyroid (43 ) and in  
an e lec tro p h o retic  study o f the thyroid  p rote in s Watson e t  a l .  (50) 
demonstrated a "Q" band o f unknown s ig n ifica n ce , present a t  or c lo se  
to  the s ta r tin g  poin t o f e lec trop h oretic  str ip s in  a l l  o f 5 thyroids  
from p a tien ts  w ith auto-immune th y r o id it is .
Murray and McG-irr (48 ) found a s ig n if ic a n t f a l l  in  the thyroid
gland uptake in  6 p a tien ts  w ith auto-immune th y r o id it is  fo llow in g
the adm inistration  o f 0 .2  to  0 .3  mgm. thyroxine d a ily  fo r  periods
varying from 10 and 20 weeks, and Owen and McConahey (43) observed
a f a l l  in  the uptake in  one p a tien t w ith tr iiod oth yron in e. In one
p a tien t w ith  auto-immune th y r o id it is ,  who presented w ith th yrotoxic
131m anifestations and had both an e levated  thyroid uptake and PBI 
value, Doniach e t  a l .(4 7 )  demonstrated the value o f the tr iio d o -  
: thyronine suppression t e s t  in  excluding th y ro to x ico s is .
Beare (42 ) observed th at a scintigram  o f the thyroid in  one 
p atien t with auto—immune th y r o id it is  showed a uniform d is tr ib u tio n  
of the rad io iod ine which follow ed the ou tlin e  o f the g o itre ; and 
t h i s /
/ t h i s  observation was confirmed by both Doniach and Hudson (47) 
and Murray and McG-irr (4 8 ) in  a small number o f  p a t ie n ts . These 
authors (47 ,48) suggested th at th is  procedure may help to  
d if fe r e n t ia te  auto-immune th y r o id it is  from e ith e r  non -tox ic  nodular 
or malignant g o itre  in  which the radioiod ine d is tr ib u tio n  i s  ir r e g -  
:u la r . Autoradiography o f th e thyroid was carried  out in  one 
p a tien t studied by Doniach and Hudson (47) who showed that the 
rad io iod in e was "taken up in  f a ir ly  evenly sca ttered  small fo c i" ,  
and Statland e t  a l .  (38) showed that the rad io iod ine was concentrated  
mainly in  the e p ith e l ia l  areas. Owen (6) and Decourt e t  a l .  (52) 
on the other hand reported an irregu lar  d is tr ib u tio n  o f the iso to p e  
in  the thyroid in  auto-immune th y r o id it is .
In  1956 S k il le m  e t  a l .  (4 0 ) showed th at a s in g le  in je c t io n  o f
1314  u n its  o f  TSH did not s ig n if ic a n t ly  increase the ra te  o f  I  
uptake in  23 p a tien ts  w ith h is to lo g ic a l ly  proven auto-immune th yro id -  
: i t i s  in  contrast to  a s ig n if ic a n t increase observed in  18 p a tien ts  
with n on -toxic g o itr e . These authors suggested that th is  t e s t  
might therefore prove valuable in  the pre-operative d if fe r e n t ia t io n  
o f auto-immune th y r o id it is  from simple non-toxic go itre  and a lso  
perhaps from thyroid neoplasm. However, Werner ( 36) noted th at  
the th yroid  gland uptake in  auto-immune th y r o id it is  "may occa sio n a lly  
respond" to  TSH stim u lation , and both Owen and McConahey (43)
S k il le m  and Evans (4 1 ) confirmed th is  in  a few p a tien ts  given  
larger  doses o f TSH (10 to  20 u n its ) .  In  a study o f  "low thyroid  
reserv e" /
/reserve"  J e f fe r ie s  e t  a l .  (53) noted the fa ilu r e  o f the PBI to  r is e  
a f te r  TSH stim u lation  in  one p a tien t w ith auto-immune th y r o id it is .
In 1957 Morgans and T rotter (54) made the in te r e s t in g  
observation  th at when potassium perchlorate was adm inistered  
fo llow in g  a tracer  dose of radioiod ine to  normal p a tien ts  the thyroid  
counting ra te  rose s l ig h t ly  and then remained constant, whereas in  
12 p a tien ts  w ith auto-immune th y r o id it is  whom they studied the  
adm inistration  o f potassium perchlorate caused a s ig n if ic a n t  d is ­
ch a rg e  o f rad io iod in e . The t e s t  was negative in  a l l  but one o f  
25 p a tien ts  w ith simple g o itre  and Morgans and T rotter (54) 
suggested th at i t  might be o f a d d ition a l d iagn ostic  va lue. Hubble 
(45) found the t e s t  p o s it iv e  in  10 p a tien ts  w ith auto-immune 
th y r o id it is  and negative in  3 normals and one p a tien t w ith  a simple 
nodular g o itr e ; and concluded th at the t e s t  was "nearly sp e c if ic " .
In ad d ition , Hubble (45) observed th at: "the degree o f discharge
correla ted  w ith the degree o f hypothyroidism, i . e .  w ith the extent 
o f  d estru ction  o f the thyroid gland. The greater the degree o f  
hypothyroidism the greater the discharge o f iod ine from the gland". 
Murray and McG-irr (4 8 ) a lso  reported favourably on t h is  t e s t  and 
found i t  p o s it iv e  in  a l l  o f 7 p a tien ts  w ith auto-immune th y r o id it is  
and negative in  a l l  o f 14 co n tro ls .
Estim ation o f the PBI in  auto-immune th y r o id it is  has been 
reported by severa l American workers. Thus in  1951, Statland e t  a l .  
(38) noted PBI values o f 0 .9 ,  2 .5 , and 4*4 PS* per 100 ml. in  3 
p a t ie n ts /
/p a t ie n ts  w ith auto-immune th y r o id it is .  In  1956 S k ille rn  e t  a l .  
(i*0) recorded PBI values in  12 p a tien ts; the r e s u lt s  o f  which 
were in  the low normal range in  9 and in  the high normal in  3*
In  the fo llo w in g  year S k il le m  and Evans (41) reported normal 
values o f PBI in  13 o f 14 p a t ien ts  with auto-immune th y r o id it is  
and concluded th a t the t e s t  was of l i t t l e  value in  the d iagn osis  
o f th is  d ise a se . On the other hand Owen (6) took the view th at  
when there was a d isp a r ity  between the r e s u lt s  o f the PBI and the  
radio iod ine t e s t s  th is  might d irec t su sp icion  towards auto-immune 
th y r o id it is .  Low or normal values o f PBI have been recorded by 
most authors (44 ,46 ,55 ) w ith the exception  o f G-ribetz e t  a l .  ( 56 ) 
who in  a study o f  6 ch ildren  found high values in  3 (8 .8 ,  9*6, and
9 .3  per 100 m l.) ,  the f i r s t  2 o f whom had normal BEI values (3*7  
and 4*2 mg. per 100 m l.) .
Personal Observations 
D espite the large number o f pu b lication s on various a sp ects  
o f auto-immune th y r o id it is  in  recent years, comparatively l i t t l e  
a tten tio n  has been given to  the mechanism of the disturbances in  
iod in e  metablism in  th is  d isea se . The purpose o f the present 
sec tio n  o f the th e s is  i s  to  determine the nature o f the abnormality 
in  iod ine matbolism in  th is  condition . By using the combination 
o f chemical and iso to p ic  techniques, p rev iou sly  described in  the 
in trod u ction  o f th is  sec tio n , a very f u l l  p icture o f iodine  
metabolism in  auto-immune th y r o id it is  has been obtained and an 
exp lan ation /
/ explanation  i s  provided fo r  th e  abnormal rad io iod ine t e s t s  
freq u en tly  found in  the d ise a se . The d iagn ostic  im p lica tio n s o f  
th e various t e s t s  usin g  ra d ioactive  iod ine are a lso  d iscu ssed .
M aterials and Methods
F if ty  p a tien ts  w ith auto-immune th y r o id it is  have been stud ied .
The d iagn ostic  c r it e r ia  were as described in  Section  1 o f t h is
Chapter o f the th e s is .  The p a tien ts  were c l in ic a l ly  a ssessed  by
the procedures described by Wayne (57) and c la s s i f i e d  as euthyroid,
eq u ivoca lly  hypothyroid, or c le a r ly  hypothyroid. As d iscussed
in  S ectio n  1 o f th is  Chapter, i t  was f u l ly  appreciated th a t such a
d is t in c t io n  was arb itrary , as there, was no sharp d iv id in g  l in e
131between the groups. R adioactive iodine was used both as I  and
*132as the sh o r t-liv e d  iso top e  I  . The rad ioactive  iod in e (su p p lied
by the Radiochemical Centre, Amersham) was proved to  be fr e e  from 
127ca rr ier  I  . Inaccuracy in  the thyroid uptake measurements due
to  b a ck -sca tter  ra d ia tion  was elim inated by checking the r e s u lt s
w ith a "phantom*' th yroid . The thyroid  gland uptake measurement
u sing  and 1 ^ ^  were comparable.
*
Standard Radioiodine T e s ts , including 4  and 48 low thyroid  uptake
131measurements and PBI a t  48  hours, were carried  out by the methods
131described by Wayne (5 7 ); PBI estim ation  was, however, 
s im p lified  by using an io n  exchange column ( 58) .
The potassium perchlorate discharge t e s t  (54) was performed as 
m od ified /
* I  am g ra te fu l to  Miss E.M. Macdonald, B .S c ., and Mrs. S.R. 
Johnston, A .I.M .L .T ., fo r  carrying out t e s t s  in vo lv in g  the  
use o f rad io iod in e.
163.
/m od ified  by Koutras e t  a l .  (38) • The th yroid  gland uptake was
measured 60 minutes a f te r  an o ra l dose o f 25 pc 1^ ^ . Immediately
th er e a fte r  500 mg, potassium perchlorate was given by mouth and
40 minutes la te r  the thyroid  uptake was again measured. The r e s u lt
was expressed as a percentage o f the i n i t i a l  reading; a value o f
l e s s  than 90$  was considered p o s it iv e .
The thyroxine suppression t e s t s  were performed by estim atin g the  
a 52 before and
2§- hour I  uptake by the th yro id / a f t e r  the adm inistration  o f
0 ,2  mg, thyroxine sodium d a ily  fo r  3 weeka.Thyrotrophin stim u lation
t e s t s  were performed in  two ways. In 10 p a tien ts  the 2^ hour
132thyroid  gland uptake o f I  was estim ated before and 24  hours 
a fte r  the adm inistration  IOUSP u n its  TSH (Armour). In  p a tien ts  
who did not respond by an increased gland uptake another measurement 
was made a f t e r  two fu rth er  in je c tio n s  o f TSH a t  24-hourly in ter v a ls
A  TLA
(59)* In  13 p a tien ts  the PBI was measured before and 24 hours
131a fte r  10 u n its  o f  TSH given 9 days a f te r  a tracer  dose o f  I  (2 6 ) ,  
♦
The PBI was measured by th e  e h lo r ic -a c id -d ig es tio n  method o f
Zak e t  a l .  (28) as m odified by FarreHand Richmond (2 9 ) .
The thyroid  clearance ra te  o f radioiod ine was measured
according to  the method o f Myant e t  a l .  ( 60) between 1 and 2j  hours
131 132a f te r  the oral adm inistration  o f 25 pc o f I  or 50 pc o f I  , 
Simultaneous estim ation  o f the radioiod ine and sta b le  iodine content 
o f /
* I  am g ra te fu l to  Mr. M.H. Richmond, B .S c ., and Mr. T. McG-hie, 
A .I.M .L .T ., for  the PBI measurements.
164.
/ o f  the urine excreted  over the same period provided data fo r  the 
estim ation  o f the PII and the AIU by the thyroid gland, using  the  
method o f S tanley (1 1 ) . The PH  ( in  pg. per 100 m l.) was 
ca lcu la ted  from the formula:
p t t  I  urine x  1 ^  (or 1 ^ )  plasma
= t131 / t132\ .I  (or I  ) urine
where I  urine rep resen ts the sta b le  iod ine o f the urine in  pg. per 
131100 m l., I  plasma the radioiod ine content o f the plasma in  per
131cen t, o f dose per ml. plasma, and I  urine the rad io iod ine content
o f the urine in  per c e n t .o f  dose per ml. urine.
The accuracy o f the in d ir ec t estim ation  o f PII was confirmed
by d ir e c t chemical determ ination (29) in  6 p a tien ts  in  whom i t  was
large  enough to  estim ate . The d ifferen ce  between the d irec t and
in d ir ec t estim ate did not exceed 15 per cen t.
The AIU ( in  pg. per hour) was ca lcu la ted  from the formula:
AIU = PII (pg. per m l.) x Thyroid Clearance o f Radioiodine
(m l. per h r .)
The ren a l clearance was ca lcu la ted  in  the same way as the
thyroid  clearance, using the urinary excretion  in stead  o f the thyroid
uptake o f ra d io a ctiv e  io d in e .
The IEI was estim ated by the method o f Nodine e t  a l .  (26) using
an in je c t io n  of 10 u n its  o f TSH given on the tenth  day a f te r
131adm inistration  of 75 pc o f  I  .
Urinary i o d i n e  was estim ated on 0 .5  -  1*0 ml. a liq u o ts  by the 
same/
Table I
Measurements o f S tab le and R adioactive  
Iodine in  Auto-immune T h yro id itis
Figure 1.
C orrelation  between h- hour Thyroid Gland 
131Uptake I  and PBI in  Auto-immune T h yro id itis  
Figure 2.
C orrelation  between U. hour Thyroid Gland 
Uptake I 131 and BMR
Table I
Measurements of Stable and Radioactive Iodine in Auto-immune Thyroiditis.
Measurements. No. of Cases. Mean S.E. Range Normal Range
2 i  hr. uptake of I 132 (# dose). 15 25.7 + 2.4 10.3 -  46.6 10.0 -  35-0
4 hr. uptake of I 131 ($ dose). 49 37-4 + 2.3 7-5 " 77.1 15.0 -  45-0
48 hr. uptake of I 131 (i(b dose). 49 40.1 + 3.1 10.2 -  79-8 20.0 -  60.0
Thyroid clearance (ml./min.). 15 22.7 + 3-7 2.9 -  52.9 8.0 -  40.0
Plasma inorganic iodine (ug.£). 14 0.20 + 0.04 0.02 -  O.58 0.08 -  0.60
Absolute iodine uptake (u g ./h r.). 14 2.0 + 0.4 0.4 -  5-9 0.5 -  6.0
48 hr. PBI131 (ji dose/l. ) . 49 0.38 + 0.08 0.05 -  2.74 0.00 -  0.2
BJ.I131 $  of PBI131) 9 31.0 + 9.0 0.00 -  95.0 0.00 - 20.0
Serum PBI (ug.$). 45 2.6
+ 0.4 0.5 -  5-3 3-0 -  7-5
Iodine U tilisa tion  Index. 14 1.7 + 0.3 0.6 -  6.0 1.0 -  10.0
In trathyroidal exchangeable iodine (mg.). 11 1.2 + 0.2 0.05 -  3.8 1.5 -  I5 .O
Renal clearance of iodine (m l./min.). 14 28.1 + 1.9 16.5 -  43.5 15.0 -  55.0
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Fig. 1.
CORRELATION BETWEEN 4  HR THYROID GLAND UPTAKE II3I AND 
PBI  IN AUTO-IMMUNE THYROIDITIS
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/same chemical rea ctio n  as used in  determ ination o f  the PBI r e s u lt s
but without p rior treatm ent. The mean recovery of iod ine added to  urine
was found by F a rre ll and Richmond (29 ) to  be 39*3% (SD t, 3*7$)• The
absence o f s ig n if ic a n t amounts o f organic iod ine in  the urine was
confirmed by the use o f an anion-exchange column (29) •
131The butanol in extractab le  radioiod ine (BII ) was estim ated
131using 5 nil. samples of plasma. The inorganic I  was removed by 
an ion  exchange column (28) and the p r e c ip ita te  remaining a f te r  
butanol ex tra ctio n  was assayed fo r  r a d io a c tiv ity .
R esu lts.
The r e s u lt s  o f the s tu d ies  o f  the metabolism o f both sta b le  
and rad ioactive  iod ine are summarised in  Table 1.
In  most cases the rad ioiod ine uptake by the thyroid a t  2 j ,  4 ,  
and 48  hours and the thyroid clearance ra te  la y  w ith in  the normal 
range, but in  severa l cases these values were above, and in  a few  
below, the normal range; the standard deviation  was th erefore la rg e .
High values were found frequ ently  in  the 4  hour measurements, whi ch 
exceeded th e 48  hour uptake in  20 of the 49 p a tien ts . This i s  
co n sisten t w ith  the short b io lo g ic a l h a l f - l i f e  o f rad io iod ine in  
auto -immune th y r o id it is  found by Doniach and Hudson (47) • The 
4  hour thyroid  gland uptake correlated  s ig n if ic a n t ly  (P< 0 .001) w ith  
both the PBI (r  » 0 .3 7 1 , P ig . 1) and BMR (r  = 0 .43$ , Fig- 2 ) .
From th ese  sca tter  grams i t  can be seen th at in  general euthyroid  
p a tien ts  had a higher uptake o f  radioiod ine than those who were 
hyp oth yroid ,/
Figure 5.
C orrelation  between 4  hour Thyroid 
131G-land Uptake I  and Serum C h olestero l.
Figure 4 .
C orrelation  between 4  hour Thyroid 
1 31G-land Uptake I  and G oitre S ize  
in  Auto-immune T h y ro id itis .
Figure 5 .
131C orrelation  between PBI and Serum 
PBI in  Auto-immune T h y ro id itis .
Figure 6.
Serum PBI in  Euthyroid P a tien ts  with  
Auto-immune T h y ro id itis .
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g ig - 3 .
CORRELATION BETWEEN 4  HOUR THYROID GLAND UPTAKE 1131 
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F ife J L
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F i g .  6 .
SERUM PBI IN EUTHYROID PATIENTS WITH 
AUTO-IMMUNE THYROIDITIS
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/hypothyroid., hut that there was a considerable overlap ip  tjie 
r e s u lt s .  No s ig n if ic a n t  co rre la tio n  (P < 0 ,1 )  pas found ]b§t#^|p 
th e  4  hour uptake and the serum ch o le stero l yalpes (r  = 0 ,1^ 1 , | ) .
There was no co rre la tio n  between th e  4  hour uptake apd the j|9itp e
s iz e  (r  = 0 .226 , F ig . 4) end th is  i s  in  agreement j&th the preyious
observations o f Doniach and Hudson (47) •
The PII values la y  w ithin the normal range, w ith the exception  of
2 p a tien ts  who had values o f 0.02 and 0 .0 6  pg. per cent r e s p e c t iv e ly .
The AIU was w ith in  the normal range w ith the exception pf one
hypothyroid p atien t who had a value of 0 ,4  pg* per hour.
131The mean value of the PBI la y  above the upper l im it  of th e
normal and in  20 p a tien ts  (4Q.8$>) th is  value was in  the thyrptopdLc
range ( i . e .  exceeding 0.39^ per dose per l i t r e ) .  From F ig . 5  i t
can be seen that euthyroid p a tien ts  tended to  have a higher
than hypothyroid p a tien ts .
The ^  varied from 0 -  95/° w ith a mean of 31 /  pf the
1 31values. Five of the 9 p a tien ts  had values of BII exceeding^Qfo
o f the t o t a l  FBI151.
The PBI values la y  in  the hypothyroid or in  the low normal 
range (mean 2 .6  pg. per cent,, h igh est value 5*3 pg* per cent,). The 
.mean PBI in  the c l in ic a l ly  euthyroid p a tien ts  (3-1 pg* per cent) 
was s ig n if ic a n t ly  lower (P< 0.001) than the mean normal (5 .2  pg. per
cent.) value (F ig . 6 ) .  Confirmatory evidence o f sub c l in ic a l
hypothyroidism in  th ese p a t ie n ts  included: a low BMR in  a ra ised
serum/
f i g u r e  7 .
E ffe c t  o f TSH Stim ulation  on Thyroid 
1*32 Uptake and P B I ^  Discharge
Fig* 7.
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/serum  c h o le ster o l in  6 , and an BCG- suggestive o f  hypothyroidism in
5 . From f ig u r e s  1 and 5 i t  can be seen th at the c l in ic a l  sta tu s
131agreed more c lo s e ly  w ith th e  PBI than w ith  the PBI or the 4  hour 
th yroid  gland uptake o f  rad io iod in e. The PBI correla ted  
s ig n if ic a n t ly  (P < 0 .0 5 ) w ith  the P B I ^  (r  = 0 .309 , F ig . 5 ) .
The r a t io  o f PBI to  AIU i s  a measure o f the capacity  o f the 
thyroid gland to u t i l i s e  the iod ine presented to  i t  and th is  has 
been termed the iodine u t i l i s a t io n  index (5 8 ) . S ix  o f 15 p a tien ts  
w ith auto-immune th y r o id it is  had r a t io s  below the lower lim it  o f  
the normal. The mean index (1 .7 ) was s ig n if ic a n t ly  lower (P< 0*02) 
than the mean o f a normal s e r ie s  (3*4) studied in  the same 
laboratory by the same methods; the iodine u t i l i s a t io n  index tended 
to  be lower in  hypothyroid p a tien ts .
In  10 o f 12 p a tien ts  w ith auto-immune th y r o id it is  in  which the  
TffT was ca lcu la ted , abnormally low values were obtained (Table 1 ) .
In  2 p a tien ts  the discharge of protein-bound ra d io a c tiv ity  a fte r  
TSH was in s u f f ic ie n t  to  allow  ca lcu la tio n  o f the in trath yro id a l 
iod in e; presumably in  the 2 p a tien ts  i t  was extremely low.
The mean value o f the renal clearance o f iodide was w ith in  the  
normal range, although a l i t t l e  lower than the mean o f a normal 
group ( 34..O ml. per m in .). The d ifferen ce , however, was hot 
s t a t i s t i c a l l y  s ig n if ic a n t .
The r e s u lt s  o f the TSH t e s t s  are summarised in  F ig . 7- Of 
10 p a tien ts  in  whom the thyroid  uptake was measured before and 
a f t e r /
/ a f t e r  TSH adm inistration  the thyroid rad io iod ine uptake increased
by 10$ or more in  on ly  3 p a t ie n ts . The discharge o f was
measured a f t e r  TSH adm inistration  in  13 p a t ie n ts , during estim ation s
o f the IEI (26) • A l l  8 euthyroid p a tien ts  responded with a r i s e  
131in  the PBI , but only  in  one was the r is e  comparable w ith th at 
found in  normal p a t ie n ts . On the other hand, only 1 o f 3 
hypothyroid p a tien ts  showed a r is e  in  the F B I*^ . A ll  34 p a tien ts  
te s te d  showed a normal suppression of th yro id al uptake o f rad io iod ine  
fo llo w in g  thyroxine adm inistration .
A p o s it iv e  potassium perchlorate discharge t e s t  was found in  
12 o f 27 p a tien ts  (44*4$). There was no co rre la tio n  between the  
c l in ic a l  s ta tu s  o f the p a tien t and the r e s u lt  of the t e s t .  The 
mean discharge o f those w ith a p o s it iv e  t e s t  was 17$  w ith a maximum of  
23$.
D iscussion
The p a tien ts  w ith auto-immune th y r o id it is  had, as a group, a 
low plasma PBI, although the absolute (or  stab le) iod ine uptake (AIU) 
by the th yroid  was normal. The low PBI r e f le c t s  decreased thyroid  
hormone production. The a ltern a tiv e  explanation -  increased  
peripheral degradation o f thyroxine -  i s  very u n lik e ly  since the  
group tended to by hypothyroid ( 61) .  The r e s u lt s  thus imply th at  
the thyroid  gland, in  sp ite  o f reta in in g  the normal amount of iod in e , 
cannot u t i l i s e  th is  iod ide in  the normal way to  produce hormone. The 
same pattern  o f iod in e metabolisni has been found in  p a tien ts  with  
co n g en ita l/
/c o n g e n ita l dyshormono gene s i s  (5 8 ) , although the abnorm ality was 
more severe and the AIU was greater than normal. From the p o in t o f  
view of handling o f io d in e , auto-immune th y r o id it is  may thus be 
considered as a form o f "acquired dyshormono gene sis"  in  which the  
thyroid  d isp lays a diminished capacity  for  u t i l i s in g  the iodine  
presented to  i t .
Other in d ic e s  o f iod ine metabolism in  auto-immune th y r o id it is
suggest that the d e fec ts  in  hormone syn th esis are m u ltip le . Thus^
a d e fic ie n c y  of organic binding o f iodine i s  in d icated  by the
discharge o f  iodine from the gland fo llow in g  the adm inistration  o f
potassium  perchlorate (47 ,48 ,54) which was observed in  12 of the
p a tie n ts  in  the present study. Furthermore, 5 of 9 p a tien ts  had an
abnormal b u tan o l-in so lu b le  iod inated  protein  which exceeded 20 per
131cent* o f the to ta l  PBI concentration. Both abnorm alities were 
present in  some o f the p a t ie n ts . B utanol-insoluble iod inated  
p rotein s have p reviously  been reported in  auto-immune th y r o id it is  
(4 0 ,4 1 ) , con gen ita l dyshormono gen esis (58 , 62- 64) > and thyroid  cancer 
( 65 , 66 ) .  Prelim inary stu d ies  in  3 of the p a tien ts  have fa i le d  to  
show th at the bu tan ol-in so lu b le  p rote in  has the immuno lo g ic a l  
s p e c if ic i t y  o f thyroglobulin  (67)* The p o s s ib i l i t y  e x is t s  th at 
the p a tien ts  had dyshormono gene s i s  before developing auto-immune 
th y r o id it is ;  but t h is  seems very u n lik e ly , since thyroid auto­
an tib od ies are only ra re ly  encountered in  congenital dyshormono genesis  
(68)/
In fluen ce
Figure 8
Small Intrathvroid
131Exchangeable Iodine Pool on PBI .
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/ ( 6 8 ) .  Moreover, Carr e t  a l .  (69) have found normal a c t iv i t y  o f  
iodotyrosine dehalogenase in  auto-immune th y r o id it is .
In many p a tien ts  w ith simple non-toxic g o itre  a discrepancy* i s  
found between the c l in ic a l  sta tu s and the radioiod ine uptake. In  
io d in e -d e fic ien cy  g o itre  the discrepancy i s  more apparent than r e a l ,  
sin ce  th e  high radioiod ine uptake i s  not a sso c ia ted  w ith a high AIU 
and can be explained on the b a s is  of a d ilu tio n  phenomenon (1 0 ) .
In such p a tien ts  the actu a l amount o f iod ide reta ined  by the thyroid  
(AIU) and the quantity o f  hormone produced are both normal. On the  
other hand, in  congen ita l dyshormonogenesis and in  auto-immune 
th y r o id it is  there i s  an actu al d is so c ia t io n  between the amount o f  
iod id e  reta in ed  and the amount o f hormone synth esised . This exp la ins  
a normal or even high radioiod ine uptake in  a hypothyroid p a tien t  
w ith auto-immune th y r o id it is .
In almost a l l  the p a tien ts  su ffer in g  from auto-immune th y r o id it is  
who have been examined, the IEI was abnormally low and th is  i s  
co n s isten t w ith the reduction  in  the b io lo g ic a l h a l f - l i f e  o f radio­
iod in e in  th is  d isea se  (47 ) .  Koutras e t  a l .  ( 9) have shown th at the 
PBI1 1^ i s  in v erse ly  re la ted  to  the s iz e  o f the IEI pool. This 
im p lies th at the high PBI1 ^  le v e l s  in  p a tien ts  with auto-immune 
th y r o id it is  i s  due to  d ilu tio n  of the rad ioactive atoms taken up by 
the thyroid  in  a sm aller pool o f in trath yro id a l iodine than normal. 
Thus, the hormonal iodine released  has a higher s p e c if ic  a c t iv ity ,  
although the to ta l  amount may be normal or reduced (Pig* 8) • Prom 
t h i s /
/ t h i s  f ig u re  i t  can be seen th at the P B I ^  i s  in  fa c t  r e la te d  not
only  to  the amount of thyroid  hormone re lea sed , but a lso  to  i t s
s p e c if ic  a c t iv i t y  which i s  in v erse ly  re la ted  to  the IEI p oo l.
131T his mechanism would account fo r  the high PBI observed in  many
of the p a t ie n ts . Since the proportion o f b u tan ol-in so lu b le
m aterial i s  the same, both in  chemical PBI and in  rad ioactive  PBI^*^
(43) f i t s  degradation ra te  i s  presumably not very d iffe re n t from
th at o f the normal hormone. I t  fo llo w s th at the b u tan o l-in so lu b le
131iodop rotein , although i t  contributes to  the PBI in  some p a tie n ts ,
131cannot be resp on sib le  fo r  the discrepancy between the high PBI
and the low PBI. This discrepancy can ohly be explained by p o s tu l-
131sating th at the high PBI does not r e f le c t  an increased production  
of thyroid  iodoproteins but a rapid turnover ra te  o f iodine w ith in  
the thyroid . This rapid turnover i s  probably the r e s u lt  o f an 
increased  TSH stim u lation . This i s  co n sisten t w ith th e fin d in g  o f  
a poor response to  exogenous TSH (F ig . 7) > presumably because th ese  
p a tien ts  are already under maximal or near maximal stim u lation  by 
endogenous TSH. The assumed increase in  endogenous TSH can be 
a ttr ib u ted  to  the low le v e l  of c ircu la tin g  PBI since the radioiod ine  
uptake by the thyroid  i s  suppressed by thyroxine adm inistration .
Apart from th ese th eo r e tic a l considerations the standard 
rad io iod ine t e s t s  may be o f value in  the d iagn osis of auto—immune 
th y r o id it is .  Thus, a pattern  o f some diagnostic  value i s  the 
combination of a high PBI^"  ^ w ith e ith e r  a low or normal radioiod ine  
uptake and a low PBI. The routine radioiod ine t e s t s  show, however, 
marked/
/marked v a r ia b il ity  and may be com pletely m isleading sin ce  euthyroid  
p a tien ts  may show r e s u lt s  co n sisten t w ith th y ro to x ico s is  (51 )•  In  
th ese circum stances the triiod othyronin e or thyroxine suppression  
t e s t  w i l l  prove of value in  d if fe r e n tia t in g  the ’'pseudo-toxic1* 
auto-immune th y r o id it is  from the mild thyrotoxic (see  Chapter I I I ,  
Section  2 , fo r  further d iscu ssio n  of th is  problem .). The TSH t e s t  
i s  o f no help in  th is  p a rticu lar  problem (40 ) ,  although i t  i s  o f  
value in  d if fe r e n t ia t in g  auto-immune th y r o id it is  from simple non -toxic  
g o itr e , in  which an in variab ly  normal response occurs (4 l)»  The 
IEI i s  a lso  normal in  simple non-toxic g o itre  (10,70) but th is  t e s t  
i s  too elaborate and time-consuming to  be o f p r a c tic a l h elp . In  
contrast to  the fin d in g s of Morgans and T rotter (54)j&nd others ^
(45>48) the potassium perchlorate discharge t e s t  gave normal r e s u lt s  
in  about only h a lf  o f th e p a tien ts; n everth eless a p o s it iv e  t e s t  i s  
d ia g n o st ic a lly  valuab le, sin ce  i t  i s ,  w ith the exception of 
dyshormono gene s i s  of the peroxidase d e fic ien cy  type (71)» ra re ly  
p o s it iv e  in  other forms of thyroid d isorder.
The fin d in g  o f a low PBI in  c l in ic a l ly  euthyroid p a tien ts  
confirms the previous observations of S k il le m  e t  a l .  (40)* and 
provides a ra tio n a le  fo r  treatment o f a l l  p a tien ts  w ith thyroxine 
sodium therapy.
The d e fec ts  in  iodine metabolism in  auto-immune th y r o id it is  are 
e s s e n t ia l ly  those which would be expected i f  a form o f dyshormono- 
gen esis occurred along w ith a decreased IE I. The standard ra d io -  
iod ine t e s t s  which are u su a lly  used in  c l in ic a l  p ractice  o ften  g ive  
abnormal/
186.
/abnormal r e s u lt s  in  th is  cond ition , but they can be explained i f  
the whole p ic tu re  o f iod in e metabolism i s  known.
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SUMMARY
A d e ta ile d  and comprehensive in v e s tig a tio n  o f iod ine metabolism  
has been carried  out in  49 p a tien ts  w ith auto-immune th y r o id it is .
The r e s u lt s  show a d isa sso c ia tio n  between the uptake o f  iod ine by 
the th yroid , i . e .  AIU, which i s  normal, and the PBI le v e l  which i s  
s ig n if ic a n t ly  decreased. These fin d in gs in d ica te  that the thyroid  
gland in  auto-immune th y r o id it is  traps a normal quantity o f  io d in e , 
but lack s the capacity  to  u t i l i s e  i t  e f f i c ie n t ly  to  form thyroid  
hormone. This fa u lty  u t i l i s a t io n  of iodine may be considered to  be 
a form of "acquired dyshormono gene s is " . Evidence o f i t s  nature i s
provided by the frequent discharge o f iod ine from the thyroid  gland  
fo llow in g  adm inistration  o f  potassium perchlorate and the presence 
o f a bu tan ol-in so lu b le  iod inated  protein  in  the plasma in  many 
p a tien ts .
The markedly reduced IEI va lues, and not the presence o f B II,
131exp la in s the frequent discrepancy between the high PBI and th e low 
PBI.
A pattern  of some d iagn ostic  value i s  the combination of a high  
PBi 131 ^ t h  e ith er  a low or normal rad ioiod ine uptake and a low PBI. 
The thyroxine (or triiodothyronine) suppression and TSH t e s t s  are o f  
value in  the d if fe r e n t ia l  d iagn osis of auto—immune th y r o id it is ,  and 
th y ro to x ico s is  and simple non—to x ic  g o itre  r e sp e c tiv e ly . A p o s it iv e  
potassium perchlorate discharge t e s t  i s  presumptive evidence o f auto­
immune th y r o id it is .
The/
/The fin d in g  o f  a low PBI in  many c l in ic a l ly  euthyroid p a tien ts  
in d ic a te s  an ea r ly  degree o f  hypothyroidism and provides a ra tio n a le  
fo r  the treatm ent o f  a l l  p a t ien ts  su ffer in g  from auto-immune th yro id -  
l i t  i s  w ith  thyroxine su b stitu tio n  therapy.
189.
S ection  5.
The D iffe r e n tia l D iagnosis o f  
Auto-immune T h y ro id itis .
190.
Most ph ysician s would agree th at th e c l in ic a l  d iagn osis o f
auto-immune th y r o id it is  presents l i t t l e  d i f f ic u l t y  when the p a tien t
a
i s  a m iddle-age female witty'firm g o itre  and hypothyroidism. 
D iagnostic d i f f ic u l t y  u su a lly  a r ise s  in  the euthyroid p a tien t;  
th e thyroid sw ellin g  being mistaken fo r  a simple g o itre  or a thyroid  
neoplasm. Euthyroid p a tien ts  w ith auto-immune th y r o id it is  may 
have anxiety  symptoms which lead the physician  to  suspect th yro- 
s to x ic o s is , and the r e s u lt s  of routine radio iod ine t e s t s  may 
apparently confirm t h is  d ia g n o sis. Less common d iagnostic  
d i f f i c u l t i e s  include dyshormonogenesis, g o itre  due to  iodide or 
goitrogen adm inistration , and subacute th y r o id it is .
In  th is  sec tio n  I  sh a ll d iscu ss the d if fe r e n t ia l  d iagn osis of 
auto-immune th y r o id it is .  I  have compared the c l in ic a l  and 
laboratory fin d in gs in  the 50  p a tien ts  w ith auto-immune th y r o id it is  
w ith  those in  other thyroid d isea ses  which may give r is e  to  
d iagn ostic  d i f f ic u l t y .  The methods used have been described in  the  
preceding sec tio n s  of t h is  Chapter o f the th e s is .
( l )  Simple Goitre 
Auto-immune th y r o id it is  i s  probably most commonly misdiagnosed 
as simple g o itre  than any other thyroid d isorder. This i s  due to  
the fa c t  th a t, apart from hypothyroidism, no absolute c l in ic a l  
d is t in c t io n  can be drawn between the 2 con d ition s. In the present 
study 509 p a tien ts  have been diagnosed as having simple g o itr e , 
and/
Table I .
Summary o f the C lin ic a l Findings in  
Auto-immune T h y ro id itis . Simple 
(xoitre, and Thyroid Neoplasm.
Table U .
E ffe c t o f Thvroxine Sodium Therapy 
on CrOitre S ize  in  Auto-immune -
T h yro id itis  and Simple G-oitre.
Table I .
Summary o f  th e  C lin ic a l  F in d in g s  in  Auto-Immune T h y r o id i t i s ,  Simple O olt're1 and Thyroid Neoplasm.
Auto-immune 
T hyro id itis  
(5 0  cases).
Simple G oitre 
(79 c a se s ) .
Thyroid Neoplasm 
(18 cases)
Age Range 28 -  70 yearB 1 6 - 2 7  years 1 9 - 7 8  years
Mean 52.5 years 36.6 years 55i7 years
Sex 923° females 96* females 72* females
Duration i Range 6 seeks -  37 years 2 seeks -  37 years 3 months -  30  years
Mean 4.6  years 7.3 years 2 .9  years
Recent increase 4 (8*) 11 (13.9*) 13 (72.7*)
^ iz e  i Range 50 -  300 g. 50 -  300 g. 50  -  200 g.
Mean 108 g. 100 g. 102 g.
Nodularity
7CMCM 24 (30/4) 13 (72*)
C lin ica l Cflnflietency "firm" : 46 (92*) "firm" 1 24 ( 30*) "firm " « 7 (38.8*)
Features "hard" 1 2 (4*) "hard" t 0 (0*) "h ard " ': 8 (4 4 . 4*)
of " s o f t” 1 2 (4*) "so ft"  1 55 (70*) Not palpable 3 (16 .g*)
G oitre Pain o r tenderness 1 (2/°) 0 (0/°) 3 (16.7*)
Pressure e ffe c ts Mild 11 (2234) 
Severe 0 (0*)
Mild 14 (18*) 
Severe 2 (2 . 5*)
Mild 2 (11.1*) 
Severe 5 (27.8*)
X-ray of trachea Compression 4 (8*) 
Deviation 8 (16/°)
Compression 8 (10.1*) 
Deviation 15 (18.9*)
Compression ^  (38.9*) 
Deviation 4 (22.2*)
Laryngeal palsy 1 (2/°) temporary 0 (0*) 2 (11.1*)
F ixation 0 (0*) 0 (0*) 9 (50*)
Cervical adenopathy 1 (2*) 0 (0)b) 6 (33*)
? Thyrotoxicosis 5 ( 10*) 13 (16.5*) 0  (0*)
Hvoothvroidism 18 (36ji) 0 (Oji) 0 (0*)
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Table I I
Effect of Thyroxine Sodium Therapy on Goitre Size 
in  Auto-immune Thyroiditis and Simple Goitre
C lin ica l Condition No. of Cases Duration of Therapy 
(months) >
Mean Neck Cir<
( inches
Before 
Mean S .D.
jumference
A fter 
Mean S.D.
Significance
Auto-immune
th y ro id itis
Simple g o itre
19
23
mean 14*6 
mean 9*1
14.78 t  1.11 
13.53 -  0.96
13.63 t  1.06 
12.98 t  0.81
p < 0.0011
> p< 0.05
p < 0.05 J
The p values have been calculated from the mean difference of the values before 
and a f te r  treatment and i t s  standard e rro r, and not from the differences between 
the means.
/and  the c l in ic a l  fin d in g s in  79 o f th ese  p a tien ts  are 
summarise d  in  Table I .  I t  can be seen that the con sisten cy  o f the  
g o itre  i s  o f some importance in  d if fe r e n t ia t in g  auto—immune 
th y r o id it is  and simple g o itr e . Thus, a "soft" g o itre  was present 
in  on ly  4  per cent of the p a tien ts  w ith auto-immune th y r o id it is ,  
whereas i t  was found in  ~J0 per cent o f those w ith simple g o itr e . 
Moreover, p a tien ts  w ith simple g o itre  are on the average younger, 
and have a longer h isto ry  o f g o itr e . (Table I ) .
Shrinkage o f the thyroid sw ellin g  with dried thyroid  ex tra ct  
or thyroxine sodium therapy has been observed in  both auto-immune 
th y r o id it is  ( 1- 8 ) and simple g o itre  (9-14) > and has been confirmed 
in  the present study (Table U ) . Although the g o itre s  in  auto­
immune th y r o id it is  had as a group a much greater (P ^O .05 ) 
reduction  in  s iz e  than the simple g o itr e s , th is  observation cannot 
be applied as a d iagn ostic  t e s t  in  an ind iv idu al p a tien t because 
o f the v a r ia tio n s in  shrinkage of the go itre  in  the 2 groups.
In  the present study the p r e c ip it in  t e s t  has been found to  
provide a valuable means o f d if fe r e n t ia t in g  the 2 d isorders. None 
of the 509 p a tien ts  diagnosed as having simple g o itre  had a 
p o s it iv e  p r e c ip it in  t e s t ,  including 38 p a tien ts  who la te r  came to  
surgery and were confirmed h is to lo g ic a lly . This contrasts with  
the fin d in g s in  auto-immune th y r o id it is , where the p r e c ip itin  t e s t  
was p o s it iv e  in  76 per cent, of the p a tien ts . On the other hand 
the CP t e s t  was o f l e s s  value in  d if fe r e n tia t in g  the 2 conditions, 
s in c e /
Table H I .
Prevalence o f Thyroid A uto-antibodies  
in  Simple G oitre.
Figure 1.
Biochemical 8tu d ies in  Auto-immune 
T h y ro id it is . Simple Non-Toxic G-oitre. 
and Thyroid Neoplasm.
Table IV.
Iodine Metabolism in  Auto-immune 
T h yro id itis  and Simple G-oitre.
Table V.
131Perchlorate Discharge T ests . BII 
determ inations, and TSH t e s t s  in  
Auto-immune T h yro id itis  and Simple
G-oitre.
Table I I I .
Prevalence of Thyroid Auto-antibodlee in Simple Qoitre.
Ho. of 
Cases.
Positive Thyroid Auto-antibody Teats
Authors Year Bef. Ho.
Preo. CP TBC
Paine et al. 1957 15 20 1
Boitt and Doniach 1958 16 198 1+ 17 144
Anderson et al. 1959 17 44 0 4
Belyavln and Trotter 1959 18 33 0 4
Blizzard et al. 1959 19 19 3+ 8
Cline et al. 1959 20 5 0
Hackett et al. 1960 21 16 10
Schade et al. 1960 22 26 2 8
Present Series 509 0 46
^Diagnosis not confirmed by histological examination.
Fig* 1.
BIOCHEMICAL STUDIES IN AUTO-IMMUNE THYROIDITIS 
SIMPLE NON-TOXIC GOITRE AND THYROID NEOPLASM
Gamma
Globul ins
Thymol
T u r b i d i t yl O O n Auto-fmmune 
Thyroiditis
Simp is  Non - 
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Thymol
F l o c c u l a t i o n
ESR
D e t e r m i n a t i o nOO Auto -immune 
T hyroiditis
IOO Sim p/s Non -  
Toxic Goitre
lOOn T hyro id
Neoplasm
mm I hru n i t s
AbnormalNormal Range
198.
Table IT
Iodine M etaboll— In  Auto-Immune T h y ro id itis  and S tap le  G o itre .
Auto-immune Thyroiditis Simpis Goitre
Measurementa. Ho. of Cases. Bean and S.B.
Ho. of 
Cases. Mean and S.B.
2j  h r. uptaka I 132 (£ doaa). 
4 hr. uptaka I 131 (> doee).
15
49
25.7 -  2.4 
(10.3 -  46.6)
37.4 -  2.3 
(7-5 -7 7 .1 )
53
107
3 2 .8  *  1.85
(21.7 -  76 .4 )
4 6 .8  -  4.1 
(17.1 -  75-2)
48 h r. uptaka I ^ 1 ( $  doee). 49 40.1 -  3.1 (10.2 -  79.8) 107
49.3 -  4.9 
(16.0 -  81.2)
Thyroid clearance (ml./min.). 15 22.7 -  3.7 (2.9 -  52-9) 53
50.2 -  5.2 
(6 .6  -1 55 .4 )
Plasma inorganic Iodine (ug.£) 14 0 .2 0  -  0 .0 4  (0 .0 2  -  O.58) 53
0 .0 8  -  0.008 
(0 .0 2  -  0 . 19)
Absolute iodine uptaka (ug ./h r.) 14 2 .0  -  0.4 (0.4 -  5.9) 53
1 .8  -  0.16 
(0.7 -  5.9)
48 h r. PBI131 (% dosa/l. ) . 49 0 .3 8  -  0 .0 8  (0 .0 5  -  2 .74) 107
0.06 -  0 .0 2  
(0 .0 5  -  0.35)
Sarua FBI (ug.^). 45 2.6 -  0.4 (10.5 -  5-3) 53
5 .1  -  0.17 
(2 .8  -  8 . 2 )
Intrathyroidal exchangeable iodine (tag.) 
Banal olearanoe of iodine (m l./rain.).
11
14
1 .2  -  0 .2  
(0.05 -  3.8
28.1 -  1 .9  
(16.5 -  43.5)
3
21
10.3
(6 .2  -  14. 6 )
37.8 -  2.6 
(16.0 -  63.7)
Range i s  given in  Braoketa below mean and S.B.
Table V.
Perchlorate Discharge T ests, BIX 3 determ inationst and TSH te s ts  in  Auto-Immune 
T hyro id itis  and Simple Qoitre.
Measurements Auto-immune Thyroiditis Simple Goitre
No. Tested 32 13
Perchlorate Discharge
No. Positive 12 0
Tests
p Positive 37.5 0
48 hr. B II131
No. Tested 9
PBI131)
No. Abnormal 5 -
7> Abnormal 55-6 -
TSH Tests No. Tested 16 7
(both I 131 Uptake No. Normal 2 7
and PBI131 Discharge) /> Normal 12.5 100
/ s in c e  i t  was p o s it iv e  (both + and ++) in  9 per cent, in  simple 
g o itre  and in  92 per c e n t .in  auto-immune th y r o id it is .  The r e s u lt s  
of the p r e c ip it in  and CF auto-antibody t e s t s  obtained by other  
workers ( 16-18 ,22) are summarised in  Table I I I ,  and are in  general 
agreement w ith my own observations. However, both R o itt and 
Doniach ( 16) and B lizzard e t  a l .  (19) reported p o s it iv e  p r e c ip it in  
t e s t s  in  p a tien ts  w ith simple g o itr e , but i t  i s  to be noted th at  
the d iagn osis was not confirmed by h is to lo g ic a l examination.
As p rev iou sly  d iscussed  in  Section  3 of th is  Chapter o f the  
th e s is ,  the fin d in g  o f ra ised  gamma-globulin le v e l s ,  abnormal thymol 
tu rb id ity  and f lo c c u la tio n  t e s t s ,  and an e levated  ESR, i s  
presumptive evidence o f auto-immune th y r o id it is  in  a goitrous  
p a tien t who has no systemic or connective t is s u e  d isea se . The 
value of th ese  determ inations in  the d if fe r e n t ia t io n  o f auto-immune 
th y r o id it is  from simple g o itre  i s  i l lu s tr a te d  in  F ig . 1 .
The r e s u lt s  o f radioiod ine and sta b le  iodine stu d ies  in  auto­
immune th y r o id it is  and simple goitre* are compared in  Tables IV and 
V. I t  can be seen that n eith er  the radioiod ine uptake nor AIU
help  to  d if fe r e n t ia te  the 2 d isorders, but the fin d in g  o f  a high  
1 31 1 31PBI or BII in  a sso c ia tio n  w ith a normal uptake and low PBI 
favours auto-immune th y r o id it is . On the other hand, a low PII with  
a high thyroid clearance in d ica tes  iodine d e fic ien cy , and favours 
simple g o itr e . The IEI i s  low in  auto-immune th y r o id it is , and i s /
* I  am g ra te fu l to  Dr. D.A. Koutras for  the r e s u lt s  o f the stu d ies  
in  iodine metabolism in  simple g o itr e .
/ i s  normal in  simple g o itr e , but th is  t e s t  i s  too elaborate  
as a routine d iagn ostic  procedure.
From Table V i t  can be seen that the potassium perch lorate
discharge t e s t  i s  h e lp fu l in  d if fe r e n t ia t in g  the 2 d ise a se s .
Although p o s it iv e  in  only h a lf  the p a tien ts  w ith auto-immune
th y r o id it is ,  i t  i s  n everth eless in variab ly  negative in  simple
g o itr e . The TSH t e s t  a lso  provides a good t e s t  fo r  d istin g u ish in g
i  32the 2 con d ition s. This i s  e sp e c ia lly  so now th at I  i s  
r e a d ily  a v a ila b le . In auto-immune th y r o id it is  the response o f  
the gland i s  impaired, whereas i t  i s  normal in  sim ple g o itr e . A 
normal suppression o f uptake w ith thyroxine or triiodothyronine  
therapy occurs in  both conditions and i s  th erefore o f no value a s  
a d if fe r e n t ia l  t e s t .
(2) Thyroid Neoplasm.
Although thyroid neoplasm i s  a rare d isease  i t s  d if fe r e n t -  
: ia t io n  from auto-immune th y r o id it is  i s  of considerable p r a c tic a l  
importance. The 2 d isea ses  may be confused c l in ic a l ly  and on 
h is to lo g ic a l  c r ite r ia  (23) • In auto-immune th y r o id it is , both  
carcinoma, u su a lly  p a p illa ry  ( 2A ), and non-spithel i a l  lymphoid 
tumours ( 25 , 26) ,  are sa id  to  occur more freq u en tly  than expected .
Experience o f  th is  problem in  the present study i s  lim ite d  
to  18 p a tien ts  w ith h is to lo g ic a l ly  proven thyroid  neoplasms 
( see Appendices fo r  further d e t a i l s ) . L it t le  d i f f ic u l t y  mas 
experienced in  these p a tien ts  in  d if fe r e n t ia t in g  th yroid  neoplasm 
fr o n /
Table VI
Prevalence o f Thyroid A uto-antibodies  
in  Thyroid Neoplasm.
Table VI.
Prevalence of Thyroid Auto-antibodies in Thyroid Neoplasm.
Authors Year Bef. No.
No. of 
Cases.
Positive Thyr 
Prec.
oid Auto-ant 
CP
Lbody Tests 
TEC
Paine et al. 1957 15 6 0 2
Doniach et al. 1958 29 36 0 4 9
Stuart and Allan 1958 27 6 2 3
Belyavin and Trotter 1959 48 25 0 6
Blizzard et al. 1959 19 2 0
Cline et al. 1959 20 1 0
Hackett et al. 1960 21 2 1
Present Series 18 1 2
/from  auto-immune th y r o id it is  -  the presence o f a ra p id ly  enlarge* "g 
g o itre  o f short duration, a sso c ia ted  with pain and tenderness, 
severe pressure e f f e c t s  including vocal cord p a r a ly s is , or c erv ica l 
lymphadenopathy, drawing a tten tio n  to  the n eo p la stic  process 
(Table I ) .
The p r e c ip it in  t e s t  was p o s it iv e  in  one p a tien t with a 
p a p illa ry  adeno-carcinoma of the thyroid; sec tio n s  of the gland 
in  th is  p a tien t a lso  revealed the presence of severe chronic thyroidi- 
: i t i s .  P o s it iv e  p r e c ip it in  t e s t s  have been reported in  2 p a tien ts  
by Stuart and A llen  (27) and in  one p a tien t by Smart and Owen (2 8 ), 
although in  the m ajority of p a tien ts  the t e s t  has been negative  
(Table V i) . The prevalence of p o s it iv e  CP t e s t s  in  the present 
se r ie s  (2 o f  18) corresponds w ith the expected incidence o f 10 
per cent, of fo c a l th y r o id it is  in  thyroid neoplasms (3 0 ).
As p rev iou sly  d iscussed  in  Section  3, the r e s u lt s  of the  
thymol tu rb id ity  and flo c c u la tio n  t e s t s  and e lectrop h oresis o f  the  
serum prote in s are o f some value in  d if fe r e n t ia t in g  the 2 d ise a se s , 
although the ESR i s  ra ised  in  both conditions (F ig . l ) .
Routine radioiod ine t e s t s  have been carried out in  p a tien ts
131with thyroid neoplasms. High normal PBI va lues, due perhaps 
to  a sso c ia ted  th y r o id it is  or to the production o f abnormal 
bu tan o l-in so lub le  iodinated  proteins (31)> were found in  3 p a tien ts , 
and mig^it have led  to d iagn ostic  d i f f i c u l t i e s  had the c l in ic a l  
fea tu res  been a ty p ica l. Doniach and Hudson (32) and Murray and 
McG-irr (3 3 ) /
/McG-irr (33) have suggested th a t topographical survey o f the g o itre
in s u f f ic ie n t
migfct be h e lp fu l in  d if fe r e n t ia t in g  the 2 d is e a s e s ; /  experience  
has been gained w ith th is  and other a n c illa r y  radioiod ine t e s t s  to  
make any comment on th e ir  d iagn ostic  value.
In conclusion , i t  i s  c lea r  that in  d if fe r e n t ia t in g  auto—immune 
th y r o id it is  from thyroid neoplasm, the r e s u lt s  o f  the p r e c ip it in  
t e s t  must be in terp reted  w ith caution and only in  conjunction w ith  
carefu l c l in ic a l  assessm ent and other laboratory in v e s t ig a tio n s .
I f  the c l in ic a l  fin d in gs are a t a l l  suggestive of neoplasm, then 
biopsy should be performed.
(3) T h yrotox icosis .
Euthyroid p a tien ts  with auto-immune th y r o id it is  may sim ulate 
mild th y ro to x ico s is  and have radioiod ine t e s t s  which confirm th is  
d ia g n o sis. In the present study 5 of the 30 p a tien ts  su ffer in g  
from auto-immune th y r o id it is  presented in  th is  way. This problem 
w i l l  be f u l ly  d ea lt with in  Section  2 , Chapter H I  o f  the th e s is .
(4 ) Dy shormonogene s i  s .
Dyshormonogenesis may ra re ly  present as a g o itre  and hypo­
thyroidism  in  adult l i f e  (34) and so sim ulate auto-immune th y r o id it is .
131 131Radioiodine t e s t s  may be m isleading since the PBI and BII 
may be e levated  due to  the formation o f abnormal iodinated  p rotein s  
(35)* The PBI may be low and the response to  TSH stim ulation  
impaired. Moreover, the potassium perchlorate discharge t e s t  i s  
p o s it iv e  in  the peroxidase-defic ien cy  type of dyshormonogenesis (3&) • 
Pour/
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/Four adu lt p a tien ts  with dyshormonogenesis were encountered in  
the present study who migjtit have been misdiagnosed as auto-immune 
th y r o id it is ,  although in  a l l  4  the g o itre  was Hs o f tM in  con sisten cy . 
Three o f the p a tien ts  had peroxidase d efec ts  and deaf-mutism  
(Pendred*s syndrome) and the fourth had a dehalogenase d efect (3 7 ) . 
A ll  4  were r ea d ily  d iffe re n tia te d  from auto-immune th y r o id it is  by 
sta b le  iodine stu d ies  and the fin d in g  o f a g rea tly  increased AIU (3 7 ) . 
The p r e c ip it in  and CF t e s t s ,  serum flo c c u la tio n  t e s t s ,  gamma-globulin 
va lu es, and ESR determ ination, were a l l  normal.
(5) 11 Iodide11 G-oitre.
The protracted use o f iod id es for  asthma or b ron ch itis  may
o cca sio n a lly  be complicated by the development o f a go itre  w ith  or
without hypothyroidism (40 -4 6 ), and so be confused with auto-immune
th y r o id it is .  P aris e t  a l .  (45) have r ecen tly  summarised the
d if fe r e n t ia l  d iagnosis between the 2 con d ition s. L it t le  help can
be obtained from the con sisten cy  o f the go itre  or the c l in ic a l  s ta tu s , 
131and the PBI and BII values may be elevated  in  both con d ition s.
On the other hand, the PBI i s  low or normal in  auto-immune 
th y r o id it is  and high during iodide adm inistration, and th is  serves 
to  d if fe r e n t ia te  the 2 d ise a se s . Only one p a tien t was observed 
during the course o f the present in v estig a tio n  who presented w ith  
a g o itre  and hypothyroidism due to the taking of "Felsol'* powders; 
the p r e c ip it in  and CF t e s t s  and the serum flo ccu la tio n  t e s t s  and 
gamma-globulin values were normal and spontaneous recovery occurred 
w ith stopping the powders.
The/
/The d if fe r e n t ia l  d iagnosis o f iod ide g o itre  and auto-immune 
th y r o id it is  r e s t s  prim arily  on the h is to r y  o f in g estio n  o f  io d id es  
or iodine conta ini ng compounds, but the a p p lica tio n  o f s ta b le  
iod in e  measurements w i l l  g rea tly  f a c i l i t a t e  the d if fe r e n t ia t io n  
o f the 2 d iseases*  Further experience i s  necessary in  order to  
a sse ss  the d iagn ostic  value o f the ser o lo g ic a l and biochem ical 
t e s t s .
(6) G-oitre due to  G-oitrogens.
G-oitre w ith or without hypothyroidism may r e s u lt  from the 
in g estio n  o f a goitrogen or from i t s  ap p lica tion  to the sk in  (4 7 ) . 
One such case due to  the prolonged ap p lica tio n  of a r e so r c in o l-  
contain ing cream to  a varicose u lcer  in  th e le g  was observed in  the 
present study. The precipitin ,C Fjand serum flo c c u la tio n  t e s t s  
were negative and the gamma-globulin and ESR values normal.
S tab le iodine stu d ies  showed a normal accumulation o f iod ine ( i . e .  
AIU) by the thyroid gland w ith a low le v e l  o f PBI -  a pattern  
sim ilar  to  th a t seen in  auto-immune th y r o id it is . Confirmation o f  
the d iagn osis was obtained by shrinkage o f the go itre  and 
disappearance o f hypothyroidism w ith withdrawal o f the ointment.
(7) Subacute T h y ro id itis .
This i s  a rare d isease  in  th is  country, but occa sio n a lly  may 
cause d i f f ic u l t y  in  d if fe r e n t ia l d iagn osis. The onset of auto­
immune th y r o id it is  may be abrupt and assoc ia ted  w ith pain in  the  
g o itre  and fe v er , and thyroid auto-antibodies may be tem porarily  
p resen t/
208.
/p resen t in  subacute th y r o id it is  (1 5 ,1 9 ,2 0 ) . However, in  
subacute th y r o id it is  the rad io iod ine uptake by the thyroid  i s  
depressed during the acute stage o f the d isea se , and th is  
d if fe r e n t ia te s  the 2 con d ition s.
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SUMMARY
The d if fe r e n t ia l  d iagnosis o f auto-immune th y r o id it is  i s  
d iscu ssed  in  r e la t io n  to  simple non-toxic g o itr e , thyroid  neoplasm, 
dyshormonogenesis, "iodide?1 g o itre  and g o itre  due to  goitrogens, and 
subacute th y r o id it is .  Auto-immune th y r o id it is  and simple non-toxic  
g o itre  can be rea d ily  d if fe re n tia te d  on the b a sis  o f  a combination 
o f c l in ic a l  and laboratory fin d in g s including se r o lo g ic a l,  
biochem ical and radioiod ine t e s t s .  Most cases o f auto-immune 
th y r o id it is  can be d if fe re n tia te d  from thyroid  neoplasm, but the 
occasional occurrence o f a p o s it iv e  p r e c ip it in  t e s t  in  the la t t e r  
makes i t  necessary to  carry out thyroid  b iopsy when the c l in ic a l  
fin d in g s are equivocal. The d if fe r e n t ia l  d iagnosis o f auto-immune 
th y r o id it is  with dyshormonogenesis, ffiod id e,, g o itr e , and g o itre  due 
to  goitrogens, can be made on the b a sis  of a ca refu l h is to r y  and 
laboratory t e s t s ,  but fu rther experience w i l l  be required to  a sse ss  
th e value o f th e immunological and biochem ical t e s t s .  Subacute 
th y r o id it is  can u su a lly  be d if fe r e n t ia te d  on the c l in ic a l  h is to r y  
and the r e s u lt s  o f radioiod ine t e s t s .
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S u rgical treatment o f the g o itre  in  auto—immune th y r o id it is  
lead s to  a high incidence of post-op erative  hypothyroidism ( l ) .
For th is  reason, recommendations fo r  surgery are g en era lly  lim ited  
to  the r e l i e f  o f pressure e f f e c t s  or to  the e lim in ation  o f  an 
a sso c ia ted  neoplasm (2 -5 ) ,  although both Keleher (6) and Priebe  
and P atterson  (7) have recen tly  advocated subtota l thyroidectomy 
as th e  treatment o f ch o ice .
A v a r ie ty  o f  conservative measures, including treatment w ith  
radium (8 -9 ) ,  X-rays (1 0 -1 5 ), s tero id s  (2 ,1 5 -1 6 ), th io u r a c il (17) 
and m eth ylth iou racil ( 18) ,  and bismuth ( 19) have been tr ie d  in  the  
p ast with variab le su ccess. A ll  have, however, been la r g e ly  
superseded by treatment w ith desiccated  thyroid ex tra ct, which has 
proved sa tis fa c to r y  in  both reducing g o itre  s iz e  and correctin g  
hypothyroidism and the serum biochem ical abnorm alities (12-14-, 
20- 26) .
Personal Observations.
Macgregor (27) has suggested a more exten sive use o f  the pure 
and sy n th etic  thyroid  compounds in  view o f the variab le  e ff ic a c y  
of dried thyroid preparations, but so fa r  no study has been 
reported o f the use o f thyroxine sodium in  the treatment o f auto­
immune th y r o id it is .  Opportunity has, th erefore , been taken to  
study the e f f e c t  o f thyroxine sodium 0.1 mg. tw ice d a ily  by mouth 
in  19 o f the p a tien ts  o f the present study. The duration of 
treatment varied from 2 to  56 months w ith a mean follow -up of 
15*4 months.
The/
FIGURE 1.
E ffe c t o f Thyroxine Sodium Therapy on G-oitre S ize ,
TABLE I ,
E ffec t o f Treatment w ith  Thyroxine Sodium in  19 
P a tien ts  w ith  Auto-immune T h yro id itis.
Woman, aged 40 years (T hesis No. 16) .  Marked shrinkage o f  
g o itre  a fte r  36 months thyroxine sodium therapy. I n i t ia l  neck 
circumference 15*5 inches; f in a l  neck circumference 13*5 inches.
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TABLE I .
Effect of Treatment with Thyroxine sodium in 19  patients with Auto -immune Thyroiditis.%
Mean Heck
Circumference 
(inches). 
Mean S.D.
Thyroid
Precipitin 
Mo. Poe. £ Poe.
Auto-Antibody 
Feats 
Cooplenent-Pixation 
Bo. Pos. V Pos.
Albumin 
Mean S.D.
Serum Protei 
(g./100 ml 
Globulin 
Moan S.D.
r.s
)
y  Globulin 
Kean S.D.
Scrum Flooc 
(ur
Thymol Turbidity 
Mean S.D.
ulatlon Testa 
i t s ) .
Thymol Flocoulation 
Mean S.D.
I.S .8.
(mm./first hr.) 
Mean S.D.
Before 
After 
P values
14.78 -  1.11
1 3 .63  -  1 .06 
< 0.001
16 6 4 .2  
13 68 .4
19 100 
19 100
4 .2 3  -  0 .40  
4 .59  -  0 .3 6  
< 0.001
2.66 i  0 .67
2 .34 -  0 .6 2  
4 0.001
1 .4 1  1 0 .57  
1 .00  i  0 .3 9  
4  0.001
7 .0  -  4 .5
4.0 -  2.2 
4 0.001
2.0 -  1.5 
1 .0  -  0 .1  
4  0.01
25  ■ i j  
1 5 1 9 
4  0 .01
The P v s lu e s  hsve le c n  c a lc u la te d  from ta e  near* d if f e r e n c e  o f th e  v a lu e s  b e fo re  and a f t e r  t re a tm e n t and ita  
stan d a rd  e r r o r  and not from the d if fe re n c e e  between th e  means.
/The r e s u lt s  o f th is  in v e s tig a tio n  are summarised in  Table 1 
and are given in  more d e ta il  in  the Appendices. There was a 
variab le  but s ig n if ic a n t  (P< 0 .001) reduction in  go itre  s iz e ,  
which was quite marked in  severa l p a tien ts  (F ig . 1) and 
p a r tic u la r ly  so in  those w ith  small g o itr e s  of recent onset. There 
was a lso  a s ig n if ic a n t resto ra tio n  of the biochemical abnorm alities 
w ith thyroxine sodium therapy (Table l ) ,  although with 3 exceptions, 
the p r e c ip itin  and CF t e s t s  remained unchanged. Changes in  the 
biochem ical and sero lo g ica l t e s t s  were even more pronounced in  
p a tien ts  trea ted  by surgery (see  Appendices).
The in d ica tio n s fo r  treatment with thyroxine sodium in  the 
euthyroid p a tien t with auto-immune th y r o id it is  remains debatable, 
although Hubble (26) and C rile  ( 13) are in  agreement in  recommending 
thyroid  replacement therapy even when the p a tien t i s  not hypothyroid. 
In the preceding sec tio n s of th is  Chapter of the th e s is  i t  was 
emphasised th at th e c l in ic a l  d iv is io n  between euthyroid and 
hypothyroid was e n t ir e ly  arb itrary , since many of the euthyroid  
p a tien ts  had laboratory evidence of thyroid un d eractiv ity , e . g .  
low BMRs, ra ised  serum ch o le stero l lev e ls ,a n d  abnormal e le c tr o ­
cardiograms. Furthermore i t  was shown th at the c l in ic a l ly  
euthyroid p a tien ts  had as a group a s ig n if ic a n t ly  lower le v e l  o f  
serum PBI than a normal control group. I t  i s ,  th erefore , eon- 
: eluded th at thyroxine sodium in  p h y sio lo g ica l replacement dosage 
i s  in d icated  in  a l l  p a tien ts  w ith auto-immune th y r o id it is  
ir r e sp e c t iv e  of th e ir  c l in ic a l  s ta tu s .
SUMMARY
The e f f e c t  of treatm ent w ith  thyroxine sodium 0.1 mg. 
tw ice d a ily  by mouth has been studied  in  19 p a tien ts  w ith auto­
immune th y r o id it is .
A variable but s ig n if ic a n t shrinkage of the g o itre  was 
a sso c ia ted  w ith a return to  normal o f the biochem ical abnorm alities, 
although there was l i t t l e  change in  the r e s u lt s  of the p r e c ip it in  
and CF auto-antibody t e s t s .
Mild degrees o f hypothyroidism detected  only  by laboratory  
procedures are not infrequent in  auto-immune th y r o id it is ;  
consequently, thyroxine sodium should be prescribed in  a l l  p a tien ts  
ir re sp e c t iv e  o f th e ir  c l in ic a l  s ta tu s  and the treatment continued  
fo r  l i f e .
Rarely su rg ica l in terven tion  may be necessary to  r e lie v e  
pressure symptoms when thyroxine sodium therapy has fa i le d  to  
reduce the s iz e  o f the g o itr e . X-ray or s tero id  therapy may 
provide a lte r n a tiv e  methods o f treatment ih  these circum stances i f  
surgery i s  contraind icated .
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S ir  W illiam G-ull ( i )  f i r s t  described a " cretin o id  condition  
supervening in  adult l i f e  in  women" in  1874* and the d isease  was 
named "myxoedema" by W.M. Ord (2) in  1877> account o f the 
abnormal amount o f  mucin in  the subcutaneous t is s u e s .  In  1893 
H alliburton (3) pointed out th at "myxoedema" was by no means a 
constant feature and suggested the term "hypothyroidism", which 
has been favoured by recent w riters on the subject (4 )•
Hypothyroidism may r e s u lt  from a number of conditions g iv in g  
r is e  to  thyroid destruction  or dysfunction or be secondary to  
p itu ita r y  fa ilu r e  but i t  i s  the spontaneous "primary" form of the  
disease with which the fo llow in g  account i s  concerned.
Past views regarding A etio logy and Pathogenesis o f Primary
Hypothyroidism.
In 1931 McG-avack (5) voiced the opinion o f most w riters o f
textbooks on D iseases o f the Thyroid (6 -8 ) when he considered
th at "the m ajority o f cases of spontaneous hypothyroidism are
due to an atrophy of the thyroid gland, the a e tio lo g y  of which
i s  s t i l l  undetermined". There i s  an undoubted genetic  fa c to r
(9-12) and Draper ( 13) considered th at p a tien ts  w ith th e d isease
"tend to  be broad shouldered, short-necked, and stocky, to  have
a sunny d isp o s itio n  and a sense o f humour". On the other hand,
Werner (8) considered emotional depression or "apathetic withdrawal"
as a p o ss ib le  predisposing cause. Females are predominantly
a ffec ted , e sp e c ia lly  multiparae ( 14) > but the ro le  the ovarian
hormones/
Figure 1.
I l lu s tr a t io n  o f h is to lo g ic a l  appearances 
in  the thyroid gland in  myxoedema. 
Committee appointed by the C lin ic a l  
S o c ie ty  of London ( 1888) .
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Fig. 1.
T he rem nant o f  a lobule  is seen undergo in g  atrophic  changes .  Tiie  
epithelium  (e.) is  proliferating and at the  sam e t im e  a trophy ing ,  as  
seen specia lly  at  the m argin o f  the  lobule. T h e  destruction  is secondary  
to  the  invasion o f  the  interstit ia l  capsular t issue  (c.), which is th ickened  
by leucocytes (I.). The process is apparently  one of contracti le  or 
atrophic cirrhosis.
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/hormones play in  th e  pathogenesis i s  obscure. O ccasionally the  
onset o f the d isease  may be preceded by some years w ith a h is to r y  
of th y ro to x ico sis  (15"*17)j a-nd Eason (18) considered th at in  th ese  
cases primary hypothyroidism might represent the f in a l  end r e s u lt  
o f a "burnt-out" th y ro to x ico s is .
The R elation  of Auto-immune th y r o id it is  to  Primary Hypothyroidism.
H isto r ica l A spects.
The h is to r ic a l  aspects o f the p o ssib le  re la tio n sh ip  between 
the 2 d isea ses  can be considered under 3 headings: ( l )  Morbid 
Anatomy, (2) Iodine Metabolism and Biochemical a sp ects , and (3) 
Immunology. These w i l l  now be b r ie f ly  o u tlin ed .
( l )  Morbid Anatomy. Opportunities to  study the morbid anatomy of 
the thyroid in  primary hypothyroidism have been infrequent, and 
in  most reports the gland i s  reported as showing "a variab le  degree 
o f atrophy and f ib r o s is " . However, in  a h is to lo g ic a l study based 
on 13 cases, the Committee appointed by the C lin ica l Society  o f  
London ( 19) in  1888 , reported, "lymphocytic in f i l t r a t io n ,  sca ttered  
e p ith e l ia l  c e l l s ,  disappearance o f  a c in i and o f co llo id"  in  add ition  
to  f ib r o t ic  replacement of the parenchyma. In one of the 
i l lu s t r a t io n s  in  th is  report (F ig . l )  the appearances appear to  be 
very sim ilar to those seen in  auto-immune th y r o id it is . Indeed* 
J affe  (20) and Bastenie (21) both concluded that from a h is to lo g ic a l  
point of view there was no e s se n tia l d ifferen ce  between the 2 
d iseases; th is  view has a lso  been supported by recent stu d ies (22, 
23).
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(2) Iodine Metabolism and Biochemical A spects. In 1956 
S k il le m  e t  a l .  ( 24) proposed th at auto-immune th y r o id it is  was
Hprimary thyroid fa ilu r e  w ith compensatory thyroid enlargement", 
whereas primary hypothyroidism without a g o itre  represented "de­
compensated thyroid  fa ilu r e" , on the grounds th a t the thyroid was 
in se n s it iv e  to stim u lation  by TSH in  both con d ition s. The reason  
fo r  the in a b il i ty  o f the thyroid to  enlarge in  response to  TSH 
stim ulation  in  p a tien ts  w ith primary hypothyroidism was however 
obscure. In add ition , S k i l le m  e t a l .  (24) drew a tten tio n  to  
hypergammaglobulinaemia and abnormal c o llo id a l  gold curves which 
occurred in  both d isea ses .
(3) Immunology. In 1942, Lerman ( 23 ) observed that rab b its  
experim entally immunised aga in st human thyroglobulin  developed  
antibody to  th e ir  own th yroid s, and th at they became hypothyroid 
over the course o f about 6 months. The p o ssib le  relevance of 
th ese fa c ts  to  the pathogenesis of primary hypothyroidism escaped  
a tten tio n  u n t i l  1957, when Doniach and R o itt (26) described thyroid  
auto-antibodies in  p a tien ts  w ith the d isea se . This fin d in g  
supported the e a r lie r  h is to lo g ic a l s tu d ies , and the hypothesis o f  
Ski l l e m  e t a l .  ( 24) ,  o f a b asic  u n ity  between the 2 d ise a se s .
Personal Observations.
The present in v estig a tio n  confirms and extends th ese e a r lie r  
observations, and supports the b e l ie f  that auto-immune th y r o id it is  
and primary  hypothyroidism share a common pathogenetic b a s is .
The/
Figure 2.
Comparison in  Age D istr ib u tio n  in  
Auto-immune T hyro id itis  and 
Primary Hypothyroidism.
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COMPARISON IN AGE DISTRIBUTION IN AUTO-IMMUNE 
THYROIDITIS AND PRIMARY HYPOTHYROIDISM
17 1 Auto-  immune 
T h y ro i d i t i s
Pr  imary 
Hypothyroidi sm
15 -
13 -
75 8 04 0  4 52 5 55 6 0 65 7 03 0 3 5 5 0
Years
/The c l in ic a l ,  sero lo g ica l and biochem ical fea tu res have been 
studied in  71 p a tien ts  with primary hypothyroidism and compared 
w ith those in  50 p a tien ts  w ith auto-immune th y r o id it is .
M aterials and Methods 
The c l in ic a l  d e ta ils  of the 71 p a tien ts  w ith primary hypo­
thyroidism  are summarised in  the Appendices. The d iagn osis o f  
primary hypothyroidism was based on c l in ic a l  fea tu res  of hypo­
thyroidism  (4 ) in  an agoitrous subject with no evidence of hypo­
p itu ita r ism . The d iagnosis was confirmed by serum ch o le ster o l 
and BMR determ inations, 13-lead ECGs, routine radioiod ine t e s t s ,  
and serum PBI estim ation s. The methods used have been described  
in  d e ta il  in  Chapter I I .
R esu lts
( l )  C lin ica l Features
Age. The age d is tr ib u tio n  in  the 2 d isea ses  was s tr ik in g ly  
sim ilar  (P ig . 2 ) . The age range fo r  p a tien ts  w ith  primary 
hypothyroidism was 34 to  73 years (mean age 55 .0  y ea rs), and 
28 to  70 years (mean age 52*5 years) in  auto-immune 
th y r o id it is .
Sex. Females were predominantly a ffec ted  in  both d ise a se s , 
although the proportion o f males (l8*3  per cent.) was higher  
in  primary hypothyroidism than in  auto—immune th y r o id it is  
(8 per cen t) .
Past H istory o f T hyrotoxicosis. This was e l i c i t e d  on carefu l 
enquiry/
Table I
Prevalence o f Thyroid A uto-antibodies  
in  Primary Hypothyroidism.
Figure 3»
Biochemical Studies in  Auto-immune
T h yroid itis  and Primary Hypothyroidism.
Table I.
Pravalanoa of Thyroid Auto-antibodlea In Primary Hypothyroidlan.
Authors Tear Bef. Bo.
Ho. of 
Caaaa.
Poaltiva Thy 
Prao.
rold Auto-ant: 
CP
Lbody Teata 
THC
Hurray 1958 29 45 9 30
O n n  and Saart 1958 30 78 63
Boltt and Donlaoh 1958 28 101 19 64 66
Andoraon at al. 1959 31 90 13 48
Balyavin and Trottar 1959 32 19 4 10
Bllssard at al. 1959 33 4 0 7
Cllna at al. 1959 34 2 0
Baekatt at al. i960 35 20 12
Prsasnt Sarlsa 71 11 36
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BIOCHEMICAL STUDIES IN AU TO-IM M UN E THYROIDITIS  
AND PRIMARY HYPOTHYROIDISM
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/en q u iry  in  5 p a tien ts  (7*0 per cent.) w ith primary hypo­
thyroidism , as compared with 6 per cent, in  auto-immune 
th y r o id it is .
Family H istory of Thyroid D isease . A fami ly  h is to r y  of 
thyroid d isease  was obtained in  8 p a tien ts  (11 per cent,) w ith  
primary hypothyroidism as compared w ith 16 per cent, in  
p a tien ts  with auto-immune th y r o id it is . A fam ily  h is to r y  
o f thyroid d isease  was obtained p a r ticu la r ly  in  those p a tien ts  
w ith primary hypothyroidism who had p o s it iv e  p r e c ip it in  t e s t s .
(2) Immunology
The prevalence o f p o s it iv e  p r e c ip it in  and CF t e s t s
(1 5 *5 and 4-6*5 Per cent, r e sp ec tiv e ly ) in  the 71 p a tien ts  with
primary hypothyroidism in  the present study i s  in  c lo se
agreement with the r e s u lt s  obtained by other workers (28-35)
(Table I ) ,  but con trasts with the much higher prevalence of
these auto-antibodies in  the 50 p a tien ts  with auto-immune
th y r o id it is  -  76 and 92 per cen t, r e sp e c tiv e ly . P o s it iv e  skin  
t e s t s  are found in  both conditions (see  Chapter I I ,  Section  2 ) .
( 3) Biochemistry
In Section  3 of Chapter I I  of the th e s is  i t  was shown 
th at ra ised  gamma-gLobulins, abnormal thymol tu rb id ity  and 
f lo c c u la tio n  t e s t s ,  and elevated  ESR va lu es, were found in  
p a tien ts  with both primary hypothyroidism and auto-immune 
th y r o id it is . These abnorm alities were, however, more 
pronounced in  p a tien ts  w ith auto-immune th y r o id it is  (F ig . 3) 
and in  p a tien ts  with primary hypothyroidism w ith p o s it iv e  
p r e c ip it in /
Figure 4.
R esu lts o f Routine Radioiodine T ests  
in  Hypothyroid Auto-immune T h yro id itis  
and Primary Hypothyroidism.
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/p r e c ip it in  t e s t s ,  suggesting that they were a sso c ia ted  w ith
the auto-immune process and not w ith the hypothyroidism per s e .
(4 ) Iodine Metabolism
Radioiodine t e s t s * These are summarised in  P ig . 4 .  I t  can be
seen that in  general p a tien ts  w ith primary hypothyroidism had
131both a low 4-hour uptake and low PBI , whereas hypothyroid
p a tien ts  with auto-immune th y r o id it is  had a normal uptake and 
131elevated  PBI . Some overlap, however, does occur.
Potassium perchlorate discharge t e s t s .  These were performed 
in  7 p a tien ts  and p o s it iv e  t e s t s  Sim ilar to  those found in  
auto-immune th y r o id it is  were present in  2 .
TSH t e s t s . These were carried  out in  15 p a tien ts  w ith primary
hypothyroidism. No increase was noted in  the 2-^ —hour uptake 
132o f I  in  any o f the p a tien ts . This corresponds w ith  the
fin d in gs in  auto-immune th y r o id it is  (see  Chapter I I ,  S ection  4 ) .  
131BII . This was estim ated in  2 p a tien ts  with primary hypo-
131thyroidism who had high PBI va lu es. High values were 
found in  both -  35 and 40 per cen t, r e sp e c tiv e ly  of the to t a l
P B j151 y a j.u e s .
(5) Intermediate Syndromes
Several p a tien ts  in  the present study with primary hypo­
thyroidism had what might be described as an "interm ediate1' 
syndrome between th is  d isease and auto-immune th y r o id it is .
The follow ing i s  an i l lu s t r a t iv e  c a se :-
A woman, aged 60 years, complained of increasin g physical 
t ir e d n e ss /
2 34-
/t ir e d n e s s , mental lethargy, acroparaesthesiae, deafness,
co ld  in to leran ce , and hoarseness o f a y ea r 's  duration. She
had a ls o  been aware o f lo s s  o f h a ir , dryness o f the sk in ,
and weight in crease , but had not been con stip ated . There
was no past h is to ry  o f thyroid d isease  and no fam ily  h is to r y
of thyroid d isorder. On ph ysica l examination she presented
the ty p ica l appearances o f hypothyroidism but had no palpable
thyroid t is s u e .  A dditional in v e s tig a tio n s  included:
p r e c ip itin  t e s t  (+ ), CF t e s t  (++), thymol tu rb id ity  3 u n its ,
thymol flo c c u la tio n  1 u n it , gamma glob u lin  1 .2  g. per 100 m l.,
ESR 40 mm. in  the f i r s t  hour, radioiod ine te s t s :  4-hour uptake
1 3118,8  per cent per dose, 48-hour PBI 0 .58  per cent per dose
per l i t r e ,  potassium perchlorate discharge t e s t  p o s it iv e ,
131 1 31BU 35 P0i* cen t.o f  PBI , and serum PBI 3*0 pg. per 100 ml.
In v estig a tio n s confirmed the diagnosis o f hypothyroidism:
BMR46 per c e n t ., serum ch o lestero l 370 mg. per 100 m l., and
ECG- co n sisten t with hypothyroidism.
Comment
The fin d in gs in  the present in v estig a tio n  show that no c lea r  
divid ing l in e  can be drawn between primary hypothyroidism and auto­
immune th y r o id it is ;  th is  supports the h is to lo g ic a l evidence that 
the 2 d isea ses  are variants o f the same fundamental process. The 
pathogenesis o f primary hypothyroidism i s  assoc ia ted  auto-immunisation 
in  a proportion o f cases, but the fundamental problem o f causation  
remains obscure. The actu a l le s io n  which provokes thyroid auto- 
immunisati on/
/im m unisation has not been id e n t if ie d , although i t  i s  probable 
th at approximately 5 per cen t, o f cases o f primary hypothyroidism  
represent a "burnt-out" th y ro to x ico s is . The low prevalence o f  
thyroid auto-antibodies in  primary hypothyroidism may be due to  the  
small shrunken gland containing l i t t l e  or no c o llo id  and a meagre 
quantity o f antibody forming c e l l s  ( 36) •
SUMMARY
The c l in ic a l  and laboratory fea tu res  in  71 p a tien ts  w ith  
primary hypothyroidism have been compared w ith th ese in  50 
p a tien ts  with auto-immune th y r o id it is .  The fea tu res  common to  
both d isea ses  included: -
(1) C lin ica l -  age d is tr ib u tio n , female preponderance, past 
h isto ry  of th y ro to x ico s is , and fam ily  h is to r y  o f g o itr e .
(2) Immunological -  p r e c ip it in  and com plem ent-fixation (CF) 
thyroid auto-antibody t e s t s ,  and sk in  t e s t s .
(3) Biochemical -  ra ised  gamma-globulins, abnormal thymol 
tu rb id ity  and flo c c u la tio n  t e s t s ,  and e levated  ESR 
determ inations.
(4 ) Radioiodine stu d ies  -  ra ised  48-hour P B I ^  and B I I ^  
values, p o s it iv e  perchlorate discharge, and unresponsive 
ness to  TSH stim u lation .
Several p a tien ts  had "intermediate" syndromes between the  
2 d isea se s .
I t  i s  concluded th at primary hypothyroidism and auto-immune 
th y r o id it is  are variants o f the same p ath o log ica l p rocess.
Section 2.
The R elationship  o f Auto-immune 
T h yro id itis  to  T hyrotoxicosis.
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That a p o ssib le  a sso c ia tio n  e x is t s  between auto-immune 
th y r o id it is  and th y ro to x ico sis  has long been suspected, and the  
demonstration o f thyroid auto-antibod ies in  the blood serum of 
p a tien ts  w ith both d iseases strengthens t h is  view. The fo llow in g  
h is to r ic a l  review o u tlin es  the specu lation  and fa c t  concerning 
the a sso c ia tio n  between the 2 d isea se s .
H is to r ica l Outline
( l )  Round-cell in f i l t r a t io n  in  the Thyrotoxic G-land and i t s  
r e la t io n  to the P ath olog ica l changes of Auto-immune 
T h y ro id itis .
Focal le s io n s  o f chronic th y r o id it is  have long been recognised  
as an in teg ra l part o f the h is to lo g ic a l p icture in  th y ro to x ico s is . 
Thus, G reenfield ( l )  in  h is  Bradshaw lectu re  in  1893> noted th at  
Mp r o life r a tiv e  change i s  l ia b le  to  be follow ed by fib rou s over­
growth” in  the thyrotoxic gland, and the presence o f lymphocytes 
a ttracted  the a tten tio n  o f several workers a t the beginning o f the 
century (2 -1 2 ). However, i t  was not u n t i l  Brunger*s report o f  
2 p a tien ts  in  1914 (1 3)> that chronic th y r o id it is  in  the thyrotoxic  
gland became generally  recognised ( 14- 16) .  In 1934 Smith e t  a l .
( 17) noted the s im ila r ity  between th is  fo ca l le s io n  and the changes 
seen in  auto-immune th y r o id it is , and 2 years la te r  Broders ( 18) 
pointed out th at chronic th y r o id it is  in  varying degrees was present 
in  the majority of thyrotoxic glands. Chronic th y r o id it is  o f an 
un sp ecified  degree was found in  75 per cen t, o f  th yrotoxic  g la-n^s 
by Simmonds ( 9) ,  in  83 per cen t, by Kocher (1 9 ) , in  90 per cen t, 
b y /
A y  Wegelin (2 0 ), and in  100 per cen t, by Warthin (12) and Heife 
(2 1 ) . In the m ajority o f cases the degree o f rou n d -cell i n f i l -  
:tr a tio n  was s lig h t  although both H ellw ig (22) and Greene ( 23) 
found "severe11 th y r o id it is  in  a quarter o f th e ir  ca ses . These 
"severe" degrees o f round -cell in f i l t r a t io n  were considered by 
H ellw ig (22) to  be ch a ra cter is tic  o f auto-immune th y r o id it is ,  "a 
fa c t  of p articu lar  in te r e s t  th at has been overlooked by most 
authors". B eattie  e t  a l .  (22*.) went further and stated: "Thus
the la t t e r  stages of a primary hyperplastic  to x ic  (primary exoph- 
:thalm ic) g o itr e , there may be degeneration and general atrophy 
of the epithelium  as a r e su lt  of exhaustion. In some ca ses , the  
degeneration and atrophy are fo c a l, and around and obscuring the  
degenerating a c in i, c o lle c t io n s  of lymphocytes appear, sometimes 
forming lymph nodes. The name lymphadenoid g o itre  has been applied  
to  th is  type of change". Lindsay e t a l .  ( 25) a lso  considered  
that auto-immune th y r o id it is  might be fo c a l in  i t s  d is tr ib u tio n  
since they could fin d  no s ig n ifica n t q u a lita tiv e  d ifferen ce  between 
the le s io n  seen in  thyrotoxic glands and the s l ig h t ly  more 
extensive le s io n  c la s s if ie d  as auto-immune th y r o id it is .  Friedman 
(26) a lso  supported th is  view and found transform ation to  Htirthle 
c e l l s  so uniform in  t is su e  removed a fte r  operation fo r  th y ro to x ico sis  
th at he concluded "that some of the gland remnants were in d is t in g ­
u ish a b le  h is to lo g ic a lly  from Hashimoto1s d isease" . Contrary 
opinions were, however, expressed by J o l l  (2 7 ) , Statland e t  a l .
(2 8 ) , and Harland and Frantz (2 9 ), but i t  i s  to be noted that th ese  
workers/
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/workers a r b itr a r ily  defined auto—immune th y r o id it is  as a d iffu se  
and generalised  process and excluded a l l  cases showing th yrotoxic  
fea tu res  from th e ir  s e r ie s .
(2) C lin ica l S ign ifican ce of Round-cell I n f i l t r a t io n  in
Thyrotoxic Glands.
Whatever the path o log ica l s ig n ifica n ce  of the rou n d -cell 
in f i l t r a t io n  in  thyrotoxic glands and i t s  a sso c ia tio n  w ith auto­
immune th y r o id it is  i t  appears from the stu d ies o f  W h itese ll and 
Black (30) a t the Mayo C lin ic , and workers in  t h is  country (2 3 ,3 1 ) , 
th at i t  may be of c l in ic a l  importance. Thus, W h itesell and Black 
( 30) found the incidence of p ost-op erative hypothyroidism in  a 
s e r ie s  o f 86 thyrotoxic p a tien ts  with varying degrees of lymphocytic 
and fib ro c y tic  replacement to  be 24 per cen t, in  those w ith  
lymphocytic in f i l t r a t io n  only, and 34 per cen t, in  those w ith  mixed 
fibrolym phocytic le s io n s;  in  p a tien ts  showing 40  to  50 per cen t, 
replacement the incidence o f post-operative hypothyroidism  
approached 70 per cen t. In a study of 2 ,114 thyroidectom ies 
reported by L ev itt ( 31) the incidence of post-op erative hypothyroidism  
in  glands showing " e p ith e lia l hyperplasia" only was 0 .3  per c e n t.,  
whereas the incidence was 27 per cen t, in  glands showing " d iffu se  
lymphoid hyperplasia". These r e s u lt s  were even more str ik in g  in  
the s e r ie s  o f 570 cases studied by Greene (23) ,  -  0 .3  per cen t, 
with "no lymphadenoid changes", 38*3 per cen t, with "mild 
lymphadenoid changes", and 83*3 per cent w ith "advanced lymphadenoid 
changes"; th is  author concluded that "hypothyroidism occurs 
extrem ely/
Table I.
Summary of the Findings in  Cases
a lle g e d ly  I l lu s tr a t in g  the C o-existence  
of Auto-immune T h yro id itis  and 
Thyrotoxi co s i  s .
ifosue X. Stuasary of th e  Finding* in  Cases a l le g e d ly  I l l u s t r a t i n g  th e
Co-existence of Auto-insrune Thyroditis and Thyrotoxicosis,
Author* Toar R ot. No. A(*. Sax. C lin ic a l  D e ta ils  and 
Response to  Therapy.
labora tory
in v e s tig a tio n s
Thyroid
H isto lo g y
P .lo o . 193* 32 26 F Excessive sw eating . Unable 
to  g a in  w e igh t. S lig h t 
enlargem ent of r i g h t  lobe 
of th y ro id . Pulse r a te  
120 p e r m inute . No 
improvement w ith  tre a tm e n t.
B.U.R. *43? 
Serum ch o les­
t e r o l  I93mg*.
"Areas o f"h y p e rtro p h ic"  
( to x ic )  etrueia and 
enormous lymphoid 
i n f i l t r a t i o n ”
Poor o t  a l . 195* 33 35 F N ervousness and re e e n t 
w eight lo s s .  G o itre , warm 
m oist palm s, trem or of 
f in g e r s .  Pulse r a te  8 6 per 
■ in . No u en tio n  o f responee 
to  trea tm e n t.
B.U.R. -2% "T ypical o f  H ashim oto 's 
d isease *
BojBob o t  a l . 1935 3* 20 F He d e t a i l s  f i v t n . B.U.R. *30# "T ypical o f  U ashim oto 's 
d is e a s e ”
"T ypical o f  flnahim eto 'n  
d ise a se "
27 U D iabetes U e ll l tu s .  Weight 
lo s s .  Exophthalmos and 
trem or. Responded to  a n t i -  
th y ro id  th erap y  and gained 
40 pounds in  w eight. B.U.R. 
f e l l  to
B.U.R. **79
30 F T iredness  and sw eating . 
G o itre  p re s e n t. B.U.R. f e l l  
to  +0% w ith  tre a tm e n t.
B.U.B. *23J( "T ypical o f  H aahim eto'n 
d iaoaao"
Kdon and 
T ro tto r
19*3 35 35 F G eneral i l l - h e a l t h  w ith  
weight lo s s  and ankle 
sw e llin g  f o r  3 months. 
G o itre  m oderately en la rged  
and firm  and Von G ra e fe 's  
sig n  p o s itiv e  in  each eye . 
P e r io r b i ta l  oedema and 
p r e t i b i a l  myxoedema. 
G enera lised  p igm en tation . 
Skin warm and m o ist. A tr ia l  
f i b r i l l a t i o n  90 to  100 per 
min. Became hypothyroid 4 
months a f te r  o p e ra tio n . •
B.U.B. **89, *
m 9 0 7 9  — 3
•CCOOl.BO,
Areas sh o w in g "e p lth e lia l 
h y p e rp la s ia  to g e th e r  
w ith  w ide-eprend  ch ro n ic  
th y r o d i t is "
MeSoaia 
aad Haora 19*3 36 3 « 
a«*
BOt
U « l
*  sex
given
Complained o f nervousness 
and p a lp i ta t io n s .  A ll 
had a g o i t re  and 1 had 
exophthalm os. Response to  
trea tm e n t n o t reco rded .
B.U.R. *269 
*169 
-159
"T ypical o f  H ashim oto 's 
d is e a s e "  in  a l l  3 .
Carkaa 19*3 37 56 M Dyspnoea, nervousness, 
w eight lo s s ,  and d ia rrh o ea  
Hard d if fu s e  g o i t r e .  
Exophthalmos, l i d  d e tra c t­
ion  and l i d  la g . Tremor of 
hands and le g s . P u lse 130 
per min. In c reased  w eight 
w ith  trea tm e n t.
B.U.R.*769,* 
879 —A *809 
«n th r o .
.OCOiOBO.
"Areas ty p ic a l  o f 
th y ro to x ic o s is  and of 
t h y r o d i t is  o f  Hashlmeteh 
typo"
B art 19*6 3* *1 F T iredness and p a lp i ta t io n s  
O o itrs  fo r  30 y e a rs . 
Q .M .R.-U* 8 days a f te r  
op era tio n
B.N.R. +0* "T ypical c f  H ashim oto'c 
d ia e a se ”
35 F Weakness and nervousness. 
G o itre  p re s e n t ." S l ig h t  
widening of the p a lp e b ra l 
f i s s u re s "  P u lse 100 p er 
■ in .
B.U.R. 0* 7 days a f te r  
o p e ra tio n .
B.M.&.+260 
senaa cho les­
t e r o l .  119ngjt
"T ypical o f  H ashim oto 's 
d iseaso "
60 F Nervousness and se n sa tio n  
o f h e a t. G o itre  and 
exophthalm os. Pulse 90 per 
■ in . B .U,K.-19£ 12 days 
a f te r  o p e ra tio n .
B.U .R .-5* "T ypical of H aehlm oto's 
d ise a se "
F o d if . aad 
l l r a a a o
19*7 39 U U A c u te ly . i l l  w ith  fe v er 
and a r th r a lg i a .  
N ervousness, h ea t 
in to le ra n c e ,  excessive  
sw eating , good a p p e t i te ,  
w eight lo s s .  Firm g o i t r e .  
No eye e igne . Response to  
trea tm e n t n o t recorded .
B.U.B.+69* "H ashim oto's th y r o d i t is  
supervened on a  sim ple 
g o i t r e "
Bahaaa aad 
A rata
19*9 * •  . 27 F 6 months h is to ry  of ra p id  th y ro id  en largem ent. Less 
o f  33 pounds in  w eight 
( a t t r ib u te d  by au th o rs  to  
c o - e x is t in g  d ia b e te s  m e ll-  
i t u e ) .
F irm , d if fu s e  g o i t r e .  
Exophthalmos, trem or. 
N ervousness dec reased  
and gained w eight w ith  
tre a tm e n t.
B. U.R. •*■%?> "Areas ty p ic a l  o f 
th y ro to x ie o a is , 
to g e th e r  w ith  lymphoid 
i n f i l t r a t i o n  w ith  
lymph f o l l i c l e s  and 
germ inal c e n tre s ”
Uahhla 1959 *2 30 F Ne d e t a i l s  g iv en , bu t 
had p re p to s ie . Considered 
to  be eu thy ro id  a t  the t im  
o f in v e s t ig a t io n .
P re c ip i t in  tea  
p o s i t iv e .  Sen* 
f lo c u la tio n  te  
normal.
I ^ ^ t e a t e  4~hr 
uptake 29^/dos 
48 -h r FBI1*1 
0 .4 4 jt/d o se /l.  
Potassium  
p erc h lo ra te  
d isch arg e  te a l 
p o s i t iv e .
PBI 4 .9 pg*.
BUR +&%
t  " C h a ra c te r is t ic  o f 
a  H ashim oto 's d ise a se  
s t s  and T hyrotoxicosis."
e
l a i t o a 1937 *1 U F Loot one s to n e  in  w eight 
U  4 months and had 
sw eating , trem or mad
« «  l o .
B.U.R *3 
a f t e r  4 months 
trea tm e n t w ith  
m o tb y l- th ie u ri- 
o i l  became 
hypothyro id . 
Thyroid e x tta c t  
p re sc rib ed  and 
gland d isappeai
"Biopsy showed 
H ashim oto 's d is e a s e " . 
No m eation o f 
th y ro to x ic  ep ith e liu m .
*ed.
J— .......................„
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/extrem ely  ra re ly  (perhaps never) a f te r  removal o f thyroids which 
have no lymphadenoid changes, short o f to t a l  thyroidectomy".
In these 3 stu d ies the c l in ic a l  sev e r ity  o f the th y ro to x ico s is  
was le s s  in  those p a tien ts  whose glands showed severe th y r o id it is ;  
W h itese ll and Black (30) found a trend towards a reduction in  the  
BMR and the incidence of a tr ia l  f ib r i l la t io n .  N either L ev itt (31) 
nor Greene (23) found a co rre la tio n  between the degree of 
th y r o id it is  present and the age and sex of the p a tien t, although  
W h itese ll and Black (30) found the mean age o f  p a tien ts  w ith  
fibrolym phocytic replacement to  be 5*4 years le s s  than those w ith  
lymphocytic in f i l t r a t io n ,  and th at males had c o n s is te n tly  l e s s  
th y r o id it is  than fem ales in  corresponding decades. Greene (23) 
could fin d  no corre la tion  between the degree o f th y r o id it is  found 
and the g o itre  type, although L ev itt ( 31) noted le s s  th y r o id it is  in  
d iffu se  g o itr e s . Exophthalmos was found in  these 3 s tu d ies  to  be 
increased in  p a tien ts  w ith th y r o id it is  present in  th e ir  glands; 
W hitesell and Black (30) observed an incidence o f 60 per cent .o f  
exophthalmos in  th e ir  p a tien ts  showing more than 30 per cen t, 
fibrolym phocytic replacement.
(3) C lin ica l A ssociation  between Auto-immune th y r o id it is  and
th y ro to x ico s is .
The a lleg ed  co-ex isten ce  o f auto-immune th y r o id it is  and 
th yro tox icosis  has been frequently  reported (32-42)* In  general 
the p a tien ts  in  these reports f a l l  in to  2 main groups (Table l)*  
F ir s t ly , there are the p a tien ts  w ith h is to lo g ic a lly  proven d iffu se  
t h y r o id it is , /
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/ t h y r o id i t i s ,  i . e .  auto-immune th y r o id it is ,  who have m anifested  
fea tu res , often  mild and u su a lly  tra n s ien t, o f th y ro to x ico s is  
(3 3 ,3 4 ,3 6 ,3 8 ,3 9 ,4 1 ) . The evidence o f th y ro to x ico s is  in  th ese  
p a tien ts  i s  unconvincing, and J o ll  (27) who discussed  t h is  problem 
a t some length  a ttr ib u ted  the a lleg ed  to x ic  fea tu res to  " lo ca l 
pressure, apprehension of cancer, e tc ."  In the second group ( 32 , 
3 5 ,3 7 ,4 0 ,4 1) the d iagn osis o f th y ro to x ico sis  i s  more cer ta in  
although by no means unequivocal (Table 1) .  In th is  group 
subsequent h is to lo g ic a l examination o f the excised  thyroid  revealed  
various degrees o f chronic th y r o id it is , but i t  i s  d i f f i c u l t  from 
the tex tu a l d escrip tion s to  decide whether the th y r o id it is  was 
s u f f ic ie n t ly  extensive to  ju s t i fy  the d escr ip tion  auto-immune 
th y r o id it is .
As mentioned in  Chapter I I  a past h is to r y  of th y ro to x ico s is  
car be e l ic i t e d  in  a small proportion o f p a tien ts  with auto-immune 
th y r o id it is . Fraser and Nordin (43) reported a p a tien t w ith  
confirmed th yro tox icosis  who spontaneously developed hypothyroidism  
w ith in  3 years; unfortunately no h is to lo g ic a l examination was 
carried out.
(4 ) Evidence of Progression of th yro to x ico sis  to  Auto-immune
th y r o id it is .
Many w riters have supported the proposition  o f a progression  
of th yro tox icosis  to auto-immune th y r o id it is . Thus, in  1927, in  
h is  address to  the Edinburgh Medico-Chirurgical S oc iety , Eason (2*4 ) 
presented both c l in ic a l  and h is to lo g ic a l evidence (but not s e r ia l  
s tu d ie s ) /
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/s tu d ie s )  that auto-immune th y r o id it is  had antecedent th y ro to x ico s is . 
In 1938 Vaux (45) suggested that "the c l in ic a l  evidence o f  
th y ro to x ico s is , e sp e c ia lly  in  ea r ly  ca ses , correla ted  w ith the 
h is to lo g ic a l fin d in gs o f decreasing degrees o f e p ith e l ia l  hyper­
p la s ia  and increasin g d estru ction  o f the a c in i as the condition  
progresses, p o in ts  to  some excessive  evo lu tion  fo llow in g  a 
th y ro to x ico sis  of mild degree", and in  1948 G-oldberg and Davson (46 ) 
concluded thatMa. to x ic  phase i s  s u f f ic ie n t ly  frequent ( in  auto­
immune th y r o id it is )  to  count as an important fa c to r  in  the 
pathogenesis".
In 1951 L ev itt (31) traced an apparently continuous patholog- 
: ic a l  process from to x ic  d iffu se  go itre  through auto-immune 
th y r o id it is  to  struma fib rosa : "the thyrotoxic gland undergoes a
gradual tr a n s it io n  from e p ith e l ia l  hyperplasia c h a r a cter is tic  o f 
c la s s ic a l  Graves* d isease through successive phases o f lympho- 
e p ith e l ia l  hyperplasia, fo c a l and then d iffu se  lymphoid hyperplasia  
(lymphadenoid g o itr e ) , and fibro-lym phoid hyperplasia (Hashimoto’ s 
disease) to  the f in a l  stage of f ib r o s is  (R iedel*s th y r o id it is )" .  
L ev itt (31 ,48 ,49) postu lated  that these 2 apparently separate 
d iseases -  auto-immune th y r o id it is  and th y ro to x ico sis  were, in  fa c t ,  
successive stages of a s in g le  d isease of the thyroid . G-oetsch 
and Kamner (49) and Chesky e t  a l .  (50) supported th is  view and 
the la t te r  authors went further and included subacute th y r o id it is  
as a stage in  the process.
Lennox (51) and others (52,53) strongly  c r it ic i s e d  L e v it t 's  
concept/
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Table I I
H is to lo g ic a l Progression of T hyrotoxicosis 
to  Auto-immune T h y ro id itis :
Summary o f Findings in  Cases Reported in  
the L iterature with Twice-removed
Thyrotoxic Glands.
Table II.
H is to lo g ic a l P ro g ress io n  of T h y ro to x ico sis  to  Auto-immune 
T h y ro d itis : Suninnry o f F ind ings in  Cnsc-s R eported in  the  
L i te r a tu r e  w ith  Twice-removed T hyrotoxic  G lands.
Authors Year Ref No. No. of Cases Interval between opc-retion Conxnents
Warthin 1929 5*i 2 15 years
7 operations during 18 years
"Lymphoid Hyperplasia"found 
in later specimens.
Reinhoff et al. 193<* 55 10 Not Stated No evidence of progression
Roussy et al. 193'* 56 2 2 and 7 years Lymphocytes and fibrosis in 
the second specimens.
Levitt 1951 31 22 Not Stated 16 progressed: *» retrogressed 
and 2 remained unchanged
Spjut et al. 1957 57 57 3 months to 25 years No convincing progression.
5 cases judged as "near 
misses”,but changes interpre­
ted as "exhaustion atrophy"
Curran et al. 1958 58 7 1 and 14-} years No evidence of progression
Sclare 1959 59 2 15 and 20 years Convincing evidence of 
progression in one case. 
First biopsy specimen not 
available in other.
/concept on the grounds that i f  i t  were correct proved progression  
from th yro to x ico sis  to  auto-immune th y r o id it is  should be common, 
and th is  was c er ta in ly  not so fa r  from the evidence given by 
L ev itt (3 1 ). In  22 of the p a tien ts  in  L evitt* s study in  whom 
thyroid biopsy had been carried  out fo llow in g  a previous operation, 
only 16 showed h is to lo g ic a l progression to a more advanced phase, 
whereas 4  had regressed , and 2 had remained unchanged.
H is to lo g ic a l d e ta ils  were unfortunately not provided, but the  
"progression" in  the 16 p a tien ts  was s l ig h t .  Furthermore, in  
twice-removed thyrotoxic glands studied by other workers (54~59) 
few have m anifested progression to auto-immune th y r o id it is  (Table I I)  
Thus, i t  appears that most of the evidence of a natural progression  
of th y ro to x ico sis  to auto-immune th y r o id it is  i s  based on the 
c l in ic a l  s id e  (43 *44 ) and only iso la te d  p a tien ts , such as the one 
reported by Sclare (39)* provide p ath olog ica l support fo r  such a 
concept.
(5) Immunological Studies in  T hyrotoxicosis.
As early  as 1908, Marinesco ( 60) demonstrated a p o s it iv e  CF 
reaction  between aqueous ex tra cts  of th yrotoxic gland and the serum 
of p a tien ts  from whom the glands were taken. Papazolu (61) in  
1911 extended these observations, and demonstrated p o s it iv e  CF 
reactions in  26 of 38 thyrotoxic p a tien ts , but not in  normal controls  
and concluded on th is  evidence that the thyroid gland had acted as 
an antigen ic stimulus and caused the formation of an tib od ies. In  
1915/
Table III
Prevalence o f Thyroid A uto-antibodies 
in  T hyrotoxicosis.
Table III.
Prevalence of Thyroid Auto-antibodies in Thyrotoxicosis
Authors Year Ref No. Total no. 
of cases
P o s it iv e  thyro id  
Auto-antihody t e s t s
Precipit. in CF ritC
Paine e t  a l . 1957 67 4 1
R o itt  and Doniach 1958 68 181 2 67 103
Anderson e t  a l . 195v 69 247 5 128
Belyavir. and Trot ter  1959 70 66 6 28
Blizzard e t  a l . 1959 71 94 1 34
Cline e t  a l . 1959 72 11 0 0 2
Blagg I960 73 263 155
Schade e t  a l . i 960 74 28 8 10
Hales e t  a l . 1961 75 98 43
Present Series 468 5 231
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/1915 Beebe (62) attempted to trea t p a tien ts  w ith th y ro to x ico s is  
w ith thyroid  a n ti sera , and from h is  report appeared to have a 
modicum of su ccess. In 1942, Lerman ( 65) attempted to  immunise 
a thyrotoxic p atien t against sheep thyroglobulin . Although a low 
antibody t i t r e  developed, no c l in ic a l  improvement resu lted .
These e a r lie r  observations appear to have aroused l i t t l e  
in te r e s t  and i t  was not u n t i l  1957> one year a fte r  the d iscovery  of 
thyroid auto-antibodies in  auto-immune th y r o id it is  (64) th at  
p o s itiv e  CF (65) and p r e c ip it in  (66) t e s t s  were described in  
th y ro to x ico s is . These observations have sin ce  been confirmed and 
extended by a number of workers (67-75) and p o s it iv e  TRC auto­
antibody t e s t s  have a lso  been described in  th y ro to x ico sis  (67*68, 
71-76). The prevalence of p o s it iv e  thyroid auto-antibody t e s t s  
reported in  the lite r a tu r e  i s  summarised in  Table I I I  and compared 
with those found in  468 thyrotoxic p a tien ts  in  the present study.
I t  can be seen that the prevalence of p o s it iv e  p r e c ip it in  t e s t s  is  
extremely small (approximately 2 per c e n t .) ,  whereas p o s it iv e  CF and 
TRC auto-antibody t e s t s  are present in  approximately 50 per cen t, 
of thyrotoxic p a tien ts  . The t i t r e s  of CF and TRC auto-antibodies  
in  th yrotox icosis  are, however, much lower than those found in  
auto-immune th y ro id itis  and primary hypothyroidism (6 8 ).
I t  was o r ig in a lly  suggested by Doniach and R o itt (77) and 
G-oudie e t  a l .  (66) that the thyroid auto-antibodies in  th y ro to x ico sis  
might bear a r e la t io n  to  the degree o f round -cell in f i l t r a t io n  in  
the gland. Some evidence fo r  th is  has recen tly  been found by 
Schade/
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/Schade e t a l .  (74) using the TRC t e s t .  Furthermore, Doniach
and R o itt (77) suggested th at i f  th is  le s io n  ’'represented a lo c a lis e d
immune response, then thyroglobulin  re leased  a t operation might be
expected to  a c t as a boosting dose and to  stim ulate increased
antibody production, w ith consequent d estru ction  o f the resid u a l
thyroid". S im ilar ly , they suggested that " a fter  therapeutic  
131doses o f I   ^ thyroglobulin i s  known to  be re lea sed , suggesting  
that auto-immunisation may play a ro le  in  the onset of hypo­
thyroidism , p a r ticu la r ly  when i t  occurs a f te r  treatment w ith  
r e la t iv e ly  sm all doses o f the iso top e" . In support of the f i r s t  
of these hypotheses Witebsky e t  a l .  (78) reported the development 
of thyroid auto-antibodies in  the serum of a th yrotoxic p a tien t  
a fte r  su btota l thyroidectomy, although R o itt and Doniach (68) 
more often  found a f a l l  in  t i t r e s  o f thyroid auto-antibodies  
fo llow in g  operation. In support o f the second hypothesis B lizzard
e t  a l .  (TO) reported that none of 6 p a tien ts  with th y ro to x ico sis
131requiring more than 25 me I  to achieve cure had thyroid auto­
antibodies in  th e ir  serum. R oitt and Doniach (68) could fin d  no 
d ifferen ce  in  the prevalence o f thyroid auto-antibodies in  p a tien ts  
in  prolonged rem ission a fte r  carbimazole treatment than in  a 
control untreated s e r ie s .
In  an admirable review of the thyroid and auto-immunity in  
December 1960 the S co ttish  Medical Journal (79) concluded that 
there was as y e t no adequate data r e la t in g  serum antibody le v e ls  in  
th yrotox icosis  to  the subsequent natural h is to ry  o f the d isease  or 
t o /
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/ t o  the r e su lts  o f treatment* However, la te r  in  the same month
Blagg (73) reported a co rre la tio n  between the TRC auto-antibody
131t i t r e s  and the outcome of I  therapy*
The purpose o f the present in v e s tig a tio n  was to  a s se ss  the 
c l in ic a l  s ig n ifica n ce  of both the p r e c ip it in  and CF thyroid auto­
antibody t e s t s  in  th y ro to x ico s is . The in v e s tig a tio n  i s  based on 
a study of 468 thyrotoxic p a tien ts  and the problem has been 
approached by studying the r e s u lt s  o f the thyroid auto-antibody  
t e s t s  in  r e la t io n  to  the c l in ic a l  fea tu res o f the d ise a se , to  the 
degree of round -cell in f i l t r a t io n  found in  the thyroid gland a t  
operation, and to the outcome of antithyroid  drug, rad io iod in e, 
and su rg ica l treatm ent. The r e s u lt s  o f th ese in v e s tig a tio n s  help  
to  e lu cid ate  the nature o f the auto-immune rea ctio n  in  th y ro to x ico s is , 
and a lso  have important p ra c tica l im p lication s in  the management of 
the thyrotoxic p a tien t.
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Section  2 (a)
The C lin ica l S ign ifican ce  o f the 
P r e c ip it in  t e s t  in  T hyrotoxicosis.
i. r‘,;vir A " -  d  ,z <- i -"'d. ; - 
tr. rrtj,^r«..L d f d S . i l ' i ~ & <  5u
In Chapter I I  o f the th e s is  i t  was shown that c irc u la tin g  
p rec ip ita tin g  thyroid auto—antibod ies are present in  a large  
proportion of p a tien ts  w ith auto-immune th y r o id it is .  In  th is  
sec tio n  i t  i s  shown that the a p p lica tion  o f th ese  immunological 
t e s t s  in  p a tien ts  with symptoms suggestive  o f th y ro to x ico s is  i s  o f  
considerable p ra c tica l importance^ since 2 groups o f p a tien ts  have 
been id e n t if ie d , in  whom the correct d iagnosis could not otherw ise  
have been made, and where mismanagement might have occurred.
In the f i r s t  group evidence o f auto-immune th y r o id it is  was 
found in  p a tien ts  with undoubted th y ro to x ico s is . Only one f u l ly  
documented case o f th is  a sso c ia tio n  has been p rev iou sly  described
(8 0 ,8 1 ). The second group o f p a tien ts  had been referred  to  the  
c l in ic  because o f suspected th y ro to x ico sis  and radioiod ine t e s t s  
had appeared to  confirm th is  d iagn osis. Further in v e s t ig a tio n s , 
however, showed that these p a tien ts  were in  fa c t  euthyroid and 
that the presence of auto-immune th y r o id it is  explained the abnormal 
laboratory fin d in g s.
M aterials and Methods
The p a tien ts  were assessed  c l in ic a l ly  by the procedure 
described by Crooks e t  a l . ( 8 2 ) .  By th is  method a numerical value 
i s  given to  c l in ic a l  symptoms and signs; a to t a l  value c a lle d  the  
" c lin ic a l d iagnostic  index” i s  thu3 obtained. When le s s  than 11, 
th is  index i s  normal; between 11 and 19 the d iagnosis i s  equivocal; 
an index of 20 and above in d ica tes  th y ro to x ico s is . The rad io iod in e, 
th yro id /
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Table I .
Summary of C lin ic a l D e ta ils  and 
R esults o f In v estig a tio n s  in  Five 
Cases o f T hyrotoxicosis w ith  
P o s it iv e  P r e c ip it in  T ests (Croup 1),
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/th y ro id  auto-antibody, and biochem ical t e s t s  were performed by 
the methods described in  Chapter I I  o f the t h e s is .  The TRC 
auto-antibody t e s t s  were k indly performed by Dr. A.E. Stuart o f  
the Department of Pathology, U niversity  o f  Edinburgh.
R esults
1• Thyrotoxicosis with severe chronic th y r o id it is .
The fin d in gs in  5 p a tien ts  w ith unequivocal th y ro to x ico s is  
and p o s it iv e  p r e c ip it in  t e s t s  (Croup l )  are summarised in  Table I .  
The case reports o f these p a tien ts  are summarised below. The 
diagnostic  index la y  w ith in  the thyrotoxic range in  every p a t ien t.  
Patien t No. 1 , a woman, aged 38 years, complained of p a in less  
thyroid enlargement gradually increasing  fo r  1 year and asso c ia ted  
with tired n ess and lo s s  o f approximately 2 stones (16  k g .) in  
weight, desp ite a good a p p etite . On examination, she was extremely 
nervous and had a sinus tachycardia o f approximately 120 b eats per 
minute. A firm  s l ig h t ly  enlarged g o itre  w ith a b ru it was present 
and b ila te r a l exophthalmos was noted. The movements were 
hyperkinetic and there was a f in e  fin g er  tremor. The sk in  was 
warm and m oist.
Subtotal thyroidectomy was carried out a fte r  preparation with  
carbimazole and potassium iod id e. During the pre-operative  
preparation the p atien t gained 14 lb . (6 ,4  kg .) in  weight and 
became c l in ic a l ly  euthyroid.
The/
Figures 1-3.
H isto lo g ic a l appearances of the 
thyroid gland in  a thyrotoxic  
p atien t with a p o s it iv e  
p r e c ip it in  t e s t .
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F i^ . 1 .
Patien t No. 1. Area showing chronic th y r o id it is  w ith d iffu se  
round-cell in f i l t r a t io n , colloidophagy, and dense lymphocytic 
aggregates. (Haematoxylin and eosin . x^O).
261.
Fig. 2.
P atien t No.1. Severe chronic th y r o id it is  showing dense and 
intim ate in teracinar in f i l t r a t io n  with round c e l l s .  Thyroid 
a c in i are p a rtly  destroyed, and those remaining show Askanazy- 
c e l l  change. (Haematoxylin and eosin  x 110).
262.
i M i  3 -
P atien t No. 1. Area of thyroid showing usual featu res of
th y ro to x ico sis . Chronic th y r o id it is  i s  absent. Such areas were
scanty and sm all. (Haematoxylin and eosin . x 110).
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/The excised  thyroid t is s u e  weighed 40 g . and was smooth,
*
pink and lobu lated . Microscopy revealed  severe and ex ten sive  
chronic th y r o id it is , together w ith fea tu res  suggestive  o f  thyro- 
:to x ic o s is .  The chronic th y r o id it is  con sisted  o f  numerous large  
lymphoid f o l l i c l e s  w ith large germinal cen tres, and ex ten sive  
in ter -a c in a r  in f i l t r a t io n  with lymphocytes and plasma c e l l s .  This 
la t t e r  change varied in  in te n s ity  in  d if fe r e n t areas and occasional 
small areas amounting to  a smal l  proportion of the thyroid t is s u e  
remained unaffected . The thyroid epithelium  was arranged in  small 
a c in i, or so lid  clumps, and showed var ia tio n s in  nuclear s iz e ,  
increase of cytoplasm and eo sin o p h ilia , amounting in  p laces to  f u l ly  
developed A skanazy-cell change. Some o f these fea tu res are 
i l lu s tr a te d  in  F ig s . 1 and 2 . Colloidophagy was present in  many 
of the a c in i. In some areas, and p a rticu la r ly  where chronic 
th y r o id it is  was mild or absent, the a c in i showed fea tu res ty p ica l  
o f th yro tox icosis  -  hyperplastic  columnar epithelium  farming sm all 
a c in i containing p oorly -sta in in g  c o llo id  with sca llop in g  a t the 
edges (F ig . 3)* The appearances were compatible w ith a thyrotoxic  
gland showing in  add ition  changes o f severe chronic th y r o id it is .
The patien t made an uneventful post-op erative recovery, but 
3 months a fte r  the operation she had gained a fu rther 17 lb . (7 .7  kg .)  
in  weight and complained of lethargy and cold in to leran ce . The 
symptoms/
*
I  am gratefu l to  Dr. J.R. Anderson o f the U n iversity  Department 
of Pathology fo r  the in terp reta tion  o f the p ath olog ica l fin d in gs  
in  these p a tien ts  and fo r  the photomicrographs in  th is  sec tio n .
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/symptoms improved w ith thyroxine sodium therapy and the p a tien t  
was w e ll and euthyroid when seen 3 months la te r .
P atien t No 2 . a fem ale, aged 20 years, gave a h is to r y  o f thyroid  
enlargement and prominence o f the eyes o f  3 months* duration. She 
had a lso  noticed  increasin g dyspnoea on exertion , p a lp ita tio n s , 
tired n ess, heat in to leran ce, nervousness, ex cessiv e  sweating and 
an increase in  a p p etite , although her weight was constant. The 
go itre  was d iffu se  and firm  with a b ru it over both lo b es . There 
was exophthalmos, l id  re tra c tio n  and l i d  la g , hyperkinesis and f in e  
fin g er  tremor were present. The skin was hot and m oist and the 
restin g  pulse rate  was 103 beats per minute.
A fter  pre-operative treatment w ith  potassium io d id e , subtota l 
thyroidectomy was performed.
The excised  thyroid t is su e  weighed 60 g. Microscopy showed 
accentuation of the lobu lar arch itectu re, with rather l e s s  than h a lf  
o f the thyroid lob u les showing changes ty p ica l o f th y ro to x ico sis  
w ith  l i t t l e  or no th y r o id it is . The remainder o f the lob u les  
showed varying degrees of superimposed chronic th y r o id it is  which 
included in te r fo ll ic u la r  in f i l t r a t io n  with plasma c e l l s  and sm aller  
numbers of lymphocytes, occasional lymph f o l l i c l e s ,  colloidophagy, 
and changes in  the epithelium  from the columnar type ty p ic a l of 
th yro tox icosis  to  Askanazy c e l l  type, sometimes w ith lo s s  of 
f o l l ic u la r  arrangement and aggregation of the c e l l s  in  small clumps. 
The degree of these changes varied in  d ifferen t lob u les and in  
d if fe r e n t /
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/d i f fe r e n t  parts of the same lo b u le . Many lob u les were, however, 
d if fu se ly  and severely  involved .
The p atien t made an uneventful p ost-op erative  recovery. When 
la s t  seen 1 year a fte r  the operation she was w e ll and euthyroid .
The p r e c ip it in  t e s t  a t  th is  time was negative.
P atien t No. 5 . a fem ale, aged 56 years gave a h is to ry  o f a sudden 
onset of a tender and p a in fu l go itre  which appeared "overnight” .
The pain in  the thyroid  la s te d  only a few days, but the g o itre  
p ersisted  and p rogressively  increased in  s iz e  over the next 8 
months. At her f i r s t  attendance the p a tien t complained o f fa tig u e  
and i r r i t a b i l i t y ,  and had no dyspnoea on exertion , p a lp ita tio n s , 
heat in to leran ce, excessive  sweating or change in  ap p etite  or 
weight. On examination, a moderately enlarge, firm , nodular g o itre  
was present. A sinus tachycardia of 93 beats per minute was 
recorded and the skin was warm and m oist. A therapeutic t r i a l  w ith  
m ethylthiouracil was commenced and some i n i t i a l  improvement was 
noted. Three months la te r  the thyroid p r e c ip itin  t e s t  was found 
to  be p o s it iv e  and m ethylthiouracil therapy was d iscontinued. S ix  
months la te r  the patien t returned complaining o f excessive  tir ed n ess , 
p a lp ita tio n s , dyspnoea on exertion , excessive  sweating and recent 
preference fo r  cold weather. The g o itre  had not changed n oticeab ly  
in  s iz e  or consisten cy but a b ru it was now present over the whole 
gland. Hyperkinesis and a f in e  fin g er  tremor were present. The 
akin/
/s k in  was warm and moist and a sinus tachycardia o f 96 b ea ts  per 
minute was recorded.
The p atien t received  a pre-operative course of m eth ylth iou racil 
and Lugol1s iodine and with th is  symptomatic improvement occurred, 
the signs o f th y ro tox icosis  disappeared, and the p a tien t gained 7 lk« 
(3 .2  kg .) in  w eight.
A subtotal thyroidectomy was performed; the excised  thyroid  
t is su e  weighed 65 g« and was firm and lobu lated . The h is to lo g ic a l  
fea tu res were complex. The appearance in  some areas was th at of 
th yro tox icosis  w ith  columnar epithelium  lin in g  the v e s ic le s  which 
contained scalloped and p oorly -sta in in g  c o llo id  and showed numerous 
p ap illary  projections in to  the v e s ic le s .  Marked nuclear pleomorphism 
of the thyroid epithelium  was seen and nuclear debris and phagocytes 
occupied some o f the v e s ic le s .  The c o llo id  varied considerably  
in  amount and in  in te n s ity  of s ta in in g . Numerous fo c i  of plasma 
c e l l s  and lymphocytes and lymph f o l l i c l e s  were p resen t, and some 
areas of Askanazy c e l l  change were found. In ad d ition , severa l 
fo c i  o f necrosis o f up to 0 .5  cm. in  diameter were seen in  areas 
which were not adenomatous and there were a lso  patches o f f ib r o s is  
with th ick  w alled v e s s e ls , some of which showed acute inflammatory 
in f i l t r a t io n  o f the w all and some chronic p e r ia r i t e r i t i s .  The 
appearances were con sisten t with th y ro to x ico sis  and superimposed 
vascular changes and chronic th y r o id it is  a ffe c t in g  approximately 
25 per cent, o f the thyroid t is s u e .
Two months a f te r  the operation the p a tien t developed hypo­
thyroid ism ./
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/hypothyroidism . When la s t  seen 2 years la te r ,  she was w e ll and 
euthyroid and taking 0.1 mg. o f thyroxine sodium d a ily . The 
p r e c ip it in  t e s t  a t th is  time was negative .
P atien t No. A. a woman, aged 66 years, gave a h is to r y  of protrusion  
and excessive  lacrim ation of the eyes, and p a in le ss  thyroid  sw ellin g  
of 5 years duration. In 1954 she developed symptoms of thyro- 
:to x ic o s is  and treatment w ith m ethylth iouracil produced rem ission  
of symptoms. M ethylthiouracil therapy was discontinued in  
September, 1957* Following th is  the p a tien t had a relap se  and 
when seen in  December 1957* she complained of dyspnoea on e f fo r t ,  
p a lp ita tio n s , excessive  tired n ess, nervousness and heat in to leran ce , 
and excessive sweating. She had lo s t  approximately 28 lb .
(12 .8  kg .) in  weight, despite an increased a p p etite . On examination 
the thyroid gland wa3 d iffu se  and moderately enlarged, firm  but not 
tender. A bruit was present over both lo b es . B ila te r a l  
exophthalmos’ was present, which was more obvious on the r ig h t s id e . 
Lid retra ctio n  was present on the r igh t and b ila te r a l  l i d  la g  was 
noted. There was some lim ita tio n  of outward and upward movement 
of the r ig h t eye, and conjunctival in je c t io n  was present a t the 
outer isthmus, although there was no chemosis or p e r io rb ita l oedema.
A cataract was present in  the r ig h t eye, which was b lin d .
Hyperkinetic movements and fin e  fin g er  tremor were present and the 
skin was hot and dry. A sinus tachycardia of 95 b eats was 
recorded.
Treatment with potassium perchlorate 400  mg. 6-hourly was 
commenced/
268.
/commenced but a few weeks la te r  congestive cardiac fa ilu r e  
developed which improved with digoxin and d iu re tic  therapy. Four 
months la te r  the dose of potassium perchlorate was reduced to  
250 mg. 4  times d a ily , and 2 months la te r  she was considered to  
be euthyroid and the dose was fu rther reduced to  250 mg. tw ice  
d a ily . The p a tien t remained w ell and euthyroid on th is  maintenance 
dose o f potassium perchlorate but when seen 7 months la te r  she 
was complaining of severe pain and aching in  the region  o f  the 
thyroid gland which radiated upwards in to  both s id es  o f her neck.
This pain had kept her awake a t night and was only p a r tly  r e liev ed  
by asp ir in  ta b le ts . On examination the thyroid gland was firm , 
but not tender. There was no pyrexia; the fauces were normal 
and there was no cerv ica l lymphadenopathy. A repeat p r e c ip it in  
t e s t  was negative and the serum flo c c u la tio n  t e s t s  were again  
normal. The ESR (Y/estergran) was 48 mm. in  the f i r s t  hour, although  
the to ta l  and d if fe r e n t ia l white c e l l  count were normal. Mumps 
complement-fixation t e s t  was negative . The pain in  the thyroid  
gland p ersisted  in term itten tly  and gradually disappeared over a 
period o f 3 weeks, w hile the sedim entation ra te  f e l l  to  5 mm. in  
the f i r s t  hour a month la te r . With a maintenance dose of 250 mg. 
potassium perchlorate 250 mg. tw ice d a ily  the p atien t has remained 
euthyroid. She was la s t  seen in  March, 1960, when th e p r e c ip it in  
t e s t  was negative.
P atien t No. 5 » & woman, aged 49 y©ars had f i r s t  noticed  a go itre  
5 months previously and for  10 months had complained o f excessive
tiredness,/
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Table I I .
Summary of C lin ic a l D e ta ils  and 
R esu lts o f In v estig a tio n s  in  Five 
Cases of Auto-immune T h yroid itis
presenting  
(G-roup 2 ) .
T
ab
le
 
II
.—
Su
m
m
ar
y 
of 
C
lin
ic
al
 
D
et
ai
ls 
an
d 
Re
su
lts
 
of 
In
ve
st
ig
at
io
ns
 
in 
Fi
ve
 
Ca
se
s 
of 
A
ut
o-
im
m
un
e 
T
hy
ro
id
iti
s
270+
G
am
m
a­
gl
ob
ul
in
N
or
m
al
R
ai
se
d
-
Se
ru
m
 
Fl
oc
cu
la
 
tio
n 
| 
T
es
ts
A
bn
or
m
al
o
C
.F
.T
.
+
+
+
+
+
+
+ + 
+ +
u
H
Pr
ec
ip
iti
i
T
es
t
+ 1 + +
B
.M
.R
.
(%
)
+ 
19
+
28 +
7 -2
1
CQ M E
S<3| 3
-3 4-
6
5-
3
4-
6
4-2
&
<5 § M 
O 0(2
0
1 1 4- +
| 
+
1H
c
•3
Th
yr
oi
d 
] 
| S
up
pr
es
si
on
 
Te
st 
|
Su
pp
re
ss
ed
*•3CQ
o4 P.
B
. 
1-
13
1 
(% 
D
os
e/
i
0-
41
0-
49
0-
42
0-
46
0-
40
4-
H
ou
r 
U
pt
ak
e 
(% 
D
os
e)
45
-6
46
-4
50
-6 m fN
5! $
G
oi
tr
e
i
Fi
rm
, 
di
ff
us
e,
 
50 
g.
Fi
rm
, 
no
du
la
r,
 
50 
g.
Fi
rm
, 
» 
di
ff
us
e,
 
75 
g.
Fi
rm
, 
no
du
la
r,
 
75 
g.
Fi
rm
, 
di
ff
us
e,
 
50 
g.
u
D
ia
gn
os
l
In
de
x
r- ON 2 14 18
A
ge an
d
Se
x
62 
F
34
"F
48 
F
63 
M
 
45 
F
C
as
e
N
o. - s .5 > >
/t ir e d n e s s , nervousness, heat in to lera n ce , and weight lo s s ,  d esp ite
an increased ap p etite; there had been no pain in  the th yroid  gland
and no pressure symptoms. On examination the th yroid  gland was
markedly enlarged, firm and nodular* A b ru it was present over both
lo b es . Exophthalmos was absent, but b i la te r a l  l id  r e tr a c tio n  and
l id  la g  was noted. Hyperkinetic movements and fin e  f in g e r  tremor
were present and the skin was hot and m oist. The pu lse ra te  was
87 beats per minute.
In view o f the p atien t*s age, i t  was decided th at she was
su itab le  for rad ioactive iod ine therapy. Accordingly, 16 mo. o f
1 31 \rad ioactive iodine (I  ) was given by the method described by 
Crooks e t  a l .  (79) and 5 months la te r  the p a tien t was s t i l l  
th yrotox ic, although improved. A fu rther 12 me. o f rad ioactive  
iodine was given and when next seen  3 months la te r
the p atien t was euthyroid. When la s t  seen 18 months fo llow in g  the  
f i r s t  therapeutic dose o f rad io iod ine, the p a tien t was w e ll and 
euthyroid. At that time the p r e c ip it in  t e s t  was s t i l l  s tron g ly  
p o s it iv e .
2 . Auto-immune th y r o id it is  sim ulating th y ro to x ico s is .
Five p a tien ts  suspected o f th y ro tox icosis  on c l in ic a l  grounds
who had radioactive iodine t e s t s  con sisten t w ith th is  condition
(Croup II)  are summarised in  Table I I .  The f in a l  d iagn osis was
shown to  be euthyroid auto-immune th y r o id it is . The case reports
are given below. The d iagnostic index la y  w ith in  the equivocal
range in  every p a tien t. The Thesis Numbers o f the 3 p a tien ts  in  
th is  Group are resp ectiv e ly : 31, 11, 12, 21 and 4 3 . For further  
d e ta ils  see Appendices, Chapter I I ,  Section  1 .
272.
P atien t No 1 , a woman, aged 62 years, gave a h is to r y  o f  thyroid  
enlargement o f 6 years duration. During the previous 2 years  
she had complained o f  p a lp ita tio n s , t ir e d n e ss , and s l ig h t  
preference fo r  cold weather. On examination, a sm all, firm , 
d iffu se  g o itre  without a b ru it was p resen t. There were no eye 
s ig n s. Movements were hyperkinetic and the hands were warm and
m oist. No fin g er  tremor was observed and the pulse ra te  was 84
beats per minute.
No a n ti thyroid therapy was prescribed and the p a t ie n t 's  
symptoms gradually disappeared with reassurance. Thyroxine therapy 
was la te r  prescribed and with th is  the go itre  diminished in  s iz e .  
P atien t No. 2 . a woman, aged 34 years gave a h is to r y  o f g o itr e ,  
dyspnoea on e f fo r t , p a lp ita tio n s , t ir ed n ess , preference fo r  cold  
and nervousness of 3 years' duration. On examination, a sm all, 
firm , nodular, go itre  without a b ru it was present, but no l i d  
retra ctio n  or l id  la g  was noted. hyperkinesis was presen t, but 
there was no fin g er  tremor. The skin was dry and m oist and the 
restin g  pulse rate was 89 beats per minute. Treatment w ith  
potassium perchlorate 230 mg. 4  tim es d a ily  was begun and there was 
s lig h t  symptomatic improvement. When see 3 months la te r  the  
p atien t had developed hypothyroidism, which was confirmed by 
electrocardiography, BMR^ and serum ch o lestero l determ inations. 
Treatment was discontinued and she recovered spontaneously.
Following th is  the p atien t remained euthyroid and 4  months la te r  
a su rg ica l biopsy o f the thyroid was carried out.
The/
/The excised  t is su e  showed widespread chronic th y r o id it is ,  
w ith lymphoid f o l l i c l e s ,  plasma c e l l  i n f i l t r a t i o n  and Askanazy c e l l  
changes. There was a lso  irregu lar  f ib r o s is .
S ix  weeks a fter  the su rg ica l b iopsy the p a tien t developed  
hypothyroidism. This responded to replacement therapy w ith  
thyroxine sodium 0.1 mg. tw ice d a ily  and the g o itre  di minished 
in  s iz e .
P atien t No 3. a woman, aged 48  years gave a two-year h is to r y  o f  
go itre  and increasing dyspnoea on exertion , t ired n ess , nervousness 
and lo s s  o f weight desp ite  a normal a p p etite . On examination 
the thyroid  gland was moderately enlarged, d iffu se! and firm . There 
was no b ru it . B ila te r a l exophthalmos was present, but there was 
no l id  retra ctio n  or l i d  lag  and no hyperkinesis. Pine f in g er  
tremor was present and the hands were warm and m oist. The r e s tin g  
pulse rate  was 112 beats per minute. Thyroxine sodium was 
prescribed and the go itre  became sm aller.
Patient No 4 . a man, aged 63 years, gave a h isto ry  o f g o itre  o f 6 
months duration and a h isto ry  o f increasing dyspnoea on exertion , 
excessive  tired n ess, in tolerance of heat and nervousness o f 1 y ea r 's  
duration. On examination, a firm , moderately enlarged, nodular 
goitre  was present and accompanied by a b ru it . Exophthalmos was 
noted, but there was no l i d  retra ctio n  or l id  la g . There was no 
hyperkinesis, or f in e  fin g er  tremor and the skin was coo l and m oist. 
The restin g  pulse rate  was 81 beats per minute.
The patien t was treated  w ith potassium perchlorate 250 mg. 
o r a lly /
/o r a l ly  4  tim es d a ily . This treatment was continued fo r  12 weeks 
but there was no symptomatic improvement and the p a tien t has s in ce  
remained w e ll and euthyroid. The p a tien t was given 0 .2  mg. thyroxine  
sodium d a ily  which produced a reduction in  the s iz e  o f  the g o itr e .  
P atien t No 5 . a woman, aged 45 years, gave a 3 year h is to r y  o f  
nervousness, excessive  sweating, in to leran ce o f heat and weight lo s s .  
The patient had been aware o f a g o itre  of 11 years duration but 
had noticed  no recent increase in  s iz e .  On examination the thyroid  
was s l ig h t ly  enlarged, d iffu se  and firm  and without a b r u it .
S lig h t b ila te r a l exophthalmos was presen t. There was no 
hyperkinesis and no fin g er  tremor. The skin was hot and dry. The 
res tin g  pulse rate was 97 beats per minute.
No antithyroid  therapy was prescribed, and the symptoms 
gradually disappeared with reassurance. She remained w e ll u n t i l  
2 years la te r , when hypothyroidism developed. Thyroxine Sodium 
0 .2  mg. d a ily  was prescribed and the go itre  diminished in  s iz e .
DISCUSSION
A p o s it iv e  p r e c ip itin  reaction  i s  almost in variab ly  a sso c ia ted  
with extensive destructive th y r o id it is  such as i s  found in  auto­
immune th y r o id it is  or in  some p a tien ts  with primary hypothyroidism
(68 , 69 , 81) .  In 3 of the proved thyrotoxic p a tien ts  in  Group I ,  
in  whom subtotal thyroidectomy was carried  out, h is to lo g ic a l  
examination of the gland showed fea tu res o f th y ro to x ico s is  and, in  
addition , fo ca l chronic th y r o id it is  of far  greater extent and 
sev er ity  than i s  usu a lly  seen in  a thyrotoxic thyroid . The 
fe a tu re s /
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/fe a tu r e s  were sim ilar to  those described by Doniach and Hudson (80) 
in  th e ir  p a tien t. These fin d in gs demonstrate th a t auto-immune 
th y r o id it is  and th yro to x ico sis  can be present sim ultaneously in
the same p a tien t, and may be the explanation fo r  the spontaneous 
development o f hypothyroidism in  p a tien ts  with th y ro to x ico s is  
reported in  the lite r a tu r e  (43) • They might a lso  exp la in  the past  
h is to r y  of th y ro to x ico sis  obtained from a sm all proportion o f  
p a tien ts  with auto-immune th y r o id it is  (44) • The low incidence o f  
both p o s it iv e  p r e c ip it in  t e s t s  and the severer degrees of lymph- 
:adenoid change in  th yro tox icosis  probably exp la in s why th is  
p articu lar  sequence of events i s  r e la t iv e ly  uncommon.
These p a tien ts  revea l the in ter e st in g  combination o f a hyper- 
:p la s t ic  and destru ctive le s io n  occurring sim ultaneously and on the  
b a s is  of the fin d in gs one can speculate on the a e t io lo g ic a l fa c to rs  
involved . I t  i s  p o ss ib le  th at th y ro to x ico sis  might predispose to  
the occurrence of auto-immune th y r o id it is . A ltern a tiv e ly , both  
conditions might have a predisposing co n stitu tio n a l fa c to r  (83) .
The f i r s t  p o s s ib il i ty  i s  supported by the work of Long and Shewell 
(84) who have demonstrated the enhanced immunological reaction s  
in  thyroxine-fed guinea-pigs, and by the demonstration by Stuart and 
A llan (76) of the lo s s  of in te g r ity  o f the basement membrane in  the  
human thyrotoxic gland. The a sso c ia tio n  o f the 2 d isea ses  in  
these p a tien ts  does not, however, n ecessa r ily  support the general 
concept popularised by L ev itt (31) th at there i s  a natural prog­
r e s s io n  from th yrotox icosis  to  auto-immune th y r o id it is .
The/
/The fin d in g  o f a p o s it iv e  p r e c ip it in  t e s t  in  a th yro tox ic  
p atien t may have p ra c tica l s ig n ifica n ce , since i t  has been shown 
that when p a r tia l thyroidectomy i s  performed on glands w ith  severe  
degrees of chronic th y r o id it is , there i s  an increased l i a b i l i t y  
to  the development o f post-op erative hypothyroidism (23*30,31*
85). Although the therapeutic response was variab le in  th ese  
p a tien ts  (Group 1 ) the unusually rapid development of hypothyroidism  
in  Patients No. 1, and 3, a t 3 and 2 months r e sp e c tiv e ly  a f te r  
operation suggests that the chronic th y r o id it is  was s u f f ic ie n t ly  
severe to  impair the fu nction  of the thyroid remnant. On the other  
hand, patien t No. 2 remained w ell and euthyroid one year a f te r  her 
operation, and the remaining 2 p a tien ts  of th is  Group (P a tien ts  No.
4  and 5 ) were both severely  to x ic  and r e la t iv e ly  r e s is ta n t  to  other  
forms of therapy. I  therefore b e liev e  that u n t i l  further  
experience has been gained o f th is  type of p a tien t the treatment of 
choice should be antithyroid  drug therapy, since treatment by surgery 
or rad ioactive iodine might hasten the onset o f hypothyroidism.
In contrast to  these p a tien ts  w ith unequivocal th y ro to x ico s is  
and associa ted  auto-immune th y r o id it is  (Group 1) ,  there i s  the  
further group of p a tien ts  with auto-immune th y r o id it is  who are of 
p articu lar  importance in  that the c l in ic a l  fin d in gs and the r e s u lt s  
of laboratory in v estig a tio n s  may lead  to  an incorrect d iagn osis o f  
th y ro to x ico sis . The 5 p a tien ts  of t h is  type (Group I I ) ,  were a l l  
suspected on c l in ic a l  grounds of having th y ro to x ico s is , and th is  
susp icion  appears to be confirmed by radioiodine s tu d ies . The 
d ia g n o sis/
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/d ia g n o sis  o f auto-immune th y r o id it is  in  th is  group was confirmed 
by p o s it iv e  p r e c ip it in  t e s t s  or by h is to lo g ic a l  examination o f the  
gland, and th y ro to x ico sis  was excluded on the b a s is  o f serum PBI 
determ inations and normal thyroxine suppression t e s t s .  This i s ,  
in  my opinion, the type of p a tien t freq u ently  reported in  the  
lite r a tu r e  as demonstrating the a sso c ia tio n  of th y ro to x ico s is  w ith  
auto-immune th y r o id it is  (33 ,3^ ,36 ,38 ,39 ,^ )  an& I  agree w ith  J o l l  
(2 7 ), that the a lleg ed  thyrotoxic fea tu res in  th ese p a t ie n ts , w ith  
the exception of the g o itre , can be a ttr ib u ted  to  anxiety  or 
apprehension. The value of ro u tin e ly  performing p r e c ip it in  t e s t s  
and serum flo c c u la tio n  t e s t s  or e lectrop h oresis  of serum p roteins  
in  p a tien ts  with suspected th y ro to x ico sis  i s  c le a r ly  demonstrated 
in  th is  group, s in ce , i f  the d iagnosis had been reached on the 
b a sis  o f the c l in ic a l  fin d in gs and the standard rad ioactive  iodine  
t e s t s  alone, destru ctive antithyroid  therapy might have been 
prescribed. I t  m i$it be argued that the 4  p a tien ts  o f Group I I ,  
w ith p o s it iv e  p r e c ip itin  t e s t s ,  in  whom the thyroid was not 
examined h is to lo g ic a lly , were examples of th y ro to x ico sis  
associa ted  with auto-immune th y r o id it is  in  which the la t t e r  been  
s u f f ic ie n t ly  extensive to  produce spontaneous rem ission of thyro- 
:to x ic o s is .  This p o s s ib i l i t y ,  however, does not a f f e c t  the 
therapeutic im plications of the fin d in g . Furthermore, i f  tbyro- 
:to x ic o s is  had previously  been present the remnant o f fu nction in g  
thyroid tis su e  in  some o f  the p a tien ts , a t le a s t ,  should have 
behaved lik e  to x ic  glands and have had negative suppression t e s t s ;  
a l l /
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/ a l l  in  fa c t  were normally suppressed. In  the f i f t h  p a tien t o f  
th is  group w ith a negative p r e c ip it in  t e s t  there was no h is to lo g ic a l  
evidence of th y ro to x ico s is .
I t  i s  concluded that auto-immune th y r o id it is  and overt 
th yro tox icosis  can c o -e x is t  and th at th ese p a tien ts  can be recognised  
by a combination of immunological and biochem ical procedures. I t  
i s  probable th at p a tien ts  with tr u ly  ’thyrotoxic* auto-immune 
th y r o id it is , i f  l e f t  untreated, would u ltim a te ly  become euthyroid  
or even develop hypothyroidism. They do not present a d iagn ostic  
problem in  so fa r  as th e ir  hypothyroidism i s  concerned, but the 
a sso c ia tio n  of the 2 d iseases c le a r ly  contraind icates d estru ctive  
therapeutic measures. Antithyroid drugs should be used to  con tro l 
the symptoms in  these p a tien ts . On the other hand, the ’pseudo- 
toxic* patien t with auto-immune th y r o id it is  presents prim arily  a 
diagnostic problem because o f p o ssib le  confusion w ith th y r o to x ic o s is ,  
and th e ir  ex isten ce makes i t  necessary not to  p lace too much re lia n ce  
on the r e su lts  of the routine radioiod ine t e s t s ,  e sp e c ia lly  i f  the  
c l in ic a l  fea tu res are a ty p ica l. The most h e lp fu l t e s t s  in  th ese  
p a tien ts  are the thyroxine (or triiodothyronine) suppression t e s t  
and the chemical estim ation  of the PBI. Where th ese t e s t s  are not 
availab le  a p r e c ip itin  t e s t  fo r  thyroid auto-antibodies should be 
performed. I t  i s  even more simple to carry out the thymol 
tu rb id ity  or flo c c u la tio n  t e s t s  or e lectrop h oresis of the serum 
protein s, and th is  would have given adequate warning in  the 5 
p a tien ts  o f th is  group who have been described.
SUMMARY
A group o f 5 p a tien ts  i s  desoribed w ith unequivocal 
th y ro to x ico sis  and p o s it iv e  p r e c ip it in  t e s t s  fo r  th yroid  auto­
antib od ies. In 3 in  whom h is to lo g ic a l  examination was carried  
out, there were changes co n sisten t with the co -ex isten ce  o f  
th yro tox icosis  and extensive th y r o id it is , in d istin g u ish a b le  from 
auto-immune th y r o id it is . A further group o f 5 p a tien ts  w ith  
suspected th y ro to x ico sis , apparently confirmed by routine rad io a ctiv e  
iodine t e s t s ,  were subsequently shown to  be euthyroid and to  have 
auto-immune th y r o id it is . I t  i s  recommended that immunological 
t e s t s  for  thyroid auto-antibodies should be carried  out in  a l l  
cases of overt or suspected th y ro to x ico s is  to  prevent unnecessary  
d estructive therapy and the rad ioactive  iodine s tu d ies  in  equivocal 
cases of th yro tox icosis  should be in terpreted  in  the l ig h t  o f th ese  
t e s t s .
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In the h is to r ic a l  sec tio n  i t  was pointed out th a t auto­
antibod ies to  the "microsomal" antigen  can be detected  in  a large  
number of p a tien ts  with th y ro to x ico s is  by the CF t e s t  (6 8 -7 0 ), but 
that the s ig n ifica n ce  o f these antibodies i s  not known. The 
present study reports a c l in ic a l  and p a th o log ica l assessm ent o f the  
CF te s t  in  2*68 thyrotoxic p a tien ts . The problem has been approached 
in  3 ways. F ir s t ly , the CF t e s t  has been studied in  r e la t io n  to  
the c l in ic a l  fea tu res o f th y ro to x ico sis  and to  the response to  
antithyroid  therapy. Secondly, s e r ia l  determ inations of the CF 
t e s t  have been carried out fo llow in g  various forms of an tith yro id  
therapy. Thirdly, the r e la t io n  has been studied between the 
r e s u lt s  of the CF t e s t  and the extent of rou n d -cell in f i l t r a t io n  
found in  the thyroid gland a fte r  operation.
M aterials and Methods
2*68 p a tien ts  with th yro tox icosis  were studied o f whom 253 
were untreated and 215 had received  s p e c if ic  an tith yro id  therapy.
The d iagnosis was based on the c lin ic a l, and laboratory c r it e r ia  
described in  the previous sec tio n .
The CF te s t  was performed as described in  Chapter I I  of the 
th e s is . The fo llow ing c l in ic a l  c r ite r ia  were recorded in  add ition  
to  the age and sex of the patien t: the presence of a g o itr e , i t s
consistency (d iffu se  or nodular), i t s  s iz e  ( s l ig h t ly  enlarged, 
approximately 50 g. -  moderately enlarged, 75 g. -  very  la rg e , 100 g. 
or more), and i t s  duration ( le s s  than 1 year -  1 to  5 years -  5 
years and mor^. In a l l  p a tien ts  the " c lin ic a l d iagn ostic  index" 
(82)/
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/ m  was recorded. This index i s  a q u a n tita tiv e  estim ate of the 
symptoms and sign s and c o r r e la te s  w ith  th e  s e v e r ity  of the d ise a se .
The presence o f  ocular s ign s was noted in  every ca se , the c r it e r ia  
b ein g  described by Crooks e t  a l .  (8 2 ) .
The type of treatm ent given , ( i f  a n y),b efore  the f i r s t  CF t e s t  
was noted in  each p a t ie n t . Potassium  perch lorate was the most
A ^
freq u en tly  used a n tith y ro id  drug. In  the case o f I  therapy the  
doses were p rescrib ed  by the method o f Crooks e t  a l .  ( 86) and th e  
number o f doses given  recorded.
The response to  treatm ent was stu d ied . Hypothyroidism
fo llo w in g  surgery or rad io iod in e was recorded on ly  i f  permanent
(86) and was confirmed by c h o le s te r o l, BMR,or PBI d eterm inations,
131and EC& s tu d ie s . R esistan ce  to  I  therapy was defined  as  p e r s is t ­
e n c e  o f hyperthyroidism  a f te r  2 or more doses.
The in cid en ce of drug rea c tio n s  in c lu d in g  sk in  rash es and 
haem oto log ica l com plications was noted . A p a tien t was considered  
to  have a fa m ily  h is to r y  of thyroid  d isea se  i f  she was a?/are o f a 
r e la t iv e  w ith  a th yroid  d isorder.
S e r ia l  s tu d ie s  o f  th yroid  auto-antibody  t e s t s  (both p r e c ip it in  
and CF) were done in  145 o f the un treated  group before and a fte r  
r e c e iv in g  variou s forms of therapy. In  a l l ,  416 t e s t s  were done 
and the p a t ie n ts  were fo llow ed  up fo r  p eriod s varying from 1 to  23 
months. (mean fo llow -u p  6 .7  months).
The h is t o lo g ic a l  sec tio n s  were a v a ila b le  fo r  study in  56 cases  
and the degree of ro u n d -ce ll in f i l t r a t io n  was r e la te d  to  the r e s u lt  of 
th e /
/ th e  CF t e s t .  Round c e l l  in f i l t r a t io n  was a ssessed  by counting the 
number of low-power f i e ld s  contain ing rou n d -cell aggregates out 
of 30 f i e ld s  examined fa r  each gland. This examination was done 
by Dr. R.B. Goudie (o f the U niversity  Department o f Pathology, 
Western Infirmary, Glasgow) who had no knowledge o f the r e s u lt s  o f  
the CF t e s t s .
♦
S t a t i s t ic a l  Methods 
The data are presented in  contingency ta b le s  showing the 
d istr ib u tio n  o f p a tien ts  w ith each ch a ra c ter is tic  by the rea ctio n  
to  the CF t e s t .  Any apparent varia tion s in  the CF t e s t  r e s u lt s  
with the other c la s s if ic a t io n s  were examined fo r  s t a t i s t i c a l  
s ig n ifica n ce . The usual chi-square t e s t  o f a sso c ia tio n  in  
contingency ta b les  i s  in se n s it iv e  when the groupings are in  some 
natural order of measurement and any re la t io n s  may be expected to  
vary c o n s isten tly  with th is  natural order. Here, t e s t s  more 
se n s it iv e  than chi-square can be devised to examine the hypothesis 
that the d is tr ib u tio n  of p a tien ts  with a ch a ra cter is tic  changes 
p rogressively  with increasing p o sitiv en ess  o f the CF rea ctio n .
There are a number o f t e s t s  of th is  kind (87- 89) .  A simple but 
reasonably e f f ic ie n t  method was used in  the present a n a ly s is . 
Negative, p o s it iv e  and double p o s it iv e  CF reaction s were scored  
0 , 1 and 2 resp ec tiv e ly  and the an a ly sis  was carried out as i f  
th ere /
*
I  would lik e  to  thank Dr. W. Brass, M.A., o f the S t a t is t ic s  
Department, U niversity o f Aberdeen, who k ind ly  performed the 
s t a t i s t ic a l  analyses in  th is  sec tio n .
Table I .
C orrelation between the Complement- 
F ixation Test and Sex in  Thyrotoxicosis 
(lt68 oases).
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Table I .
Correlation between the Complement-Fixation Test and
Sex in  Thyrotoxicosis (468 ca ses)
Complement- 
lix a t io n  Test
Females Males
Ho. * No. 1o
( - ) 201 84*8 56 1 5 .2
(+) 80 80.8 19 19 .2
(++) 11C 83.3 22 1 6 .7
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/th e r e  were sca le  measurements. When the other c h a r a c ter is tic  
considered was a dichotomy the n u ll hypothesis o f no a sso c ia tio n  
was then examined by a t  t e s t  of the d ifferen ce  between 2 mean 
scores. When the other c h a r a cter is tic  was a lso  an ordered 
c la s s if ic a t io n  i t  was lik ew ise  treated  as a sca le  measurement w ith  
the groups a t equal in ter v a ls  apart and the regression  o f th e  CP
score on th is  measurement was te s te d . In general, only a t  t e s t
o f the lin ea r  component o f regression  was applied  but fo r  1 
rela tion sh ip  (w ith age) the quadratic component, which was c le a r ly  
important, was te s ted  a lso . The standard c r it e r ia  of s t a t i s t i c a l  
s ig n ifica n ce  are used, i . e .  t  deviations which would have been 
exceeded by chance in  le s s  than 3% and o f t r ia l s  on the n u ll  
hypothesis of no a sso c ia tio n  are ca lled  ,f s ig n ifica n t"  and "higjhly 
sign ifican t"  r e sp ec tiv e ly .
R esults
1 • C lin ica l S ign ifican ce of S ingle Determinations o f the CF t e s t
Since no correla tion  was found between the sex o f the p a tien t
and the r e su lt  o f the CF te s t  (Table I ) ,  male and female p a tien ts  
were analysed togeth er. On the other hand, an ti thyroid therapy 
was found to  influence the r e su lts  of the t e s t  (see  below ), 
therefore p a tien ts  who had received  no previous treatment (253  
p a tien ts) and those previously  given a n ti thyroid therapy (215 
p atien ts) were analysed separately . For convenience these groups 
are referred  to  below as "untreated" and "treated" r e sp e c tiv e ly .
(A) "Untreated" Group (253 p a t ie n ts ) .
The/
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/The r e s u lt s  are summarised in  Table I I  (Appendices)•
Age. There were no s ig n if ic a n t d ifferen ces  in  the mean ages  
o f the groups with a ( - )  t e s t  (43*2 y e a rs) , w ith a (+) t e s t  
(4 1 .4  y ea rs), and with (++) t e s t  (4 2 .7  y ea rs). However, as  
can be seen from Table I I I ,  the p o s it iv i t y  o f the CF t e s t  was 
increased in  the middle-aged group (30  to 60 y ea rs).
Consequently the quadratic component o f th is  change in  mean, score 
w ith age was h igh ly  s ig n if ic a n t . The mean gland s iz e s  in  the 
groups aged 60 years or more (49*0 g .)  and le s s  than 30 years 
of age (6 9 .9  g«) were lower than in  the group aged between 30 
and 60 years ( 70 .0  g . ) ,  but th is  did not wholly account fo r  
the higher incidence of p o s it iv e  t e s t s  in  the middle age group.
Table I I I
R ela tion  between Age  and Complement-Fixation T est
Ape  in  years No. of Cases w ith  CF Test Mean Score
- + ++ T o ta l
Under 30 30 7 7 44 0.48
30-39 35 17 18 70 O.76
40-49 32 16 20 68 0.82
50-59 26 8 14 48 0.75
6C-69 9 1 2 12 O.42
70 and over 9 2 0 11 0.18
T o ta l 141 51 61 253 0.68
_&oitre. The p o s it iv i ty  of the CF t e s t  was d ir e c t ly  re la ted  
to  go itre  s iz e  (P < 0 .0 5 ) and in v erse ly  re la ted  to  the duration  
o f /
/ o f  the g o itre  (P < 0 .0 5 ) . The r e s u lt s  o f  th e CF t e s t  aid 
not vary s ig n if ic a n t ly  w ith the con sisten cy  o f  th e goitre*
Tahle IV
R elation  "between S ize  and Duration o f  G oitre
and Complement-Fixation Test*
ITo* o f  Cases w ith CF Test Mean Score
- + ++ T otal
Absent 15 2 4 19 0 .55
50 48 20 11 79 0.53
S ize  (g) 75 45 18 24 87 O.7 6
100 55 11 22 68 0 .81
T otal 128 4.9 57 234 0 .7 0
Duration
(months) 0-11 40 10 55 91 0 .92
12-59 54 8 14 56 0.64
6o and over 10 5 2 15 0.47
! T otal 84 29 49 162 0.78
in te n s ity  and Duration o f Symptoms. There was no in d ica tio n  
that the r e su lts  of the CF te s t  were re la ted  to  e ith e r  the 
sev er ity  o f the i l ln e s s ,  as assessed  by the c l in ic a l  d iagn ostic  
index, or the duration o f the symptoms.
Eve S igns. There was no co rre la tion  between the r e s u lt  of 
the CF te s t  and the presence of the exophthalmos o f Graves* 
d isease  or of exophthalmic ophthalmoplegia. This i s  in  
contrast to  the fin d in gs o f a re la tio n sh ip  o f TRC antibody 
t i t r e s  to  exophthalmos by Hales e t a l .  (7 5 ).
Family H is to r y ./
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TPowity  H istory. P a tien ts  w ith a fam ily  h is to r y  o f thyroid  
d isease had a h i^ ier  incidence o f p o s it iv e  CP t e s t s  (P approac- 
:im ately  0 .1 ) . The same trend was a lso  found in  the group 
w ith previous antithyroid  treatm ent, and when the evidence  
from both groups i s  considered together the r e s u lt s  are 
s ig n ifica n t (P < 0*05). (Table V) .
Table V
R e la t io n  betw een Fam ily H is to r y  o f  T hyroid  Disease 
and C om plem ent-Fixation T e s t .
Fam ily H is to r y l\To . o f  Cases w ith  CF T est Mean Score
With
Y/ithout
+ ++ T o ta l  
U n trea ted "
36 17 22 75 
105 34 39 178
0.81
0.63
T o ta l 141 51 61 253 0 .68
With
W ithout
"Treated."
25 10 29 64
71 38 42 151
1.06
0.81
T o ta l 96 48 71 215 0.88
Drug R eactions. Reactions to antithyroid  drugs, e ith e r  mild  
or severe, did not vary with the r e su lts  o f the CF test*  
Response to  treatm ent. In p a tien ts  treated  w ith surgery the 
p o s it iv i ty  o f the CF t e s t  was found to  increase in  the order: 
relap se a fte r  operation, euthyroid and hypothyroid (Table V i). 
T h is/
/T h is  trend was ju st on the borderline o f s ig n if ic a n c e - 
(P approximately 0 .0 5 ) . In the case o f rad io iod ine therapy  
the reverse e f f e c t  was found and the t e s t  became l e s s  p o s it iv e  
in  the order: hypothyroid, euthyroid, euthyroid w ith 1 dose 3
and r e s is ta n t  (P < 0 .0 1 ) . (Table V I). Further a n a ly s is  showed 
that th is  was p a r tly  due to  the fa c t  that the mean gland s iz e  
was sm aller in  the group w ith negative t e s t s  (59  g*) than in  
the group w ith (+) (65 g .)  or (++) (80 g .)  t e s t s ,  although the 
resid u a l trend when gland s iz e  had been allowed fo r  was s t i l l  
s ig n if ic a n t .
Table VI
R elation between Outcome of 
and Complement-f ix a tio n  Test
Treatment
#
Response to Ho • of Cas es with CF Test Mean Score
Treatment - + ++ T otal
Surgery
Relapse 7 2 2 11 0.55fii thyroid 16 q 14 39 0.95Hypothyroid 0 2 2 4 1 . 5C
Total 07 13 18 54 0.91
Radioiodine
Therapy
R esistan t 7 3 13 23 1.26
Uuthyroid 
(One dose) 31 11 16 58 O.7 4
Ilypothyro id 8 4 1 13 O.4 6
Total 4 6 18 30 94 O.G~
No d e fin ite  conclusions could be reached regarding the  
r  e la t i  onship/
Table VIII.
R elation  between Previous Treatment 
and Complement-Fixation T est.
292.
Table VHI
R elation between Previous Treatment
and Complement-Fix a t ion Test*
No* of Cases with CF Test Mean Score
- + ++ Total
’TFntreated" 141 51 61 253 0.68
"Treated"
Drugs + Surgery 23 10 15 48 0.83
Drugs only 47 19 21 87 0*70
Radioiodine 26 19 35 80 1.11
T otal Treated 96 48 71 215 0.88
ITo. of Doses 1131
One IS 13 18 49 1.00Two 7 4 7 18 1.00
Three or more 1 2 10 13 1.69
Total 26 19 35 80 1.11
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/r e la t io n s h ip  o f the CF t e s t  to  the r e s u lt s  o f a n ti thyroid  
therapy (Table VH Appendices) because o f the short period  
o f follow -up (mean approximately 10 months).
(B) "Treated” Croup (215 p a t ie n ts ) .
There was a s ig n if ic a n t ly  higher number o f p a tien ts  with  
p o s it iv e  CF t e s t s  in  the "treated" group than in  the "untreated" 
group (P < 0 .0 2 ) . From Table VIII i t  can be seen that th is  
was la r g e ly  due to the p a tien ts  who had been p reviously  
trea ted  w ith rad io iod in e. The CF te s t  r e su lts  fo r  these  
were su b sta n tia lly  more p o s it iv e  than the corresponding 
measurements fo r  other p a tien ts  (P < 0 .0 1 ) , but the la t t e r  did  
not d if fe r  s ig n if ic a n t ly  from the values fo r  the untreated  
p a tien ts . Furthermore there was a s ig n if ic a n t co rre la tion  
(P C 0.05) between the p o s it iv i ty  of the CF t e s t  and in creasin g  
doses o f 1 (Table V III). The "treated" group as a whole 
was sim ilar to  the "untreated" group with respect to  mean 
age, con sisten cy  o f the go itre  and c l in ic a l  sev er ity .
(Table IX Appendices) •
Table X.
Changes in  Complement-Fixation Test 
A fter  I  and A nti thyroid Drug Therapy.
Table X
Changes in  Com pi eacnt -Tixat i  on Test after I1^! and 
Anti-Thyroid Drug Therapy•
Before
Treatment
Change in  mean C.F. score = +0*12
B efore 
Treatment
-"inti-Thyroid P:cg3
after Treatment
- + ++ Total
- 21 1 1 23
+ a 2 4 14
++ 3 1 13 17
Total 32 4 18 54
-berspae.a:'ter Tre 
+
etxent
++ Total
- 33 2 6 41
+ 4 4 3 11
++ 2 0 22 24
Total 39 6 31 76
Change in mean C.F# score => -0*15
2* The E ffe c t  o f therapy on the r e s u lt s  o f the CF t e s t .
The e f f e c t  o f therapy on s e r ia l  measurements o f the CF te s t  
i s  shown in  Table X. I t  can be seen that the incidence o f  
negative t e s t s  i s  higher fo llow in g  antithyro id  drug treatment and 
the in cid en ce o f p o s it iv e  (++) t e s t s  i s  higher fo llow in g  radio­
iod ine therapy. N either of these trends i s  s ig n if ic a n t when 
considered sep arately , but when taken together th is  d ifferen ce  in  
trends i s  s ig n if ic a n t (P < 0 .0 2 ) , This i s  con sisten t w ith the 
fin d in g  of a higher incidence o f p o s it iv e  t e s t s  in  p a tien ts  who had 
been trea ted  with raddoiodine therapy. I t  i s  p o ssib le  that had 
the fo llow -up  period been longer, the trend towards a p o s it iv e  
t e s t  in  those who had received  radioiod ine therapy would have been 
more apparent.
Figure 1.
R elation  between the CF t e s t  and the  
degree of rou n d -cell in f i l t r a t io n  in  
the thyroid .
Figure 2.
R elation  between complement-fixation
T est. Round-cell I n f i l t r a t io n  and 
Response to Therapy.
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RELATION BETWEEN COMPLEMENT-FIXATION TEST 
AND ROUND-CELL INFILTRATION IN THYROTOXIC GLANDS
O POSITIVE PRECIPITIN TEST
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30 -
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o .
Complement-F Ixation Test
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S l g .  2 .
RELATION BETWEEN COMPLEMENT-FIXATION TEST, 
ROUND-CELL INFILTRATION AND RESPONSE TO THERAPY
O HYPOTHYROID • EUTHYROID + RELAPSE AFTER OPERATION
+ + +
Complement-Fixation Test
3 . R ela tion  between the CF t e s t  and the degree of ro»T^-oell
in f i l t r a t io n  in  the thyroid.
From F ig , 1 , i t  can be seen that there i s  a d irect r e la tio n  
between the degree o f round -cell in f i l t r a t io n  in  the thyroid and 
the p o s i t iv i t y  o f the CF t e s t .  There i s ,  however, a wide sca tter  
in  th e  d is tr ib u tio n  o f  the in f i l t r a t io n  measurements in  the 3 CF 
t e s t  c a teg o r ie s . To reduce the erra tic  e f fe c ts  of the 
extreme observations the an a ly sis  was carried out on the square 
ro o ts  o f the measurements o f  round-cell in f i lt r a t io n . The 
r e la t io n  w ith the CF t e s t  r e s u lt s  was then found to  be h igh ly  
s ig n if ic a n t  (P< 0 .0 0 1 ). From F ig . 2, i t  can be seen that hypo- 
sthyroidism  occurred ex c lu siv e ly  in  p a tien ts  with p o s itiv e  CF t e s t s ,  
and e sp e c ia lly  in  those w ith severer degrees of round-cell 
in f i l t r a t io n ,  whereas relap se a fter  operation occurred in  those with  
negative t e s t s  and le s s e r  degrees of lymphoid replacement. I t  can 
a lso  be seen that 3 of the 4  patien ts  with extensive lymphocytic 
in f i l t r a t io n  (present in  50 out of 50 f ie ld s  examined) became 
hypothyroid a f te r  surgery. Two of these p atien ts  had p o s it iv e  
p r e c ip it in  t e s t s  and were described in  greater d e ta il  in  the 
previous sec tio n .
DISCUSSION
In the present study a s ig n ifica n t correlation  has been 
demonstrated between the r e su lts  of the CF t e s t  and the degree of 
rou n d -cell in f i l t r a t io n  in  the thyroid gland (F ig . 1 ) . This may 
be o f p ra c tica l importance since the incidence o f post—operative 
hypothyroidi snv/
/hypothyroidism  i s  greater w ith  in creasin g  lymphocytic replacement 
in  the th yrotox ic  gland (2 3 ,3 0 ,3 1 ,8 5 ) . These observations have 
been confirmed in  th e present study and moreover, the CF t e s t  has 
been shown to  co rre la te  w ith  the degree o f ro u n d -cell in f i l t r a t io n  
in  the th yroid  gland (P < 0 .0 0 1 ) , and so to  be o f some p r e d ic tiv e  
value in  the outcome of su rg ica l treatm ent (P < 0 .0 5 ) .  I t  i s  
concluded th at th yrotox ic  p a tien ts  w ith a p o s it iv e  CF t e s t  are b est  
trea ted  i n i t i a l l y  w ith a course o f a n tith y ro id  drugs u n less  there  
i s  a d e f in ite  in d ic a tio n  fo r  surgery.
Schade e t  a l .  ( i 960) have reported a c o rre la tio n  between th e  
degree o f ro u n d -ce ll in f i l t r a t io n  in  th yrotox ic  glands and the  
le v e l  o f TRC au to -a n tib o d ies  but concluded th at there was no 
r e la t io n sh ip  w ith  the CF t e s t .  This conclusion  seems u n ju s t if ie d  
s in ce  th ese  authors found a higher incidence o f p o s it iv e  CF t e s t s  
in  p a t ie n ts  w ith  lymphoid in f i l t r a t io n  in  the th yroid  gland; the 
absence o f  s t a t i s t i c a l  s ig n ifica n ce  can be a ttr ib u ted  to  the sm all 
number o f cases (8  p o s it iv e  CF t e s t s  in  t o t a l ) .  Furthermore, 
th ese  authors carr ied  out th e ir  se r o lo g ic a l t e s t s  a t varying  
in te r v a ls  a f t e r  thyroidectom y which i s  known to  produce a f a l l  in  
the c ir c u la t in g  antibody le v e l s  (Owen and Smart, 1958).
A much h igher incid en ce (P < 0 .0 1 )  o f p o s it iv e  CF t e s t s  was 
found in  p a t ie n ts  who had rece iv ed  treatm ent w ith rad io iod ine  
(Table V III) .  Furthermore, s e r ia l  determ inations o f the CF t e s t
A TLA
in  p a t ie n ts  r e c e iv in g  I  therapy showed a s ig n if ic a n t ly  greater  
in crea se  in  p o s it iv e  CF t e s t s  than in  those r ec e iv in g  an tith yro id
d ru gs/
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/drugs (Table X I); but the p r e c ip it in  t e s t  showed no change.
The increased  p o s i t iv i t y  o f the CP t e s t  a fte r  therapy may be
r e la ted  to the h is to lo g ic a l  le s io n s  resembling auto-immune
th y r o id it is  which have been found by various workers in  the thyroid  
131gland a fte r  I  therapy (90-92). I t  has therefore been suggested
th at d estru ctive  forms o f antithyroid  therapy might predispose the
thyroid  to  the development of auto-immunity (71 ,77)• Profound
morphological changes are found in  the thyroid e p ith e lia l  c e l l s  
131a fte r  I  therapy (93) which may in i t ia t e  an auto-immune process 
due to leakage o f  microsomal antigen . However, an in terestin g  
fin d in g  i s  the absence of correla tion  between the r esu lt o f the 
CP t e s t  and the success o f treatment with radioactive iodine; th is  
may be a ttr ib u ta b le  to lack of uniform ity of irrad ia tion  by the 
gland a ffec te d  by chronic th y r o id it is .
C orrelation o f the r e su lts  of a p o s itiv e  CP t e s t  with age 
shows a s tr ik in g  s im ila r ity  to  the age d istr ib u tio n  o f "focal 
th y ro id itis"  found in  a large ser ie s  of thyroid glands by Woolner
e t  a l .  (9 k ). The low incidence of p o s itiv e  CF t e s t s  in  the
p a tien ts  under 30 years o f age might conceivably be due to  
p ersisten ce  o f immunological tolerance to thyroid antigens. In  
view o f the observations of blood group is o —antibodies by Thomson 
and K ette l (95) and o f antibodies to  in flu en za l v iruses by Sabin 
e t  a l .  (9 6 ), the low incidence o f p o s itiv e  CP t e s t s  in  patien ts  
over the age o f 60 years may be due to a diminished antibody
forming p o te n tia l. The absence of s ig n ifica n t sex d ifference in
th e /
/ th e  incidence of p o s it iv e  CP t e s t s  in  th yro tox icosis  i s  in  
s tr ik in g  con trast to  the increased incidence o f p o s it iv e  CP te s t s  
in  euthyroid fem ales without overt thyroid d isea se . Although 
there i s  an increased  prevalence o f a l l  types of thyroid d isease  
in  the fem ale, i t  appears that there i s  no immunological d ifference  
in  a ffe c te d  males and fem ales.
Doniach e t  a l .  (98) invoked an auto-immune reaction  to  explain  
the pathogenesis o f severe exophthalmos on the b a sis  of the  
lymphocytic in f i l t r a t io n ,  oedema, and fragmentation of muscle 
found in  the ocular t is s u e . The incidence o f p o s itiv e  p rec ip itin s  
found by th ese workers (99) was nearly 10 per cent, in  a group of 
90 malignant exophthalmos sera, whereas i t  was only 0 .5  per cen t, 
in  over 300 thyrotoxic sera from p atien ts  with benign or absent 
eye s ig n s . Hales e t  a l .  (75) a lso  found a p o s itiv e  correlation  
between the TRC auto-antibodies and the exophthalmos o f Graves* 
d isea se , but no corre la tion  has been found with e ith er  the 
p r e c ip it in  t e s t  (p o s it iv e  in  only 1 o f 42 p a tien ts  with severe  
exophthalmos) or CP te s t  in  the present study.
Approximately 5 par cent, o f p atien ts receiv ing  antithyroid  
drugs fo r  treatment of th yrotox icosis  develop delayed hyper­
s e n s i t iv i ty  a l le r g ic  reactions (100). B lizzard e t a l .  (71) 
reported an increased prevalence o f p e n ic i l l in  reactions in  
p a tien ts  w ith thyroglobulin auto—antibodies, but no such correlation  
has been found in  the present study between the r e su lts  o f the CP 
t e s t  and the onset o f drug a l le r g ie s .  This i s  perhaps not so 
su r p r is in g ,/
/su r p r is in g , s in ce  the 2 immunological systems are quite d is t in c t  
(101).
H all e t  a l .  (102) have produced evidence o f a g en e tica lly  
determined p red isp o sitio n  to  the formation of thyroid auto­
a n tib o d ies . I t  has been shown that p a tien ts  with a fam ily h istory  
o f thyroid d isease  have a higher incidence of p o s itiv e  CP t e s t s .  
These fin d in g s are comparable to  the higher prevalence o f  
rheumatoid a r th r it is  found in  r e la t iv e s  of p atien ts with p o s itiv e  
Rose-Waaler t e s t s  (103)» This comparison between the 2 d iseases  
i s  p a r tic u la r ly  relevan t in  view of the a ssocia tion  which has been 
found between auto-immune th y r o id it is  and rheumatoid a r th r it is  
(se e  Chapter IV, S ection  1 ) . These considerations suggest that 
the fa m ilia l fa c to r  in  the inheritance o f thyroid disease, may be 
asso c ia ted  with a p red isposition  to  the development o f thyroid  
auto-an tib od ies •
SUMMARY
The s ig n ifica n ce  of a p o s it iv e  thyroid complement-fixation  
(CP) t e s t  in  th y ro to x ico s is  has been in vestiga ted  by studying the 
c o rre la tio n  between various featu res o f the d isease in  468  p a tien ts . 
A s ig n if ic a n t  co rre la tio n  was found between the p o s it iv i ty  o f the 
CP t e s t  and ( 1) the degree of lymphocytic in f i l t r a t io n  in  the 
gland, (2) the incidence of post-operative hypothyroidism, ( 3) 
s iz e  o f the g o itr e , (4 ) previous treatment with radioiod ine, and 
(3) a fam ily  h isto ry  o f thyroid d isease . No correlation  was 
found between the r e s u lt s  o f the t e s t  and the incidence of 
rea ctio n s to  a n ti thyroid  drugs. The r e su lts  suggest that 
th yrotox ic  p a tien ts  with p o s it iv e  CP t e s t s  should be treated  
i n i t i a l l y  w ith a n ti thyroid  drugs u n less there i s  a d e fin ite  
in d ica tio n  fo r  surgery.
C H A P T E R IV.
The C lin ica l A ssooiations of Auto-immune 
T h yro id itis.
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Introduction .
For many years only foreign  prote in s were considered to  be 
true a n tig en s. Horse serum, fo r  in stan ce, was long known as a 
potent antigen  when in jec ted  in to  humans but did not provoke 
antibody form ation in  the horse. In 1901 Landsteiner ( 1) made h is  
important d iscovery o f the blood group substances and drew 
a tten tio n  to the fa c t  that agglu tinating  antibodies against these  
blood group substances may develop in  humans, but not in  the 
in d iv id u a l h im se lf. These antibodies were ca lled  isoan tib od ies. 
E hrlich  and Morgenroth (2) were able to  produce isoantib od ies by 
in je c t in g  goats with red blood c e l l s  from other goats, but not 
again st the goat’ s own blood c e l l s .  This in a b ility  to  produce 
antibody to o n ese lf  was interpreted by Ehrlich as a fundamental 
b io lo g ic a l law o f  nature and enunciated as "horror autoxicus"•
In  recen t years a group of d iseases has emerged which has 
proved an exception to th is  general law o f immunity and in  which 
auto-immune mechanisms may play a v i t a l  r o le . Witebsky e t  a l .  (3) 
have la id  down cer ta in  c r ite r ia  which should be f u l f i l l e d  before 
im p licatin g  the r o le  o f an auto-antibody in  the pathogenesis o f a 
d isea se . These in c lu d e ^ ( l)  The d irect demonstration o f free  
c ircu la tin g  an tibod ies that are a c tiv e  a t body temperature or of 
cell-bound antibodies by in d irect means, (2) The recogn ition  of 
the sp e c if ic  antigen against which th is  antibody i s  d irected , ( 3) 
The production o f antibodies against the same antigen in  
experim ental/
/ experim ental anim als; (4 ) The appearance o f p athological changes 
in  the corresponding t is s u e s  o f an a c t iv e ly  sen sit ize d  Animal that 
are b a s ic a lly  s im ila r  to those in  the human d isease."
I t  has been seen that these c r ite r ia  have come to  be f u l f i l l e d  
in  auto-immune th y r o id it is .  Auto-immune processes are a lso  c lea r ly  
evident in  cer ta in  acquired haemolytic anaemias, in  which antibodies  
rea ctin g  aga in st red c e l l s  may be present, which can be shown to  
be cy to to x ic  in  vivo (4 ) • Thrombocytopenia and leucopenia may be 
asso c ia ted  w ith  auto-immune haemolytic anaemia and cytotoxic  
an tib od ies to p la t e le t s  (5 ) and leu cocytic  agglutin ins (6) have been 
demonstrated. Auto-immune mechanisms have a lso  been suspected in  
the connective t is s u e  disorders and in  systemic lupus erythematosus 
the LE c e l l  t e s t  has led  to the discovery of several fac to rs  which 
react w ith c e l l  n u cle i (7)* and in  rheumatoid a r th r it is  the 
ser o lo g ic a l fa c to r  underlying the Rose-Waaler te s t  has been shown 
to  be a macroglobulin which behaves somewhat akin to an auto-antibody 
( 8 ) .  In  Sjbgren's d isease , rheumatoid a r th r it is  often  c o -e x is ts  
and a p o s it iv e  LE c e l l  t e s t  i s  occasionally  found (9 )j  
p r ec ip ita tin g  antibodies have been described to lachrymal and 
sa liv a ry  glands (1 0 ) .  Sim ilarly  p recip ita tin g  antibodies have been 
described in  chronic p a n crea titis  (11 and Broberger and Perl mann 
(12) have reported the ex isten ce  o f antibodies against normal colonic  
ex tract in  the blood-serum of children with u lcera tive  c o l i t i s .  
Complement—fix in g  adrenal ahtibodies have a lso  been described in  
primary adrenal atrophy (*13), and sperm agglutinating antibodies 
have/
/h ave been demonstrated in  some p a tien ts  w ith o r c h it is  ( 14) and 
oligosperm ia (1 5 ) . Auto-immunity has a lso  been suspected in  a 
v a r ie ty  o f other cond itions including progressive h e p a tit is  ( 16) ,  
chronic renal (17) and cardiac ( 18) d isea ses , and in  the 
encephalom yelitides ( 19) and m ultiple sc le r o s is  (20), although the 
evidence in  th ese d isea ses  i s  le s s  convincing.
Although c irc u la tin g  thyroid auto-antibodies can rea d ily  be 
demonstrated in  the blood sera of a high proportion of p atien ts  
w ith  auto-immune th y r o id it is , l i t t l e  i s  known regarding the factors  
which predispose cer ta in  p a tien ts  to develop these auto-antibodies. 
Accordingly i t  would be o f in te r e s t  to  determine whether these  
fa c to r s  operate only  fo r  thyroid t is su e  antigens, or whether the 
in d iv id u a ls  concerned are prone to develop auto-antibodies to  
t is s u e  antigens in  general. This problem may be approached in  2 
ways; f i r s t l y ,  p a tien ts  with auto-immune th y ro id itis  may be 
examined fo r  the presence of auto-antibodies other than those 
s p e c if ic  fo r  thyroid t is su e ;  and secondly, the c l in ic a l  a ssoc ia tion  
of Immune th y r o id it is  w ith ’’auto-immune11 d iseases can be studied.
The f i r s t  approach was adopted by Y/hite e t a l .  (21) who demonstrated 
antinuclear fa c to r s  in  the serum of a proportion of p a tien ts  with 
auto—immune th y r o id it is  . The second approach i s  the one adopted 
in  the present in v estig a tio n , in  which the c lin ic a l a ssociation s of 
auto—immune th y r o id it is  with the connective t is su e  disorders, 
acquired haemolytic anaemia, and c irrh o sis  of the l iv e r  have been 
stud ied . The immnnft response in  p atien ts with these various 
co n d itio n s/
/c o n d it io n s  has a lso  been studied by measuring the a n tito x in  
t i t r e s  a f t e r  primary immunisation to tetanus toxo id . The r e su lts  
of th ese  in v e s tig a tio n s  are discussed in  r e la tio n  to  current concepts 
o f  antibody form ation and immunological tolerance*
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S ection  1.
The A saooiation o f Auto-immune th y ro id itis  
and th e Connective t is su e  d iseases, 
with p articu lar  reference to  
Rheumatoid A r th r itis .
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Our present concept o f the d iseases o f connective t is su e  
springs la r g e ly  from the work of Klinge ( 1) who in  1933 f i r s t  
drew a tten tio n  to  the systemic character o f the connective t is su e  
le s io n s  and th e ir  s im ila r ity  to the t is s u e  changes in  the hyper- 
: s e n s i t iv i t y  s ta te ;  from Klemperer e t  a l .  (2) who in  1942 f i r s t  
conceived the n oso log ica l u n ity  of the connective t is su e  or 
"collagen” d isea ses; and from Hench e t a l .  (3) who in  1949 
discovered the therapeutic e ff ic ie n c y  of the adrenal stero id  
hormones. The d isea ses  which so fa r  have been suggested as 
belonging to th is  group of d iseases include: rheumatoid a r th r it is ,
system ic lupus erythematosus, dermatomyositis, scleroderma, 
p o ly a r te r it is  nodosa, rheumatic fever , and acute n ep h ritis.
Rheumatic fev er  and acute n ep h ritis  are in  a rather sp ecia l category  
in  view o f th e ir  a e tio lo g ic a l r e la tio n  to streptococcal in fec tio n  
and th e ir  predominant attack on children, and fo r  these reasons w il l  
not be considered fu rth er. The ro le  of auto-immunity in  the 
pathogenesis o f the connective tis su e  d iseases w i l l  now be b r ie f ly  
ou tlin ed  together w ith the h is to r ic a l aspects o f the a ssoc ia tion  of 
th ese  d isea ses  and auto-immune th y r o id it is .
Auto—immunity in  the Connective Tissue D iseases.
Review
The theory o f h y p ersen sitiv ity  as the pathological basis of 
the connective t is su e  d i s e a s e s  has attracted  much atten tion  during 
the past 2 decades. The evidence for  th is  theory i s  la rg e ly  based 
on the observations made by Rich (4 ) that h is to lo g ic a lly  id en tica l 
f o c a l /
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/ f o c a l  co llagen  and n ecro tis in g  vascular le s io n s  to those found 
in  the connective t is s u e  d isorders, can be caused in  animals by 
immunisation w ith  fo re ig n  p rote in s. Experimentally angrloid, 
w ith i t s  locu s in  the connective t is s u e , can be produced by 
hyperimmunisation (5) and i t s  r e la t iv e ly  frequent occurrence in  
rheumatoid a r th r it is  (6 -8) has suggested to some workers the 
p a r tic ip a tio n  of h y p ersen sit iv ity  in  the pathogenesis o f th is  
d isea se  (5 ) .  Moreover, the hypergammaglobulinaeraia in  rheumatoid 
a r th r it is  has a lso  been invoked as evidence of a hyperimmune 
response in  th is  d isease (1 0 ,1 1 ). However, the outstanding 
problem in  invoking h yp ersen sitisa tion  to explain the pathogenesis 
o f the connective t is s u e  d iseases i s  that no sustained hyper- 
: s e n s i t iv i t y  s ta te  has as yet been described in  man or in  the 
experim ental animal (5 ) ,  and the search fo r  an exogenous antigen  
has so fa r  proved unrewarding (12).
The p o s s ib i l i t y  that auto-immunisation to components of body 
t is s u e s  may p lay  a ro le  in  causation of the connective t is su e  
d ise a se s , has been considered by several workers ( 5 ,12-14)« In  
the experimental animal immunisation with homologous t is su e s  
conjugated w ith streptococcal vaccine r e su lts  in  the formation of 
auto—an tib od ies to  heart, connective tissue-, and muscle, and 
p ath o log ica l changes in  the same organs which resemble those in  
rheumatic fev er  (15) • In the human, i t  i s  the newer work with the 
rheumatoid and L E c e l l  fa c to rs , which poin ts more p articu larly  to 
the ro le  of auto—immunity in  the pathogenesis of the connective 
t i s s u e /
/tissue disorders.
The rheumatoid fa c to r , f i r s t  described by Waaler in  192*0 ( 16) 
and then re-d iscovered  8 years la te r  by Rose e t  a l .  (17 ), has been 
shown to  be a gamma^obulin ( 18) which belongs to the category of 
macro g lob u lin s w ith a sedim entation c o e ff ic ie n t  of 19S as compared 
with the sedim entation c o e ff ic ie n t  of 73 fo r  normal gamma-globulin 
(19) • Normally, however, in  whole serum the rheumatoid fa ctor  
e x is t s  as a lo o se  combination o f several molecules of 7S gamma­
glob u lin , which forms a complex with a sedimentation c o e ff ic ie n t  of 
22 S (2 0 ) .
Several m odifications of the Rose-Waaler te s t  have now been 
developed ( 18) ,  and i t  i s  c lear  that the reaction  i s  in  the nature 
o f an antigen-antibody reaction  ( 18) and that the rheumatoid factor  
can combine w ith i t s  own naturally  occurring 7S gamma-globulin (5) • 
The p o s s ib i l i t y  th at the Rose-Waaler t e s t  represents an auto-immune 
rea ctio n  thus becomes a tenable hypothesis, and the demonstration 
o f rheumatoid fa c to r  by flu orescen t antibody techniques in  the 
antibody-forming plasma c e l l s  ( 21) supports such a hypothesis. 
However, i t  i s  necessary to  postu late a high degree of non­
s p e c if ic i t y ,  s in ce  reactant gamma-globulin may be obtained in  a 
wide v a r ie ty  of anima.1 sp ecies ( 2 2 ) . G-lynn and Holborow (1A-) 
have put forward the a ttra c tiv e  hypothesis that the rheumatoid 
fa c to r  i s  the r e su lt  on the part of the rheumatoid patient to  
a lte r a t io n  in  autogenous p rote in s, which i s  ignored by the 
immunological mechanisms of the normal in d iv idu al. These workers 
a ls o /
/a l s o  considered th at the pattern  of t is s u e  damage in  rheumatoid 
a r th r it is  resembled a delayed-type of h y p ersen sitiv ity  reaction  
and th a t, th erefo re , the d isease was probably independent o f  
c ir c u la tin g  an tib o d ies; th is  might provide an explanation fo r  the 
occurrence o f a generalised  a r th r it is  of rheumatoid type in  
p a tien ts  w ith agammagLobulinaemia ( 23) .
A s tr ik in g  number of autologous t is su e  components to  which 
c irc u la tin g  an tib od ies can be found are present in  patien ts  
su ffer in g  from system ic lupus erythematosus. Thus, gamma-globulins 
which rea ct w ith  red blood c e l l s  occur frequently (24)^nd leu cocytic  
a g g lu tin in s  may a r ise  without previous transfusions ( 25) .
P la te le t  a g g lu tin in s  may be found in  assoc ia tion  with thrombocyto- 
:penic purpura (26) % and a gamma-globulin may be present which has 
antithrom boplastic a c t iv i t y  (27) • Another gamma-glob u lin  which 
may be present i s  one which g ives r is e  to a fa ls e  p o s itiv e  
Wassermann rea ctio n  ( 24 ) • There i s  a lso  a gamma-globulin which 
i s  deposited  in  large amounts in  the f ib r o t ic  le s io n s  o f the spleen  
(28) and in  the glomerular le s io n s  in  lupus neph ritis (29) .
A m an ifestation  o f systemic lupus erythematosus of great 
current in te r e s t  of immunological nature i s  the ,!L E cell"  t e s t .
The d iscovery  o f th is  t e s t  by Hargraves e t a l .  (30) i n 1948 bas 
le d  to the id e n t if ic a t io n  o f a group of factors which react with 
d iffe r e n t co n stitu en ts  o f the c e l l  nucleus (31) • Separate factors  
are present which rea ct w ith pure DNA and histone (32) end cyto­
plasm ic fa c to r s  have a lso  been demonstrated (31) • Like the 
rheumatoid/
/rheumatoid fa c to r , the L E c e l l  fa c to r  has been shown e lec tr o -  
rp h o retica lly  and u ltr a -c e n tr ifu g a ily  to  be a gamma-gLobulin ( 33) 
and a lso  to  be in a c tiv a ted  and q u a n tita tive ly  precip itated  by 
a n ti serum to  normal human gamma-globulin ( 34) .  Immunologically 
i t  has the c h a r a c te r is t ic s  o f the 7S gamma-globulin ( 35) although 
o cca s io n a lly  a small amount o f high molecular weight gamma-globulin 
may a lso  be present (3 4 ) . P o sitiv e  L E c e l l  t e s ts  have a lso  been 
reported in  dermatomyositis ( 36) ,  scleroderma ( 37) ,  and p o ly a r te r it is  
nodosa ( 38) ,  which a lso  have a c l in ic a l  and pathological overlap 
w ith  each other and w ith rheumatoid a r th r it is  and systemic lupus 
erythematosus ( 39) .
Thus, there i s  a t present evidence fo r  the ro le  of auto-immunity in  
the pathogenesis o f the connective tis su e  d iseases. Both the serum 
fa c to r s  underlying the Rose-Waaler t e s t  in  rheumatoid a r th r it is  and 
the L E t e s t  in  system ic lupus erythematosus possess the character- 
s i s t i c s  of human antibody gamma-globulin, and a lso  share some of the 
fea tu res o f  au to -an tib od ies. However, in fusions of Rose-Waaler 
p o s it iv e  sera (40 ) and L E c e ll -p o s it iv e  sera (41) into human 
volunteers have been without s ig n ifica n t e f fe c t ,  and in fan ts bora 
to  mothers w ith system ic lupus erythematosus seem to  su ffer  no 
i l l  e f f e c t s  d esp ite  the d etection  o f p o s it iv e  L B c e l l  t e s t s ,  which 
may la s t  up to 7 weeks fo llow ing  d elivery  (2*2-44) • Moreover, the 
known is o la te d  connective t is su e  components, with the exception of 
r e t ic u l in  (4 5 ) , are v ir tu a l ly  non-antigenic (2*6-52), and tissu e  
cu ltu re experiments using sera from p atien ts suffering  from systemic 
lu p u s/
/lu p u s erythematosus have been unable to d etect c y to to x ic ity  (34). 
Hence, w hile  no evidence has appeared which d ir e c t ly  contradicts  
the hypothesis th a t auto-immunisation i s  involved in  the pathogenesis 
of the connective t is s u e  d isea ses , the supportive evidence must be 
considered incom plete.
The A ssoc ia tion  of Auto-immune T hyroiditis and the  
Connective Tissue D iseases.
That an a sso c ia tio n  e x is t s  between thyroid d isease and the
connective t is s u e  d isea se s  has long been suspected. Low BMRs
(53-59) and c l in ic a l  hypothyroidism (6O-61) have been observed in
a number o f p a tien ts  with rheumatoid a r th r it is ,  although
Baggenstoss e t  a l .  ( 62 ) were unable to fin d  h is to lo g ic a l evidence
of hypothyroidism in  30 p a tien ts  dying from rheumatoid a r th r it is .
The a s so c ia tio n  of th yro tox icosis  and rheumatoid a r th r it is  has
been reported (59 , 60 , 63- 65 ) ,  and the presence of lymphorrhages in
the muscles in  both conditions suggested to L evitt ( 66) that these
2 d isea se s  might share a common pathogenesis. Short e t a l .  (59)
found a much higher prevalence of non-toxic goitre in  patien ts with
than in  a control ser ie s  
rheumatoid a r t h r i t i i /  (7  o f 293) and Jones (63) considered that
rheumatoid a r th r it is  was more common in  regions where simple goitre
was prevalen t. The a sso c ia tio n  o f auto—immune th y ro id itis  with
rheumatoid a r th r it is  has been recorded in  only a few patien ts (67—
69) ,  although 2 o f the 293 p a tien ts  studied by Short e t a l .  (59)
had an u n sp ecified  type of th y r o id it is . Thyroid disease (70 ),
including auto-immune th y r o id it is  (71) has a lso  been observed in
o th er /
/form s o f  connective t is s u e  d isease , and h is to lo g ic a l abnormalities 
c h ie f ly  c o n s ist in g  o f f ib r o s is  ( 72) ,  have been described in  
scleroderma. L E c e l l s  have been reported occasion a lly  in  p atien ts  
w ith thyroid  d isea se  (7 3 ) , and Heaton (74) has recen tly  brought 
togeth er evidence fo r  the a sso c ia tio n  of Sjttgren's d isease with  
system ic lupus erythematosus and rheumatoid a r th r it is ,  and auto­
immune th y r o id it is .
Thus, a t present there i s  su ff ic ie n t  evidence to  suggest a 
r e la t io n sh ip , o f a type as yet undetermined, between the connective 
t is s u e  d ise a se s  and thyroid abnorm alities in  general.
Personal Observations
In the present in v e s tig a tio n  I  have studied the p ossib le  
re la tio n sh ip  between auto-immune th y ro id it is  and rheumatoid a r th r it is  
by studying 2 groups o f p a tien ts . The f i r s t  group presented  
prim arily w ith the thyroid d isease and was examined for  evidence of 
rheumatoid a r t h r i t i s .  I  have compared the prevalence of a r th r it is  
in  t h is  s e r ie s  and in  p a tien ts  attending c l in ic s  of the same 
h o sp ita l d ea lin g  with other d isea ses . The second group consisted  
o f p a tien ts  w ith  rheumatoid a r th r it is ;  the pi*evalence o f p o sitiv e  
t e s t s  fo r  thyroid auto-antibodies was studied. Seven p atien ts  
i l lu s t r a t in g  the c l in ic a l  a sso c ia tio n  between the 2 conditions have 
been se le c te d  fo r  f u l le r  presentation .
I  have a lso  studied the prevalence of p o s itiv e  thyroid auto- 
antibody t e s t s  in  a sm all number o f p atien ts  with a variety  of 
connective t is s u e  d isea ses , including Sjttgre^s d isease.
M aterials and Methods 
P a tien ts  in  the f i r s t  group (Group 1A) presented prim arily  
w ith auto-immune th y r o id it is , and those in  the second (Group 2A) 
w ith rheumatoid a r th r it is .  Group 3 comprised p atien ts  with other 
connective t is s u e  d ise a se s , including Sjttgren's d isease.
Group 1A comprised 50 p a tien ts  with auto-immune th y ro id it is  
(46  women, 4  men) • Their ages ranged from 28 to  70 years with a 
mean age o f 51*9 fo r  women and 59 for  men. The c l in ic a l  find ings  
in  th is  group are given in  d e ta il  in  the Appendices. The 
d iagn osis o f auto-immune th y r o id it is  was based on the c r ite r ia  
p rev iou sly  described in  Chapter I I  of the th e s is . These p atien ts  
had a l l  been referred  because of the thyroid abnormality; they  
were examined fo r  c l in ic a l  evidence of rheumatoid a r th r it is  by 
the methods suggested by K ellgren and Lawrence (75 ), and fo r  
r a d io lo g ic a l evidence of diseased hands ( 76) .  Rose-Waaler te s t s  
were a lso  performed in  a l l  p atien ts  o f th is  group, by the method 
described by Greenbury (77) • The Rose-Waaler te s t  was considered 
p o s it iv e  when the serum t i t r e s  exceeded 1/ 16 . L E c e l l  t e s t s  were 
a lso  carried  out in  37 p a tien ts  of th is  group.
A con tro l s e r ie s  (Group 1B) was examined in  the same way fo r  
evidence o f rheumatoid a r th r it is .  This group included 179 women 
p a tien ts  a ttend ing other c l in ic s  in  the h osp ita l; 125 p atien ts  
from the d ia b etic  c l in ic ,  and 54  p atien ts with dyspeptic symptoms 
from a general su rg ica l c l in ic .  The mean age (55 years) was 
sim ilar  to  th at in  Group 1A.
Group 2A/
Group 2A co n s isted  o f 73 u n se lected  p a tien ts  w ith rheumatoid 
a r t h r it is  (49 women, 24  men) who attended the c l in ic s  a sso c ia ted  
with t h is  h o s p ita l . Their ages ranged from 17 to  74 years, w ith  
a mean fo r  women o f 53 years and fo r  men of 52 years. The 
diagn osis of rheumatoid a r t h r it is  in  th ese  p a tien ts  was based on 
the presence o f ty p ic a l a r th r it ic  d e fo rm ities , and was confirmed 
by an X-ray o f the hands which s a t i s f ie d  the c r i t e r ia  given by 
K ellgren ( 76) and/or a p o s it iv e  Rose-Waaler t e s t .  The p a tien ts  
in  th is  group were examined fo r  evidence of thyroid  d isease  by 
the c l in ic a l  and laboratory  methods described in  Chapter I I  o f the 
th e s is .  The c l in ic a l  d e ta ils  in  th is  group are summarised in  the 
Appendices. T ests fo r  thyroid au to-an tibod ies (both p r e c ip it in  
and CF) were performed by the methods described in  Chapter I I .  
N on -sp ecific  CF t e s t s  excluded 5 p a t ie n ts , reducing the number 
av a ila b le  fo r  a n a ly s is  to  70.
The r e s u lt s  of the thyroid auto-antibody t e s t s  in  th is  group 
were compared w ith the prevalence o f p o s it iv e  t e s t s  in  a s e r ie s  o f  
h o sp ita l p a tien ts  (Group 2B) p rev iou sly  reported from the same 
laboratory ( 78) .
Group 5 co n sisted  of 21 p a tien ts  (18 fem ales, 3 males) with  
various connective t is s u e  d ise a se s , inclu d ing  9 with system ic lupus 
erythematosus, 6 w ith scleroderma, 2 w ith dermatomyositis, 2 w ith  
p e r ia r te r it is  nodosa, and a lso  2 p a tien ts  su ffer in g  from Sjttgren’ s 
d isease . Their ages ranged from 22 to  67 years, w ith a mean age 
of 48.8  for  women and 44 fo r  men. The c l in ic a l  d e ta ils  in  th is  
group/
Table I.
In v estig a tio n s  in  7 p atien ts  with 
Auto-immune T hyroid itis and 
Rheumatoid A r th r itis
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Table I .
I n v e s tig a tio n *  In  7 p a t ie n ts  w ith  A u to -lo ia u n e  T h y ro id i t is  und H heum nto ld  A r th r i t i s .
Cat* lo .
1
4 hr. uptake 
{ i  doae)
tadiolodine Studl
48 hr. PBI1J1 
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2 45-6 0.41 - 3-3 ♦ 9 285 * 7 0 .6 8 - 15
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:oople-
pentary
3 0 .9 0 ♦ - 27
6 30.0 0 .40 ♦ 9 215 ♦ ♦♦ 8 1*35 - ♦ - 13
7 U .O 0.14 . ♦ 0 .5 -1 8 165 * ♦♦ 3 1.30 ♦ ♦ • 26
/group are summarised in  the Appendices. The diagnosis of 
system ic lupus erythematosus was based on the c l in ic a l  featu res  
and was confirmed in  each p atien t by a p o sitiv e  L E c e l l  t e s t .
The d iagn osis o f scleroderma, dermatomyositis, and p e r ia r te r it is  
nodosa, was confirmed by h is to lo g ic a l examination of a ffected  
t is s u e s .  The d iagnosis of Sjogren*s disease was based on the 
c l in ic a l  fin d in g s o f xerostomia and kerato-con ju n ctiv itis  s icca , 
and was confirmed by p o s it iv e  Schirmer (79) and Rose Bengal (80) 
t e s t s .  Several o f the p a tien ts  in  th is  group had received stero id  
therapy and were in  rem ission when examined.
R esults
Group 1A; Auto-immune th y r o id it is .
S ix  o f 2*j6 women had an a r th r it is  o f  rheumatoid type confirmed
by e ith e r  a p o s it iv e  Rose-Waaler t e s t  or by rad io log ica l evidence
o f the d ise a se , or both (Table I ) .  A further 3 women in  th is  
p o s it iv e
group hac/Rose-Waaler t e s t s  without c l in ic a l  or rad io log ica l evidence 
of iheumatoid a r th r it is .  Equivocal c l in ic a l  and rad io logical 
sign s were present in  one woman patien t with a negative Rose-Waaler 
t e s t .  As th ese  if p a tien ts  did not s a t is fy  the s tr ic t  diagnostic  
c r ite r ia  o f  the present in v estig a tio n  they were not counted as 
cases o f rheumatoid d isease in  the s t a t i s t ic a l  an a lysis . One of 
the if men in  t h is  group had rheumatoid a r th r it is  and also  had a 
p o s it iv e  L E c e l l  t e s t  (Table I ) . The prevalence of rheumatoid 
a r th r it is  in  the women p a tien ts  with auto—immune th y ro id itis  
(Group 1A; 6 o f k6 cases) i s  much higher (P < 0 .01 ) than in  the
co n tr o l/
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/c o n tr o l  cases (Group 1B; 2 o f 179 c a se s).
The case h is to r ie s  of the 7 p a tien ts  of group 1A with  
c l in ic a l  and laboratory evidence of auto-immune th y ro id itis  and 
rheumatoid a r th r it is  are described below. The r e su lts  of the
in v e s t ig a tio n s  in  th ese p a tien ts  are summarised in  the accompanying 
ta b le  (Table i ) .
Case Reports
P a tien t No. 1 . (T hesis No. 15), a woman, aged 67 years, had had 
a g o itre  fo r  8 months. The go itre  appeared shortly  a fter  a 
f e b r i le  i l ln e s s  and a t the onset was associated with discomfort 
in  the reg ion  of the thyroid , e sp ec ia lly  on swallowing. She 
complained o f nervousness and i r r i t a b i l i t y  and her doctor 
prescribed carbimazole without s ig n ifica n t e f fe c t . The patien t  
a lso  had had a r th r it is  of 9 years* duration which had been treated  
with s a l ic y la te s .  On examination a large, firm, nodular go itre  
was presen t. There were no signs of hyper- or hypo-thyroidism. 
T ypical severe rheumatoid a r th r it is  was present in  the hands, f e e t ,  
w r is ts , elbows, knees and ankles. Subcutaneous nodules were 
p resen t. A thyroid biopsy was carried out and the h is to lo g ica l  
fin d in g s were co n sisten t with auto-immune th y ro id itis . Treatment 
w ith thyroxine sodium in  a dose of 0 .2  mgm. d a ily  was followed by 
dim inution in  the s iz e  of the gland.
P a tien t No. 2 . (T hesis No. 31), a woman, aged 61 years, had had a 
go itre  fo r  the past 6 years. During the previous two years she 
had conqplained o f excessive  tired n ess, p a lp ita tion s and preference 
f o r /
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/ f o r  co ld . She a lso  su ffered  from s t i f f n e s s  and p a in fu l sw ellin g  
in  the jo in ts  o f the hands, w r ists  and elbows. On examination 
a sm all, firm , nodular g o itre  was p resen t. The hands were warm 
and moist and showed c la s s ic a l  rheumatoid a r t h r it is .  The r e s t in g  
p u lse  ra te  was 83 beats per minute. In v estig a tio n s  (Table i )  
showed, however, th at the p a tien t was euthyroid (PBI 3»3 (ig. per 
c e n t .,  BMR +9 per c e n t .) .  The p r e c ip it in  and com plem ent-fixation  
t e s t s  confirmed the d iagnosis o f auto-immunising th y r o id it is .  
Thyroxine sodium was prescribed and the g o itre  diminished in  s iz e .  
P a tien t No. 3 . (T hesis No. 32), a woman, aged 65 years, had had 
rheumatoid a r th r it is  fo r  17 years and a g o itre  fo r  3 years. A 
thyroid  neoplasm was suspected and a su b tota l thyroidectomy was 
performed; h is to lo g ic a l  examination showed auto-immune th y r o id it is  
Two years la t e r  the p atien t developed hypothyroidism and on exam- 
:in a tio n  the r ig h t lobe of the thyroid was ju st palpable and 
firm . C h aracteristic  rheumatoid a r th r it ic  deform ities were 
present in  the hands, w r is ts , elbows, shoulders and knees, and 
subcutaneous nodules a t the l e f t  elbow and l e f t  w r ist . Treatment 
w ith thyroxine sodium was follow ed by dim inution of the s iz e  of the  
gland remnant.
P a tien t No. A. (T hesis No. 2*j0) , a woman, aged 32 years, was 
referred  because o f a recent increase in  the s iz e  of a go itre  which 
had been present fo r  37 years. The p a tien t had generalised  
a r th r it is  of 3 years* duration which had been treated  with  
s a lic y la te s  and phenylbutazone. On examination she was euthyroid  
w ith /
/w ith  a la rg e , d if fu se , s o f t  g o itr e . Rheumatoid a r th r it is  of  
moderate se v e r ity  was present in  the hands, w r is ts , elbows, knees 
and an k les. Thyroid b iopsy showed severe and extensive auto­
immune th y r o id it is  in  ad d ition  to  areas o f normal ep ithelium . 
Treatment w ith  thyroxine sodium was follow ed by diminution in  the 
s iz e  o f the remnant.
P atien t No. 5 . (T hesis No. 41 )> a woman, aged 66 years, had had 
rheumatoid a r th r it is  fo r  3 years and a thyroid  sw ellin g  fo r  18 
months. On examination the thyroid gland was moderately enlarged, 
d iffu se  and firm . There were no sign s of hyper- or hypo­
thyroidism . Moderately severe rheumatoid a r th r it is  was present 
a ffe c t in g  mainly the hands, w r is ts , elbows and knees. Treatment 
with thyroxine sodium was follow ed by dim inution in  the s iz e  o f  
the gland.
P a tien t No. 6 . (T hesis No. 4 6 ) ,  a woman o f 37 years complained o f  
discom fort and " tigh tn ess” in  her throat a sso c ia ted  w ith a thyroid  
sw ellin g  o f 2 months* duration. She a lso  gave a h is to ry  of 
p a in fu l hands, w r is ts , elbows, and knees of 2 years* duration. On 
examination the thyroid  was moderately enlarged, d iffu se  and firm . 
There were no sign s o f hyper- or hypo- thyroidism . Moderately 
severe rheumatoid a r th r it is  was present a ffe c t in g  mainly the hands, 
w r ists , elbows, and knees. Treatment with thyroxine sodium was 
follow ed by diminution in  the s iz e  of the gland.
P a tien t No. 7. (T hesis No. 4 ) j a man, aged 62 years, was 
referred  because o f suspected hypothyroidism. He a lso  gave a 
h is to r y /
/h is to r y  of jo in t pains p a r tic u la r ly  in  the hands and w r ists  of 
severa l years* duration. On examination he was obviously hypo­
thyroid , w ith a sm all firm  g o itr e . Typical rheumatoid changes 
were present in  the hands and w r ists  and there was lim ita tio n  o f  
movement and s t i f f n e s s  o f the elbows and shoulders. In ad d ition  
th e p a tien t had small irreg u la r  p u p ils , which, however, reacted  
normally to  l ig h t .  The Wassermann rea ctio n  and treponemal 
im m obilisation t e s t  were both stron g ly  p o s it iv e , but there was no 
other evidence of s y p h il i t ic  d isea se . Following treatment w ith  
thyroxine sodium the g o itre  became im palpable.
Group 2A: Rheumatoid A r th r it is .
Twelve o f 46  p a tien ts  w ith rheumatoid a r th r it is  had p o s it iv e  
CF t e s t s .  This incidence i s  much higher (P < 0 .0 1 ) than in  female 
contro l cases (27  o f 243) • Two o f  the cases w ith  rheumatoid 
a r t h r it is  and p o s it iv e  CF t e s t s  a lso  had p o s it iv e  p r e c ip it in  t e s t s .  
Both were hypothyroid without a g o itr e . None o f the remaining 10 
cases w ith  p o s it iv e  CF t e s t s  had c l in ic a l  evidence o f thyroid  
d ise a se , although one had a high normal 48 -hour P B I ^  (0 .3 3  per  
cent d o s e / l i t r e ) .  No co rre la tio n  was found between the CF t e s t  
r e s u lt s  and th e  duration o f the a r t h r it is ,  or the r e s u lt s  of the  
Rose-Waaler and L E c e l l  t e s t s .  None o f the 24  male cases w ith  
rheumatoid a r t h r it is  had c l in ic a l  evidence of thyroid  d isease  and 
a l l  had negative thyroid  auto-antibody t e s t s .  S ix  out o f 292 male 
con tro ls  had p o s it iv e  CF t e s t s .
Group 3; Connective T issue D isea ses, and Sjftgren*s d isease .
Four/  ^ ^
Table II.
Thyroid A uto-antibodies in  Connective
«
T issue D isea ses, and S .iogre^ s D isease .
Table II.
Thyroid Auto-antibodies in Connective Tissue Diseases, and Sjogren's Disease.
Thyroid Auto-antibody Tests
No. of Preo. Complement-fixation
Clinical Condition Sex (+ and ++) Anti-
Cases.
(+) Specific Non-specific Complementary
Systemic lupus F 9 1 4 1
Erythematosus. M
Scleroderma.
P
M
4
2
1 1
Derma tODQrositis.
P
11
2 1
Periarteritis P 1
Nodosa. U 1
Sjogren* s F 2 1 1
Disease. U
Totals . 21 1 4 5 1
/Four cif the 21 p a t ien ts  in  t h is  group bad p o s it iv e  th yroid -  
s p e c if ic  CF t e s t s  (Table H ) . This incidence i s  h igher then in  
th e con tro l cases (Croup 2h ), but the sm all numbers do not permit 
s t a t i s t i c a l  conclusions to  be drawn. The fin d in g s  in  th ese  4 
p a t ie n ts  are o f in t e r e s t .  One, a woman of 60 years with Sjbgren's 
d isea se  and rheumatoid a r t h r it is ,  had a large firm g o itre  and a 
p o s it iv e  p r e c ip it in  t e s t ;  thyroid biopsy revealed  extensive  
Asksnazy—c e l l  change but no chronic th y r o id it is .  Another, a woman 
xaf 6 4  years w ith derm atom yositis, developed hypothyroidism without 
a  g o itr e  one year a f t e r  the onset o f  her i l ln e s s .  The th ird , a 
woman of 49  years developed primary hypothyroidism 19  years after 
th e  onset o f  Eaynaud’ s phenomenon and scleroderma. The fourth  
p a t ie n t , a  woman o f 60  years, with system ic lupus erythematosus, 
had no c l in ic a l  or laboratory evidence o f thyroid d isea se .
D iscu ssion .
The present study provides s t a t i s t i c a l  evidence o f an 
a s so c ia t io n  between auto-immune th y r o id it is  and rheumatoid 
a r t h r i t i s .  The p a tien ts  with auto-immune th y r o id it is  (Group 1A) 
had a l l  been referred  because of thyroid d isease  being suspected, 
an  unexpectedly high, proportion had evidence of rheumatoid 
a r t h r i t i s .  This prevalence i s  very much higher (P < 0.901) than 
that of rheumatoid a r th r it is  reported by Ivliall e t  a l .  ( 81) i n  
fem ales in  an urban and rural population in  South '//ales. in the 
group of p a tien ts  studied by M iall e t a l .  the c r ite r ia  for  
d ia g n o sis /
Table III.
Survey E stim ates o f the Prevalence o f Rheumatoid A r th r it is .
Table I I I
S u r v e y  K e t i m a t e s  o f  t h e  P r e v a l e n c e  o f  R h e u m a to id  A r t h r i t i s .
Authors and Bef. No. Year Country
Prevale
Males
nce/1 0 0. 
Femalee
Age Group 
(years)
Diagnostic Criteria
Holsti and liantasalo (82) 1936 Finland 0.3 0.9 All
"Chronic arthritid' known to Public 
Health Nurses in their districts.
Edstrdm (8 3) 1944 Sweden 1.3 2.7 All
"Chronic arthritis" recognised by 
specially trained medical Btudents 
in the home.
Kellgren et al. (8 4 ) 1953 England 1.4 3.3
over
15
Clinical - based on brief 
examination in the home.
Kellgren and Lawrence (75) 1956 England 2-5 1 1 .0
55 to
64
Clinical, confirmed by positive 
X-ray and/or Bose-Vi'aaler test.
Cobh et al. (8 5 ) 1957 U.S.A. 0.6 4-7
O 
-*■ 
<
ui
 
a A.H .A . definitions, probable and definite by clinical and X-ray 
findings.
liiall et al. (81) 1958 Wales 1.3 0.7
between 
15 and 35
Clinical, confirmed by X-ray and/ 
or Sose-Waaler test.
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/ d iagnos i s  ana th e age d is tr ib u tio n  were the same a s  in  Group 1A. 
The prevalence o f  rheumatoid a r th r it is  in  Group 1A i s  a lso  higher  
than th a t reported by workers in  other cou n tries using various 
c r it e r ia  (75 ,81-85) -  Table I I I .
Conclusions derived from h o sp ita l populations, however, o ften  
give a b iased  p ictu re of the a sso c ia tio n  between d isea ses  (8 6 ), 
because th e occurrence of 2 d iseases in  the same person g ives an 
in creased  p ro b a b ility  of being referred  to h o sp ita l (Berkson*s 
f a l l a c y ) . For th is  reason i t  was thought d esirab le  to  compare 
th e  incidence o f rheumatoid a r th r it is  in  Group 1A with that o f  a 
group of p a tien ts  (Group 1B) from the same area referred  to  the  
same h o sp ita l w ith  d isea ses  in  which e ith e r  a p o s it iv e  or negative  
co rre la tio n  w ith rheumatoid a r th r it is  seemed h igh ly  improbable.
The incidence o f rheumatoid a r th r it is  was much higher in  the 
group o f  p a t ien ts  w ith auto-immune th y r o id it is  than in  the contro l 
group (P < 0 .0 1 ) .  I t  i s  therefore u n lik e ly  th at the high incidence  
o f rheumatoid a r t h r it is  in  Group 1A has a r isen  from errors due to  
b iased  sampling.
An a sso c ia tio n  between auto-immune th y r o id it is  and rheumatoid 
a r t h r i t i s  i s  a lso  stron gly  supported by the fin d in g  in  Group 2A.
The incidence of p o s it iv e  th y ro id -sp ec if ic  CF t e s t s  in  female 
p a tien ts  with rheumatoid disease (Group 2A) was much higher 
(P< 0*01) than that found in  a hospital control population 
(Group 2B). Twelve patients In Group 2A had a positive CF test; 
Goudie et a l .  (78) have shown that histological examination o f  
thyroid/
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/th y ro id  gland in  such cases w i l l  revea l fo c a l le s io n s  o f auto­
immune th y r o id it is .  Two of th ese p a tien ts  had, in  ad d ition , 
p o s it iv e  p r e c ip it in  t e s t s  and were hypothyroid. There i s  thus 
good evidence th at they had d iffu se  auto—immune th y r o id it is  since
i t  has been shown that c la s s ic a l  auto-immune th y r o id it is  and 
"primary*1 hypothyroidism are c l in ic a l  varian ts o f the same 
p ath o log ica l process. (See Chapter I I I ,  S ection  1 ) .
The high prevalence o f rheumatoid a r th r it is  in  the p a tien ts  
w ith auto-immune th y r o id it is  and the high prevalence o f both 
p o s it iv e  p r e c ip it in  and CF t e s t s  in  the p a tien ts  w ith rheumatoid 
a r th r it is  are h igh ly  suggestive evidence in  favour of a true 
a sso c ia tio n  between these d ise a se s . The study included only 20 
men w ith rheumatoid a r th r it is ,  and th is  number i s  too small
to  draw conclusions regarding the a sso c ia tio n  of auto-immune 
th y r o id it is  and rheumatoid a r th r it is  in  th is  sex . The fin d in gs  
in  Croup 3 a lso  suggest that an a sso c ia tio n  might e x is t  between 
auto-immune th y r o id it is  and the connective t is s u e  d isea ses , 
inclu d ing  Sjftgren* s d isease; but the high incidence of non­
s p e c if ic  CF t e s t s  in  p a tien ts  w ith system ic lupus erythematosus and 
the sm all number o f p a tien ts  studied precludes s t a t i s t i c a l  
eva lu a tion . Since the completion o f th is  work Holborow (37) 
and others (71 ,88) have demonstrated serum an ti-n u clear  fa c to r  in  
p a tien ts  with auto-immune th y r o id it is , thus suggesting an 
a sso c ia tio n  with systemic lupus erythematosus, and Anderson e t a l .  
( 89) using th e TRC method have demonstrated a s ig n if ic a n t increase  
i n /
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/ i n  thyroglobulin  au to-an tib od ies in  p a tien ts  w ith a l l  forms of 
connective t is s u e  d isea se , inclu d ing rheumatoid a r th r it is .  On 
the other hand, Hijmans e t  a l .  (90) have been unable to demonstrate 
an increased  prevalence o f thyroid CP t e s t s  in  p a tien ts  with
rheumatoid a r t h r it is ,  although demonstrating a c l in ic a l  and 
ser o lo g ic a l overlap between auto-immune thyroid d isease and 
system ic lupus erythematosus. The discrepancy between my own 
fin d in g s in  rheumatoid a r th r it is  and those o f Hijmans e t a l .  (90) 
may p a rtly  be explained on the greater s e n s i t iv i t y  of the CP t e s t  
used in  the present study in  resp ect to  serum concentration and 
to  the amounts o f complement used.
In an extensive review o f rheumatoid a r th r it is  in  r e la t io n  to  
other d isea ses  Short e t  a l .  (59) have reported th at the only associated 
condition  which they could f in d  was with thyroid d isea se . Some
o f th e ir  cases o f simple g o itre  may w ell have been examples of
auto-immune th y r o id it is  since a t that time immunological t e s t s  were 
not a v a ila b le  in  th is  f i e ld .  Both auto-immune th y r o id it is  and 
rheumatoid a r th r it is  have cer ta in  s im ila r it ie s .  For example, 
both are d isea ses  o f fem ales of the same age (9 1 ,9 2 ) . In both
d isea ses  hypergammaglobulinaemia (93,94) i s  a sso c ia ted  with
lymphocyte and plasma c e l l  in f i l t r a t io n  -  in  the thyroid in  auto­
immune th y r o id it is  (95) and in  the synovial membrane o f the jo in ts  
in  rheumatoid a r th r it is  ( 96);  and both conditions may improve 
w ith s tero id  therapy (97,93)* The fin d in g  of a c l in ic a l  assoc­
i a t i o n  between these d isea ses  provides some support fo r  the view that 
a u to - /
L
/ auto-immunisation may p lay  a part in  the pathogenesis o f 
rheumatoid a r t h r i t i s .  Further study o f p a tien ts  w ith both  
d isea ses  may help  to  e lu c id a te  th e ir  in ter -r e la tio n sh ip  and so 
throw l ig h t  on the fundamental nature of the auto-immune process.
SUMMARY
The Incidence of rheumatoid a r th r it is  in  $0 unselected  
p a tien ts  w ith  auto-immune th y r o id it is  was s ig n if ic a n t ly  higher than 
th a t  in  a con tro l s e r ie s  o f h o sp ita l p a tien ts  w ith d isea ses  with  
no hnown a sso c ia tio n  w ith rheumatoid a r th r it is .  Thyroid auto­
an tib od ies were a lso  demonstrated in  a s ig n if ic a n t ly  higher number 
o f u n selected  p a tien ts  w ith  rheumatoid a r th r it is  than in  a control 
s e r ie s .  d e t a i l s  are given o f 7 p a tien ts  in  whom the a sso c ia tio n  
was p resen t. A high incidence o f thyroid auto-antibodies was 
a lso  demonstrated in  p a tien ts  su ffer in g  from m iscellaneous 
connective t is s u e  d isea se s , including Sjbgren's d isea se . The 
a sso c ia tio n  between these d isea ses  may be explained on the b a s is  
th at auto-immune mechanisms p lay  some part in  th e ir  pathogenesis.
Section 2.
The A ssoc ia tion  o f  Auto-immune T h yroid itis  
and Acquired Auto-immune Haemolytic Anaemia.
The f i r s t  reco g n itio n  o f auto-immunity in  haem olytic anaemia 
was in  1904 by Donath and Landsteiner ( 1) who demonstrated a 
haemolysin rea ctin g  w ith the p a tien t*s red blood c e l l s  in  paroxysmal 
haemo gLobinuria. A uto-agglutination  was a lso  described independent­
l y  by Widal e t  a l .  (2) and Chauffard and T ro isier  (3) in  1908, but 
th ese  observations appear la r g e ly  to have been overlooked. In 1936, 
however, Dameshek and Schwartz (4 ) drew a tten tio n  to  the presence 
o f haemolysins in  p a tien ts  su ffer in g  from haemo ly t i c  anaemia and in  
1946 Boorman e t  a l .  ( 5 ) reported a d irect a n ti-g lo b u lin  reaction  or 
Coomb's t e s t  (6) in  a proportion o f ca ses . Following these la t t e r  
observations a considerable amount o f work has been carried  out on 
the auto-imraune asp ects  of the haem olytic anaemias and th is  has been 
admirably reviewed by Dacie (7) • For the present purpose only  
cond ition s giv in g r is e  to a p o s it iv e  Coomb's t e s t  w i l l  be 
considered as f a l l in g  in to  the 11 auto-immune” group.
I t  appears th at auto-imraune haemolytic anaemia comprises a 
number o f d isorders of varying a e tio lo g y  and pathogenesis, involving  
warm and cold  antibody typ es, each with id iop ath ic  and secondary 
v a r ie t ie s  (8 ) .  The serum in  these anaemias contains auto-antibodies  
in  the sense th at they react with the p a t ie n t's  own red blood c e l l s .  
The antibody i s  an incomplete one which can be demonstrated by the 
d ir e c t or in d irec t Coomb's t e s t  or by various m odifications such 
as the use o f try p sin -trea ted  c e l l s  ( 9 )• There i s  evidence that 
the warm and cold antibod ies are p h y sica lly  d iffe re n t (1 0 ). There 
a lso  appears to  be a f a ir ly  c lo se  co rre la tio n  between the t i t r e  o f  
antibody/
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/an tib od y  and. the c l in ic a l  sev e r ity  o f the haemolytic process (7 ) .
The p rec ise  r o le  the auto-antibod ies p lay in  the pathogenesis
of the haem olysis i s  not c lea r . Dacie (7) has suggested that the
an tib od ies may r e su lt  from m odification  o f the a n t ig e n ic ity  o f the
erythrocytes by e ith e r  v iru s, tox in  or drug; or, a lte r n a tiv e ly ,
th a t they are the consequence o f mutation with formation of abnormal
gamma-globulins. Evidence in  favour o f the ro le  of auto-immunisation
in  the pathogenesis of the d isease includes the fin d in g  of hyper-
gammaglobulinaemia (1 1 ) , low serum complement le v e ls  (1 2 ) , and
a sso c ia ted  leucopenia (7)> and thrombocytopenia (13)*
The A ssoc ia tion  of Auto-immune T h yro id itis  and Acquired Auto-immune 
Haemolytic Anaemia.
H isto r ica l Aspects 
A ca refu l review of the lite r a tu r e  has revealed only 2 reports  
of the co -ex isten ce  o f auto-immune th y r o id it is  and acquired auto­
immune haemolytic anaemia. In the f i r s t  Wasastjerna (14) 
described a 47-year old woman who suffered  sim ultaneously from a 
severe haem olytic anaemia and had a g o itre  which was proved 
h is to lo g ic a l ly  to  be due to  auto-immune th y r o id it is . Both the  
Coomb's t e s t  and p r e c ip it in  t e s t  were p o s it iv e ;  with more d e ta iled  
stu d ies  Wasast jerna was able to  demonstrate that the 2 types of 
antibody were d is t in c t .  In the second report by White e t  a l .  (15) 
the p a tien t concerned was a woman of 48 years who had a Coombs 
p o s it iv e  haem olytic anaemia and a g o itr e . The p r e c ip it in  t e s t  was, 
however, negative and no thyroid biopsy was performed and the 
d iagn osis o f auto-immune th y r o id it is  was based on the c l in ic a l  
fin d in g s .
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Personal Observations 
In  the present in v e s t ig a tio n  I  have studied the p o ss ib le  
a sso c ia tio n  between auto-immune th y r o id it is  and acquired auto-immune 
haem olytic anaemia. As in  the previous sec tio n  I  have approached 
the problem by f i r s t  examining a group of p a tien ts  with auto-immune 
th y r o id it is  fo r  evidence o f acquired auto-immune haemolytic anaemia, 
and secondly by studying the prevalence o f thyroid auto-antibodies  
in  p a tien ts  with acquired auto-immune haemolytic anaemia.
M aterials and Methods 
Two groups o f p a tien ts  were studied; Group 1 with auto-immune 
th y r o id it is ,  and Group 2 with acquired auto-immune haem olytic anaemia. 
Group 1 con sisted  o f 50 p a tien ts  (if6 fem ales, 4  males) w ith auto­
immune th y r o id it is .  Their ages ranged from 28 to 70 years, w ith a 
mean age o f  52*5 years. The d iagnosis of auto-immune th y r o id it is  
was based on the c r it e r ia  described in  Chapter I I  o f the th e s is .
F u ll blood examination, including r e ticu lo cy te  counts and Coomb*s 
t e s t s ,  were carried  out in  a l l  p a tien ts  o f th is  group and in  
ad d ition  radiochromium (C r^ ) stu d ies were performed in  5 p a tien ts , 
by the method described by M ollison and V eall ( 16) .
Group 2 comprised 22 p a tien ts  ( l 8fem ales, 4  males) with acquired 
auto-immune haem olytic anaemia. The age range in  th is  group was 
18 to  70 years with a mean age o f 52*5 fo r  women and 54*0 fo r  men.
Each p a tien t was examined c l in ic a l ly  fo r  evidence o f thyroid d isease  
and the prevalence of thyroid auto—antibod ies was studied using  
the p r e c i p i t a t i o n  and com plem ent-fixation methods described in  
Chapter H /
/jChsap&erzII -of the t h e s i s .
-The c l in ic a l  d e ta ils  in  th is  ^group are summarised in  the 
-Appendices; a l l  the p a t ie n ts  had a p o s it iv e  Coombs t e s t .  Three 
qpaiients -with j&cmplement&ry-CF rea ctio n s and two w ith  n o n -sp ec ific  
CF t e s t s  have been excluded from the s t a t i s t i c a l  a n a ly s is ,
-reducing the number a va ilab le  to 17*
R esults
Group 1 : Auto-immune th y r o id it is
The r e s u lt s  of the haem atological in v estig a tio n s  in  th is  
group are given in  d e ta il  in  the Appendices. Only one p a tien t  
in  th is  group was found to have a haemolytic anaemia, and the case-  
report o f th is  p a tien t i s  described below:
T hesis Mo. 42- A woman of 57 years had had a go itre  for  2 years. 
On examination, the thyroid was moderately enlarged, d iffu se  and 
firm , and there were no signs of hyper- or hypo- thyroidism . 
In v estig a tio n s  confirmed the diagnosis of auto-immune th y r o id it is ;  
p r e c ip it in  and CF t e s t s  p o s it iv e , thymol tu rb id ity  5 u n its , thymol 
f lo c c u la tio n  3 u n its , gamma-globulin 1 .09  g. per 100 m l., 4  hour 
gland uptake 60 .3  per cent /  dose, 48  hour P B I ^  0 .24  per 
cent d o s e / l i t r e ,  potassium perchlorate discharge t e s t  p o s it iv e ,  
and serum PBI 3 .0  pg. per 100 ml. Blood examination was normal:
Hb 84 per cent., PCV 40 per cent., IvICH C, 31.5 per cent,., and 
white blood count 5j100 cells per cu. mm. The OSR was 15 mm. in 
the first hour and the serum bilirubin 1 .4 mg. per 100 ml.
Treatment with thyroxine sodium in  a dose o f 0*2 mg. d a ily  was
Table I .
R esu lts of P r e c ip it in  and Complement- 
F ixation  Test in  Acquired 
Haemolytic Anaemia.
Table I .
Results of Precipitin and Complement-Pixation test
in Acquired Haemolytic Anaemia.
Clinical Croup Total ho.
Thyroid Auto-antibody Tests
of ..acts.
Precipitin (+) Compleraent-Pixation (+) ; no (++)
Acquired Haemolytic F 13 1 5
Anaemia
H 4
P 243 27
Hospital Controls
M 240 6
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/fo llo w ed  by dim inution in  the s iz e  o f the gland.
S ix  months a f te r  her f i r s t  attendance the p a tien t complained
o f  la ss itu d e  and dyspnoea on exertion , and on examination she
looked pale and s l ig h t ly  io t e r ic .  The t ip  of the spleen was ju st
p alp ab le. In v estig a tio n s confirmed the d iagnosis o f haemolytic
anaemia: Hb 68 per c e n t .,  PCV 31*5 per c e n t ., MCHC 32 per c e n t .,
white blood count 4*000 c e l l s  per cu. mm., d if fe r e n t ia l white blood
count normal, p la t e le t  count 155*000 c e l l s  per cu. mm.,
r e t ic u lo c y te  count 5 per c e n t .,  Coombs te s t  n egative, n on -sp ec ific
co ld  a g g lu tin in s  present to  t i t r e  o f 1 in  4  with normal group 0
c e l l s ,  r e d -c e ll  f r a g i l i t y  normal, no abnormal haemoglobins were 
51d etected . The Cr h a l f - l i f e  was 12 days, and seq uestration  o f  
red blood c e l l s  was demonstrated in  the sp leen . The serum 
b ilir u b in  was 2 .6  per cen t. Liver biopsy was normal.
The p a tien t declined  to have splenectomy and has been 
observed fo r  a period o f 2 years without s ig n if ic a n t a lte r a tio n  in  
the le v e l  o f haemoglobin or r e t icu lo cy te  count.
Group 2 : Auto-immune Haemolytic Anaemia
The r e s u lt s  o f the p r e c ip itin  and CF t e s t s  in  th is  group are 
summarised in  Table 1 and f u l l  d e ta ils  o f in v estig a tio n s  are given  
in  the Appendices. From Table 1 i t  can be seen that 5 o f 13 
fem ales with auto-immune haemolytic anaemia had p o s it iv e  CF t e s t s ,  
inclu d ing  one w ith a p o s it iv e  p r e c ip it in  t e s t .  This incidence i s  
higher (P <  0 .02) than in  women contro ls (27 o f 243) studied in  
the same laboratory by the same methods (17)* None o f the 4  
w ith auto—immune haemolytic anaemia had p o s it iv e  thyroid auto- 
antibody t e s t s .
D iscu ssion
The in te r e s t in g  fin d in g  in  the present in v e s tig a tio n  i s  th e  
high prevalence of thyroid au to-antibod ies in  female p a tien ts  w ith  
acquired auto-immune haem olytic anaemia (Group i ) .  Five o f the 
13 fem ale p a tien ts  in  th is  group had p o s it iv e  th y ro id -sp e c if ic  CF 
t e s t s ;  an incidence which i s  much higher (P < 0 .0 2 ) than th at in  
27 of 243 female h o sp ita l controls reported by Goudie e t a l .  (1 7 ), 
from the same laboratory. However, in  contrast to  the high  
prevalence o f thyroid auto-antibodies in  th is  group none of the 
p a tien ts  w ith auto-immune th y r o id it is  comprising Group 1 had auto­
immune haemolytic anaemia, although one p atien t developed an 
acquired id io p a th ic  Coombs negative haemolytic anaemia s ix  months 
a fte r  her f i r s t  attendance a t the c l in ic .
The high prevalence o f thyroid auto-antibodies in  p a tien ts  
su ffer in g  from auto-immune haemolytic anaemia lends support to  the  
view th at auto-immunisation may be of importance in  the pathogenesis 
of th is  d isea se . The p red isp osition  to develop thyroid auto­
immunity in  p a tien ts  w ith auto-immune haemolytic anaemia may be 
due to an enhanced antibody forming p o ten tia l, since p a tien ts  with 
t h is  d isease rea d ily  produce antibodies to blood group substances 
( 7 ) .  On the other hand the development of thyroid auto- 
immunisation may be due to a disturbance of the mechanism of 
immunological to lerance operating in  normal health , in  which case 
the present fin d in gs would support the view beld  by Dacie (7) that 
the pathogenesis of auto-immune haemolytic anaemia i s  prim arily  
re la ted  to a disturbance in  the immunological c e l l s  o f the r e t ic u lo ­
e n d o th e lia l/
/ -e n d o th e lia l  system.
The present in v e s tig a tio n  does not exp la in  the nature qf  the 
a sso c ia tio n  between auto-immune th y r o id it is  and auto-immune 
haem olytic anaemia, but i t  serves as a u se fu l poin ter to  the 
problem, which fu rth er  study may help to e lu o id a te .
SUMMARY
Thyroid au to-an tib od ies were found in  a much higher  
proportion o f fem ales w ith auto-immune haemolytic anaemia than 
in  a con tro l s e r ie s  o f female h o sp ita l p a tien ts . The ca se -h isto ry  
o f one p a tien t w ith auto-immune th y r o id it is  who developed an 
acquired id iop ath ic  Coombs negative haemolytic anaemia i s  described. 
The fin d in gs lend support to the view that auto-immunity plays a 
r o le  in  the pathogenesis of auto-immune haemolytic anaemia.
Section 3.
The A ssocia tion  o f Auto-immune 
T h y ro id itis  and C irrhosis o f the L iver.
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Introduction
C irrhosis (Greek kirrhos = yellow ) of the l iv e r  i s  a d isease  
o f world-wide d is tr ib u tio n . I t  i s  due to  a v a r ie ty  o f causes, 
inclu d ing  chronic alcoholism , v ir a l  h e p a t it is ,  m alnutrition, 
m etabolic d ise a se s , p a r a s it ic  and sp iroch aetal in fe c t io n , poisons  
and p assive  venous congestion; but the f in a l  end p ictu re i s  the 
same ( 1 ) .  H is to lo g ic a lly  the d isease i s  characterised by a 
d is to r te d  reconstruction  of the normal arch itecture brought about by 
l i v e r - c e l l  n e cro s is , connective t is su e  p ro lifer a tio n , and parenchymal 
regeneration .
P orta l c irr h o s is  i s  the commonest type of chronic l iv e r  d isease  
in  t h is  country, but i s  r e la t iv e ly  rare and accounts fo r  approximate- 
: ly  0*3 per cen t, of a l l  deaths in  Scotland (2 ) .  Studies o f the 
a e t io lo g ic a l  fa c to rs  involved in  Great B rita in  (1 , 3) have shown 
th a t chronic alcoholism  and v ir a l h e p a t it is  together account fo r  
approxim ately h a lf  the cases, whereas in  the remainder the a e tio lo g y  
i s  com pletely obscure. A lcoholic  c irr h o s is  occurs predominantly in  
m ales, but other forms o f the d isease occur more commonly in  fem ales 
(1 , 3 ) .
The Role of Auto-immunity in  the pathogenesis of 
C irrhosis o f the Liver.
Although many in stan ces of hepatic c irrh o sis  can be d ir e c t ly  
r e la ted  to e ith e r  a preceding v ir a l h e p a t it is  or excessive  a lco h o lic  
in tak e , i t  s t i l l  remains uncertain what fa c to r s , i f  any, determine 
the onset o f progressive l iv e r  damage in  ind iv idual ca ses . In  
1944/
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/ l% 4 , Eaton e t  a l .  (4 ) f i r s t  in i t ia t e d  specu lation  regarding the 
p o ss ib le  ro le  o f immunological processes in  the progression o f  
acute v ir a l h e p a t it is  to  c irr h o s is  o f  the l iv e r ,  when they described  
complement-fixing l iv e r  an tibod ies in  the blood-serum o f p a tien ts  
w ith acute h e p a t it is .  Seven years la te r  Zimraermann e t a l .  (5) 
suggested th at "hypergammaglobulinaemia in  acute h e p a t it is  might 
in d ica te  the production o f a n t i l iv e r  protein  that continues to  
cause n ecrosis  o f the l i v e r .” In 1956 Mackay e t  a l .  (6) suggested  
th at l iv e r  c e l l s  damaged by e ith e r  a v irus or to x ic  agent might be 
rendered a n tigen ic  and so in i t ia t e  an auto-imraune reaction  which 
becoming self-p erp etu a tin g  would f in a l ly  lead to chronic l iv e r  
damage. Later Mackay e t  a l .  (7) brought together evidence in  
support of an auto-immune b a sis  for  c irrh o s is  of the liv e r :  marrow
plasm ocytosis, hypergammaglobulinaemia associa ted  with plasma and 
lymphocytic in f i l t r a t io n  in  the l iv e r ,  the occasional occurrence o f  
p o s it iv e  LE c e l l  t e s t s  with m anifestations of system ic lupus 
erythematosus ("lupoid” h e p a tit is )  (6 -1 2 ), the presence o f "auto­
immune” complement-fixing antibod ies o f the type described by 
Gadjusek (13)> and. the occasional response of the l iv e r  
n ecro tisin g -p rocess to  s tero id  therapy (14)»
Most attem pts to demonstrate l iv e r  auto-antibodies have so fa r  
proved unsu ccessfu l, although Dausset and Marchal ( 15) described a 
"heat la b i le  substance behaving as an auto-antibody" in  a c irrh o tic  
p a tie n t . Hunter e t  a l .  ( 16) have a lso  recen tly  claimed to have 
demonstrated au to -agg lu tin in s to l iv e r  in  p a tien ts  with chronic 
l iv e r  d isea se .
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The In terre la tio n sh ip s  between the Thyroid and Liver
The l iv e r  p lays an important ro le  in  the catabolism  o f the  
thyroid  hormones. Not only i s  thyroxine s e le c t iv e ly  taken up by 
the l iv e r  (1 7 ) , but i t  a lso  penetrates the l iv e r  c e l l s  ( 18) ,  and 
i s  then secreted  in to  the b i le  p artly  conjugated as glucuronides 
(19) and p a r tly  in  the form of o( -keto d er iv a tiv es  (2 0 ) . Some 
thyroxine reappears in  the s to o ls  but i s  reabsorbed in  the in te s t in e  
thus e sta b lish in g  an entero-hepatic c ircu la tio n  ( 21) .  Thyroxine 
i s  a lso  deiodinated by the l iv e r  (2 2 ). Experimental obstructive  
jaundice in  r a ts , produced by lig a tu re  o f the b i le  duct, has been 
shown to r e su lt  in  suppression o f thyroid a c t iv ity  ( 23 ) ,  but in  
acute h e p a t it is  in  man high le v e ls  of serum protein-bound iodine  
have been reported ( 24 , 25) which has been interpreted  as being due 
to  an increased thyroxine-binding of the serum proteins ( 25 ) 
s im ilar  to  that in  pregnancy (26) and during treatment with  
oestrogens ( 27) • On the other hand the le v e ls  o f serum protein  
bound iodine in  c irr h o s is  have been reported as low ( 24) ,  normal 
(28 ,29) or s l ig h t ly  e levated  (2 5 ) . Radioiodine stu d ies o f thyroid  
fu n ction  in  p a tien ts  with c irrh o sis  have shown variable r e su lts ;  
the thyroid gland uptake o f radioiod ine has been reported a 3 e ith er  
normal (25) or increased (2 8 ,2 9 ) . With few exceptions (3 0 ), the 
plasma protein—bound r a d io a c tiv ity  has been found normal in
c irr h o s is  ( 25) .
Conversely the thyroid hormones are known to acce lera te  the 
rate  of both chemical and enzymatic reaction s in  the l iv e r .  In 
th y r o to x ic o s is /
/th y r o to x ic o s is  a mild disturbance o f  hepatic  fu nction  i s  not 
uncommon (3 1 ) , and minor h is to lo g ic a l  changes in  the l iv e r  are 
frequ en tly  found (3 2 ) . An increased incidence of hepatic c ir r h o s is  
in  th yrotoxic p a tien ts  has n o t, however, been confirmed by recen t 
stu d ies  ( 33) although the prognosis in  acute v ir a l h e p a t it is  i s  
poorer when th y ro to x ico s is  c o -e x is ts  ( 1 ) .  Thyroidectomy and hypo- 
sphysectomy have been found to r e su lt  in  c irr h o s is  of the l iv e r  in  
dogs ( 34) ,  but c ir r h o s is  of the l iv e r  has only occa sio n a lly  been
reported in  spontaneous hypothyroidism in  man ( 35- 39)•
The A ssoc ia tion  of Auto-immune T h yro id itis  and C irrhosis o f the L iver
H isto r ica l Aspects
Farrant (40 ) appears to have been the f i r s t  to  have described  
h is to lo g ic a l  changes in  the thyroid gland in  p a tien ts  with c irr h o s is  
o f the l iv e r .  In 1914 th is  author found that "the thyroid taken 
from 6 cases of c irr h o s is  o f the l iv e r  a l l  showed considerable 
f ib r o s is" . In a study o f the h is to lo g ic a l changes in  the endocrine 
glands in  c irrh o s is  in  1932 B arrelet (41 ) confirmed Farrant's 
observations, and could fin d  no corre la tion  between the degree of 
f ib r o s is  present in  the thyroid and "either the age, or the form of 
the c irrhosis"  (tra n sla ted  from the French). In 1957 Barr and 
Sommers (4 2 ) reported an exten sive c lin ico -p a th o lo g ica l study o f the 
endocrine changes in  100 p a tien ts  dying w ith hepatic c irrh o s is  and 
found what they described as "fibrous atrophy" of the thyroid  in  31 
per c e n t .o f  the p a tien ts  (29 of 94) as compared with 18 per cent.
(15 o f 108) in  a control s e r ie s . On the other hand the presence 
of su b -c lin ic a l auto-immune th y r o id it is  appears to have been 
m entioned/
/m entioned by only a few workers (4 3 ,4 4 ) , although Bastenie (45 ) 
drew a tten tio n  to  the increased  frequency o f th is  le s io n  in  1937.
The co -ex isten ce  of auto-immune th y r o id it is  and c irr h o s is  o f  
the l iv e r  was f i r s t  described in  1956 by Luxton and Cooke (46 ) .
These authors described 2 p a tien ts  with both d iseases in  a s e r ie s  
o f 24 p a tien ts  with the former condition , and a lso  noted abnormal 
bromsulphthalein (BSP) t e s t s  in  a further 5* Later Luxton (47) 
in  drawing a tten tio n  to the remarkable h is to lo g ic a l resemblances 
between the 2 cond itions suggested that c irrh o s is  o f the l iv e r  
might be termed "Hashimotosis o f the l iv e r ” . These s im ila r it ie s  
had p rev iou sly  been noted by Shaw and Smith (48 ) in  1925; in  
describ ing the h is to lo g ic a l appearances of auto-immune th y r o id it is  
these authors observed that "the change, i . e .  hyperplasia i s  sim ilar  
to  the compensatory regeneration which takes place in  c irr h o s is  o f  
the liv e r " . Continental workers (49) had a lso  previously  described  
auto-immune th y r o id it is  as "cirrhose de la  thyrolde".
In a study of 106 p a tien ts  with auto-immune th y r o id it is  in  
1958 R o itt and Doniach (50) mentioned 4  p a tien ts  who had un sp ecified  
forms o f l iv e r  d isease; in  one of th ese , however, l iv e r  b iopsy  
showed "periportal lymphoid in f i l t r a t io n  and f ib r o s is" . In the  
fo llow in g  year Doniach e t  a l .  (38) described the c l in ic a l  d e ta ils  of  
3 p a tien ts  w ith c irrh o s is  of the l iv e r  and auto-immune th y r o id it is ;
2 of th ese p a tien ts  had a go itre  and were subsequently shown by 
biopsy to  have auto—immune th y r o id it is  and the th ird  had primary 
hypothyroidism. The c l in ic a l  and laboratory d e ta ils  in  these  
p a t ie n ts /
Table I .
C lin ic a l A ssocia tion  of Auto-immune 
T h yro id itis  and C irrhosis of the 
L iver reported in  the L iteratu re.
Table I .
Clinical Association of Auto-immune Thyroditis and 
Cirrhosis of the Liver reported in the Literature.
Authors and Year Ref. No. Age Sex Clinical Details and Laboratory Findings
Doniach et al/l959> 37 69 M Sadden onset of painful hard goitre, followed 15 days 
later by fever and jaundice. Precipitin test positive} 
thyroid histology confirmed auto-immune thyroditis. 
Liver biopsy "suggestive of recent hepatitis with 
progression to Cirrhosis". LE cells not looked for.
55 F History of jaundice at 8 years of age and of "puberty" 
goitre of 5 years duration. At age of 51 years 
developed a goitre. Precipitin test positive; thyroid 
histology consistent with auto-imraune thyroditis#
At age of 53 years became janndiced; liver-biopsy 
consistent with cirrhosis.
Limbosch (1959) 51 50 F Hypothyroid with snail firm goitre. Precipitin test 
positive; Thyroid biopsy; Auto-imraune thyroditis 
with severe fibrosis. Liver palpable and biopsy 
revealed "fine fibrosis with a little lymphocytic 
infiltration*(translated).
LlcConakey and 
Callaghan (i960) 52 57 F Goitre at age of 51 years, which was confirmed 
histologically to be auto-imraune thyroditis. Jaundice 
at age of 54 years; liver biopsy consistent with 
cirrhosis. Preoipitin test positive.
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/p a t ie n ts  with auto-immune th y r o id it is  and c ir r h o s is  o f th e  l iv e r  
are summarised in  Table 1, together with p a tien ts  w ith both 
cond ition s described by Limbosch (50) and McConakey and Callaghan (52) 
From t h is  ta b le  i t  can be seen that the p a tien ts  are middle-aged and 
th at only one i s  a male. The a e tio lo g y  of the c irr h o s is  in  th is  
male p a tien t i s  probably v ir a l h e p a t it is , but the a e tio lo g y  i s  
obscure in  the female p a tien ts . The onset o f the go itre  appeared 
to  precede the l iv e r  d isease  in  a l l  the p a tien ts , with the exception  
o f the one reported by Limbosch (51) in  whom the onset of neith er  
d isease  was s ta ted . The a sso c ia tio n  of primary hypothyroidism with 
"lupoid" h e p a t it is  has a lso  been reported (3 6 ).
Thyroid auto-antibodies have a lso  been described in  p a tien ts  
w ith c irr h o s is  of the l iv e r  without overt thyroid d isease (50,53*54)*  
In a post-mortem survey o f the CF t e s t  in  r e la t io n  to thyroid  
h is to lo g y , Goudie e t  a l .  (53) found th is  t e s t  p o s it iv e  in  6 o f 17 
p a tien ts  with hepatic c ir r h o s is . When these r e su lts  were considered  
sep arately  fo r  sex the incidence of th y ro id -sp ec if ic  CF t e s t s  in  the  
fem ales (6 of 11) was s ig n if ic a n t ly  higher than in  other female 
h o sp ita l p a tien ts  without l iv e r  d isease (27 of 243). These workers 
suggested th at th e ir  fin d in gs should serve "as a poin ter to  the 
problem and w i l l  help to  so lve i t  only by furn ish ing evidence of the 
thyroid le s io n  during l i f e ,  thus perm itting d eta iled  in v estig a tio n s  
in  the l iv in g  in ta c t p a tien t" .
Personal Observations
The purpose o f the present study i s  to in v estig a te  the nature
o f /
/ o f  the p o ssib le  a sso c ia tio n  between auto-immune th y r o id it is  and 
c ir r h o s is  o f  th e l iv e r .  The plan o f the study i s  sim ilar  to  th at 
described in  the in v e stig a tio n s  of the a sso c ia tio n  o f auto-immune 
th y r o id it is  and the connective t is su e  d isea ses , and auto-immune 
haem olytic anaemia. A group of p a tien ts  with auto-immune th y r o id it is  
has been examined for  evidence o f l iv e r  d isease; and the incidence  
o f th yroid  auto-antibodies in  p a tien ts  with c irrh o sis  o f the l iv e r  
has been in v estig a ted . The presence of thyroid auto-antibodies in  
p a tien ts  su ffer in g  from hepatic c irrh o s is  has been studied in  
r e la t io n  to the c lin ico -p a th o lo g ica l featu res o f the l iv e r  d isea se .
M aterials and Methods
The fo llow in g  groups o f p a tien ts  were studied:
Group I  consis ted o f 50 p a tien ts  (46 fem ales, 4  males) w ith auto­
immune th y r o id it is . The age range o f th is  group was 28 to  70 years, 
w ith a mean age o f 52 .5  years. The d iagnosis of auto-imraune 
th y r o id it is  was based on the c r ite r ia  described in  Chapter I I  o f the 
t h e s is .  Each patien t was ca re fu lly  screened for stigmata of l iv e r  
d isease  and bromsulphthalein (BSP) t e s t s  (55) were carried out in  
42 p a t ie n ts . In 6 p a tien ts  who had abnormal BSP t e s t s  needle 
biopsy o f the l iv e r  was performed.
D eta ils  of the c l in ic a l  and laboratory fin d in gs in  th is  group 
are summarised in  the Appendices.
Group I I  con sisted  of 30 p a tien ts  (16 fem ales, 14 males) with  
c irr h o s is  of the l iv e r .  The mean age o f the female p a tien ts  was 
51.5  years (age range 39 to  71 years) and 55.1 years fo r  the males 
(a g e /
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/(a g e  range 37 to  71 y e a rs). The d iagn osis o f c ir r h o s is  o f  the  
l iv e r  was based in  24 p a tien ts  on h is to lo g y  of the l iv e r .  In the 
remainder the d iagn osis was based on the c l in ic a l  fin d in g s and 
standard l iv e r  fu nction  t e s t s .  The incidence o f thyroid  auto­
an tib od ies in  t h is  group was studied by both p r e c ip itin  and CP t e s t s ,  
using the methods described in  Chapter II  of the th e s is .  Three 
p a tien ts  (1 fem ale, 2 males) with n o n -sp ecific  CP t e s t s  (d etected  
by te s t in g  against l iv e r ,  kidney and adrenal ex tracts) and 3 p a tien ts  
(2 fem ales, 1 male) whose sera was strongly  anti complementary, were 
excluded from the study, reducing the number ava ilab le  fo r  a n a ly sis  
to  2 4 *
Routine radioiod ine t e s t s ,  including measurements o f the 4  hour 
thyroid gland uptake and 48  hour plasma protein-bound r a d io a c tiv ity  
(P B I*^) were performed in  a l l  p a tien ts  by the methods described in  
Chapter I I  o f the th e s is .  A dditional t e s t s  of thyroid function  
included potassium perchlorate discharge t e s t s  and estim ations o f the  
serum PBI.
D e ta ils  o f the c l in ic a l  and laboratory fin d in gs in  th is  group 
are summarised in  the Appendices.
R esults
Croup I . None o f the p a tien ts  w ith auto-immune th y r o id it is  had 
evidence o f c ir r h o s is . However, 6 o f the 1+2 p a tien ts in  whom BSP 
t e s t s  were performed had abnormal r e su lts  exceeding 6% reten tion  at 
45 m inutes. Of these 6 p a tien ts , one had hepato-splenomegaly and 
had had a gastrectomy for  g a str ic  neoplasm; hepatic biopsy in  th is  
p a t ie n t /
Table I I
Incidence of Thyroid A uto-antibodie3 
in  C irrhosis o f the L iver.
Table I I I
R esu lts of In v estig a tio n s of Thyroid 
Function in  5 Female C irrhotic P a tien ts  
with Thyroid A uto-antibodies.
Table I I .
Incidence o f Thyroid A uto-antibodies in  C irrh o sis  o f the L iver.
C lin ic a l Group Sex Total No. of cases
Thyroid Auto-antibody T ests
P re c ip it in  (+) Complement-Fixation (+) an-' (++)
P 13 1 5C irrh o s is  o f L iver
M 11 1
P 243 27
H ospita l C ontrols
M 240 6
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Table I I I .
Results o f Inv estig a tio n s  o f Thyroid fNinotioo in  5 Penale 
C irrho tic  P a tien ts  with Thyroid Auto-antibodies.
Case Jc* .
C lin ica l
S ta tus Ooitre
Thyroid
P reo ip itin
uto-antibody 
Pests.
Coeq>lcaent-
P ization
R>
4 hour uptake 
io —)
dioiodine Tests 
p b i '31
(£  d o e e /l.)
Perehlorate
Discharge
FBI
(j«*./100 m l.) Thyroid H lsto lofy
1 58 Euthyroid lone ♦ 4+ 10.2 0.22 4 3-5
2 71 - - 4 27.8 0.13 - 3.0 Vo p o s t-ao rta s  exeainatloa of thyro id  perforaed.
3 <3 " " - ♦♦ 24-5 0.54 4 3.4 Fooal th y ro id itis  p rs s sn t .
4 45 " - - H 20.2 0.21 - 4.4 Fooal th y ro id i tis  p resen t.
5 59 * " - +4 43.1 0.05 - 5-5
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/p a t ie n t  showed no evidence o f e ith er  c irr h o s is  or hepatic m etastases 
another w ith normal l iv e r  h isto lo g y  had a splenomegaly ascribed  to  an 
acquired id iop ath ic  Coombs negative haemolytic anaemia. The case-  
rep ort.o f the la t t e r  p a tien t Ihaa been presented in  the previous 
sec tio n  o f th is  Chapter of the th e s is .  The remaining 4  p a tien ts  
a l l  had normal l iv e r  h is to lo g y .
Croup I I .  Of the 11 male p a tien ts  1 had a th y ro id -sp ec if ic  CP t e s t
(Table I I )  and another with negative thyroid  auto-antibody t e s t s
had primary hypothyroidism. Because of the high incidence o f
chronic alcoholism  in  the male p a tien ts  (7 of 11) and the very low
incidence of thyroid CF t e s t s  no further a n a ly s is  of th is  group
has been attempted.
The incidence o f p o s it iv e  th y ro id -sp ec if ic  CF t e s t s  in  the
female p a tien ts  (5 of 13) was much higher (P < 0 .0 2 ) than in  a group
of female h o sp ita l controls (27 of 243) matched fo r  age and studied
by the same methods in  the same laboratory ( 5 3 )  • From Table I I I
i t  can be seen that h is to lo g ic a l examination of the thyroid was
carried  out in  2 p a tien ts , and revealed fo c a l th y r o id it is  in  both.
Moreover, radioiodine t e s t s  in  these 2 p a tien ts  were con sisten t with
131the presence of th is  le s io n : one had a 48 hour PBI in  the
thyrotoxic range i . e .  exceeding 0 .4  per cen t, per dose per l i t r e  of 
plasma, and had the p o s it iv e  perchlorate discharge te s t  found in
131auto-immune th y r o id itis ;  the other had a high-normal 48 hour PBI 
value, i . e .  exceeding 0»2 per cen t, per dose per l i t r e  of plasma.
131A further p a tien t in  th is  group a lso  had a high-normal 48 hour PBI J
and/
/and a p o s it iv e  perchlorate discharge t e s t .
The mean PBI (5*0 jig. per 100 m l.) in  the fem ale c irr h o tic
p a tien ts  was not s ig n if ic a n t ly  d ifferen t from the mean (5*2 jig. per
100 m l.) o f a normal s e r ie s  in  th is  laboratory. This fin d in g  i s
in  agreement w ith  r e s u lt s  obtained by Ship ley and Chudzik (2 8 ) , but
con trasts w ith the low values reported by Kydd and Man (24) and the
high values reported by V anotti and Beraud (2 5 ).
No co rre la tio n  was found between the occurrence o f thyroid
s p e c if ic  CF t e s t s  and the c lin ico -p a th o lo g ica l fea tu res o f the
hepatic c irr h o s is  (see  Appendices). There was, however, a tendency
fo r  p a tien ts  with thyroid auto-antibody to show evidence o f excess
c irc u la tin g  oestrogens, e .g .  "feraing" o f the cerv ica l mucus in  3
o f 4  post-menopausal p a tien ts  (5 6 ) . In contrast 0 o f 7 p o st-
*
menopausal p a tien ts  with negative CF te s t  showed th is  fea tu re .
None of the c irrh o tic  p a tien ts  in  the present study had a p o s it iv e  
LE c e l l  t e s t  or c l in ic a l  evidence o f system ic lupus erythematosus.
D iscussion
The s ig n ifica n t fin d in g  in  the present study i s  the high 
incidence of thyroid auto-antibodies in  middle-aged females with  
c irr h o s is  of the l iv e r  (Group I I ) . Five o f the 13 female p a tien ts  
with c irrh o sis  had th y ro id -sp ec if ic  CF te s t s ;  an incidence which i s  
much/
* I  would lik e  to thank Dr. R.R. MacDonald o f the U niversity  
Department of O bstetrics and Gynaecology, Western Infirmary,
Glasgow, who kindly carried out these t e s t s .
/much higher (P < 0 .0 2 ) than that in  27 o f 243 female h o sp ita l 
con tro ls  matched fo r  age and studied in  the same lab orato iy  (53) • 
This fin d in g  agrees w ith the previous observations o f  G-oudie e t  a l .  
(53) in  a post-mortem survey of the CF t e s t  and thyroid  h is to lo g y  
in  c irrh o s is  o f the l iv e r ;  and with the prelim inary stu d ies o f  
Sclare e t  a l .  (57) using the tanned r e d -c e ll  haemagglutination  
method.
None o f the 5 female c irrh o tic  p a tien ts  w ith p o s it iv e  CF t e s t s
had c l in ic a l ly  overt thyroid d isea se . Goudie e t  a l .  (53) have
demonstrated th at a t h y r o i d - s p e c i f i c  CF t e s t  i 3  associa ted  with the
presence o f le s io n s  of Hashimoto-type th y r o id it is  and therefore the
5 su b jects mentioned above probably a l l  have th is  le s io n . Indeed
the ex isten ce  o f th y r o id it is  was confirmed in  2 o f the 5 p a tien ts  in
whom post-mortem examination was performed (Table I I I ) .  Furthermore
radioiod ine t e s t s  in  a th ird  p atien t were con sisten t w ith auto-immune
131th y r o id it is ;  since there was high-normal PBI value and a 
p o s it iv e  perchlorate discharge t e s t  (Table I I I ) .
In contrast to  the fin d in g in  the female p a tien ts  with c irrh o s is  
only 1 o f 11 males had a p o s it iv e  th y ro id -sp ec ific  CF t e s t .  However 
i t  i s  of in ter e st  that one other male p atien t with negative antibody 
t e s t s  had hypothyroidism without a g o itre . Presumably, had th is  
p a tien t*s thyroid been examined the h is to lo g ic a l changes of auto­
immune th y r o id it is  might w ell have been revealed, since i t  has been 
shown that primary hypothyroidism and auto-immune th y r o id it is  are 
probably variants of the same pathological process (see  Chapter I I I ,  
S e c t i o n  l ) .  The f i n d i n g s  o f  a  p rep o n d e ra n c e  o f  thyroid auto­
a n t i b o d i e s /
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/a u to -a n tib o d ies  in  female p a tien ts  with hepatic c irr h o s is  may be 
comparable w ith  the sim ilar  sex -d istr ib u tio n  found in  rheumatoid 
a r th r it is  and auto-immune haemolytic anaemia. In contrast w ith the  
high incidence o f rheumatoid a r th r it is  in  auto-immune th y r o id it is  
c ir r h o s is  o f the l iv e r  did not occur in  any o f the p a tien ts  with  
auto-immune th y r o id it is  comprising G-roup I .
The fin d in g  of an abnormally high incidence of thyroid auto­
an tib od ies in  the female p a tien ts  with c irrh o sis  o f the l iv e r  may 
be o f fundamental importance in  our understanding o f the respon sib le  
underlying pathogenetic mechanism in  some cases o f the d isea se , 
sin ce  i t  supports the concept o f Mackay e t a l .  (7) that auto-immune 
mechanisms may be im plicated. A p a r a lle l may be drawn between 
auto-immune th y r o id it is  and c irrh o sis  of the l iv e r .  In both 
d isea ses  hypergammaglobulinaemia i s  associated  w ith lymphocytic and 
plasma c e l l  in f i l t r a t io n  of the a ffec ted  organ, and both disorders  
may be found in  a sso c ia tio n  with a Coombs p o s it iv e  haemolytic 
anaemia (58,59) and an ti-nu clear formation (6 0 ,6 l) .  Furthermore, 
Murray (62) has demonstrated p a r tia l arrest o f the d isease with  
diminution in  go itre  s iz e  in  auto-immune th y r o id it is  with stero id  
therapy, and 0 !Brien e t  a l .  (1A-) have shown that in  some p a tien ts  
w ith chronic h e p a tit is  the l iv e r  necrosing process i s  s e n s it iv e  to  
cortison e. The p o s s ib il ity , th erefore , a r ise s  that while stero id  
adm inistration may confer l i t t l e  or no b en efit  in  the m ajority of 
p a tien ts  suffering from c irrh o sis  o f the l iv e r ,  a small group of 
female c irrh o tic  p a tien ts  may e x is t  in  whom stero id  therapy would 
be/
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/b e  worth a t r i a l .  I t  i s  te n ta t iv e ly  suggested th a t in  the  
c irr h o tic  p a tien t in  whom the presence o f thyroid  auto-immunity can 
be demonstrated, c o r t ico id  therapy might conceivably a rrest the 
d isease  and thereby improve l i f e  expectancy.
SUMMARY
Thyroid auto-antihodies were found in  a much higher proportion  
of middle-aged fem ales with c irrh o sis  of the l iv e r  than in  a control 
s e r ie s  o f female h o sp ita l p a tien ts . No co rre la tio n  was found 
between the presence of the thyroid auto-antibodies and the c l in ic o -  
pa th o lo g ic a l fea tu res of the l iv e r  d isea se , although p a tien ts  with  
thyroid auto-antibodies had evidence of oestrogen excess.
The fin d in gs lend support to  the view that auto-iramunity may 
p lay  a ro le  in  the pathogenesis of c irrh o s is  o f the l iv e r ,  and i t  
i s  suggested th at stero id  therapy might be b e n e fic ia l in  c irr h o tic  
p a tien ts , who have thyroid auto-antibod ies.
Section 4.
The Antibody-forming P o ten tia l 
in  Auto-inmune Disease.
Introduction
I t  has long been known that animals d if fe r  in  th e ir  capacity  
to  produce antib od ies to  a given an tigen ic  stim ulus (1 ,2 ) ,  and 
recent experim ental stu d ies  have shown that the same i s  a lso  true  
fo r  health y human beings (3 -5 )• Furthermore, a proportion of  
p a tien ts  su ffer in g  from certa in  d isea ses , in  which auto-immune 
mechanisms have been im plicated, have been found to  respond w ith  
unusual vigour to stim ulating doses of foreign  antigen s. Thus, 
p a tien ts  w ith systemic lupus erythematosus have been found to be 
among the most p r o lif ic  producers of antibodies to blood group
substances (3 ,6 -8 ) .  They have a lso  been reported to produce
/to a n t ib io t ic s  , .
demonstrable antibodies/m ore frequently  than other p a tien ts  (9 ) .
S im ilarly , p a tien ts  with rheumatoid a r th r it is  have been found to
produce s ig n if ic a n t ly  more c ircu la tin g  a n tito x in  to tetanus toxoid
immunisation than do con tro ls (10) ,  although normal antibody
responses have been observed by other workers to heterologous blood
groups (3) ,  and pneumococcal polysaccharides (11) .  In c irrh o tic
guinea-pigs Long ( i 2) has demonstrated enhancement o f antibody
formation to diphtheria toxoid and skin te s t in g  with tuberculin , and
Havens e t a l .  (13,14) have reported high a n tito x in  t i t r e s  to  tetanus
and diphtheria toxoids in  several p a tien ts  with a lco h o lic  c irrh o s is ,
who had been previously immunised with these antigens. On the
other hand Cherriclc et a l .  (15) have found normal responses to
tetanus immunisation in  p a tien ts  who had predominantly id iop ath ic
Laennec1s c ir r h o s is .
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Personal Observations
The purpose o f  the present in v e s tig a tio n  was to study the 
antibody-forming in  p a tien ts  w ith auto-immune th y r o id it is  and primary 
hypothyroidism in  order to  a scer ta in  (a) whether p a tien ts  with th ese  
d isea ses  respond normally or not on primary immunisation with a 
foreign  antigen , and (b) whether the antibody le v e ls  found correla te  
w ith the c l in ic a l  fin d in gs or w ith the r e su lts  of the thyroid auto­
antibody t e s t s  or gamma-globulin le v e ls .  Since sero lo g ica l hyper­
r e a c t iv ity  might account for  the a sso c ia tio n  of auto-immune 
th y r o id it is  with the connective tis su e  d isea ses , and c irr h o s is  of the 
l iv e r ,  the antibody response was determined in  p a tien ts  su ffer in g  
from these cond itions. The observations were contro lled  by 
measuring the antibody response in  a group of normal subjects matched 
fo r  age and sex.
Tetanus toxoid  was chosen as the provoking antigen in  these  
stu d ies  because accurate and w e ll-e sta b lish ed  techniques were 
ava ilab le  for a ssess in g  the a n tito x in  response, and because man does 
not natu ra lly  have c ircu la tin g  tetanus an titox in ; thus the e f fe c t  
o f primary immunisation could be studied in  p a tien ts  who were in  
the unimmunised s ta te . Furthermore, reaction s a fte r  in jec tio n  of  
tetanus toxo id  are rare and u su a lly  m ild.
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M aterials and Methods 
The fo llow ing  groups o f p a tien ts  were studied:
Clinical Condition Total No. 
of Cases.
Male
Sex
Female
Age (yrs.) 
Mean Bange
Auto-immune thyroiditis. 20 2 18 51-9 40 - 63
Primary hypothyroidism. 17 1 16 46.5 38 - 67
Cirrhosis of the liver. 16 16 55-3 OJ VO 1 —J
Connective tissue diseases. 11 11 47.5 22 - 64
Controls. 13 13 53.6 35 " 69
Totals. 77 3 74 51.1 22 - 71
The diagnosis o f the various d iseases was based on the c r ite r ia  
described in  e a r lie r  parts of the th e s is .  The c l in ic a l  data of the 
p a tien ts  i s  summarised in  the Appendices. The aetio lo g y  in  the 16 
p a tien ts  with c irrh o sis  was as fo llo w s :-  10 had cryptogenic d isease , 
4 had chronic h e p a tit is , and 2 had a lcoh o lic  c irr h o s is . The group 
of p a tien ts  w ith connective t is su e  d iseases in clu d ed:- 5 p a tien ts  
with systemic lupus erythematosus, 2 p a tien ts  with scleroderma, 1 
p atien t with dermatomyositis, and 3 p a tien ts  with rheumatoid a r th r it is .  
The control group consisted  of h o sp ita l p a tien ts  with fu nctional 
i l ln e s s e s  in  whom I could fin d  no evidence of organic d isease . 
P a tien ts /
TABLE I .
Tetanus A ntitoxin  in  T itr es  in  Auto-immune T h yro id itis. 
Primary Hypothyroidism, C irrhosis of the L iver, and 
M iscellaneous Connective Tissue P isorders.
TABLE I .
Tetanus Antitoxin Titrec in Auto-immune Thyroiditis, 
Primary Hypothyroidism, Cirrhosis of the liver, and 
Miscellaneous Connective Tissue Disorders.
No. of Cases with Tetanus Antitoxin Titres. (Units per ml.).
Clinical Group. Total
> 0 .0 1 > 0 . 0 2 > 0 . 0 5 > 0 . 1 > 0 . 2 0 . 5 > 1 . 0 > 2 . 0 > 5*00 . 0 1 < 0 . 0 2 < 0 . 0 5 < 0 . 1 < 0 . 2 -c 0 . 5 < 1 . 0 2 2 . 0 < 5-0 < 1 0 . 0
Auto-immune A 2 4 1 1 20
thyroiditis. 4 4
Primary 4 2 2 2 3 2 2 1?
hypothyroidism.
Cirrhosis 4 2 1 2 3 2 2 16
of liver.
Connective 1 A 1 1 3 1 11
tissue diseases. 4
Hospital 1 5 5 2 13
controls.
/P a t ie n ts  w ith a previous h isto ry  o f tetanus toxo id  in jec tio n s  
which might have a ffec ted  the antibody response were excluded from 
the study.
Each p a tien t received  two intramuscular in jec tio n s  o f 1 ml.
(about 9 L f )  o f the same batch of tetanus toxoid , a t an in terv a l
o f s ix  weeks. The tetanus toxoid was stored in  a re fr ig era to r  a t
2° C. u n t i l  used. Blood serum was taken fo r  estim ation  of a n tito x in
t i t r e  ex a ctly  2 weeks a fte r  the second in je c t io n . The concentration
o f tetanus a n tito x in  in  the sera was determined in  mice by the method
of G-lenny and Stevens ( 16) ,  and the r e s u lt s  were expressed in
*
in tern a tio n a l u n its . Because the p a tien ts  were i n i t i a l l y  in  the  
u n sen sitised  s ta te  and because o f the r e la t iv e ly  short in terv a l  
between the two in jec tio n s  the antibody response can be regarded as  
the r e su lt  of primary immunisation (17) -
R esults
The r e s u lt s  of primary immunisation to tetanus toxoid  are 
summarised in  Table 1. The wide sca tter  in  ind iv idu al a n tito x in  
t i t r e s  precludes s t a t i s t ic a l  a n a ly s is . However, from Table 1 i t  
can be seen th at there i s  no obvious d ifferen ce  in  the antibody 
response of p a tien ts  with auto-immune th y r o id it is , primary hypo­
thyroidism , c irrh o sis  o f the l iv e r ,  connective t is s u e  d isorders, and 
th e /
* I  am gratefu l to  Miss M ollie Barr, M.Sc., of the Wellcome 
Research Laboratories fo r  carrying out the tetanus a n tito x in  
t i t r a t io n s .
FIGURE 1.
R elationship  between Tetanus A ntitox in  T itres and
G-amma-globulin Levels in  Auto-immune T hyroid itis  
and Primary Hypothyroidism.
TABLE I I .
Tetanus A ntitoxin  T itres  in  R elation to  R esults of 
P r e c ip it in  Test in  Auto-immune T h yro id itis  and 
Primary Hypothyroidism.
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FIG, 1.
RELATIONSHIP BETWEEN TETANUS ANTITOXIN TITRES AND 
GAMMA-GLOBULIN LEVELS IN AUTO-IMMUNE THYROIDITIS 
AND PRIMARY HYPOTHYROIDISM
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TABLS I I .
Tetanus A ntitoxin  T itr e s  in  re la t io n  to  r e su lts  o f P rec ip itin  
Test in  Auto-iroroune T h yro id itis  and Primary Hypothyroidism.
P r e c ip it in  Test JJo. o f  Cases with Tetanus A ntitoxin  T itres  (u n its per m l.) T otal
> 0 , 0 1 > 0 , 0 2  >0.05 > 0 . 1 > 0 . 2 > 0 .5 > 1.0 > 2 . 0  > 5 . 0
< 0 '01  < 0. 02 <0.05  < 0 . 1 < 0 . 2 < 0 .5 < 1.0 < 2.0 < 5 . 0  <10.0
(+) 3 4 3 4 4 1 1 20
( - ) 5 2 1 2 3 2 2 17
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/ th e  control su b jects . Furthermore, in  auto-immune th y r o id it is  
and in  primary hypothyroidism no co rre la tio n  was found between the  
a n tito x in  t i t r e s  and the c l in ic a l  sta tus and gamma-globulin le v e ls  
(F ig . 1) ,  and the r e su lts  of the p r e c ip itin  t e s t s  (Table U ) .  
P a tien ts  with connective t is su e  d isea ses  who were rece iv in g  stero id  
therapy had a n tito x in  t i t r e s  sim ilar to those found in  p a tien ts  not 
rece iv in g  th is  treatment.
D iscussion
The r e s u lt s  in  the present in v estig a tio n  show that p a tien ts  with  
auto-immune th y r o id it is  and primary hypothyroidism have a normal 
response to  primary immunisation to tetanus toxoid . I t  i s  probable 
that the a n tito x in  t i t r e s  represent the true antibody-forming 
p o ten tia l in  these p a tien ts , since no correlation  was found between 
the le v e ls  of a n tito x in  and the c l in ic a l  s ta tu s , gamma-globulin 
le v e ls  (F ig . 1 ) or r e su lts  of the p rec ip itin  t e s t s  (Table I I ) . I t  
fo llo w s , th erefore , that hyper-im munisability cannot be prim arily  
involved in  the pathogenesis of auto-immune thyroid d isease .
Havens et a l .  ( 13 , 14) have reported that a proportion o f  
p a tien ts  su ffer in g  from c irrh o sis  of the l iv e r  have a hyper-immune 
response to tetanus immunisation, but th is  has not been confirmed in  
the present study, or by Cherrick et a l .  ( 18) who a lso  used tetanus 
toxoid  as antigen . The toxoid used by Havens e t a l .  (13,14) was 
alum -precipitated and the p atien ts  studied by these authors had 
predominantly a lco h o lic  c ir r h o s is , but i t  seems u n lik e ly  that these  
d ifferen ces  could account for the d iscrepancies between the r e su lts  
o f /
/ o f  these s tu d ies . A more l ik e ly  explanation i s  th at th e p a tien ts  
studied by Havens e t  a l .  (13,14) bad a l l  been immunised to  tetanus  
toxoid  some years previously  and th ese workers were thus te s t in g  
th e ir  response to  re-immunisation. Greenwood e t  a l .  ( 18) have 
shown that in  sarco id osis  and in  r e t ic u lo s is  the antibody response 
in  p a tien ts  with no previous immunity i s  impaired, whereas i t  i s  
normal in  those who have been immunised in  the p a st. The 
discrepancies in  the r e su lts  o f these stud ies in  c irr h o tic  p a tien ts  
may therefore be due to d ifferen ces between primary immunisation 
(a s  in  the present study and in  that reported by Cherrick e t  a l .  (15))> 
and re-immunisation (a s in  the stu d ies of Havens et a l .  ( l3 ,1 4 ) i
A sim ilar  explanation may a lso  hold for the discrepancy between 
the normal antibody response to primary immunisation to  tetanus toxoid  
in  p a tien ts  w ith connective t is su e  d iseases and the hyperimmune 
response observed by other workers in  th is  group of d iseases to  
in flu en za l vaccines (3)> p e n ic i l l in  (9)> mismatched blood (3*
6 -8 ) . The u n sen sitised  sta te  does not s t r ic t ly  e x is t  in  r e la t io n  
to  th is  la t t e r  group of antigens. Most adult persons have been 
in fec ted  w ith influenza in  the p ast, and few have not had p e n ic i l l in  
a t some tim e. M iller  e t a l .  (19) have shown that even the f i r s t  
dose o f Group B c e l l s  to a Group A ind iv id u al represents a booster  
challenge to the production of iso a g g lu tin in s , and sim ila r ly  
Group A substance i s  so w idely d istr ib u ted  in  nature (20-22) that 
i t  i s  v ir tu a lly  certa in  that a l l  human beings come in  contact with  
i t  during th e ir  l i f e .  In the present study the cr iter io n  of the  
u n sen sitised /
/u n se n s it ise d  s ta te  was s t r ic t ly  adhered to and the antigen used 
was one which p a tien ts  do not normally come in to  contact w ith .
I t  may be that the use o f a re-immunisation procedure, such
as the mismatched blood technique, may have been a more appropriate
means o f d etectin g  immunological h y p er-rea ctiv ity  in  the p articu lar
group of d isea ses  studied . A uto-antibodies may develop in
su scep tib le  in d iv idu als only a fte r  repeated exposure to  the antigen
concerned. Re-immunisation w ith further "booster” doses o f
tetanus toxoid  might therefore have revealed immunological
d ifferen ces  in  the p a tien ts  in  the present study. On the other
hand Lewis and Loomis ( 1 ) have demonstrated th at the primary response
to an antigen i s  the most accurate r e f le c t io n  of an ind iv id u al to
produce antibody. On the b a sis  of the r e su lts  o f the present
in v estig a tio n  i t  therefore seems reasonable to conolude that a
involved
general enhancement of the immunity mechanisms i s  not prim arily , in  
the pathogenesis o f auto-immune thyroid d isea se , c irrh o sis  o f the  
l iv e r ,  or the connective t is s u e  d isea ses .
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SUMMARY
An experiment i s  described which was designed to  measure the  
antibody-forming p o ten tia l in  auto-immune th y r o id it is , primary 
hypothyroidism, c irrh o s is  o f the l iv e r ,  and connective t is s u e  
d isea se . S ix ty-fou r p a tien ts  with these c l in ic a l  d isea ses  and 
13 healthy control subjects were immunised with two in jec tio n s  o f  
tetanus toxoid  a t six-weeks in terv a l; a n tito x in  t i t r e s  were 
estim ated in  the blood-sera taken 2 weeks a fte r  the second in je c t io n .  
The r e s u lt s  showed sim ilar le v e ls  of immune response in  a l l  the 
c l in ic a l  groups. No correla tion  was found between the tetanus 
a n tito x in  t i t r e s  and the c l in ic a l  s ta tu s , gamma-globulin values, 
and p r e c ip it in  t e s t s  in  p a tien ts  with auto-immune th y r o id it is  and 
primary hypothyroidism. I t  i s  concluded that a general hyper- 
im m unisability i s  not prim arily involved in  the pathogenesis o f  
auto-immune thyroid d isea se , c irrh o s is  of the l iv e r ,  or connective  
t is s u e  d isea ses .
Section 5.
TV»Q Problem of Auto-im munity.
335.
The demonstration o f a c l in ic a l  a sso c ia tio n  between auto­
immune th y r o id it is  and the apparently d iverse conditions o f  the 
connective t is su e  d isea se s , acquired haemolytic anaemia, and c ir r h o s is  
of the l iv e r ,  in  each of which there i s  some evidence of an auto­
immune mechanism, b ids us now take stock of the s ig n ifica n ce  of 
these fin d in gs and the ro le  o f auto-immunity in  the pathogenesis o f  
d isea se .
Even when the presence of auto-antibody to  a p articu lar  t is su e  
can be demonstrated there s t i l l  remains the question o f whether the 
antibody i s  the causal agent or merely the consequence o f the 
p athological process. At present, i t  appears from animal experi­
m ents th at auto-immunisation can c er ta in ly  cause le s io n s  in  the 
appropriate t is su e  which c lo se ly  resemble the corresponding 
naturally-occurring d isease in  humans. However, there i s  a poor 
co rre la tion  between the amount of humoral antibody in  these experi­
m ents and the extent of the lesions produced ( l ) .  I t  may be that 
the use o f Freund's adjuvants in  these animal stud ies confers a 
q u a lita tiv e  as w ell as a qu antitative d ifference to  the antigen ic  
stim ulus, s in ce , with the p o ssib le  exception o f auto-immune 
haem olytic anaemia, none of the serum auto-antibodies so far  
described have proved cytotox ic  e ith er  in  v itro  or in  v ivo. Moreover, 
human auto-immune d isease can occur without any o f the known serum f 
auto-antibodies being demonstrable, and the c l in ic a l  sjTidromes of 
systemic lupus erythematosus and rheumatoid a r th r it is  (2,3)* and 
acquired haemolytic anaemia (4 )* have been reported in  p a tien ts  with 
agammaglobulinaemia, /
336.
/agammaglobulinaemia, in  whom the production of* serum antibody i s  
g rea tly  impaired ( 5 , 6 ) .  Thus, the evidence i s  a t present against 
a d irec t causal r e la tio n sh ip  between the c irc u la tin g  au to-antibod ies  
and t is s u e  damage. A p a r a lle l might be drawn between serum auto- 
antibod ies and the biochem ical disturbances in  m etabolic d isea se , 
such as the ra ised  serum iron  le v e ls  in  haemochromatosis.
I f  the serum auto-antibod ies are not d ir e c t ly  respon sib le for  
t is s u e  damage, then th e ir  presence may r e f le c t  a more fundamental 
immunological reaction , in vo lv in g  the non-humoral or Mcell-bound” 
antibody system, such as i s  evident in  tuberculin  h y p er sen sit iv ity  
and in  homograft reaction s (7 ) .  Holman and Deicher (8) have 
demonstrated delayed-type skin  reaction s to autologous leu co cy tic  
ex tra cts  in  p a tien ts  with systemic lupus erythematosus, and Paterson  
(9) has achieved p assive  transm ission of a l le r g ic  encephalom yelitis  
in  r a ts  using lymph node ex tr a c ts . As yet there i s  no d irec t  
evidence th at delayed h y p ersen sit iv ity  p lays a ro le  in  the patho- 
: genesis of auto-immune th y r o id it is , and indeed skin responses to  
thyroid t is su e  ex tra cts  in  p a tien ts  with th is  condition were con­
s i s t e n t  w ith an Arthus reaction . I t  i s ,  however, extrem ely  
d i f f ic u l t  to  exclude a delayed s e n s i t iv i t y  component in  the 
presence o f concomitant Arthus r e a c t iv ity , and further a n a ly s is  of 
skin rea ctio n  in  p a tien ts  with auto-immune th y r o id it is  would 
therefore be o f value, in  p articu lar  a f te r  in je c t io n  of the 
ind iv idual an tigen s. The problem of delayed h y p ersen sit iv ity  in  
auto-immune d isease might a lso  be in v estig a ted  by attem pting  
p a ss iv e /
387.
/t r a n s fe r  using lymphocytes of im m unologically induced d isea se  in  
inbred stra in s  of experim ental anim als.
What in i t ia t e s  th e auto-immune process s t i l l  remains uncertain . 
G-ear (10) has postu lated  th at the action  of a v iru s, b a c te r ia l to x in , 
or drug, on t is s u e  components might render them a n tig en ic , and so lead  
to  auto-antibody form ation. Thus, th is  author (11) has shown that 
in  monkeys, emulsions o f normal l iv e r  are not a n tig en ic , whereas 
ex tra cts  of l iv e r  from a monkey with yellow  fever  or from a rabbit 
w ith neoarsphenamine poisoning evoke s ig n if ic a n t  antibody responses. 
Furthermore, the immunological b a s is  of strep tococca l in fe c t io n  
lead ing to  rheumatic fever  or acute glom erulo-nephritis, sedormid 
purpura (12) ,  and the occurrence o f L E c e l l s  in  hydrallazine  
s e n s it is a t io n  (13)> i s  con sisten t w ith m odification  of the an tigen ic  
structure o f body co n stitu en ts. Such a mechanism might explain  the  
formation of thyroid auto-antibodies in  subacute (mumps) th y r o id it is ,  
although th is  d isease  does not as a ru le  lead  to progressive auto- 
immunisation in  sp ite  of the fa c t  that the in fe c t io n  leads to  
continuous acinar c e l l  breakdown with re lea se  of c o llo id  fo r  several 
weeks. There i s  no in  v itro  evidence o f an a lte r a tio n  in  the 
a n t ig e n ic ity  of the thyroid  auto-antigens in  auto-immune 
th y r o id it is  (14)> and i t  seems u n lik e ly  th at the co -ex isten ce  of 
th is  d isease  w ith other auto-immune d isea ses  can be explained on 
the b a s is  of m odification  of the a n t ig e n ic ity  of t is s u e  components, 
u n less i t  were postu lated  that a s in g le  agent, such as a v iru s, 
could in i t ia t e  an auto-immune reaction  in  one or several d iffe re n t  
organs/
/ organs sim ultaneously.
A more a ttr a c tiv e  explanation of the c l in ic a l  a sso c ia tio n  of 
auto-immune th y r o id it is  w ith other auto-immune d isea ses  i s  that i t  
i s  due to a breakdown in  the mechanisms of immunological to lerance  
th a t operate in  h ea lth . In 1949 Burnet and Fenner (15) proposed 
th at except during fo e ta l  l i f e  the body was capable of d is tin g u ish -  
:in g  between the t is s u e s  of "self" and the t is s u e s  o f " n o t-se lf" .
In support o f th is  hypothesis they c ite d  the e a r lie r  observation of 
Owen ( 16) th at in  bovine tw ins each twin commonly p ossesses red c e l l s  
o f the o th er1s blood group in  add ition  to i t s  own, due to  mixing of 
th e ir  blood in  the common p lacenta. In add ition  Anderson e t  a l .
(17) demonstrated th at recip roca l akin g ra fts  in  n on -id en tica l 
bovine twins were accepted as reg u la rly  as in  id e n t ic a l tw ins. In  
a s e r ie s  of b r i l l ia n t ly  conceived experiments in  inbred s tr a in s  of 
mice, Medawar ( 18) was able to  show that the in je c t io n  of 
g e n e t ic a lly  fore ign  c e l l s  in to  the developing foetu s produced a 
s ta te  of sp e c if ic  and "acquired immunological tolerance" which 
allow ed th e acceptance o f homografts from donors of the same stra in  
in  la te r  l i f e .
On th is  foundation Burnet ( 19) formulated h is  "clonal selection "  
theory of antibody form ation. He suggested that the capacity  o f  
an in d iv id u al to  produce a given antibody i s  a g e n e tic a lly  determined
q u ality  of c er ta in  "clones" (Greek n jp vo s  = branch) of r e t ic u lo ­
en d o th e lia l c e l l s  which respond to contact with th e ir  appropriate 
a n tigen /
3 8 9 .
/a n tig e n  by the form ation of antibody. A great v a r iety  of clones  
are normally present, each of which i s  capable of responding to  one 
or a group of antigens by production o f immunity. Burnet a lso  
suggested th at these prim itive  c e l l s  are suppressed or elim inated  
by contact w ith the appropriate antigen , thus providing a mechanism 
whereby the immature animal can be rendered to lera n t to homograft 
rea c tio n s. I t  seems reasonable, th erefore , to propose that 
undesirable auto-immune reaction s may be a consequence o f a fa ilu r e  
of a mechanism normally present fo r  the a cq u is itio n  o f immune 
to lerance to  normal body con stitu en ts during embryonic l i f e .
I t  i s  an e s se n tia l featu re o f Burnet's "clonal selection "  
theory of antibody formation th at mutation o f the clones o f  
immunologically competent c e l l s  and of the immunological patterns  
i s  always in  process. Random mutation i s  bound, th erefore , to  
produce a proportion o f immunological patterns rea c tiv e  against 
body components, and presumably in  in d iv id u a ls  a hom eostatic 
mechanism e x is t s  whereby these "forbidden" patterns are elim inated . 
The development o f auto-immune disorders and in  p a rticu la r  th e ir  
c l in ic a l  a sso c ia tio n s  can therefore be in terpreted  on the b a s is  
o f a p a r tia l or complete fa ilu r e  o f th is  normal hom eostatic 
mechanism, which allow s the "forbidden" clones of c e l l s  to  
p r o life r a te  and, in  reactin g  w ith the antigen involved, i n f l i c t  
damage on the body. "Forbidden" clones of immunologically competent 
c e l l s  may a lso  be stim ulated to p r o life r a te  by contact w ith certa in  
an tigen s, such as len s protein , thyroglobulin , and spermatozoa, which 
f o r /
/ f o r  reasons of the time o f th e ir  appearance and th e ir  anatomical 
lo c a tio n , the body has not acquired immunological to leran ce. In  
th ese circum stances damage to the an tigen ic  organ concerned may 
be necessary fo r  in i t ia t io n  o f the auto-immune process.
Exploration of immunological tolerance to these antigens during 
foetal or early neonatal l if e  in experimental animals may, therefore, 
prove fru itfu l.
Less c le a r ly  immunological but of fundamental importance are 
the observations of Moscona (20) of the capacity  of c e l l s  to  
recognise and react with one another. I so la ted  c e l l s  in  suspension  
can apparently recombine to form t is s u e s  sim ilar  to  those of th e ir  
o r ig in , and in  doing so , w i l l  avoid or r e je c t c e l l s  o f unlike  
o r ig in . Moreover, mixtures of c e l l s  w il l  segregate them selves 
according to t is s u e s  o f o r ig in . The mechanism of th is  phenomenon 
remains obscure, bht i t  i s  conceivable that these reaction s between 
c e l l s  are a more general expression of the fu nction  of antibody 
form ation. A pplication  o f these observations to the t is s u e s  and 
immune systems o f p a tien ts  with auto-immune d isease may be 
rewarding. Thus, abnorm alities in  the behaviour o f one c e l l  or 
t is s u e  toward another in  c e l l  suspensions may be demonstrated, and 
abnormal to lerance mechanisms may be found, in  which the p a tien t  
lias lo s t  to lerance of h is  own c e l l s .  Perhaps a lso  c e l l s  w ith  
d iffe re n t somatic composition e x is t  in  p a tien ts  w ith auto-immune 
disease  and react with other c e l l s  to  which they normally would be 
com patible. A search fo r  chromosomal abnorm alities in  the d ifferen t  
c e l l s /
8° 1 .
/ c e l l s  involved in  auto-immune d isease might therefore he o f value.
The production of auto-antibodies i s  probably an inherent 
abnormality o f the host response, in  p articu lar  of the immunolog- 
: i c a l ly  competent c e l l s  them selves. In the present th e s is  no 
evidence was found of an enhanced antibody-forming p o ten tia l in  
p a tien ts  w ith auto-immune th y r o id it is  and in  other "auto-immune" 
d isea ses  to  primary immunisation to  tetanus toxoid . The in d iv id u a l­
i t y  in  response may be linked to the p a t ie n t 's  own a b i l i t y  to  
recognise damaged t is s u e  as antigen and may a lso  have a hered itary  
b a s is . In the present th e s is  an increased frequency o f thyroid  
auto-antibodies has been found in  r e la t iv e s  o f p a tien ts  with auto­
immune th yro id itis^  and in  th y ro to x ico sis  a fa m ilia l p red isp o sitio n  
to  develop anti-m icrosom al thyroid auto-antibod ies appears to  be 
a sso c ia ted  with a fa m ilia l p red isp osition  to thyroid d isease  in  
general. S im ilarly  in  the connective t is s u e  d iseases serum fa c to r s  
sim ilar  to  those found in  systemic lupus erythematosus and rheumatoid 
a r th r it is  have been found in  unaffected  r e la t iv e s  of p a tien ts  
su ffer in g  from these d isea ses  (2 1 ) . These observations suggest a 
hered itary  p r e s isp o s it io n  to an abnormal immune response, which in  
some p a tien ts  may m anifest i t s e l f  as auto-immune th y r o id it is ,  
w hile in  others as rheumatoid a r th r it is  or system ic lupus erythema- 
ito su s , and in  a few as sero lo g ica l reaction s without c l in ic a l  
symptoms. A u se fu l approach to the further study of auto-immune 
d isease would, th erefore , l i e  in  the exploration  of r e la t iv e s  w ith  
these various cond itions, and the genetic  background of p a tien ts  
w ith /
/w ith  th ese i l ln e s s e s ,  in  p a rticu la r  in  those in  whom 2 or more 
auto-immune d isea ses  c o -ex is ted .
L i t t l e  i s  as y e t known of the environmental fa c to r s  which may
predispose to  the development of auto-immune d isea se , but a fa c to r
of some importance which has emerged in  the present study i s  the
p red ilec tio n  of fem ales to  develop these d ise a se s . Thus, not
only are most "auto-immune'* d iseases more commonly found in  fem ales,
but the c l in ic a l  a sso c ia tio n s  of these d isea ses  appear to  occur more
freq u en tly  in  th is  sex than in  the male. Dameshek (22) has
suggested th at the proneness o f the female to  develop auto-immune
d isea se , may be due to  the lib er a tio n  of antigen ic  substances during
menstruation, which because of i t s  period ic character, may correspond
to  the "booster” in jec tio n s  of an immunising procedure. However, no
d ir e c t re la tio n sh ip  could be estab lish ed  between ovarian fu nction
and the onset of auto-immune th y r o id it is ,  although i t  i s  of in te r e s t
th at thyroid auto-immunisation in  female c irr h o tic  p a tien ts  appeared
to  be a sso c ia ted  with excess c ircu la tin g  oestrogens. I t  i s  p o ss ib le
th at the proneness of the female to  auto-immunity i s  g e n e tic a lly
determined, but the absence of any sex d ifferen ce  in  the incidence
of complement-fixing antithyro id  auto-antibodies in  thyrotoxic  
does not
patien ts/su pport, such a view. Further in v e stig a tio n  of the ro le  
of the ovarian hormones in  regu la tion  o f the immune response i s ,  
however, d esira b le .
At present, the lack of understanding of the b asic  mechanisms 
involved in  antibody formation and immunological to lerance does not 
perm it/
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/perm it the formation o f a w e ll-d efin ed  hypothesis o f auto-immune 
d isea se . I t  i s  uncertain whether auto-antibod ies a r ise  because of 
fa ilu r e  to  acquire to leran ce, because o f sub tle  a lte r a tio n s  in  the 
chemical c o n stitu tio n  of au to-antigen s, or because o f some derange- 
:ment of the antibody-forming mechanism which renders i t  incapable 
of recognising " self" ; or whether the auto-antibod ies merely r e f le c t  
the p athological changes brought about by "cell-bound*1 or delayed  
h y p ersen sitiv ity  mechanisms. N evertheless, the demonstration in  the 
present th e s is  of a c l in ic a l  a sso c ia tio n  between auto-immune 
th y r o id it is  and the connective t is s u e  d isea ses , acquired haem olytic  
anaemia, and c irr h o s is  of the l iv e r ,  i s  co n sisten t w ith the view  
th at auto-immunisation plays a fundamental, i f  ill-u n d ersto o d , ro le  
in  the pathogenesis o f  th ese con d ition s. The danger i s  one of 
forcin g  the analogy too fa r , and one must r e s t  content w ith the 
observations thus fa r , and await the e lu c id a tio n  th at further research; 
may afford .
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SOME ILLUSTRATIVE CASB-BEPOKTS
40 0.
Patient No. 6.
This patient, aged 63 years, presented with a goitre of 3 
years duration. She also complained of a cough which she 
attributed to the goitre, and had been av/are of slight hoarseness, 
although she had no other symptoms of hypothyroidism. The hypo­
thyroid diagnostic index was +1.
Investigations were as follows
Precipitin test: (-)
C-P test: (++)
Thymol Turbidity: 6 units.
Thymol flocculation: +2.
G-amma-globulin: 0.79 g./lOO ml.
E.S.R. (Westergren): 37 mu/first hr.
I^3  ^ t e s t s  4  h r . uptake: 27 . 8$ /d o se .
48 hr. PBI131: 0 .2 2 ^ /d o se /l .
Potassium perch lorate  
discharge t e s t  ( I  3 ) :  n eg a tiv e .
BMR (Robertson and R eid): O?o.
Serum C h olestero l: 285 m g ./l00 ml.
ECG-: no evidence of hypothyroidism.
PBI: 3*1 (Jig./lOO ml.
Comment: In  the presence o f a negative p r e c ip it in  t e s t  the
d iagn osis of auto-immune th y r o id it is  could only be presumptive. 
Treatment w ith thyroxine sodium 0.1 mg. tw ice d a ily  by mouth caused  
shrinkage of the g o itre  (Mean neck circum ference reduced by one inch  
in  12 months). Subsequent thyroid  biopsy confirmed auto-immune 
th y r o id it is .
P a t ie n t  No. 12.
This 48 year old woman presented w ith a g o itre  and symptoms of 
th y ro to x ico s is . The c l in ic a l  d e ta ils  of her i l ln e s s  and the r e su lts  
of the laboratory in v e s tig a tio n s  are reported in  d e ta i l  in  Chapter 
I I I  Section  2 . The r e s u lt s  of the routine radio iod ine t e s t s  
(4 hr. uptake 50 .6$  dose, 48 hr. PBI131 0 .42$  d o s e / l . )  and the BMR 
determ inations (+28$) appeared to confirm th is  d iagn osis, although 
the thyroxine suppression t e s t  and estim ation  of the serum protein  
bound iodine ( 5 » 3  pg./lOO ml.) showed that she was euthyroid. The 
p r e c ip itin  t e s t  was strongly  p o s it iv e  and the serum f lo c c u la tio n  
t e s t s  s l ig h t ly  abnormal (thymol tu rb id ity  3 u n its , thymol f lo c c u la tio n  
+1, and i t  was the routine performance of th ese t e s t s  which f i r s t  
drew a tten tio n  to the true s ta te  of a f fa ir s .
403.
P a t ie n t  Nci 13.
This 67 year o ld  woman had had a g o itre  fo r  8 months. She had 
a lso  had severe rheumatoid a r th r it is  fo r  9 years. The c l in ic a l  
d e t a i l s /
4-04*
/ d e t a i l s  and the r e s u lt s  o f laboratory fin d in g s  are described in  
d e ta i l  in  Chapter IV, S e c tio n  1*
*
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P a t ie n t  No. 15.
This 57 year old p a tien t presented with symptoms of hypo­
thyroidism . She was unaware of a d iffu se ly -en la rg ed  (50 g .)  g o itr e , 
which was found on neck palp ation . The hypothyroid d iagn ostic  index  
was +24 .
The r e s u lt s  of the laboratory in v e stig a tio n s  were as fo llow s:
P r e c ip it in  t e s t  (+)
CF t e s t  (++)
Thymol tu rb id ity  8 u n its .
Thymol f lo c c u la tio n  +3.
G-amma-globulin 1.16 g ./ l0 0  ml.
ESR (Westergren) 30 mm . / f i r s t  hour. 
t e s t s  4  hr. uptake 24*3^ dose
48 hr. PBI131 0.18?S d o s e / l i t r e .
BMR (Robertson and Reid)-267o.
Serum c h o le s ter o l 125 mg./lOO ml.
ECG- co n sisten t w ith hypothyroidism.
PBI 0 .7  Hg./lOO ml.
Treatment and Progress With thyroxine sodium therapythe g o itr e  in
th is  p a tien t has v ir tu a l ly  disappeared, and her hypothyroidism has
Been corrected .
Comment. This p a tien t draws a tte n tio n  to  the importance of 
palp ation  of the neck fo r  the presence of a g o itr e  in  the in v e s t ig a ­
t i o n  o f hypothyroidism. The fin d in g  o f a firm  g o itr e  i s  v ir tu a l ly  
d iagn ostic  o f  auto-immune th y r o id it is .
407.
P a t ie n t  No. 20.
This 48 year old woman presented with a firm nodular goitre
of 2 years duration. Clinically she was euthyroid and the
hypothyroid diagnostic index was +3.
The results of laboratory investigations were as follows:
Precipitin test: negative.
CP test: negative.
Thymol turbidity: 7 units.
Thymol flocculation: +3*
G-amma-globulin 2.06g./l00 ml.
ESR (Westergren): 12 mm./first hr.
Tests: 4 hr.uptake: 16.5$ dose.
48 hr. PBI131 0.05??/dose/litre.
1 32Potassium Perchlorate Discharge Test (i ): negative. 
BMR (Robertson and Reid):-17%- 
Serum cholesterol 205 mg./lOO m l.
408.
PBI: 2 .5  p s - /100 ml.
Thyroid biopsy showed extensive fibrosis of the thyroid with 
extension beyond the capsule* with, in addition* chronic thyroiditis 
and Askanazy-cell change.
Comment. The interesting features in this patient are the 
negative auto-antibody tests in the presence of highly abnormal 
flocculation tests and gamma-globulin levels; and the histological 
findings in the thyroid gland. It is possible that fluorescent 
antibody studies might have shown an antibody to a colloid constituent 
other than thyroglobulin. The extension of the disease process 
beyond the capsule found on histological examination would lead 
some histologists to diagnose Riedel*s struma. However, the 
presence of round cell infiltration and Askanazy-cell change suggest 
a fibrous variant of auto-immune thyroiditis.
-  • - i  *
P a t ie n t  No. 23.
This 44 year old woman presented with symptoms of hypothyroidism.
She had been unaware of a diffuse and moderately (75 g«) enlarged*
firm goitre. The hypothyroid diagnostic score was +29.
The results of the laboratory investigations were as follows:
Precipitin test: (+)
CP test: (++)
Thymol turbidity: 1 unit.
Thymol flocculation: +0.
ESR (Westergren): 8 mra./first hr.
131I tests. 4 hr. uptake: 2Q.0fi> dose.
48 hr. PBI^^: 0.23/o dose/litre.
BMR (Robertson and Reid): -l8?o.
Serum cholesterol: 335 mg./lOO ml.
ECG-: consistent with hypothyroidism.
PBI: 2.1 pg./lOO ml.
Treatment and Progress./
/Treatment and P rogress. Thyroxine sodium therapy com pletely  
r e liev e d  the hypothyroidism and caused the g o itr e  to  shrink  
considerably  and to  become ” s o f t ” in  co n sisten cy .
P a t ie n t  No* 26.
This 43 year old woman presented with a g o itre  assoc ia ted  with
a "choking” sen sation . She had had the g o itre  fo r  19 years. On
examination the g o itre  was markedly enlarged (125 g . ) ,  d if fu se , and
"soft" in  con sisten cy , and the pyramidal lobe was c le a r ly  palpable.
C lin ic a lly  the p a tien t was euthyroid -  hypothyroid d iagn ostic  index
-4 .  The r e s u lt s  o f laboratory in v estig a tio n s  were as fo llo w s:-
P r e c ip it in  te s t :  (+)
CF te s t :  (++)
Thymol tu rb id ity : 14 u n its .
Thymol flo ccu la tio n : +4*
ESR (W estergren): 23 m m ./first hr. 
j } ^  Tests 4  hr. uptake 48.3/^ dose.
48 hr. PBI1-51 0.34^ d o s e / l i t r e .
412.
Potassium Perch lorate Discharge T est: n eg a tiv e .
BMR (Robertson and R eid ): +9^ 6.
Serum ch o le ster o l:  133 mg./lOO ml.
ECG-: normal.
PBI: 2 .3  *ig./lOO ml.
Comment. A c l in ic a l  d iagn osis o f "simple" g o itre  could e a s i ly  have
been made in  th is  p a tien t, e s p e c ia lly  as the g o itr e  was "soft" in
consistency^ The serum PBI la y  in  the hypothyroid range, although
/
c l in ic a l ly  and by other laboratory c r it e r ia  th e p a tien t was euthyroid. 
With thyroxine sodium 0.1 mg. tw ice d a ily  there was considerable  
shrinkage in  g o itre  s iz e  and r esto r a tio n  to  normal of the biochem ical 
abnorm alities.
413.
P a t ie n t  No. 27.
This 54 year old woman presented with a goitre of 11 years 
duration with recent increase in size. She also complained of 
slight dysphagia and had symptoms of hypothyroidism (hypothyroid 
diagnostic index +20). At the onset of her goitre she had 
manifested symptoms of thyrotoxicosis and had received a course of 
antithyroid drugs lasting 10 months. On examination there was 
clear evidence of hypothyroidism, and the goitre was diffusely 
enlarged (150 g.), firm, and the pyramidal lobe was palpable. 
Results of Investigations were as follows:
Precipitin Test: (+)
CF Test: (++)
Thymol turbidity: 3 units.
Thyxftol Flocculation: + 2 ,
G-amma-globulin: 0 .9  pg./lOO ml.
ESR (W estergren): 9 m m ./first hr.
I 1^1 T ests . 4  hr. uptake: 40 .0$dose.
48 hr. PBI1-51: 0 .47^  d o s e / l i t r e .
BMR (Robertson and Reid) -  21$.
Serum ch o le stero l: 285 mg./lOO ml.
ECG-: co n sisten t wiih hypothyroidism.
PBI: 4 .1  {ig./lOO ml.
Comment. This p a tien t presented the c la s s ic a l  c l in ic a l  tr ia d  o f
auto-immune th y r o id it is ,  namely, a middle-aged female w ith a firm
g o itre  and sign s of hypothyroidism. I t  i s  p o ss ib le  th a t th is
p a tien t rep resen ts a "burnt-out" th y ro to x ico s is .
415.
P a t ie n t  No, 53.
This 55 year old woman had had a goitre for 3 years. On 
examination the goitre was diffuse, firm, and moderately enlarged, 
and there was no evidence of hypothyroidism (hypothyroid diagnostic 
index +2). The patient gave a convincing history of thyrotoxicosis 
15 years previously. She had also suffered from giant urticaria 
for many years.
The results of laboratory investigations were as follows: 
Precipitin Test: (+)
CP Test: (++)
Thymol turbidity: 5 units.
Thymol flocculation: +3*
416.
ESR (W estergren): 38 m m ./first hour.
1 ^  T ests . 4  hr. Uptake:39.O^dose.
48  hr. P B I^ ^ :0 .21$  d o s e / l i t r e .
Potassium P erch lorate Discharge Test: n egative .
BMR (Robertson and R eid): +10/2.
Serum C h olestero l: 350 mg./lOO ml.
ECG-: Normal.
PBI: 2,1 pg./lOO ml.
Comment. Although apparently c l in ic a l ly  euthyroid i t  i s  c lea r  from
the r e s u lt s  of the serum ch o le ster o l and PBI determ inations th a t th is
p a tien t has m ild thyroid in su ff ic ie n c y  which i s  not c l in ic a l ly
m an ifest. Treatment w ith thyroxine sodium brought about considerable
shrinkage in  g o itre  s iz e .
417.
P a t i e n t  No. %,
T h is  50 y e a r  o ld  woman p r e s e n te d  w i th  a  g o i t r e  o f 4  y e a r s  
d u r a t io n  and  symptoms s u g g e s t iv e  o f h y p o th y ro id is m . T h ree  y e a r s  
p r e v io u s ly  she had  b een  a d m it te d  to  h o s p i t a l  f o r  t r e a tm e n t  o f 
s e v e re  e x o p h th a lm ic  o p h th a lm o p le g ia  ( s e e  o v e r)  and  was g iv e n  a 
c o u rs e  o f  c o r t i c o t r o p h i n  and  c o r t i s o n e  w ith  good e f f e c t .  A t 
t h a t  tim e  she h ad  some symptoms s u g g e s t iv e  o f t h y r o t o x ic o s i s ,  
a l th o u g h  th e  th y r o to x ic  c l i n i c a l  d i a g n o s t i c  in d e x  s c o re  was o n ly  
+4-
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131Radioiodine (I ) tests at that time showed a 4 hr* uptake 
of 39.4% dose and a 48 hr. P B I ^  of 0.53% dose/litre. The BMR 
(Robertson and Reid) was +14% and the sleeping pulse rate 65 beats 
per minute. The patient was considered to be euthyroid and no 
specific antithyroid therapy was prescribed.
Thereafter the patient remained well up until a few months 
prior to my first seeing her when she developed symptoms of hypo­
thyroidism. The patient complained of cold intolerance, acro- 
paraesthesiae, decreased sweating, increase in weight, and 
hoarseness. On examination, she had a cold, dry, and yellowish 
skin, puffiness of the supraclavicular fossae and wrists, dry hair, 
and a casual pulse rate of 66 beats per minute. The goitre was 
moderately enlarged, firm, and nodular and there was evidence of 
persistent/
/p e r s is te n t  ophthalm oplegia, e sp e c ia lly  on upward converge of the
eyes. I t  was o f  in te r e s t  th at the p a tien t had a paternal male
cousin  with th y ro to x ico s is  and exophthalmic ophthalm oplegia, and a
paternal female cousin  with th y ro to x ico s is .
. R esu lts o f laboratory in v e s t ig a tio n s  were as fo llo w s:
P r e c ip it in  Test: (+ ).
CP Test (++).
Thymol tu rb id ity : 1 u n it .
Thymol f lo c c u la tio n : 0 
Gamma-globulin: 1 .34  g*/lOO ml.
ESR (¥/estergren): 4  m m ./first hr.
1^^  T ests . 4  hr. Uptake: 20.1% dose.
48 hr. PBI131: 0.19% d o s e / l i t r e .
Potassium Perchlorate Discharge Test: p o s it iv e .
Thyroxine Suppression Tests normal.
BMR (Robertson and R eid ): -15%«
Serum C holesterol: 520 mg./lOO ml.
ECG-: co n sisten t with hypothyroidism.
PBI: 1 .3  I~ig./100 ml.
Comment: A proportion of c l in ic a l ly  euthyroid p a tien ts  with
have biochem ical evidence  
exophthalmic ophthalm oplegia/of thyroid o v era c tiv ity  and autonomous
thyroid fu n ction . Unfortunately, the c r i t ic a l  in v e s t ig a tio n s ,
i . e .  a tr i-iodothyron ine suppression t e s t  and serum PBI estim ation ,
were not carried  out 3 years ago. I t  i s  in te r e s t in g  to  specu late
whether the o r b ita l pathology in  th is  p a tien t might not a lso  be
auto-immune in  nature.
This 44 year old woman presented with a goitre of one year's
duration. She had no symptoms of hypothyroidism. On examination,
the goitre was markedly enlarged (125 g.), firm, and nodular, and
the pyramidal lobe v/as palpable.
The patient had a sister who had a goitre, and another sister
who had thyrotoxicosis. The results of laboratory investigations
were as follows:
Precipitin Test: (+).
CP Test: (++).
Thymol turbidity: 6 units.
Thymol flocculation: +2.
Gamma-globulin: 1.5 pg./lOO ml.
ESR (Westergren): 25 mm./first hr.
3%^ Tests. 4 hr. Uptake: 36.6% dose.
48 hr. PBI1^1: 0.22% dose/litre.
BMR (Robertson and Reid) : -7%
P a t ie n t  No. JL.
Serum ch o le stero l: 100 mg./lOO ml.
ECG-: Normal.
PBI: 4*1 pg./lOO ml.
Comment. Although th is  p a tien t i s  c l in ic a l ly  and by laboratory
c r it e r ia  euthyroid , n everth e less  I  f e e l  th at th is  type o f case
should he trea ted  w ith thyroxine sodium therapy. A fter  10 months'
treatment in  th is  p a tien t there has been considerable dim inution
in  g o itre  s iz e , although l i t t l e  as y e t  a lte r a t io n  in  the biochem ical
abnorm alities.
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P a t ie n t  No. 38*
This 61 y e a r  old woman presented with a r e c e n t  i n c r e a s e  in 
size of a goitre of 9 months* duration. She also complained of 
"choking”, hut had no hypothyroid symptoms. On examination, the 
goitre was markedly enlarged (200 g.), firm, and nodular. There 
were some features suggestive of mild hypothyroidism, although 
the hypothyroid diagnostic score 7/as within the normal range.
The results of the laboratory investigations were as follows:
Precipitin test: (+).
CP test: (++).
Thymol turbidity: 14 units.
Thymol flocculation: +3*
Gamma-globulin: 1.65 g«/l00 ml.
ESR (W estergren): 10 mm . / f i r s t  hr.
T es ts : 4  hr. U ptake:46.0/ dose
48 hr. PBI1-51:0.29?* d o s e / l i t r e .
BMR (Robertson and R eid): -13^ .
Serum ch o le stero l: 230 mg./lOO ml.
ECG-: co n s isten t with hypothyroidism.
PBI: 2 .4  Hg./100 ml.
Treatment and Progress. A fter  9 months' treatment with thyroxine
sodium there has been reduction in  g o itre  s iz e  and improvement in
the biochem ical fin d in g s . The r e s u lt s  of thyroxine therapy are
le s s  g ra tify in g  in  p a tien ts  w ith very large g o itr e s .
TAftT.ig I I . D e ta ils  o f Reproductive H istory in  
Female P atien t w ith  Auto-immune T h y ro id it is .
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Table I I .
D o ta lla  of R eproduction  H ia to ry  in  P enala  P a tie n t*  w ith  Anto-laamme T h y ro d it ia .
Caae
No.
U E N S *6
Uenarcha 
(Y ra .)
R u n  ii 
H is to ry  o f 
U enorrhagia
[ S T O R Y  
H is to ry  o f 
ftl igomenorrhoea
RRFR 
Age a t  
Menopause 
( y r a . )
D.O C T
W orried
V E H I  
No. o f 
C h ild ren
STORY 
No. of 
A bortions
C erv ic a l mucus 
T e s t.
1 19 54 Yea 9 22 13 47 Yea 4
3 12 48 No N egative
5 11 Yea 56 14 50 No
7 15 50 Vaa 4 28 14 ♦ 49 Yea
9 15 40 Yea 110 14 41 Yea 111 11 ♦ Yea 312 12 48 Yea 3
13 14 45 Yea 6 N egative
I t 15 Yea
15 14 50 Yea Negative16 10 No
17 13 Yea 10
18 16 50 Yea 3
19 15 50 Yea 6 Negative20 15 47 Yea 222 16 50 No
23 12 Yea 2
24 15 45 Yea 1 2
25 13 41 Yea 5
26 14 ♦ 40 Yea 2 ]
27 14 45 Yea 2 N egative
28 15 ♦ 45 Yea
30 14 44 Yea 2
31 11 40 Yea 2 2 N egative
32 14 40 Yea 1
33 16 48 Yea 4 N egative
35 14 Yea 2 1
36 17 + 45 Yea 1
37 14 Yea 4
38 14 50 Yea 5 2
39 14 Yea 2 .
40 12 51 Yea N egative ,
41 14 45 Yea 3 N egative '
42 13 + Yea 1 1 N egative i
43 11 40 No
44 11 38 Yea 1 I
45 19 54 Yea 9 2 N egative 1
46 15 55 Yea 1 3
47 14 45 No
48 16 47 Yea 3 N egative
49 15 Yea 3 3
50 14 49 Yea 3
TATK.K I I I .  D e ta ils  o f  Reproductive H iatory in  
Female H osp ita l C ontrols,
-yp-fola flC-_____ Detail* of Reproduct&? Hiatory in Female HoapitftI Control*
Ca*a
No.
K e
a  ii ~
C l i n i c a l  C o n d it io n
IS OI
U E
Age a t  
U enarch i
( Y « . )
rOUUVblTt fl
I S T R U A
l i a t o r y  o f  
U e o o rrh a g i
H I S T  
H i s to r y  o f  
Am enorrhoo
R Y
Age a t  
U enopauso 
( * r s . )
KE1
H a r r ie d
HODUCTIVE
No. o f  
C h i ld r e n
HISTORY
U s. o f  
A b o r tio n s
1 66 C h o le c y s t i t i s 16 36 Y es 1
2 56 G a s t r ic  U lc e r 16 66 " 5
3 73 H y p e r te n s io n 16 67
2
4 66 R heum atic H e a r t  D is e a s e 16 52 " 3
5 66 U i t r a l  S te n o s is 12 5
6 66 B a r b i t u r a t e  P o is o n in g 16 "
7 66 D ia b e te s  U e l l i t u a 15 65
8 63 D uodenal D ic e r 11
9 52 U i t r a l  S te n o s is 17 65 " 5 1
10 50 B ro n c h ia l  N eoplasm 16 67 "
11 66 Asthma 16 65 * 3
12 31 D uodenal U lc e r 16 No
13 76 B r e a s t  C arc inom a 12 35
(O v ario cto m r) Y es 3 t
14 66 R e c ta l  C arc inom a 15 No
15 36 A c h a la s ia  o f  C a rd la 13 *
16 76 C h o le c y s t i t i s 13 50 Y es 6
17 61 H aem orrho ids 15 56 * 2
18 67 O s te o p o r o s is 16 68 " 1
19 55 B re a s t  C arc inom a 12 69 " 2 2
20 51 C h o le c y s t i t i s 16 63 " 3
21 59 B r e a s t  C arc inom a 12 . ♦ 61 No
22 56 P y e lo n e p h r i t i s 15 66 Yen 3 3 1
23 69 O s te o p o r o s is 16 69 * 3 1
26 66 11 51 " 1
25 60 U lc e r a t i v e  C o l i t i s 15
60 " 3 •
26 67 U y o c a rd ia c  I n f a r c t i o n 16 ♦ 66 N»
27 62 R hsum ato id  A r t h r i t i s 13 50 ■
28 66 H aem atem esia 12 66 Y es 6
29 68 H y p e r te n s io n 12 57 No
30 60 U lc e r a t i v e  C o l i t i s 16 60 Y es 1
31 67 C arcinom a o f  C olon 16 60 ■ 4 1
32 72 U y o c a rd ia c  I n f a r c t i o n 15 50 " 1
33 58 C h o le c y s t i t i s 15 68 No
3* 69 U i t r a l  S te n o s is 16 ♦ 66 Y es 2
35 51 D uodenal U lc e r 16 50 • 2
36 60 P y e lo n e p h r i t i s 15 35 No
37 58 H aem orrho ids 15 65 Y es 4 1
38 77 H y o c a rd ia l  I n f a r c t i o n 13 66 " 3
39< 62 H y p e r te n s io n 15 51 * 2
60 60 H aem orrho ids 12 • 5
61 50 V a r ic o s e  U lc e r 16 No
62 62 U i t r a l  S te n o s is 16 66 Yes 2
63 67 H o d g k in 's  D ise a se 12 No
66 53 D uodenal U lc e r 16 66 T ea 3 1
65 51 H y p e r te n s io n 15 63 m 1
66 67 G a s tr ic  U lc e r 15 69 • 3
67 30 B a r b i tu r a te  P o is o n in g 13 No
68 75 C e re b ra l  T hrom bosis 13 60 Yes 3 1
69 65 Leukaem ia 13 No
50 35 A s p i r in  P o is o n in g 15
51 73 U y o c a rd ia l  I n f a r c t i o n 13 65 Yes 6
52 60 B r e a s t  C arc inom a 16 55 •
53 68 S te a to r r h o e a 15 . 69 • 3
56 56 I r o n  D e f ic ie n c y  Anaemia 13 68 • 1 1
55 50 B ro n c h ia l  N eoplasm 15 66 • 4 1
56 58 O osophageal N eoplasm 13 60 . No
57 53 H y p e rte n s io n 16 63 Y ss 4 2
58 71 Leukaem ia 15 68 ■ „ 2 2
59 66 Angina 12 52 >60 39 P a n c o n i 's  Anaemia 16 39 « 561 68 A ngina 16 47 No
62 61 U e tic u lo —sarcom a 16 50 •
63 67 A ngina 13 66 Yos 566 69 O s te o p o ro s is U 56 «
65 39 H aem atem esis 15 ♦ 43 • 1 166 66 U y o c a rd ia l  I n f a r c t i o n 15 41 m 5
67 73 O s te o p o ro a is 15 39 «68 59 U y o c a rd ia l  I n f a r c t i o n 16 49 No "
69 68 G a s tr ic  U lc e r 15 49 Yos 3
70 50 H ia tu s  h e r n ia 16 I 44 ■ 1
TABLE IV, R esu lts o f P r e c ip ita t io n  and Complement -  
f ix a t io n  t e s t s  in  P a tien ts  with Auto-immune T h yro id itis  
followed-up without Treatment,
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T a b le  IV .
Results of Precipitation and Compieraent-Fixntion Tests in Patients 
with Auto-immune Thyrortitis Followed-up without Treatment.
Case Thyroid Auto* w E E K S
No. Antibody Tests 0 1 2 3 4 5 6 7 8 9 10 n 12 13 14 15 16
2r-eH 
1 19 20
Comments
3
Prec.
CFT
+
+
+
4
4
+
+
+
4
44
4*
4
4
4 Remained Euthyroid
*7 Prec. + 4 + 4 4 iti CFT 44 44 44 44 44
9 Prec. 4 + + 4 + 4 4 „ „CFT 44 ++ 44 44 ++ 44 44
14 Prec. + 4 - 4 4 M ,1
CJT ++ 44 44 44 44
21 Prec* + 4 4 4 4 4 It It
CFT 4 44 44 44 44 44
25 Prec. 4 4 + +CFT 44 4+ 44 ++
31 Prec. 4 4 4CFT 44 44 44
33 Prec. + 4 4 4CFT 44
16 Prec.
CFT 44 ++ 44 44 44 44 Jecame hypothyroid at 7- weeks
18 Prec.
CFT ++ ++ 44 4+ Z lecnme hypothyroid atJ-k weeks.
TABLE V. D e ta ils  o f F am ilia l S tudies in  
Auto-immune th y r o id it is .
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Table V.
D e ta ils  o f F am ilia l S tud ies in  Auto-immune T h y ro id itis .
Case No. Thyroid Auto­antibody Tests
P re c ip it in  C .F.
D e ta ils  o f  Family H is to iy  o f Thyroid D isease.
13
36
37 
40 
43 
50
AC S is te r ,  2 female f i r s t  cousins and m aternal grandaunt w ith g o i t r e .  
Daughter w ith th y ro to x ico sis  p r e c ip i t in  t e s t  ( - ) ,  CF t e s t  (++). 
B rother w ith th y ro to x ico sis  p re c ip i t in  t e s t  ( - ) .
P a te rn a l male and female f i r s t  cousins w ith th y ro to x ic o s is . 
Male cousin a lso  had exophthalmic ophthalm oplegia.
S is te r  w ith g o itre  and another s i s t e r  w ith th y ro to x ic o s is . 
M aternal grandmother and aunt w ith g o i t r e .
S is te r  w ith th y ro to x ico sis .
Niece (b ro th e r1 s daughter) w ith prim aiy hypothyroidism , 
p re c ip it in  t e s t  ( - ) .
TABLE VI. R esu lts o f thyroid  Auto-ant lb  ody te s ta  
in  Female R ela tives o f  P a tien ts  w ith Auto-immune
T h y ro id itis .
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Table VI
R esults o f  Thyroid Auto-antibody T ests in  Female R ela tives
o f  P a tien ts  w ith Auto-immune T h y r o id itis .
F ro p o s itu s R e la tio n Age Evidence o f  Thyroid T hyroid  A uto -an tibody  T e s ts
No. D isease P r e c ip i t in C .E.
1 S i s t e r 47 Done - +
7 S is te r 45 None - -
S i s t e r 51 Done - -
S i s t e r 57 None - +
15 S i s t e r 60 None - +
S is te r 62 None - + +
H a lf - s is te r 66 None - + +
24 S is te r 50 N one - -
Mother 83 N one - -
26 S is te r 27 N one _ +
S is te r 35 None - -
S is te r 39 None - -
29 D aughter 30 None - -
33 S is te r 59 N one - -
45 S i s t e r 38 None - _
S is te r 40 None - -
S i s t e r 45 None — —
SECTION 2 . A Skin t e s t  in  Auto-immune 
th y r o id it is .
TATtirae I .  C lin io a l D e ta ils  o f  P a tien ts  w ith  
Auto-immune th y r o id it is .
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Table I.
Clinical Details of Patients with Auto-Immune Thyroditis
Case
No.
T hesis
No.
Age
(Y rs)
Sex C lin ic a l
S ta tu s
T hyroid  Auto­
an tib o d y  T e s ts  
P rec . CFT
S kin  T e s ts  
T T+C C ontr
T reatm ent
1 10 52 F Eu + ++ ■*■+(5) ++"(6) - T hyroxine
2 33 55 F Eu + ++ -h-(7.25)++(7-5) - None
3 30 45 F Eu + -H- ++(4.5) -H-C5) - T hyroxine
4 31 61 F Eu + ++ ++(4) ++(5-5) - None 1
5 27 54 F Hypo + ++ ++(4»5) ++(3*5) - None
6 19 66 F Hypo + ++ +-+(4 ) ++-(6. 5) - Hone
7 2 56 F Hypo + ++ ++(2. 5) +-+(3) - None
8 43 45 F Eu + ++ ++(4«5; ++(4*5) - None
9 3 52 F Eu + + +(2. 5) - None
10 24 53 F Eu +* ++ P a r t i a l
T hy ro id ­
ectomy
T hyroxine
11 50 62 F Eu + +(1-75) P a r t i a l
T hy ro id ­
ectomy
T hyroxine
12 26 43 F Eu + ++ + (3 ) - None
Skin Tests* T = thyroid extract, T+C «■ thyroid extract plus cortisone, 
Contr = control injection! (-) negative, (+) positive, and (++) strongly 
positive skin responses. Figures in brackets refer to the mean diameter 
of the skin reactions in centimetres.
Clinical Status* Eu = euthyroid, hypo = hypothyroid.
* Clear-line precipitate.
TABLE I I .  C lin ica l D e ta ils  o f P a tien ts  w ith  
Primary Hypothyroid! am»
Table I I .
C lin ic a l D e ta ils  in  P a tie n ts  w ith  Prim ary Hypothyroidism.
Case
No.
Thesis
No. (Yrs)
Sex C lin ic a l
S ta tu s
Thyroid Auto- 
antibody Tests 
P rec. CPF
Skin T es ts  
T T+C Contr
Treatment
13
14
15
16
17
18
19
20 
21
9
11
6
21
32
27
61
69
15
56
64
44
38
55 
67
56 
51 
40
E u
Hypo
Eu
Hypo
Hypo
Hypo
Eu
Eu
Eu
-(4)
-(3) $
++
+
+
+ (2 .7 5 ) + (3 .2 5 ) -
+ (2 . 25) + (2 . 5) -
Thyroxine
Thyroxine
Thyroxine
None
Thyroxine
None
Thyroxine
Thyroxine
Thyroxine
*  Late onset o f re a c tio n  a t  48 hours#
TABLE I I I .  C lin ic a l D e ta ils  o f P a tien ts  w ith
th y ro to x ico s is , simple g o itr e , thyroid  oanoer.
and in  one P atien t w ith  " U n classified ” thyroid  D isease.
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Table I I I .
C lin ical D e ta ils  o f P a tien ts  with Thyrotoxicosis, Simple G oitre , 
Thyroid Cancer, and in  one P a tien t with "U nclassified" Thyroid D isease.
Case
No.
Age Sex Diagnosis C linical
S tatus
Thyroid Auto-antibody 
te s t s  
Prec. C1T
T
Skin T ests 
T +  C Contr.
Treatment
22 66 F Thyrotoxicosis Toxic + + + - +(1-75) Methyl th io u ra c il
23 48 F " ti - - - - None
24 42 F II If - + - - None
25 48 F " II - + - - Potassium Perch lo ra te
26 76 F » II - + - - None
27 48 F " II - + + - - None
28 38 F " II - + + - - None
29 45 F " II - + + - - None
30 20 F It II - ++ - - None
31 29 F II - + + - - None
32 37 F Simple Non-Toxi 
Goitre
: Euthyrc id  - - - - None
33 27 F " II - - - - None
34 47 F " II - - - - None
35 31 F " 11 - - - - None
36 32 M Thyroid Canoer# II - - - - None
37 69 F "Unclassified" II - - +(2.25) +0»25) - Thyroid Extract
*  P ap illa ry  Menooaroinoma
Skin Testsx T -  Thyroid ex tra c t, T + C  -  Thyroid ex tract plus cortisone , Contr. -  Control in je c tio n . 
Figures in  brackets re fe r  to  diameter o f skin reactions in  centim etres.
TABLE IV. C lin ic a l D e ta ils  in  Control 
P a tien ts  without Overt Thyroid D isease.
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Table IV,
Clinical Details in  Control Patients without Overt Thyroid Disease*
Case
Ho.
Age Sex D iag n o sis Thyroid
P re c .
Auto-antibody
t e s t s
CFP
Skin
T
Tests
T + C C
36 82 F P e rn ic io u s  Anaemia - + K2.25) +<3) -
39 70 F S e n i l i ty  O steo p o ro sis - + - -
40 73 F Cor Pulmonole - + - -
41 69 F H ypertensive  H eart F a i lu re - ++ - -
42 42 F C ereb ra l Bnbolism , M itra l  
S te n o s is ,  A u ricu la r  F i b r i l l a t i o n  - - - - -
43 68 F D iab e tes  M e llitu s - - - -
44 71 F Ischaem ia Heart D ise ase , 
C ongestive C ardiac F a i lu re - - - -
45 70 F Chronic b ro n c h i t is - - - - -
46 60 F C ongestive Cardiac F a ilu re - - - - -
47 82 F S e n ile  Dementia - - - -
48 78 F Hem iplegia - - - -
49 42 U B ro n ch ia l lieoplasm - - - - -
50 56 F Uraemia P y e lo n e p h r i tis - - - -
51 52 F C ereb ra l Embolism, M itra l  
S te n o sis _ _ _ _
52 61 M Bronchial Carcinoma - - - -
53 69 F Uyooardial Infarction - - - -
54 79 F Senile Dementia - - - .
55 81 F S enility  Dementia - - - _
56 41 X Gastrio Neoplasm - - - -
Skin T ests I T -  thyroid  e x tra c t, T + C  -  thyro id  ex trac t plus c o rtiso n e , C -  
oon tro l in je c tio n . Figures in  b rackets r e f e r  to  d ia n e te r o f  sk in  reac tio n s  in  
o en tin e te rs .
TABLE V . R esu lts o f S e r ia l S tudies o f  
P r e c ip it in  and Complement F ixa tion  T ests  
a fte r  Skin t e s t in g  in  thyroid  D iseases
4 4 4 -
. R esu lts o f  S e ria l S tudies o f  P re c ip it in  and Complement-Fixation T eats a f t e r
Case
No*
Diagnosis Thyroid
Auto-Antibody
T ests
W E E K S
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ^  21 22 23 ^
1 Auto-immune f Preo
CIT
♦ t  t  ++ ++ + ++ --- ---------------------- .-----
• 2 II Preo
CIT
+ +
++ ++ _____
3 It Prec + +
4 II Preo
CIT
+
++ ++ ++ -------------------------------
5 II Preo
CFP
+ +++ ++ . -----------------------
6 II Preo
CIT
+ + + ++ ++ ++
7
8
II
II
Prec
CIT
Preo
CIT
+ +
++ ++
+ + '+ + • + + + +  + + ----------------...
9 II Prec
CIT
+ + + 
+ + +
10 II Preo
CIT
+ + - 
++ +
11 II Preo
CIT +
12 II Preo
CIT
+ + + 
+ + + + + +
13 Primary Hypo­
thyroidism
Prec
CIT + 
+
14 II Prec
CIT
+ 
i
+ 
i
+ 
i 
+ 
i
15 II Preo
CIT
+ ++ +
16 It Prec
CIT ++ -
17 II Preo
CIT ++ ++ + + +* ’ ++
18 It Preo
CIT ±+ + + j.
19 IT Prec
CIT + 
1 
+ 
1 
1 
1
+ 
1
20 II Preo
CIT
21 II Prec
CIT
" “
22 Thyrotoxicosis Prec
CIT
+ + + ■*•
++++++++
23 II Prec
CIT
-
24 II Preo
CIT — M M
25 II Prec
CIT + ++ 44- 44-26 II Prec
CIT + 
1 
+ 
1 
+ 
«
27 Preo
CIT ++ ++ ++28 Prec
CIT + + + + + + + +  ++ 4-4- .
29 II Prec
CIT ++ ++ ++
30 II Prec
CIT
+ 1 -------------
++ ++ + +
31 Prec
CIT + + + + + + '  +
32 Simple non- 
JEoxic G oitre
Preo
CIT
33 N Prec
CIT “ “ -
A n Prec
CPP
35 n Preo
CPE -  - - -
TABLE V I. R esu lts o f S er ia l Studies o f
P r e c ip it in  and Complement F ixa tion  (CF) t e s t s  
a f te r  sldn te s t in g  in  Control P a tien ts  without 
overt thyroid  D isease .
if1+6 .
Table VI.
R esults o f S e ria l S tudies o f P re c ip it in  and 
Complement-Fixation (CF) T ests a f te r  Skin 
Testing in  Control P a tien ts  Without overt 
Thyroid Disease*
Case
No.
Thyroid
Auto-Antibody
Tests 0 1
Weeks
2 3 4 5 6
38 Preo _ _
CIT + +
39 Prec _
CIT + + +
40 Preo _
CIT + +
42 Preo _
CIT - -
43 Preo _
CIT - - -
47 Prec _ _
CIT - - -
48 Prec _
CIT - - -
50 Prec _ _
CIT - -
51 Prec _
CIT - -
53 Prec
CIT - -
54 Prec _ _ _
CIT - - -
55 Prec
CIT - - -
VO Prec
CIT - -
SECTION 3. Bloohemioal S tu d ies .
TABLE I.
R esults o f Serum P rotein  In v estig a tio n s  
in  Control S u bjects*
T a b le  I
Results of Serum P rotein  Investigations in  Control Subjects
Case
Ho.
Age Sex Serui
Albumin
D
Globulin
Proteins
ot Globulin 
1
( g.lOOnl’
of Globulin 2 p Globulin y Globulin
1 35 F 5.6 1.9 0.19 0.50 0.S8 0.632 39 F 5.0 1.4 0.15 0.33 0.45 O.48
3 21 H 5.0 1.5 0.12 O.35 O.46 O.58
4 54 F 5.5 2.3 0.22 0.49 0.60 1.00
5 63 F 5.0 2.1 0.18 0.44 O.67 0.82
6 51 F 4.8 2.0 0.13 0.30 O.57 0.91
7 29 T.I 5.6 2.2 0.16 0.45 0.66 0.94
8 59 F 5.3 1.9 0.15 0.39 O.59 O.76
9 46 F 5.0 2.0 0.24 0.50 0.70 O.76
10 53 F 5.4 1.5 0.21 0.36 O.5O 0.6311 50 F 4*9 2.0 0.12 0.43 0.62 0.8312 41 F 5.5 2.2 0.16 0.50 0.61 0.92
13 39 F 5.0 1.5 0.18 0.22 0.41 0.70
14 36 F 5.5 2.2 0.24 0.49 0.63 0.84
15 31 I! 5.6 1.7 0.18 0.50 O.48 0.53
16 34 U 5.0 2.1 0.25 0.44 0.95 0.82
17 60 F 5.3 2.0 0.22 0.45 O.55 0.79
18 57 F 4.9 1.9 0.30 O.36 0.50 0.71
19 40 F 4.8 2.2 0.29 0.67 O.56 0.6820 42 F 5.5 1.7 0.25 0.49 0.49 0.4821 48 F 5.6 2.2 0.28 0.62 O.47 0.8322 51 F 4.8 1.9 0.22 0.50 O.48 0.70
23 27 3.! 5.4 1.5 0.16 0.35 0.40 0.60
24 29 3.1 4.9 1.5 0.16 O.32 0.41 0.61
25 30 K 4.8 2.0 0.25 0.38 O.56 0.8126 30 LI 5.6 1.9 0.12 0.38 O.48 0.94
Mean Age 42*1 years Age Range 2 1 - 6 3  years-
TABLE II.
R esults o f Serum P rotein  In v estig a tio n s  
in  Auto-immune T h y ro id itis .
TABLE H I .
R esults o f Serum F loccu la tion  T ests and 
Erythrocyte Sedim entation Rate in  
Auto-Immune T h y ro id itis .
451.
T a b le  I I .
R esu lts  o f Serum P ro te in  In v e s tig a tio n s  in  Auto-immune T h y ro d itis
Case
Ho.
Age Sex S I 
Albumin
R U M 
Globulin
P R
oC ^Globulin
0 T E I 1; 5 
o(_2Gl0kulin
( g./lOO n 
p Globulin
1)yf Globulin
2 56 F 4.5 2*4 0.16 0 .4 2 0 .6 2 1.42
3 52 F 4.7 2.3 0 .0 7 0.35 O .5 3 1.34
5 41 F 3.8 3.06 63 F 3.9 2 .1 0.28 O .5 3 0 .5 1 0.79
7 62 F 4.3 2 .2 0.19 0.35 0.59 1.08
8 49 F 4.3 1 .0 0.06 0 .2 1 0.19 O .5 4
9 63 F 4*3 3.2 0.16 O .5 9 O .4 7 1 .9 8
10 52 F 4 .6 2.3 0 .2 1 O.4 3 0.71 0.98
11 37 F 4.5 2 .0 0.16 O .3 4 0.60 0 .7 0
12 48 F 4*7 2 .1 0.28 O .4 5 0 .4 1 0.96
14 28 F 3.9 3.0 0 .2 6 O .4 2 O .5 8 1 .7 4
15 57 F 3*8 2.3 0.16 O .4 7 O .5 2 1.16
16 4 0 i 4-2 2 .2 O .3 6 C • /; 0 .4 0 l.ou
17 45 F 4.0 2 .0 0 .1 2 O. 3 0 0.38 1 .2 2
18 52 F 4.0 2 .0 0 .1 7 O.4 3 O .5 8 0.83
19 66 F 4.3 3-5 0.31 O .8 3 0 .7 0 1 .6 6
20 46 F 3-5 2.9 0 .1 4 O .3 6 0-34 2.06
21 63 U 3*7 2.3 0 .1 5 0 .4 0 O.5 6 1.18
22 56 F 3.5 3*5 0.09 O .3 0 O .5 8 2 .5 3
23 44 F 4.7 1 .8
24 53 F 3.8 2 .0 0.16 O .4 3 0.67 0 .7 4
25 50 F 4.3 2.5 0 .2 2 O .3 4 O.5 2 1 .4 2
26 43 F 4.2 2 .2 0 .2 4 0.38 0.49 1 .0 9
27 54 F 4 .6 1.3 0.13 0.35 0.30 0 .9 4
28 50 F 4-3 2 .2 0 .1 2 0 .5 0 O.4 9 1 .1 0
29 51 It 5.1 2 .0 0.16 0.36 O .6 5 0 .8 4
30 45 P 3.8 2.3 0 .2 1 0.38 0.81 0 .9 0
33 55 !■' 4.2 2 .2
34 51 ;.i 5.0 4 .6 O .3 3 0.79 0.80 2 .6 8
35 46 F 4«6 1.9 0 .2 2 O.4I 0 .6 3 0.64
36 50 F 4 .6 2.9 0 .1 5 0.69 O .7 2 1.34
37 44 F 4.1 3.0 0.31 O.4 7 C .6 5 1.54
38 61 F 3.9 3.0 0.30 O .4 7 0 .6 8 1.65
39 45 F 5 .0 2.4 0 .1 1 O .5 4 0 .6 6 1 .C9
43 45 I1 4.2 2 .2
44 44 F 4-3 2 .0 0.32 0.37 0 .6 6 0 .6 5
45 36 F 4-2 2 .1 0 .2 1 O .3 7 0 .6 2 0 .9 0
47 64 F 4.4 2.7 0.23 O .4 1 O . 9 0 1 .1 5
48 47 F 3.5 2.9 0.16 0.49 O .5 2 1.75
49 4 0 F 4.2 1-7
50 62 F 3.8 1 .8 0.28 O.3 7 0.47 0 .6 8
Liean Age 50.1 years Age Range 28 -  66 y ears
k52-
T a b le  I I I ,
R esu lts  o f Serum F lo ccu la tio n  T ests  and E ry th rocy te  
Sedim entation Rate in  Auto-immune T h y ro d itis .
Case
No.
Thymol
T u rb id ity
(U nits)
Thymol
F lo ccu la tio n
Cephalin
C ho leste ro l
C o llo id a l
Gold
(U nits)
Zinc Sulphate
T u rb id ity
(U n its)
E .S.R .
(mm /hr.)
2 8 3 3 5 16
3 4 1 0 5 4
5 12 3 3 5 40 7
6 6 2 0 15 37
7 4 1 1 17 4
8 6 3 3 3 66
9 1 0 0 24 34
10 14 3 2 5 40
11 5 0 2 5 5
12 3 1 0 4 22 15
14 10 3 3 5 14
15 8 3 0 5 30
16 5 4 3 5 27 30
17 12 3 3 5 32
18 3 0 3 5 18 22
19 3 0 2 2 9 6
20 7 3 2 5 12
21 4 3 2 5 12
22 10 3 5 60 57
23 1 0 0 1 3 8
24 1 0 0 1 3 46
25 2 0 5 25 826 14 4 0 5 23
27 3 2 2 5 928 5 0 5 23 10
29 1 0 1 15 1130 5 4 3 5 19
33 5 3 2 3 13 38
34 11 4 4 30 46
35 2 0 0 13 1836 1 0 0 14 437 6 2 2 22 2538 14 3 3 23 3139 4 1 1 13 1443 4 0 5 31 1344 1 0 1 8 78
45 2 0 1 8 2347 2 0 0 12 1248
49
5
4
1
0 5 1515
9
2250 1 0 0 1 18Mean Age 50.1 years Age Range 28 - 6 years.
TABLE IV.
R esults o f Serum P rotein  In v estig a tio n s  
in  Primary Hypothyroidism.
TABLE V.
R esults o f Serum F looou lation  T ests and 
Erythrooyt& Sedimentation Rate in  
Primary Hypothyroidism,
T a b le  IV,
R e su lts  o f  Serum P ro te in  I n v e s t ig a t io n s  in  Prim ary H ypothyroidism
Case
!Jo.
Age Sex Thyroid Auto­
antibody Tests 
Preo. CF
Albumin
Serum Pr 
Globulin
oteina ( 
^G lobulin
'./lOOnl.).
(^Globulin P Globulin ^Globulin
1 52 U + ++ 4«4 2 .6 0.25 0.25 0.53 0.98
2 61 c + ++ 3.7 2 .1 0.23 0.28 0.55 1.04
3 60 F + ++ 5 .6 3-0 0.27 0.35 1-23 1.15
4 56 F + ++ 4.3 2 .2 0 .2 2 0.24 1-95 0.88
7 67 F + - 3.9 2.6
6 64 F + ++ 4*7 3-0 0.05 0.08 0.71 0.71
c 64 F + - 4.5 2 .0 0 .06 0.54 0.75 1.11
11 56 F + ++ 4.7 1 .6
12 57 F - ++ 4*3 2 .2 0.29 0 .6 9 0.55 0.66
15 55 K - ++ 4 .2 2 .1 0.29 0.39 O.58 0.84
16 49 U - ++ 4 .6 1 .6 0.14 0.41 0.43 0.62
18 56 F - ++ 4.1 1.9 0.29 0.42 0.5 0 0.69
19 56 F - ++ 3.7 2 .0
2C 70 F - ++ 5-9 2.5 0.13 0.66 0.63 1.08
21 38 F - ++ 3.7 2 .1
22 39 F - ++ 4.5 2 .0
23 59 F - ++ 3-9 1.7
24 64 F - ++ 3.9 1.6
26 57 11 - + 4.0 1.6 O.O4 0.09 0.82 0.86
27 56 F - + 4.5 1.5 0.17 0.33 O.47 O.56
28 56 F - + 4-5 1.5 0.13 0.51 0.45 0.42
30 56 F - + 3-9 2.1 0.27 0.38 0.68 0.77
32 67 F - + 3.9
37 56 M - - 4.5 1.3 0.13 0.27 0.59 0.81
38 36 1.1 - - 4 .3 2.2 0.15 O.43 0.53 1.10
39 50 F - - 4.9 1.8 0.17 O.45 0.58 0.61
41 56 ? - - 4.0 1.5 0.12 0.29 0.41 0.68
42 42 F - - 4.0 2.7 0.20 O.42 0.83 1.09
44 64 F - - 4.9 1.7 0.16 O.35 0.62 0.57
45 73 F - - 4-2 2.1 0.25 0.55 O.48 0.89
46 55 F - - 4*5 1.4 0.21 0.29 0.45 0.55
48 57 F - - 3.8 1.4 0.22 0.28 0.41 0.62
49 52 11 - - 4.2 2.2
51 61 H - - 3.6 3.9 0.22 0.94 1.36 1 .4 0
54 62 F - - 4.2 2.1
63 37 F - - 4 .0 2.3
67 34 F - - 3.8 1.4
68 49 F - - 4*5 1.5
70 65 F - - 3.9 2.4
71 52 F “ ■ 4.3 2.6 0.14 0.63 0.96 0.88
Wean Age 55.4 years Age Range 34- 73 years
For fu r th e r  o l in io a l  d e ta i l s  see  appendices Chapter HI S e c tio n  1 .
TeSCkX- Results of Serum Flocculation Tests and Erythrocyte
1 Sedimentation Rate in Primary Hypothyroidism.
Case 
Ho. 1
Age Sex Thymol
Turbidity
(Units)
Thymol
Flocculation
Cephalin
Cholesterol
Colloidal
Gold
(Units)
Zinc Sulphat<
Turbidity
(Units)
3 EtS«Hs 
(mu/hr)
1 52 H 4 1 0 14 6
2 61 ]? 5 1 5 24 41
3 56 ]p 2 0 •> 17 32
4 56 F 1 0 4 15 13
5 50 F 2 0 11
6 47 F 2 0 0 0
7 67 F 1 0 15 21
8 64 F 1 0 2 11 21
9 56 F 2 0 0 3 5
11 57 3? 2 0 1 3
12 57 F 0 18
13 36 F 2 0 0 3
14 63 F 2 0 0 0 15
15 55 H 3 0 3 19
16 49 H 2 0 0 2
17 '60 F 3 0 16 . ' 5
18 56 F 0
19 56 F 3 0 0 t 17
20 70 F JO 0 3 17
21 38 F 3 0 0 2 82
22 39 F 3 0 0 4 . 8
23 59 F 1 0 2 5 13
24 64 F 0 . 0 0 31
25 38 F 3 0 2
26 57 M 1 0 0 4 18
27 56 F 1 1 1 2 ' 25
28 60 F 0 0 10 12
29 53 F 1 0 • 7 31
30 56 M O' 31
31 65 F 1 0 0
32 67 F 0 0 1 32
33 53 F 1 0 0 1 6
36 38 F 4 1 3 18 55
37 56 11 0 0 2
38 36 11 4 0 2 1 17
39 50 F 1 0 1 11 23
40 66 F 5 3 0 • 9
41 56 F ^ \ 0 0 5
42 42 F 1 0 5 3
44 64 F 0 - 0 0 22
45 73 F 1 0 0 0
46 55 F 1 0 0 M
47 62 F 0 0 0
48 51 F 1 0 1 14
49 52 LI 1 0 0 18
51 61 E 1 0 0 7
52 50 11 < 10
53 51 1 13
54 62 F 1 0 0 2 9
55 67 F 1 0
56 58 F 1 0 8
57 50 F 0 0 8 \
61 51 E 3 0 0 5 \
63 37 F 1066 56 F 0 8
67 34 F 2 0 0 2 868 49 F 2 0 0 2 20
69 40 F 5 0 1 5
70 65 F 3 1 16 18
71 52 F 1 0 0
2 14
Mean Age 3 4 .4  years*  Age Rsnge 24 -  70 y e a r s .
456.
/
Table VI,
R esults of Serum Protein  In v estig a tio n s  in  Simple G oitre.
457.
Table VI.
Results of Serum Protein Investigations in  Simple Goitre
Case Age Sex Gerum FToteina (g./lOOml)
No. Albumin Globulin 0L1 Globulin dp Globulin p Globulin ^Globulin
1 44 F 5.6 1.9 0 .1 5 0.34 O .5 4 0 .8 7
2 28 F 5.0 1.5 0.08 0.27 0 .4I 0.74
3 31 F 4.9 2 .0 0 .2 2 0.43 0.47 0.89
4 42 F 4*2 2 .1 0 .2 6 0.49 O .5 8 O.7 8
5 21 F 5*5 1.5
6 35 F 4.9 2 .1 0 .1 9 O. 5 2 0.59 0.80
7 56 F 4.3 2 .2 0 .2 0 O.3 3 0 .8 0 0.87
8 20 F 4 . 4 1 .6 0 .2 1 0.29 0.43 0 .6 2
9 53 F 4.8 2 .0 0 .2 6 0 .4 8 O . 5 6 0 .7 1
10 37 F 5.5 2.3 0 .2 1 O .5 2 0 .7 1 0 .8 6
11 47 F 5.3 1.9 0 .2 0 0 .4 3 O.4 4 O .7 8
12 32 F 4-9 1.9 0 .1 2 O.3 6 O .5 7 0.84
13 37 F 5.4 1.5 0 .1 5 0.29 O .4 5 0.61
14 42 F 5.4 1*5 0 .0 9 O .3 6 0 .5 1 O .5 4
15 25 F 4.8 2 .2 0 .1 9 O .4 7 0.43 1 .1 0
16 25 F 5.0 2.5 0.35 O .5 4 0.67 0.94
17 43 F 4.9 2 .0 0 .1 1 0.39 0.53 0.97
18 16 F 5.4 1.5 0 .2 2 O .3 7 0.40 0 .5 0
19 19 F 5.6 2 .2 0 .1 9 O.4 9 0.61 0.92
20 33 F 5.0 1.4 0.06 0.23 0 .4I 0 .7 0
21 31 F 5.6 1.9 0.23 O .4 4 O .4 5 O .7 9
22 21 F 4.9 2 .1 0.23 O .4 2 O .5 6 0 .8 6
23 39 F 4.3 1*4.
24 25 F 5-9 1.7 0.16 0.39 O .4 4 0 .7 1
25 32 F 4-2 1.9 O.1 9 O .3 8 O .3 2 1 .0 1
26 47 11 3.9 1.7 0 .2 1 0.29 O .4 6 O .7 5
27 32 F 4.5 1.9 0 .1 7 O.4 9 0.43 0 .8 1
28 33 F 4.4 1.9 0.35 O .2 5 O .4 7 0.84
29 67 F 4.2 1 .6
30 37 F 4.3 1-7
31 46 : F 4*5 1.7 0.29 0.39 0 .4 1 0.60
32 50 F 4*3 2 .1
33 39 F 4 . 6 1 .8
Mean age 3 5 .9  years Age Range 16 - 67 years.
Table VII.
R esults o f Serum F lo ccu la tio n  T ests and Erythrocyte  
Sedimentation Rate in  Simple G oitre,
u«.
R»juli» of Serua Flocculation Teata «nd^t7ttooo]rt*_3fdlgw|tatlc^ 
S>U lit Csit?<«
s
Cut *«• Six Thynol Thymol Qsphalia Colloidal lino Sulpfasta (aq/hr)So. Ttffbidltj Tlooculatiao Gbolsstorol Cold Turbidity
(Quits) (tfrilts) (Units)
1 44 7 2 0 3 6
2
3
20
51
7
7
1
1
0
0
1
5
• 9 
3
4 44 7 1 0 1 5
5 21 7 1 0 1 11
6 55 7 1 0 1 8
7 56 7 3 0 12
a 20 7 3 0 3 4
9 55 7 1 * 0 3
10 57 7 1 0 1 6
11 47 7 1 0 5 7
12 32 7 2 1 3 6
15 37 7 2 0 1 2
14 42 7 •0 4 10
15 25 7 0 2 1
16 25 7 0 3
17 43 7 3 • 0 3 3
la 16 7 0 2
19 19 7 1 0 5 3
20 33 7 1 0 3 5
Z1 31 7 1 0 1 6
22 21 7 1 0  ' 7 6
23 39 7 0 3 5
24 25 7 2 0 4 6 7*
25 32 7 3 1 2 1 2 11
26 47 1 0 3 23 9
27 32 7 1 0 1 4
29 33 7 1 0 9 2
29 67 7 0 4 12 * 16
30 37 7 1 0 12 12
31 46 7 6
32 50 7 1 0 5 3
33 39 7 3 0 3 6 5
34 42 7 1 0 0
35 26 1 0 3 12 9
36 33 7 0 1 5 11
37 47 7 1 0 8 U
38 21 1 0 0 1 a 2
39 36 7 1 0 0 1 7
40 55 7 1 0  . 15 8
41 19 0 0 4 7
42 54 7 1 0 5 19 4
43 36 7 9 0 1 3 10
44 40 7 1 0 0 7
45 32 7 1 0 7 4
46 37 7 0 1 6 3
47 40 7 I 0 0 1 2
48 27 7 1 0 0 1 6
49 27 7 0
50 45 7 1 0 0
51 43 7 1 0 1 12 7
52 16 7 1 0 0 1 ‘ 4
53 20 7 1 0 0 13
54 34 7 1 0 0 4
55 30 7 1 0 0 1 7
56 21 7 1 0 0 5 9
57 40 7 2 0 3 1 1 2
58 25 7 0 0 4 ' •
-.52 . .y _ _____ 0 0 1 18
60 47 0 0 1 4
61 34 7 1 4 25 1362 47 7 1 O'** 0 0
65 33 7 1 0 13 264 32 7' 1 0 0 2 X6560 60 7 1 0 0 0 1
66 44 7 0 1 2 x
67 50 7 1 0 0 2 2
66 46 7 1 0 3 20 669 42 7 1 0 0 4 270 39 7 2 0 2 3 4
71 a 7 2 0 0 3 2
72 47 7 2 0 0 0 5
75 33 7 1 0 0  • 274 26 7 2 0 7 8
75 36 7 1 0 fi
76 54 7 1 0 5
77 19 7 2 0 676 55 7 2 0 0 4 *
79 36 7 1 0 1 960 27 1 0 2 5 3
01 41 7 2 0 X5 862 36 7 2 0 1 7
65 31 7 1 0  • 4 5
64 49 7 1 0 u
05 36 7 3 0 0 * 3806 26 7 1 0 0 5
67 20 7 1 0 0
66 43 7 1 0 0 X09 45 1 0 0 x90
91
15
a
7
7
1
2
0
0
0 1
16
11
92 30 7 3 0 1 1
95 25 7 2 0 0
94 40 7 * 2 0 1 11 395 a 7 1 0 13
96 30 7 2 0 2 1297 j34 7 6 0 5 3
90 30 7 2 0 1 4 16 799 50 t 1 0 x
100 55 7 1 0
101 27 7 1 0
102 27 7 1 0 1
103 42 7 2 0 1 4
104 43 7 3 0 2 5 9
105 17 7 1 0 0 x 6106 20 7 2 0 0107 31 7 1 0 0 x106 30 7 1 ' 0 13
1 09 23 7 2 0 * 0 7u o 26 7 1 0 0 5
111 24 7 1  , 0 0 7n i 23 7 2 0  . 0 4
115 40 7 1 0 0 * 8114 42 7 1 0 9 6
115 41 7 1 0 0 n116 63 7 2 0 0 5117 51 7 1 0 2 1116 60 7 2 0 0 6119 23 7 2 0 0 2
120 26 7 1 0 0 * 3
121 40 7 1 0 0 3
122 42 7 3 0 X 8U125 46 7 1 0 X ■ 3
124 33 7 1 0 12 .
10
125 35 7 , 1 0 1 3
126JI 31 7 2 0 0 3
127 33 7 1 0 0 1
i«* m n p  15 -  60 ;
TABLE VIII.
R esults o f Serum P rotein  In v estig a tio n s  
in  T h yrotox icosis.
TABLE IX,
R esults o f Serum F loccu la tion  t e s t s  and 
Erythrocyte Sedimentation Rates in  
T hyrotoxicosis.
Table VIII,
R e su lts  o f  Serum P ro te in  I n v e s t ig a t io n s  i n  T h y ro to x ic o s is
Case A g e Sex Thyroid Auto- Serum Proteins ( gylOOml).
17o. Antibody te s ts Albumin Globulin ol, Globulin J.jGlo'bulin p Globulin ^Globulin
Prec. CP
1 43 P . + 4.3 2 .1
2 31 P - 4 .1 1.9 0.15 0.28 0 .5 0 0.99
3 48 P - + 4 .6 1.5 0.17 O.34 0.39 0. 6C
4 26 P - ++ 4 .7 1.8
5 21 P - ++ 3 .8 1.5 0.17 0.38 0.34 0.61
6 65 F - - 3.6 1.9 0.21 O.49 0 .42 O.78
7 66 F + ++ 4 .0 1.8 0.17 O.34 0.68 0.62
8 48 P + -H- 4 .2 1.3 0 .17 0.28 0.36 0.49q 21 P + ++ 4 .4 1.9
10 48 P - + 3 .9 2 .0 0.23 0.43 0.63 0.71
11 37 P - - 4 .4 1.8 0.19 0.43 0.47 0.71
12 54 P - + 4 .3 1.7 0.14 O.37 O.52 0 .67
13 48 P - ++ 3 .6 2.0
14 50 P - + 4 .3 2.2 0.20 0.39 O.58 1.03
15 37 1! - ++ 4 .0 1-9 0.13 0.38 C.41 0 .97
16 41 LI - -H- 4 .5 2.5 0.20 0.52 0.00 0.96
17 55 P - - 4 .0 2.6 0.28 0 .6 2 0.63 1.08
18 28 P - ++ 3 .7 1-9 0.20 0.29 0 .4 9 0.92
19 29 P - ++ 4 .0 1.6 0.10 0.35 0.43 0.6320 41 P - - 4 .8 1.6 0.19 0 .1 9 0.52 0.6921 25 U - - 4 .0 2.1 0.19 O.43 0 .57 O.91
22 37 F - - 3.3 1.3
23 43 i! - - 4 .0 2.4 0.23 O.53 0 .67 0.97
24 43 - - 4 .7 2.5 0.25 0.48 0.78 0.9925 40 P “ ++ 4 .1 2.6 0.23 0.60 0.59 1.1826 51 1!
11
- 3 .9 2*4 0.10 O.4I 0 .7 7 1.12
27 47 “ ++ 3 .6 1.9 O.24 0.34 0 .5 0 0.8128 44 H - ++ 4 .0 2.0 0.16 0.53 0 .62 0.6929 33 P - - 5 .0 1.4
30 25 F - - 5 .6 1.9
31 59 P “ ++ 3 .8 1.4 0.12 0.29 0.39 0.6032 38 P - - 4 .0 1.0 0.16 0.37 0 .4 7 0.8333 59 P “ “ 4 .2 1.6 0 . I 7 0.33 0 .2 7 0.8434
35
49
51
P
P 3 .94 .7
1.6
1 .5
O.19 0.29 0.38 O.73
36
37
20
43
P
H
•H-
+
4 .8
4 .0
1 .5
1.9
0.11
0.13
O.44
0.28
0 .4 0
0 .5 0
O.56
0.99
L'aan age 4I .8  years A g e  range 2 0 - 6 6  years.
—
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TABLE X.
R esults o f Serum P rotein  In v estig a tio n s  in  
Thyrotoxic P a tien ts  with Exophthalmic 
Ophthalmoplegia»
TABLE XI.
R esults o f Serum F loccu la tion  T ests and 
Erythrocyte Sedimentation Rates in  Thyrotoxic 
P atien ts w ith  Exophthalmic Ophthalmoplegia*
464-
T a b le  X.
Results of Serum Protein Investigations in Thyrotoxic 
Patient3 with Exophthalmic Ophthalmoplegia*
Case Age Sex Serum Proteins ( g.lOOml)
No. Altiumin Globulin o^xOlobulin ol^Globulin Globulin ^Globulin
1 33 P 3-5 1-3 0.09 0 .30 O .42 0.49
2 58 F 4.0 2.5 0.29 0.64 0.06 1 .0 1
3 42 M 4*6 2 .6 0 .2 2 O .46 O.64 1.30
4 53 M 4-0 2.5 0.28 0.65 O .55 1 .02
5 47 P 3-7 1 .8 0 .21 0 .46 0 .40 0.73
6 47 11 4.0 1.5
0.657 55 I;I 4 .8 1-5 0.17 0 .3 0 0.39
8 55 P 4 .0 2 .0
10 39 F 3-9 2 .0 0.25 0.27 0.60 0 .88
11 45 M 4 .4 1 .8 0.21 0*46 0 .4 0 0.73
12 73 F 3-6 1-9 0.23 0 .2 6 0.57 0 .8 4
13 37 M 4.0 1 .8 0.14 0.43 0*48 0.74
14 65 H 3-7 1-9 0 .15 0.45 0.53, O .76
15 25 P 4-9 1-5 0.19 0.21 O .44 0.67
16 56 Ivl 3-9 2 .1 0.13 0.79 O .47 0.72
17 69 M 4*0 2 .0 0.24 0.28 0.60 0.38
465.
T a b le  X I,
Results of Serum Flocculation Tests and Erythrocyte 
Sedimentation Rates in Thyrotoxic Patientsv/ith 
Exophthalmic Ophthalmoplegia•
Case
Ho.
Thymol
Turbidity
(Units),
Thymol
Flocculation
Cephalin
Cholesterol
Colloidal
Gold
(Units).
Zinc Sulphate 
Turbidity 
(Units^.
1 2 0 0 4 23
2 2 0
3 1 0 3 9
4 1 0 2 12
5 1 0 0 12
6 1 0 4 11
7 0 0 7
8 1 0 0 2
9 1 0 0 13
10 1 1 1
11 1 0 4 19
12 1 0 1 13
13 1
14 1 0 10
15 1 0 0 11
16 1 0 2 10
Mean Range.‘49*9 years. Age Range; 25 - 72 years*
TABLE XII.
R esults o f Serum P rotein  D etem in ation s in
Thyrotoxic P a tien ts  Euthyroid a f te r  treatm ent.
TABLE X III.
R esu lts o f Serum F loccu la tion  T ests in  
Thyrotoxic P a tien ts  Euthyroid a f te r  treatm ent.
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T a b le  X I I .
R esu lts  o f Serum P ro te in  D eterm inations in  Thyrotoxic P a tien tsE u th y ro id  a f t e r  Treatm ent
Case Age Sex Serum Proteins (g./l00ml} Treatment and Remarks.
No. Albumin Globulin otj Globulin dc2 Globulin p Globulin XGlobulin
1 50 H 5.0 1.4 0 .1 3 0.25 0.37 O.5 6 Methylthiouracil
2 70 F 5.0 1.5 0.11 0 .2 6 O.4 6 0.67 1131 Therapy
3 41 F 4 .8 2.0 0.16 0 .4 2 0.64 0.80 Sub-total thyroilectomy 1^ -3 It her apy
4 4 6 11 5.0 2.2 0.28 0.37 0.44 1.11 1131 Therapy
5 45 P 4.9 2.0 0.21 O .5 2 0.57 O.7O 1I3I Therapy
6 66 P 4.9 1.9 0.23 O .4 9 O . 5 2 O .6 7 ll31 Therapy
7 34 P 4 .8 2.2 2.27 0.37 O.5 9 0.97 Sub-total Thyrcileotony
8 65 M 4.9 1.9 0.21 0 .3 1 O .4 6 0.92 1131 Therapy
9 26 P 4-9 1.5 0 .1 9 O.3 8 O . 4 2 O. 5 2 Pot. Iodide
10 37 M 4 .8 2.0 0 .1 4 0 .3 0 O.5 2 1.03 Methylthiouracil
11 72 F 4 .8 1.9 0.08 O.3 2 0.55 O.9 5 ll31 Therapy
12 31 P 4 .8 2.0 0.24 O .4 6 O.4 8 0.82 Corbimazole
13 20 P 3.7 1*7 0.22 0 .3 1 O .4 6 0 .7 1 Pot. Perohlorate
14 53 P 4-1 1.5 0.20 O .3 6 0.42 0.53 ll31 Therapy
15 40 P 3.9 1.6 0.18 O .3 2 O .4 8 0.63 Pot. Perohlorate
16 47 F 4.2 1.9 0 .1 7 0.43 0.59 0 .7 1 ll31 Therapy
Mean age 46*4 years Age Range 20 - 7 0 years.
if68.
T a b le  X I I I .
Results of Serum Flocculation Tests in Thyrotoxic Patients 
Euthyroid after Treatment.
Case
No.
Thymol 
Turbidity 
(Unit s)
Thymol
Flocculation
Cephalin
Cholesterol
Colloidal
Gold
(Units)
Zinc Sulphate 
Turbidity 
(Units)
1 5 0 1 5
2 2 0 2 8
3 2 0 0 1
4 1 0 0 1
5 1 0 1 5
6 0 0 11
7 1 0 0 0
8 1 0 3 9
10 3 2 3 4
11 1 0 4 6
12 0 2 11
13 3 0 2 3
14 1 0 0 1
15 1 0 2 13
16 1 0 0 2
-Mean Age 46*4 years Age Range 20 - 70 years
TABLE XIV.
R esults o f Serum P rotein  In v estig a tio n s  
in  Thyroid Neoplasm.
TABLE XV.
R esu lts o f Serum F lo ccu la tion  T ests in  
Erythrocyte Sedim entation Rate in  Thyroid 
Neoplasm.
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Table XIV.
R esu lts  o f  Serum P ro te in  In v e s tig a tio n s  in  Thyroid Ueoplasm
Case
Ho.
Age Sex H isto logy
S 3 I 
Albumin
u u
G lobulin
P R 0 T 
G lobulin
s i n s
A .  G lobulin  
2
( g./lOOral) 
p  G lobulin y 'G lo b u lin
1 20 F P a p illa ry  adeno-carcinon 
11
a 3-9 2 .0 0.18 0.60 O.4 8 O.73
2 47 F 4.3 1 .8 0.18 O.4 0 O.4 O 0.83
3 75 F 11 3.4 2 .1 0.24 0 .3 0 O.4 5 0 .9 1
4 31 ;i 11 5 .0 1 .8 0 .1 9 O.5 2 O.45 O.64
5 32 II it 4 .2 1*7 0 .1 7 O.37 0.39 O.76
6 60 II it 4 .1 1 .8 0 .1 5 O.5 2 O.4I O.72
7 75 II 11 5*1 1 .8 0.16 O.55 0.37 O.73
8 19 1.1 H urthle o e l l  adeno- 
carc  inoma
5 .0 2.5 0.18 0.80 0.63 0.89
9 51 F F o l l ic u la r  adeno-carc inoma 4 .1 1 .8 0 .2 1 O.43 O.48 0 .69
10 54 F 11 5 .0 1 .8 0 .3 0 O.4I O.49 0.73
13 69 F U n d iffe ren tia te d  adeno­
carcinoma
3.8 1.9 0 .2 0 O.4 7 0.43 0 .80
14 69 F 11 5*4 1.9 0.18 O.4 9 O.44 0.79
15 72 F n 4 .9 1.9 0 .34 O.4I 0 .54 0.61
16 72 II Spindle c e l l  carcinoma 5 .0 2 .1 0 .1 9 O.48 O.4 4 0.98
17 57 F Lymphosarcoma 5*7 2 .0 0 .2 1 O.5O 0.45 0 .8 5
Iiean Age 52*3 years Age Range 19 - 75 years. For further 
Clinical details-see Appendices of Chapter I I  Section 5 .
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Table XV.
Results of Serum Flocculation Tests in Erythrocyte 
Sedimentation Rate in Thyroid Neoplasm*
Case
No*
Thymol
Turbidity
(Units)
Thymol 
Floe culation
Cephalin
Cholesterol
Colloidal
Gold
(Units)
Zinc Sulphate Turbidity 
(Units)
E*S*R*
nm/hr)
1 2 0 0
2 1 0 2 36
3 1 0 2 13 41
4 1 0 1 25
5 1 0 1 10
6 1 0 1 8 7
7 1 0 8 31
8 1 0 0 5
9 0 0 4 35
10 1 0 2 6 5
11 1 0 5 10
13 1 5 16 36
14 1 0 7
15 1 0 0 9 47
16 2 0 3 9 37
17 1 0 4 20 68
Mean Age 54*3 years Age Range 19 -  7 5  years
SECTION 4* Iodine Metabolism in  
Auto-Immune T h y ro id itis ,
TABLE I .  R esults o f Iodine Studies  
in  Auto-immune T h y ro id itis .
474.
Taible I ,
Thyroditis
Thyroxine
suppression
Po1j Perchlorate 
DischargeRadioiodine uptake (# dose) 2^ hr X1*2 4hr I*51 48hr I 131 —J ^ 2d isch arg f ;ake (/•> dose/L itre ,
r l} 2
0.6
2.6
0.5
0.7
3*1
2.5
1.6
W
0.26
0.64
0.14
0.40
27.9
44.3
27-2
29.0
37*5
54.0
45.3
37.0
40.9
40.0
28.5
23.0
54.5
55.6
66.1  
56.9 
17.3 0.7
O.32
0.13
1.38
14.9
3.3
3-7
2-5
4 .6
53-7
41.5
16.5 
51.3
35.6
4 2 .6
16.6
76.4
34.3 
17.0 
13.6 
54-2
53.1 
31.0
40.4
19.2
39.6
59.7 
26.0 
48.1
39.2
0.1230.8
0.09
O.24
0.34
0.47
0.34
0.61
19.3
44-9
45-3 
40.0
39-5
I 7.2
4.1 
2.3
4.1
+1446.6
33.126
2.9 0.12
45.6
32.0
39.0
37.0 
16.9
1*3
0.03
1.3 
4.9
2.4
36.6
46.0 
18. 7 
61.4
43.0 
6O.3  
46.2
7.5
13.9
30.0  
28.6 
47.1 
45.8
44.7
0.29
O.40
0.05
1.60
0.24
0.40
0.35
0.06
O.40
1.32
1.08
Horoal
4.3
3.0
3.2
1.5
- 0 .6
-4 .9
3.1
TABLE I I .  R esu lts o f S table Iodine  
Studies in  Auto-immune T h y r o id it is .
-T able I I ,
Be su ite  of Stable Iodine Studies in  Auto-immune T hyroid itis .
Case
Ho.
Thyroid 
Clearance 
(■1./ Bin.)
Plasma 
Inorganic 
Iodine 
(ug./ 100 el.)
Absolute 
Iodine 
Uptake 
(ug./ hr.)
Intrathyroidal
Exchangeable
Iodine
(ng.)
Protein-bound 
Iodine 
(ug./lOO ml.)
Benal Iodide 
Clearance 
(ml./min.)
7 21.2 Z . j c 4.1 0 2-5 28.0
16 15-9 0.24 2.2 2.8 28.9
21 16.7 O.58 5-9 4 .6 22.1
25 52-9 0.06 1.8 1.3 4.1 24.1
26 46.5 0.02 0.7 1.2 2.3 38.2
29 2.9 0.32 0.6 0.1 2.9 26.9
30 34.8 0 .10 2.1 0 .05 1.2 43-5
33 23.0 0.08 1.12 0.84 2.1 27 .6
34 19.3 0 .0 9 1.0 1.0 2.0 30.3
35 3.6 0.33 0.7 1.1 20.3
36 5-7 0.24 0.82 1.3 16.5
37 19.1 0.35 4.0 3.8 4.9 25 .8
38 6.7 0.09 0.4 1.1 2.4 40.4
39 17.7 0.4 1.8 27.5
48 32.8 0.11 2.1 0.4 3-1
SECTION 5. The D if fe r e n t ia l  D iagnosis  
of Auto-immune T h y ro id itis .
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TABLE I .
C lin io a l Findings in  79 P a t ie n ts ,  
w ith Simple G oitre.
UW.
Clinioal Findlnga in 79 Patients with Simple Goitre
Case
No.
Age Sex Thyroid Auto- 
antibody Tests 
Preo. CF
Duration
(Yrs.)
Firm Size
(g)
*
Diffuse Other
1 44 F _ _ 20 50 +
2 28 F - - 5 + 75 +
3 31 F - - 2 - 75 +
4 44 F - - • 15 - 100 +
5 21 F - - 16 - 100 +
6 35 F - - 3 + 75 - tDiaoomfort"and choking t
7 56 F - + 1 - 75 + Dysphonla. Tracheal compress­
ion Fixation.
6 20 F - - 16 - 500 . + 1
9 53 F - - 1 - 50 +
10 37 F - - 5 + 100 - * Tightness"
11 47 F - - 3 - 75 + "Tightness"
12 32 F - - 23 - 75 +
13 37 F - - 30 + 300 - "Choking on reoumbenoy.
M 42 F — — 0.5 — 50 +
15 25 F - - 4
_ 75 + i
16 25 F - - 7 - 75 +
17 43 F - - 2 - 100 . "Choking"
18 16 F - - 5 - 50 +
19 19 F - - 1 - 50 +
20 33 F - - 20 - 50 + ' ,
21 31 F - - 3 + 75 . Bruit present V22 21 F - ' - 10 + 75 - "Choking" \'
23 39 F — - • 20 - 75 -
24 25 F - - 2 weeks - 75 +
25 32 F - - 1 + 300 - Bruit. Discoof ort on
swallowing.
26 47 F - - 10 - 75 ♦
27 32 F - - 3 + 100 _
28 33 F - - Unaware - 75 +
29 67 F - - .0.75 + 50 +
30 37 F - - 0.75 - 50 +
31 46 F - - 1.5 . 50 _
32 50 F - - Unaware ♦ 50 +
33 39 F - - 5 + ' 75 +
34 42 F - - 0.5 • - 75 +,j
35 26 F - - 3 - 50 +
36 33 F - - 5 ♦ 50 - Painful
37 47 F - - 8 - 75 +
38 21 F - - 6 - 100 +
39 36 F - - 4 - 75 + Choking
40 55 F - - 13 + 125 -
41 19 7" - - 4 - 175 + Choking
42 54 F - . - 10 - 200 -
43 36 F - + 20 + 300 + Choking, hoarseness. - *
44 48 F - - 7 months + 100 +
45 32 F - - Unaware + 75 +
46 37 F - - 37 + 75 - Painful
47 40 F - - 11 + 100 +
48 27 F - - 6 - 75 +
49 27 F - - 16 - 75 + Oooasionally painful
50 45 F - - 1 - 100 -
51 43 F - - 0.9 + 50 -
52 16 F - - U  months + 75 +
53 20 F - - 5 - 125 - Bruit present. Choking
54 34 F - - 15 - 190 -
55 -30 F - - Unaware - 150 +
56 21 F - - 4 - 125 +
57 40 F - - Unaware - 50 +
58 25 F - - 3 + 50 +
.59 30 F - - 4 + 75 +
60 47 F - - 2 + 100 +
61 34- F - - 9 weeks 200 +
62 47 F - - 1 month _ 75 +
63 33 F - - 3 - 190 _
64 32 F - - 2 -  ■ 75 + .
65 60 F - - 6 + 100 +
66 44 F - - 5 weeks + 50 _
67 50 F - - 2.5 -  . 130 - Choking
68 46 F - - 1 - 130 +
69 42 F - - 0.29 - 75 + Painful
70 58 F - - 0.9 - 75 + f
71 21 F - 20 + 175 - Choking j
72 47 F — - 10 - 125 +
73 33 F - - 6 - 230 +
74 26 F - - 0.9 • ' 100 +
75 36 F - - 2 . 125 +
76 54 F - - 1 75 ♦
77 19 F - - 20 . . 75
78 55 F - -  • Unaware . 75 •
|79 36 F — • 14 - 75 + .
i f  Diffused jNoduisr^T
2*80.
.i
-•... V?r <? i-v ^ i l 5^
■-C- 1' .; •'
 .... '• . : - t
-
TABLE IX.
C lin ica l data on 18 P atien ts with
Thyroid Neoplasm*
     '..... ~M«|.
3T * Clinical data on 18 Patients with Thyroid Neoplasm
1 Case 
j No*
Age Sex Histology Clinioal Peatures Ihyroid-auto 
mtibody Testa 
*reo. CP
Comments
j 1
\
19 P Papillary adeno­
carcinoma
G o itre  (75g.» diffuse, and firm) of 3 
years duration* Cervical lymphadenopathy 
’Tightness" in neck* Huskiness*
-
] 2
i
i
1 .
47 P N Subtotal thyroidectomy 3° yearB ago. 
Recurrence of goitre over last 5 years* 
I25g* size, nodular, stony' - hard, and 
fixed* Choking and hoarseness.
ll31 Tests; 4hr 
uptake 46.595 dose, 
48hr* PBI1^! 0»Zf» 
dooe/l*
| 3
1
■j .
73 P If Subtotalthyroidectomy 11 years ago. 
Recurrence of goitre during past year, 
associated with "choking", hoarseness, 
and inapiratory,\J>tridor. Hard, fixed, 
tender nodular goitre (105g«)• Cervical 
lymphadenopathy.
+ + I^^Pestsj 4 hr
uptake 14.37“ dose,
48hr EBI1?1 0.09^ 
dose/l. Focal 
Hashimoto's thyroditie 
present in biopsy
L 4 31 M W . . Goitre of 2 years duration. Firm,nodular, 
and 75g. in size. Cervical lymphadenopathy.
- - I^Tests; 4 hr 
uptake 24*19® dose. 
48 hr IBlU1 0 .05$ 
dose/1.
i 5
i
32 M It Goitre of 18 months duration. Firm, nodular 
75g. gland.
” I^3lTeats» 4 hr
uptake 2 8 $ dose, 
48hr IBI151 O.O550 
dose/l.
« 60 If II Goitre of 1 years duration* Firm, nodular 
100 g. gland*. Cervioal lymphadenopathy.
- ll31 Tests; 4 hr 
uptake 23 *i$  dose.
7 75 M It Goitre of 2 years duration. Firm, nodular 
100 g. in size, and fixed
-
8 19 11 Hurthle-oell. * 
Caro inoma
Cervical lymphadenopahhy of 2 years 
duration. Thyroid not palpable
ll3lTestsi 4 hr
uptake 39•Op dose. 
48 hr HJI131 0.05$
dobe/l
9
%
51 P Follioular-oell 
Caro inoma
Coitre for 30 years* Removed 8 years 
previously. Presented with Hetastases 
in ilium>ribs)and skull.
I^Testsi 24 hr
uptake 24*2$ dose 
48 hr 0.05# 
dose/l
10 54 0 n Goitre 1 year. Hard, Tender 150 g. in 
size.
- — ll31jestsi 4hr 88$ 
dose,48hr EBI131 
0*05$  dose/l*
11 69 P N Goitre removed 7 years ago. Metaatases in 
spine
-
12 55 P If Firm, nodular goitre, I 5O g. in size. 6 
months duration. Hoarseness.
I131Testsi 4hr 
uptake 19.655 dose, 
48hr EBI131 0*29$ 
dose/l.
13 69 P TJhdifferentiaied 
adeno-oaro inoma
Goitre of 3 months duration 75S t nodular 
hard, fixed. Cervioal lymphadenopathy 
laryngeal palsy.^Dysphonia. Stridor.
ll31rests« 4 hr
uptake 26*85® dose. 
Focal Hashimoto's 
thyroditie present 
in biopsy.
' 14 69 P. n Goitre of 6 month's duration. Removed 3 
years ego. Presented with Metastases in 
Humerus.
15 72 P It Goitre of 6 month's duration. Hard, nodular 
fixed. 75g. in size* Tender* Hoarseness and 
choking.
1 " * I13LPestsi 4 hr 
uptake 18*1$ dose, 
48 hr O.47 $  dose/l
j 16 72 u Spindle-oell
Carcinoma
Goitre of 2 years duration. Painful, hard, 
fixed, and nodular* 75g* in size. Cervical 
lymphadenopathy. Hoarseness.Par&lyais of 
vocal cord.
I^3^Testsi 4 hr
uptake 38*055 dose, 
48hr 0.0555 dose/l
■S 17 57 p Lymphosarcoma Goitre of 2 years duration, with recent 
increase in size. Tender, painful, hard 
nodular, and fixed goitre. 100 g. in size 
Dyspnoea. Dysphagia ,
I^iestsi 4 hr
uptake 18.655 dose, 
48hr H3I131 0.1455 
dose /l.
18 78 p Struma Retioulosa Goitre of 5 months duration. Firm, nodular, 
15Qg. Hoarseness. -
I ^ T e s t s  4 hr 
uptake 19.65® dose* 
48hr IBI131 0.29> 
dose/l.
SECTION 6» The treatm ent o f  Auto­
immune T h y ro id itis .
TABLE I.
E ffec t o f  treatment w ith Thyroxine Sodium 
in  19 P a tien ts  w ith Auto-immune T h y ro id itis ,
^8M -
Effeot of Treatment with Thyroxine Sodium in 19 Patients with Autojjmune_Tl^roditia^
Case Mean Thyroid Serum Protein Thymol Thymol E.S.R. Duration of Treatment (months)
No* Neck Auto-antibody (g./l00ml.)>< Turbidity Floooulation (mm./hr)
Diameter Vests Alb. Glob. Glob. (units) (units)
(inches) Prec. CF.
3 14*5 + + 4.7 2.3 1.34 4 1 16 6
13*5 + + 4*8 1.9
6 14*0 ++ 3.9 2 .1 0.79 6 2 37
15*0 - •H- 3 0 23 12
7 13*5 + ++ 4*3 2 .2 1.08 4 1 4
1312*5 + ++ 4-9 3.6 1 .1 2 5 2 6
10 14*5 + ++ 4 .6 8.3 0 .98 14 3 40
13-5 + ++ 5-1 2 .1 5 2 6 4.5
12 13*75 . + ++ 4.7 2 .1 0.96 3 1 15 -
12.75 + ++ 4.5 2 .2 0.74 2 0 10 25
14 14 .0 + ++ 3.9 3.0 O .58 10 3 14
13 .0 - ++ 4.1 2.1 0 .4 2 4 2 7 28
16 15.5 _ ++ 4*2 2.2 1.60 4 4 30
14.0 - ++ 4*4 2.2 0.82 2 2 11 15
13.5 - ++ 10 36 . !
18 14 .0 ++ 4.0 2.4 0.83 4 0 22
13 .0 - ++ 4.3 2.4 0.75 2 0 12
19 12.75 + ++ 4.3 3.5 1.66 3 0 6
12.0 - ++ 4 .6 1.9 0.79 2 0 3 19
21 15.5 + ++ 3.7 2.3 1.18 4 0 20
14.5 + ++ 4.3 2.2. 1.02 1 0 9 3
22 15*25 + ++ 3.5 3.5 2.53 12 3 57
1 4 .0 + + + 5.2 2.7 1.19 4 0 21 16
23 13.75 + ++ 4-7 1.8 1 1 8
1412.5 + + + 4 .8 1.8 0 0 9 ,
25 15.74 + 4.3 2.5 1.42 2 0 815 .0 + + + 5.1 1.7 0.90 3 0 2
26 15.0 + ++ 4.2 2.2 1.09 14 4 23
13*5 + ++ 5.1 2.0 0.95 6 2 18
30 14.75
14.0
+
+
++
++
3.8 2.3 0.90 5 4 19
14 .0 + ++ 25 4
13.75 + ++ 5
13.5 + ++ 4.5 1.9 0.75 24 8
33 15.25
14.25
+ ++
++
4.2 2.2 1 .1 5 5 3 38
14 36
34
i
18.0
17.75
17.75
17.75
16 .75  
17 .0  
17 .0
+
+
+
+
+
+ +
-H-
-H-
•H-
+ +
5.0 4*6 2.68 11 
10 
10 ■ 
10 
10 
10
4
3
4 
4 
4 
4
46
60
76
59
31
O .25
0 .5
0.75
2
3
I6 .5 + ++ 3.9 4.1 2.16 9 3
39
34
4
6
37 14.5
14 .0
+ + + 4.1 3.0 1.54 6 2 25
13.75
13.5 
13.25
13.5
+
+
+ +
-H- 3.9 2.6 1.31
5 
4 
8
6
2
2
4
3
20
44
34
1
2
3
4
15.5 + ++ 4-2 2.5 1.32
5
4
3
2
22
24
&
10
38 16 .5  
15.75
15 .5  
15
+
+
+
+
-H-
++
++
++
3.9
3.9
3-0
3.0
1.65 14
12
10
3
4 
4
31
30 0.5
2
15.5 + ++ 5
15 + ++ 4.2 2.5 1.02 10 4 30
6
.9
TABLE I I .  E ffec t o f Surgery in  6 P a tien ts  
w ith Auto-immune T h y ro id it is .
2jj8 6 .
TABLE I I .
E ffe c t  o f  Surgery  in  6 Pa t e n ts  v /ith  Auto-immune T h y r o d i t i s .
Case
No.
Thyrc 
Ant i1 
Prec
3id  A uto- 
3ody T es ts  
CF
Serum
( c . / io (
Albumin
^ ro te in s  
) n l)
0 lo b u lin Gamma- 
G lo b u lin
I’hymol
T u rb id i ty
(U n its )
Thymol 
F lo c c u la tio n  
( u n i t s )
E .S .R .
(m m ./hr)
D u ra tio n  o f  
T reatm ent 
(m onths)
5 + ++ 3.8 3-0 1 .66 12 3 7
+ ++ 4 .0 3-1 1 .4 2 10 2 10 0 .5
- ++ 4 .5 2 .7 1.33 7 2 12 1 -5
- ++ 4-3 2-4 1.08 5 1 4 2
11 _ ++ 4*5 2 .0 0.9C 5 0 5
- ++ 4 .6 1 .9 0 .95 4 0 18 1 .5
20 - _ 3-5 2 .9 2.06 7 3 12
- - 3.0 2 .5 1 . 9 9 4 2 8 3
- - 4*2 2.1 1 .16 2 1 7 12
24 + ++ 3.0 2.C 0.74 1 0 4 6
+ ++ 2 0 3
- ++ 2 0 6
- ++ 1 0 12
- ++ 4-1 2 .1 0 .0 2 0 0 16 18
28 + ++ 4 .3 2 .2 1 .10 5 0 10
- ++ 4 .6 1.6 0 .5 9 2 0 7 18
50 _ + 3.0 i . e 0.66 1 0 18
- + 3.9 1 .7 0 .5 7 1 0 16 1-5
- + 1 0 8 3
- - 4 .2 1.9 0 .74 0 0 7 4
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SECTION 1. The R elationship  o f Auto-immune 
T h y ro id itis  to  Primary hypothyroid!am.
489.
TABLE I
O lin io a l F indings in  ffriLmary Bypotbyroldiam.
mo.
C lin ic a l Findings In Primary Hypothyroidism
CommentsBJ® E.C.Q. Thyroid Auto- 
Antibody T ests  
Preo
Family H iotory Serum 
o f Thyroid 
Disease
Ago Sex Hypothyroid H istory  o f 
D iagnostic G oitre  and/ 
Index or
T hyrotoxicosis
Case
Ho. CFT
295S is te r  w ith 
G oitre
Daughter w ith 
th y ro tox icosis
+27
245 Dssoribed in
Xod;--------370+14
+17200S is te r  with 
C oitre
+13
375+20
15 i t s  previous-Brother* s da ugh to r  595"
ly  ? Thyrotoxio-with hypot:.;roidism
o a is .____________________________________- - TfStT
+27
+3210
11
G oitre 20 yrs 
previously.
+23
225+27
+54
+31 EuthyrofiT+2
+28
295
ISo
+31. G o i t r e  ? 
Thyrotoxic 11 
v r s  r r e v i o u a l v
425
+2
+24 .422. -2 1
+11
+23+35 225
+33 O oitre 25 y rs 
previously.
35C
G oitre  2 yrs
previously.
+18 290
292
+13 G oitre 30 yra previously1 285 +18+21
+17 257
+23
+21
Y Thyrotoxlo B rothers 
20 y rs  previously daughter with
Coitro
+5? 333
+24 385
+18+H
+2
+30
+21
+13
+23
+12
+8 +IT47
+2 P aterna l female 
oousin w ith . 
Thyrotoxioools
Euthyroid
+27 121
+29 290
79T
270
TABLE !!♦  R esu lts  o f Radioiodine t e s t s  in
Primary gypottoroidism .
TABLE I I .
Results of Radioiodine Tests in  Primary Hypothyroidian
Case
No.
4 hr uptake 
(?s dose)
48 hr UDtake (fi doge) 48 hr IBI131 (c/o dose/l) 48 hr BIf1?1 (fS EBI^l) Pot. Perchlorate Discharge Test TSHTest B I ,
1 15.2 18.7 0 .1 5 1 .0
2 16.9 1 0 .7 O.2 4 - 1 .6
3 18.8 35.1 0.58 35 + 3.0
4 17.1 13.3 0 .0 5 - 1.5
5 3.9 0 .1 2
6 6 .1 0 .05
7 1 2 .0 24 .0 0 .8 7 40 1.5
8 - 1.3
9 1 5 .0 0.33
10 •
11 12 .1 13.2
18 11.4 0.11
13 1 2 .8 27.4 0.05
15 16.1 17.9 0 .1 0
16 -
18 18.0 8 .2 0.C5
19 2 .1
20 1 0 .5 8 .1 0 .1 0
21 15.0 15.5 0 .1 2
24 9.6 4.3 0.0 5
25
26 3.8 1.3 0.05
27 9*9 0.05
28 9.6 18.8 0 .1 0 1.7
29 0.5 0 .05 0 .6
30 10 .0 7.3 0 .05
31 3.0 0.05
33 1 2 .1 2.5 0 .05
34 -
35 -
3 6 1 1 .6 25.1 0.16 - 2 .2
37 -
38 -
39 -
40 1 5 .0
41 7.2 0 .6 0 .0 5
42 13.4 54-8 O.24 5.1
43 -
44 .
45 10.9 1 .2 0 .0 5
46 1 1 .8 16.9 0 .1 4
47 1 2 .6 30.3 0 .1 2 3.5
48 1 5 .0 29.2 1 .1 0 + 4.6
49 .
51 -
52 2 .2
55 -
56 10.5 36.7 0.05 -
61 13.2 24.1 0.18
66 11.3 49.6 0.45
67
68 13.4 21 .2 0 .1 1
69 1 .5 9.0 0.05
70 0 .0 5
SECTION 2. The R elationsh ip  of Auto-immune 
T h y ro id itis  to  T hyrotoxicosis.
SECTION 2(b‘)« The C lin ic a l S ign ifican ce  of the  
Complement-Fixation Test in  T hyrotoxioosis.
TABLE II.
R elation  between the Complement-Fixation Test
and C lin ic a l Features of Thyrotoxicosis,
Table II,
Halation between the Ccaplemeirt fixation  Teat and 
C linical Features of Thyrotoxiooaia.
Number of Cases and Results of CF te s t 
"Untreated" 'Treated1
Clinical Features + ++ Total + ++ Total
1 0 - 1 9 3 1 0 4 1 0 • 0 1
20-29 27 6 7 40 7 3 6 16
Age in 30-39 35 17 18 70 27 11 1 2 50
years 40-49 32 16 ‘20 68 28 15 22 65
50-59 26 8 14 48 25 16 26 67
60-69 9 1 2 1 2 6 2 5 13
70 and over 9 2 0 11 2 1 0 3
Diffuse 83 32 40 155 64 29 35 128
Goitre Nodular 45 17 17 79 26 17 32 75
type Absent 13 2 4 19 6 3 4 13
Goitre 50 48 20 11 79 34 18 16 68
Size 75 45 10 24 87 33 14 17 64
(ff*) 1 0 0 and more 35 1 1 22 68 23 13 34 70
Goitre 0 -1 1 40 18 33 91 17 12 7 36
Duration 12-59 34 8 14 56 32 12 21 65
(months) 60 and over 1 0 3 2 15 25 1 2 29 66
Duration of 0-11 67 31 30 128 27 9 9 45
Symptoms 12-59 65 20 28 113 42 26 29 97
(months) 60 and over 9 0 3 12 27 13 33 73
Severity of Under 10 3 0 1 4 0 0 1 1
Symptoms 11-19 11 1 3 15 0 3 1 4
(Clinical 2 0 -2 5 36 17 13 66 41 17 27 85
Diagnostic 26-30 41 18 23 82 29 18 22 69
Index) 3 1 and over 50 15 21 86 26 10 20 56
Eye Signs Exophthalmos 85 35 36 156 68 33 49 150
Severe Exophthalmos 13 5 6 24 10 6 2 18
Drug
Reaotions 12 1 5 18 10 2 8 20
ttaily History of Thyroid Disease 36 17 22 75 25 10 29 64
TOTAL 141 51 61 253 96 48 71 215
The data in  t h is  ta b le  was compiled from an a n a ly s is  of 
punch cards using the H o ller ith  system.
TABLE VII.
C orrelation  between the Qomplement-Fixation T est  
and the Response to  A ntithyroid  Drugs in  103 
“Untreated” Cases.
Table V II.
Correlation between the Complement-Fixation Teat and the 
Response to Anti thyroid Drugs in  105 "Untreated11 cases*
Complement -  
Fixation Test
O u t c o m e  o f  T r e a t m e n t
Control satisfactory Hypol?hyroid* Relayse+
No. 1° No. 1o No. 1o
(-) 49 92.4 2 3*8 2 3.8
(+) 27 93.1 1 3.4 1 3*4
(++) 19 90.4 1 4*6 1 4-8
* i . e .  during course of treatment#
+ i#e# following course of treatment lasting  18 months.
TABLE IX
C o m p a r i s o n  between the "Untreated" and "Treated"
Thyrotoxic P atien t s .
Table IX.
Comparison between th e  "Untreated" and "Treated11 
T hyrotoxic P a t ie n ts .
C lin ic a l  Feature  
T ota l Ho. o f  ca ses  
I.lean Age
Nodular 
G oitre S iz e  (mean)
Duration (mean)Th
In te n s ity *
^>.y!li *jt Oms — , . / \--------- i-'uration vmean)
"Untreated"
253
42 years 
70g.
21 months 
28
22 months
"Treated11 
215
46 years
35^ 
74g«
45 months
27+
58 months
*  The in t e n s i t y  o f  th e  i l ln e s s  as judged by th e  1 C lin ic a l  
d ia g n o stic  ind ex1
+ 1 o l in ic a l  d ia g n o stic  ind ex’ b efo re  treatm ent given*
APPENDICES CHAPTER IV .
S ectio n  1. 
S ectio n  2. 
S ection  3 . 
S ectio n  4.
P. 502 
P. 509 
P. 516 
P. 531
SECTION 1 . The A sso c ia tio n  o f Auto*xmmme
T h y r o id it is  and th e Connective 
T issu e  D isea se s , w ith  p a r ticu la r  
referen ce  to  Rheumatoid A r th r it is .
TABLE I.
C lin ic a l and Laboratory D e ta ils  in  
Auto-immune T h y r o id it is .
(Group 1A)
50k-
Table I*
C lin ioal and Laboratory D e ta ils  in  Auto-iouune 'i'hyroditla (Group 14)
Case Age Sex i’.-iyroid Auto- C lin io a l £vldenoe X-ray of Kose-Yfaaler LE o e ll Com&ents
Ho* Antibody te s t s  
RF
of A r th r it is Hands Test Test
1 70 P _ AC Hone . - .
2 56 P + 4+ Suggestive Suggestive - - Not rheum to id  a r th r i t i s
3 52 P + + None - - - See te x t fo r C lin ica l d e ta ils4 65 U + ++ Present 4 4* 4
5 41 P + ++ Hone - - -
6 65 P - ++ Hone - - -
7 62 P + 4+ None - m -
a 49 P ++ None - 4 - Not zfieuoatoid a r th r i t i s
9 65 P + - ..one - - -
10 52 » + ++ None - -
11 57 P - 4+ None - - -
12 48 P + 4+ Kono -
15 67 P + ++ Present + 4 - Soe Text fo r  o lin io a l  d e ta ils
14 28 P + 44- None - -
15 57 P + ++ None - -
16 40 P - 4+ None - - -
17 45 ? 4* 44 None - - -
i s 52 P 44 None
19 66 P + 44 None - 4* - Not rheunatoid a r th r i t i s
20 48 P . • None - - -
21 65 H + 44 None - -
22 56 P + 44 None - - -
25 44 P + 44 Hone - -
24 55 P + 44 None - •* -
25 50 P + 44 None - + - Not rheunatoid a r th r i t i s
26 43 P + 4* None - - -
27 54 P + 44 None - -
28 50 P + 44 None - - -
29 59 H - 44 None - - -
50 45 P + 44 None - - -
51 61 P + 44 Present 4 4* - Seo tex t fo r  o lin io a l  d e ta ils
52 65 P + + Present 4 4 - Soe tox': for c l in io a l  d e ta ils
55 55 P + ++ Nono - - -
54 51 II + 44 None - - -
55 46 P - 44 None - - -
56 50 P + 4+ None - “
57 44 P + 44 Nono “ “ •
58 a 7 + 44 _
59 45 P + 44 None -
40
41
42
52
66
57
P
P
P
+
+
++
AC
44
Present
Proeont
None
4
4
1 
4- 
4- * Joo sext fo r  c l in ic a l  d e ta ils  
oeo te x t  fo r c l in ic a l  d e ta ils
45 45 P + 44 None
44 44 P + 44 None _
45 36 P + 44 None _
46
47
57
64
P
P
+ +4
44
fresen t
Tone
4 - Soe tex t fo r o l in io a l  d e ta ils
48 47 P - 44 None _
49 40 P + 44 None
50 62 P • 4 None _ "
TABLE II.
O lin io a l and Laboratory D e ta ils  in  
Rheumatoid A r th r it is
(Group 2k)
C l in i c a l  and la b o r a to r y  P a t e l l a  in T lh a u a n to td  A T th r l t i e  (O rouB 2A1
i    r
Cnee
He.
Age Sex Dur. e f 
A r th r i t i s ,  
( t r . . )
Treatment* Hose-Vaaler
r
X-ray
Hands L .B .Call To a t
Thyroid Anta- 
Aatlbody ta a ta  
P roa. CTT
Comment
1 55 F 3 s . ♦ 4 4 -  ** No G oitrn
2 57 F 6 S. P B. ♦ 4 - I
3 56 F 2 S. ♦ 4 , - ■ i
4 67 F 8 S. P B. - 4 . *
5 35 F 2 S. - 4 -  a •
6 59 F 6 S. P B.C. ♦ 4 - - Ho G o itre . Rheumatic 
Heart D isease.
7 51 F 7 S.P B. C. - 4 - No G oitre ^
8 21 F 1 8 • 4 “ S tap le  G o itre . 1*31 t e s t s :  j 
.4—h r uptake 59^ dose, 48h r ]
P .B .r . 0 .0 5 9 J t/d o e e /n tre
9 59 F 4 8 . P B. ♦ - - He B eitre
10 33 F 6 8, P 8 . 0 4 - I
U 63 F 4 S. P B. - 4 - • I
12 55 F 7 S. P B. C - 4 -
13 53 F 5 S. C. 4 .
Primary hypothyroidism j14 64 F 2 S. - 4 . ♦ ♦♦
15 59 F 3 S. - 4 - Ho G oitre |
17 48 F 5 8. C. - 4 - - F e l ty 'a  eyndroae
18 63 F 6 S. C. 4 4 -  dB tlcoap la- 
■aatary
D iabetes M ellltu s 
Pulmonary T uberculosis
19 56 F 1 4 4 - ♦ +♦ Primary hypothyro id isa
20
.
46 F 7 8. P B. C 4 No g o itre» b u t 48 h r.P .B .I*  
O .337tdoee/litre . Potass in s  
p erch lo ra te  d ischarge t e s t  
n ega tive .
21 51 F 25 S. P B. C. 3. 4 4 - -  *+ 
(n a a -a p te if le ) C irrh o s is  of L iver. Ho G oitre
22 49 F 11 8. P B. C. * - - - No G oitre . 1*31 t e s t s n e n u l
2J 62 F 10 S.C. - 4 - - No Goitre
21 45 F & S. 4 - -
25 56 F 7 6. 4 - _ ♦a No G o itre , l a t e s t s  normal
26 64 F 18 S. P B. C. 4 4 ♦ — a Wo G oitre I 131to a ta  nom al
27 62 F 10 S.C. 4 4 ♦ aa No Goitro I 1^1 ta a ta  nom al
28 41 F 6 S.C. “ 4 - - S tap le G oitro. I 1^1 ta a ta  t  ha uptake 35Jf/doeet 48 hr P .B .I . 
0 .05% /doso/lltT e.
29 56 F U S.C. 4 - _ -  aa No G oitre 1*31 t e s t s  normal
50 55 F 16 S. P B. C. - 4 aa Ko G oitre I*-** te a ts  nensal
51 51 F 2 s . 4 4 - -  a No G oitre X** te s ta  n o m al. Carcinoma ef b re as t
52 46 F 11 S. P B. _ + - No G oitre
55 51 F 8 S. - 4 - -
36 51 F 15 S. P D. C. 0 . 4 4 - -
55 59 F 7 S. C. - 4 -
57 56 F 4 S. ♦ - 1 - .
58 39 F 11 S. C. 4 4 -  a No G oitre 1*31 t e s t s  normal
10 56 F 3 S. * - - Ko Goitre
m 55 F 2 s . - 4 . -
. 12 66 F 6 S. P B. - 4 - ■
■ o 57 F B S. C. ♦ 4 - •
55 F 10 S. P B, 4 4 . -
. 15 57 r 6 s .  p  a. c . - + . a 1131 t e s t s  normal
; i6 62 F 13 S. P B. C. 4 4 - - F w lty 'e  syndrome. No G oitre
! 67 44 F 3 s . 4 - - - No G oitre
; 18 
t - 
t
39 F 2 s . 4
'  '
Simple G oitro . I* 3 1 te s ts ; 4Jur 
uptake 63^ dose 148 hr P .U .I. 
0.1£ d o s e / l i tr e
! '9 60 * 4 s . ♦ -
-----------------1-----------------------------
No Goitrm
; 50 62 U 8 s .  C. ♦ 4 - - ............................
51 65 u 13 3 . P B, C. - *
52 74 u 10 S. - 4 -
55
51
54
66
u
u
14
7
S. P B. C. ♦ 4 ■
"55 63 u 3 So ♦ a.
56 54 u 2 •
57 68 u 7 s . ♦ a. *
58 61 u 11 s .  P B. c . 4 4 - -
59 74 u 4 S. ♦ _ *
60 38 u 7 S. P B. 4
1 61 40 u 21 S. P B. C. - 4 - .
62 56 u 13 S. C. - 4 _ -
65 34 u 11 5. - 4 - * I
61 18 u 2 s. - 4 - -
65 50 u 10 S. P B. ♦ - " " " "  v
l>6 32 u 14 S. P B. C. * 4 - i
6 8  57
u
u
1
5 S.
+ • -
!
70
48
65
u
u
2
8
S.
s .  P U. Ca
- -------: -------------------------------------- j.......... .................................  1
• 1
71 57 u 5 S. P B. 4 4 _ _ •
72 56 u 3 s 4 • i
73 35 u 1 4 - -
----------------------------------------------------------$
f
T n a t a n t ;  S* ee l ic y la ta a  .  I B .  ■ ph.nylbot*eena. C ■ ato ro ide  • 0 . * Gold.
TABLE III.
C lin ica l and Laboratory Data in  M iscellaneous 
Connective Tissue D iseases, including Sjogren*a 
B&sease. (Group 3 )
Estble x ix %
CUaAmk aadt DM* i»  h8*«H i® »W i O aM taU h, ft**** M m M H i
U t, k mCtU I
Thywiid ) | m t l ( i i t H  I11 MU
S r  « 5 r  ' ^ n ' ^ — — ^  »
. ,  M n M  u U >
•uum tutok* m*M r»i4ku- mJ**
{ ,  « • * * ) •  )ra»a d la -  ' m
10 S clew t o
• i t i «
17 •
18 h r i a r t i r i t i a  
Ho4«u
19 ■90
4 1 u u «21
F ♦ 1 u i o M 2,400 _ a*. 51 8.07 „ mF ♦ ♦ — » i , u 95 1,900 _ l a . •7 0.05 « m
F • ♦ — 5 8,10 68 3,600 ■a. _ «
F — ♦ ♦ 1 0,7* 73 2,050 _ ■a. 55 0.16 . 44
F ♦ ♦ — 6 1,98 50 _ la . hi 0.10 * m
F ♦ ♦ S KOI 68 4,100 ■a. 87 0.05 . 44 (K -i)
F ♦ ♦ * 82 3,100 - ■a. 17 0.18 44 (*-*)
F ♦ ♦ - 3 0,9* 113 1,100 ♦ ■a. «3 0.18 - 44 ( f t* )
( n t h ,
75 «. )F — ♦ ♦ 3 0,97 23 700 ■a. 87 0,10 • 44 (JU«)
F — « — 7 1,65 63 3,400 - ■a. >5 0.07 - •
F ♦ — • K85 35 3,100 ■a. 87 0.08 - - *+
M ♦ • — 0,56 8 7,400 _ ■a. 87 0.08 „
X ♦ • «• 8 13 3,700 ■a. 53 0.07 ♦ • •
F ♦ • • 3 39 7,400 - ■a. 83 0 .0 , _ • 44 (*-*)
F * “ - 1,18 38 5,400 - I n * . 7 0,05 -
F ♦ « 1 1,00 23 6,100 ■a. 6» 0.96
F “ “ “ 3 K30 19 8,700 - 15 1.60 ♦ - 44
F ♦ « 1 0.95 7 _ ■a.
M ♦ “ - 8 13 - ■a. *
F ♦ - ♦ 0 1.20 25 2,100 - ■a. *0 0.11 *
F ♦ ♦ ♦ 8 2,70 65 9,500
•
♦tmk__ ■a. 00Ifot)
H istology of tho thy ro id  gland sliow.d d lffuoo  Aaknna*y-call cbongo, ho t a* U y r t l l t l i o ,
SBOTIQW 2. The Aaaooiation a t Jtato-imnune T hyro id itis 
and Acquired Haemojytio Anaemia,
TABLE I.
R esu lts  of H aem atological In v e s t ig a tio n s  
in  Auto-immune T h y ro id it is .
\Results of Haematological Investigations in Auto-immune Thyroiditis
Case Hb PCV LEHC WBC D if f e re n tia l R etiou locy te Coombs C r ^  H a lf- LJarrcw Comments
No. m W (£) ( c e l l s / Count Count T est 1 l i f e *
o.mm) (£) (days)
1 69 34 30 4,200 Normal 2 N egative 25 N ormoblastic H epato-spleno­
megaly. L iver 
b iopsy  norm al. | 
Gaatreotomy f o r
g a s t r io  neoplasm || 
3 y ea rs  | 
p rev io u sly .
2 90 44 30 4,900 2 Negative
3 97 34 31 2 Negative 1
4 100 46.5 31.75 8,000 2 Negative 26 Narmoblastio
5 86 43 3P 5,700 Normal 2 Negative
6 75 36.75 30.5 7,200 Normal 2 N egative
7 96 44.5 31.75 4,800 Normal 2 Negative ;
e 64 34 28 7,000 2 N egative Iro n  d e fic ie n o y  
anaemia secondary ; 
to  m enorrhagia*
9 94 44-5 31.25 5,300 Normal 2 N egative
10 104 49 315 7,400 Normal 2 Negative
11 95 42 33 7,200 2 Negative
12 97 45 32 2 Negative ,
13 74 29.75 7,900 Normal 2 Negative
14 80 39.5 30 8,500 Normal. 2 N egative
15 78 38 30.5 4,300 Normal 2 Negative
16 84 40 31 8,400 Normal 2 N egative
17 80 37.75 31.5 6,800 Normal 2 Negative I18 96 43.5 33 4,900 2 Negative J
19 84 39 32 4,600 2 Negative
20 93 44 31 8,700 2 .Negative f
21 104 32 6,800 Normal 2 N egative 1 122 68 35 29 6,100 2 N egative Narmoblastio Iro n  D eficienoy  J !
; 23 80 36.5
anaemia* 1
32.5 7,000 Normal 2 Negative
24 96 44*5 32 6,100 2 N egative I ■80 37 32 6,000 Normal 2 N egative\ 26 
j .  27
104 46
48.5
33 5,200 Normal 2 N egative109 33. 4^000 2 N egative I] 28 90 42.5 31.5 7,700 2 Negfetive 1
| 29 93 45.75 32 5,700 2 Negative J ;
, 30 85 42 , 30 5 ,400 ' Normal 2 Negative 1 I; 31 97 35.5 32 4,900 Normal 0.5 Negative 27 > II32 74 41 26 5,800 Normal 2 N egative ! |j
: 33 88 41 31.75 4,600 2 Negative : §
34 94 49 28.5 6,700 Normal 2 Negative 25.5 ; I
; 35 80 37.75 31.75 2 Negative ! |
36 95 43 33 6,400 Normal 2 Negative I37 94 44.5 31.5 6,400 Normal 2 Negative 11138 80 39.5 30 7,100 Normal 2 Negative 1139 98 46 31.5 10,000 Normal 2 Negative 140 81 40 30 6,400 Normal 2 N egative 1I 41 85 28.5 5,600 Normal 2 Negative 1142 34 .49 31.5 5,100 y6 months 68 31.5 32 4,000, Normal 5 12 Normoblastio PShears 71 33 31 6,500 Normal 2.5 See te x t  f a r  III
43
c l in ic a l  d e ta i l s ,  1
92 42.5 32.25 8,100 2 Negative
44 76 38 30 8,400 Normal 4 .5 Narmoblastio Iro n  D eficienoy jj 
anaemia H 
a sso c ia te d  w ith H 
re c u r re n t |  
haemoptysis due I 
to  m itred atenoafc I
and pulmonary jj 
haem osiderosia.45
46
47
48 .
49
50
88
86
97
40 32 . 2 Negative fl40.5
35.5
31.5
32
4,500 Normal 2
2
Negative
Negative 1:90
86
81
42*5 31.25 5,200 Normal 2 Negative ■T42 2 Negative ' 1I
38
I 51 2 Negative
1 ■’
1 *
i *  Normal value 25-30 days*
TABLE II
R esu lts  o f Thyroid In v e stig a tio n s  in  22 P a tien ts  
-with Acquired Auto^immune Haemolytio Anaemia.
l A i T .  R esults o f  Thyroid. In v estig a tio n s in  22 P a tien ts  w ith Acquired Auto-immune Haemolytio Anaemia
3ase
Jo.
C linical C lin ic a l  
Diagnosis Status
G oitre Thyroid Auto- 
Antibody Te3ts 4 h r l1^*48 hr l 33] Pot, Serum Comments
Prec.
Compla
spec.
nent-l’ixat 
non speo.
ion
AC
Uptake 
(/« dose
Uptalce 
] ($> d o se /l
Perchlorate 
; Discharge
PBI
)
1 Retioulo Euthyroid
Sarcoma
None - + 30 0 .07 5 .2
2 Hodgkin1s 
Disease 11 i i 25 0 .0 5 4-7
5 Acquired 11 
Idiopathio 
Haemolytio 
Anaemia
i i
4 Rheumatoid- M 
A rthritis. 
Hypo-gamma- 
globulinaemia
II +
5 Acquired 11 
Idiopathio 
Haemolytio 
AnaemiA
II
" i i II 35 0.10 3 .9
7 i i  i i II -
8 II
Rheumatio Thyrotoxic Soft 
Heart D isease D iffuse $QS < * 7 l-yr to b
Subtotal thyroidec 
tooy 25 years 
previoualv.
9 Staphyloooocal Euthyroid None
pneumonia
- +
10 Acquired 11 
Idiopathio 
Haemolytio 
AnaemiA
II
.11 n II _
-If? • i  i i II
. l? i i  i i II _ 75 0.47 + 3.7
. 14 i i  i i II _
-l1? || i i 1 _ ++ 42 0.10 4 .1
16 •I i i II + 49 0 .5 6 - 3 .2 . - .-1/ i t  „ It _ +18 Reticulo •• 
Sarcoma
II - +
19 Acquired 11
Idiopathio
Haemolytio
-AnaemiA
II +
•
• 20 Hodgkin1 s 11 
Dieease
II -
21 Acquired 11
Idiopathio
Haemolytio
-AnaemiA
II + ++
r
Auto-immune 
byroid itis. 
Confirmed a t  
lutonsv, 122 " t i II - ++ 30 0.21 6.3
514-
TABLS D X .
C lin ic a l and Laboratory Findings in  
22 P a tie n ts  u ith  Acquired Auto-ismmne
Haeamolytic Anaemia.
Bo.
1
2
3
4
5
6
7
8
9
10
11
12
13
U
15
16
17
19
19
20
21
22
515.
Table III*
C l in i c a l  and L ab o ra to ry  P in d in g a  i n  22 P a t i e n t a  w ith  A cqu ired  A uto -lam ina  H ae a o ly tio  A n aaaia .
A fa Sax Hb.
( »
IK.B.C. 
( c a l l a / o . a n . )
P l a t a l a t a
( c a l l a / c . a a . )
R e tic u lo c y te
Count
(*>
Coooba
T ea t
Cold
A n tib o d la s
.H ed-call C r .5 1 H a l f -  
l i f a  (d ay e )*
LB o a l l  
t a a t
C l in ic a l  D iagnoaie
53 P 60 2 ,400 30 ,000 2 - 22 - R e tic u lo a a ro o a a .
22 P 47 3,500 3 60,000 29 - 6 - H o d g k in 'a  d ia a a a a .
26 P 46 5 ,8 0 0 12 * 0 .4 5 12 A cqu ired  id io p a th io  h a e a o ly t io  a n a a a ia .
47 P 60 2,500 140,000 14 ♦ 0 .4 6 9 - R h e u a a to id - n r th r i t ia ,  h y p o g a a a a g lo b u lin a e a la .
18 P 64 8 ,200 360,000 13 - 7 A cqu ired  id io p a th ic  h a e a o ly t io  a n a a a ia .
69 P 58 1,200 65 ,000 2 .5 ♦ 0 .4 6 16 - .
63 P 40 1,800 55 ,000 6 - 0 .4 6 14. - -
45 k 56 5 ,800 270 ,000 1? * -.43 8 - . . .  " ■
70 ? 72 7 ,200 7 - .4 3 13 - S tap h y lo c o cc a l pneu o o n la .
71 P 68 12,400 350,000 8 * - .4 6 A cquired  id io p a th ic  h a e a o ly t io  a n a a a ia .
51 ? 64 8 ,300 9 - -.4 6 -
a
55 k 48 4 ,100 220 ,000 20 - 4 .4
60 P 66 6 ,400 95 ,000 10 ♦ 17.5
. . . .  H
80 P 42 2,360 27 .66 6.2
» N
55 P 35 6 ,700 430,000 28 * - .4 6 2 .4
M H «
59 P 29 7 ,800 190, v/30 33 ♦ 5 .8 ♦
« *
20 ? 45 3,400 95 ,000 8 ♦ 6 .3 -
. . . .  a
17 P 27 4 ,600 150,000 30 - 20 - aeticuloaarcoaa.
67 P 75 12,600 2 05 ,OuU 11 - 0 .46 8 - Acquired idiopathic h a e a o l / t i e  a n a a a ia .  j
68 k 59 5 .500 140,000 6 * 13 H o dgk in 's  d ia a a a a .
49 P 43 2 ,100 18 - - Acquired idiopathic haemolytio a n a a a ia .
39 ? 58 4 ,200 190,000 7 - 8 -
« n M
SECTION 3 . The A ssoc ia tion  of Auto-immune 
T h yro id itis  and C irrhosis of the Liver.
TABLE I.
R esu lts o f In v estig a tio n s  o f L iver Function in  50 
P a tien ts  m th  Auto-immune T h y ro id itis .
O  CM CM O  r t  rH O  K \ H  
•  • • • • • • • •
VO M - O  VO K\C\I «fCM M-
O  O  O  O  O  K- \ 0  o  o• • • • •  « • • •
K M O K N O  TtKN CM K \ rj- o  CM
O CM O O  tc i '  p  .CM • • 1 .  •
M3 O  CM ! n O H O
H  O  1/3 CM 
•  •  •  •
C M K 3 M - H O O W M -
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TABLE II.
O lin io a l Data in  Female C irrhotio P a tien ts
TABLE I I I .
O lin io a l Data in  Male C irrhotio P a tien ts
520,
Table II*
... ,, W  M m t *
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Table I I I .
Caaa Wo. 1 5 7 8 10 11 12 13 14
A*«, ( y * « a ) . 58 71 56 55 62 49 46 51 46 52 63 50 58 37
A atlology. Haeaochroaotoa1a Alcoholic Alcohollo Id iopath io A lcohollo H ep a titis ile o h o llo A looholic Aleoholie H apa tltla Id iopath io Id iopath io A leobollo Aloobollo
D uration o f  I l ln a a a , (aon tha). 168 36 36 36 36 24 36 - 36 12 7 24 7 156
L ivar EnlargeBant, ( inch*a). 2-5 2 2.75 3.75 '•5 2 - 3.75 1.5 - 2.25 _ 1.5 _
Splanle " ( " ) . “ - 2 - '• 5 - - - 0.75 2 0 .5 - - _
A acltaa. - - - - ♦ - - ♦ ♦ _ * _
Oedaaa. ■ - - - ♦ - - - _ ♦ * _ *
Oeaophagaal V aricaa. ♦ - - - • - - _ _ _ _ *
L iver Palaa. - - - - - - ♦ _ _ _ _
Spider h a f l .
P ao la l T e lan g ie c tasia .
O ynasooaaatla. - - - - - ♦ - - - - _ . _
T e s tic u la r  Atrophy.
Jaundice . * - - - - - - - ♦ - - - a -
B latory  and/or Evidence 
o f  B apatie Coaa.
P rogress . Wall >•11 Wall Wall Poorly Died
Dlad Dlad Wall Poorly Dlad Dlad Wall
D uration o f  P o llo*-up , (aonttao). 24 IB 24 18 24 6
11 24 ■*36 8 11 6 9
TABLE IV.
Laboratory F indings in  Female C irrh otio  P a tien ts
TABLE V.
Laboratory F indings in  Male C irrhotio  P a tien ts
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Table IV.
Laboratory Findings In FemalaClrrbotio Patients.
C a sa  B o. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1«
S a n a  B i l i r u b i n .  ( n g .> ) 0 .5 32 2 0 .6 1 .3 1 .3 6 .6 1 0 .0 13 1 .1 1 .4 1 .7 2 .0 1 .0 1 .3 1 .2 O . i
A lk a l in a  P h o a p h a ta a a .  (K .A . u n i t a ) 4 8 .2 77 30 15 2 3 .3 31 20 69 20 16 7 25 5 1 5 .8 57 7 0 .8
Tfayaol T u r b i d i t y ,  ( u n i t a ) 8 4 4 6 12 5 5 2 5 ■ 6 3 4 8 12 11 8
T fayaol F l o c c u la t i o n *  ( u n i t a ) 1 0 4 3 4 3 4 0 3 2 2 2 3 0 0 4
S a n a  A lb u n in . ( f . j t ) 3 .3 3 .3 3 .2 3 .3 4*,0 2 -5 2 .7 2 . 2 4 .4 2 .7 3 -3 3 .7 3 .8 5 .0 3 .9 4 .0
S a n a  G lo b u lin *  ( g . 7>) 4 - 9 2 .9 3 .2 2 .1 4 .4 2 .3 3 .2 3 .1 2 .5 2 .1 2 .0 2 .2 3 .1 2 -5 2 .3 4 .7
G anna G lo b u l in .  ( g .> ) 2 .7 1 .3 1 .7 1 .3 2 .6 1 .0 1 .5 1 .3 1 .6 1 .9 1 .1 0 .9 1 .8 1 .1 1 .4 1 .8
B .S .P .  ( * ) 17 71 60 18 54 35 75 75 13 25 22 M 19 47 28 36
S a n a  T r a n a a n ln a a a .  ( u n i t a ) 104 166 212 296 142 114 68 104 751 147 83 36 55 31 114
S a n a  I ro n *  ( u g .> ) 80 35 35 110 145 35 150 35 13.' 28 ” 5 50 173 50 10 35
S a n a  T i t a n i c  8 1 2 .  ( t o t a l ) ,  ( u u g . / n l . ) 568 1433 617 1600 810 1215 705 420 550 490 150
P r o t h n a b i n  T i n a /C o n t r o l .  ( S a c . ) 1 9 /1 6 19 /1 7 32 /1 5 15 /1 6 18 /13 2 1 /1 5 2 7 /1 5 2 1 /1 5 18 /1 6 1 8 /1 5 2 0 /1 2 18 /1 5 1 7 /1 5
S a n a  C h o l a s t a r o l .  ( a g . j t ) 233 320 335 157 180 200 300 213 120 137 90 205 132 120 125 335
H b . O ) 84 96 71 91 85 »6 vo 70 78 74 79 66 85 70 43 105
•  .B .C .  ( c a l l ^ c . H . ) 7 ,4 0 0 5,4uO 7 ,8 0 0 1 0 ,500 5 ,CK>J 4 ,3 0 0 6 ,8 0 0 2,500 ’ ,4 5 0 3 ,8 0 0 7 ,8 0 0 3 ,1 0 0 2 ,7 0 0 3 ,2 0 0 5 ,4 0 0 5 ,8 0 0
B .S .B . ( ■ a . / f l r a t  h r . ) 55 88 57 10 18 34 30 56 10 8 15 24 43 48 84 39
P .O .B . ♦ - ♦ - - ♦ * - ♦ V
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Table V.
Laboratory Findlnga in Male Cirrhotic Patient*.
■i»M 1,0' 1 2 3 4 5 6 7 8 9 10 11 12 13 14
S arua B il i ru b in ,  (m g./) 0 .8 1 .0 2 .3 1 .6 1 .2 0 .7 1.5 3 .9 5-4 1 0 .2 0 .6 1 .9 0 .9
A lk a lin e  Phosphataee . (K.A. u n ita ) 10 19 9 19 10 9-2 18.8 14 62 1 5 .6 25.1 10 28.2 12
Thymol T u rb id ity , (u n ite ) 2 16 9 1 10 15 6 5 2 8 8 2 18 i
Thymol F lo o c u la tlo n . (u n ita ) 1 4 0 4 3 3 0 0 3 0 2 4 0
Serum Albumin. ( g . / ) 3 .6 3 .2 2 .3 3 .7 4 .2 4-2 3 .0 4-2 4 .8 2 .8 2 .3 2 .6 3-8 4 .0
Serum G lobu lin , ( g . / ) 2.4 6 .8 3.7 2 .4 2.8 4 .4 4 .0 2 .2 4 .0 3.7 3 .8 4 .9 4 .9 2 .7
G^ma G lobu lin , ( g . / ) 1-53 4.04 1.79 1.02 1.48 2.47 2.14 0.97 1.4< 2 .4 6 2 .15 3.31 2.72 1.36
B .'s .P . T aa t. (*) 0 41 25 17 24 7 0 .5 20 19 26 37-5 12 38.5 15 0
•arum Tranaaminaaa. (u n ita ) 90 100 75 83 60 213 61 50 35 103 .32 151 250 34
Serum I r o n . (ug .£ ) 200 10 150 40 205 180 74 75 180 35 45 155 80 155
Serum Vitam in B12 . ( t o t a l )  (u u g ./m l.) 447 583 458 353 1022 647 1670 620 131 675 763 707 1860 640
Prothrom bin T im e/C ontro l. (a e c a .) 24/16 19/13 2 1 /1 5 19/16 18/14 20/15 19/16 18/14 16/13 21/15 19/16
Serum C b o le a ta ro l. ( mg. / ) 100 120 140 140 130 170 98 280 205 155 390 103 180 125
Hb. (* ) 102 90 ’05 86 93 110 ” 5 85 75 70 91 93 106 67
V .3.C. (o e lla /c .m m .) 6,200 5,600 8 ,4 0 0 7 ,0 0 0 4 ,6 0 0 8,000 6,400 7,200 5,200 2,400 3,750 4,600 9,000 3,500
K.S.B. (m m ./f ira t h r . ) 10 102 45 45 40 4 5 90 88 3 64 115 4 24
P.O.B. + + - + - - - a
TABLE VI.
L iver H isto logy  in  Female C irrhotic P a tien ts
TABLE VII,
L iver H isto logy  in  Male C irrhotio  P a tien ts
So.
1
2
3
4
5
7
e
9
11
12
13
14
15
16
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Table 71 .
Liver Histology in  Female Cirrhotic P atients.
H a t u r e
P o r t a l  C e l l u l a r i t y
o f
S p e c i m e n L y m p h o c y t e s
L y m p h o i d
P o l l i c l e c .
P o l y m o r p h o ­
n u c l e a r
L e u c o c y t e s .
P l a s m a
C e l l s .
N e c r o s i s
P a t t y
C h a n g e
H y p e r t r o p h y F i b r o s i s
ails
Thrombi
■'■edge + ♦ - - 4 - + 4 4 44 -
A u t o p s y +* - - 4 4 - + 4 4 4 4
A u t o p s y * - 4 4 - - 4 44 -
A u t o p s y + + - 4 4 4 + - 4 4 44 4
S e e d l e + + - 4 - + + + 4 44 t 4 4 4
A u t o p s y + - ♦ ♦ - - 4 4 4
A u t o p s y + - 4 4 + + 4 4 4 -■
S e e d l e + - - - - - 4 -
• e d g e + - 4 4 4 ♦ - 4 44 . 4
■ e d g e + - 4 4 4 * ♦ 4 44 -
Autopsy ♦ - 4 4 4 + - 4 44 +
K e e d l e ♦ - 4 4 - + 44 44 -
Autopsy ++ - 4 4 * ♦ 4 444 ♦
H e e d l e ♦ - 4 - - 4 4 -
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Table V£E.
L iv e r  H is to lo g y  I n  M ale C i r r h o t i c  P a t i e n t s .
Portal Cellularity
Case
Ho.
Heture
of
Specimen Lymphocytes LymphoidFollicles
Polymorpho­
nuclear
Leucocytes.
Masma
Cells
Necrosis FattyChange Hypertrophy Fibrosis
Bile
Thrombi
Bile Duot 
Proliferation
1 Needle + - - + - - + +++ - -
3 Needle ♦+ - - ++ - + ++ - +
8 Autopsy + - + - + ++ ♦ - +
9 Wedge + - + + ♦ + + - -
10 AutopBy - - ♦ ++ - - + ♦ ♦
11 Needle + - - ♦ - + + ♦ ♦
13 Autopsy ♦ - - + - ♦ ++ +++ + ♦
14 Needle ♦ - - + + + + ♦ • ♦
TABLE V III.
R esu lts of Invest jg a tion s of Thyroid Function in  
Female C irrhotio  P a tien ts
TABLE IX
R esults of In v estig a tio n s  o f Thyroid Function in  
Male O iirh otio  P a tien ts
Table VIII
Results of Investigations of Thyroid Function in Female Cirrhotic Patients.
Case Age. C lin ic a lS ta tu s G o itre
Thyroid
P r e c ip i t in
Luto-antibody 
T ea ts .
Complement-
F ix a tio n
Ha
4 hour uptake 
(£  dose)
d io io d in e  T ests
FBI131 
(£  d o e e / l . )
P e rc h lo ra te
D ischarge
FBI
(jig./lO O  a d .) Thyroid H isto logy
1 58 E uthyro id Hone ♦ 4+ 10.2 0.22 ♦ 3 .5
2 71 - - + 27.8 0.13 3 .0 Ho p o s t - w r i . ,  exam ination  o fth y ro id  perform ed.
3 63 " H 24.5 0.54 ♦ 3 .6 Fooal t h y r o i d i t i s  p re s e n t .
4 45 1 " - H 20.2 0.21 - 4 .4 Focal t h y r o id i t i s  p re s e n t .
5 59 " " ++ 43.1 0.05 - 5-5
19.3 0.23 4 .3
6 57 E uthyro id None ”
7 62 . - - AC
32.0 0 .0 5 ■ 7.0 Focal t h y r o id i t i s  p re s e n t.
2J.1 0.28 - 4 .9 Focal t h y r o id i t i s  p re se n t.
8 58 ** ”
b - 9 0 .1 - 7-5
9 64 " ** -
31.6 0 .1 2 _ 4 .6
10 61 * - “
2 2 .0 0 .0 5 _ 3.7
11 54 " - AC
24.5 0 .0 5 + 5-5
12 39 " - "
21.4 0 .1 - 5 .8 Fooal t h y r o id i t i s  p re se n t.
13 61 * • "
36.7 0 .0 5 - 8 .0
14 67 n - "
49-4 0 .15 - 5-3 Focal t h y r o id i t i s  p re s e n t.
15 51 ♦ ♦n o n -sp e c if ic ) 26.6 0 .0 5 4 .0
16 54 '
Table IX,
R esu lts  o f In v e s tig a tio n s  o f Thyroid fu n c tio n  ^ p^ tale_C irrho tio__P ttlen t£ lM
CSSS Age ■ C lin io alS ta tu s O oltrs
Thyroid
F rs o lp lt ln
oi to -an tibody 
"a s t s .
Coapleaent-
P lx a tle s
l a
4 hour uptake 
(> dose)
iio lo d in e  T ests
PBi 131
d o e e /l.)
P erc h lo ra te
Discharge
p h
(M ./1 0 0  s i . ) Thyroid H istology
1 58 Bu thy ro id Bono - - 29.0 0.23 - 4 .2
2 71 " " - - 37.2 0.05 - 5.2
3 56 " " - - 18.8 0.23 - 3.2
4 55 " " (■o n -sp e cific) 41.2 0.25 - 5 .0
5 62 " " - - 26:8 0.05 - 6.2
6 49 " " - - 17.8 0.05 - 5-9
7 46 " - - - 24.2 0.05 - 5.6
8 51 " " - - 45-2 0.17 - 4 .2
9 46 " ” - t+ 33.2 0.05 - 4 . 8
10 52 " " - - 21.0 0.05 ♦ 4 .7  Tlnyrold a c t axaadnsd.
11 63 ypothyroid - - - 7 .2 0.00 - 1.0
12 50 BUthyroid " - AC 27.3 0.05 - 5-7 Tl lyrold not examined.
13 58 » > _ + 14.1 0.05 - 5-4
(non-apeoific) 13.6 0.05 _ 4 .8
14 37
SECTION lu The Antibody-forming P o te n tia l in  
Auto-immune D isease .
532i*)-
TABLE I .
O lin io a l D e ta ils  and R esu lts of Primary Irmmmi sa tion  
to  Tetanus Toxoid in  Auto-immune T h y ro id itis .
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Table I.
C lin ic a l D e ta ils  and R esu lts  o f Primary Immunisation to  Tetanus Toxoid in  Auto-immune Thyroiditis
T hesis
No.
Age Sex C lin ic a l
S ta tu s
Thyroid Auto- 
Antibody T ests 
Free . CF
Ca-una -g lobu lin  
(mg.5-)
Tetanus A ntitoxin 
T i tre s  (U nits/m l) Comment s .
2 56 F Hypothyroid + ++ 1.42 ^ 0 .1 * 0 .2
3 52 F Euthyroid + + 1.34 > 0 . 5<1.0
4 63 11 Hypothyroid + + + 1.30 >0.1*0.2 Rheumatoid A r th r i t i s .  L .E .c e ll 
t e s t  p o s i t iv e  L aten t s y p h ilis
5 41 F Hypothyroid + + + 1.66 0.01
6 49 F Hypothyroid + ++ 0.54 >5<1C
1C 52 F Hypothyroid + + + 0.96 0 .1
12 46 F Euthyroid + ++ 0.96 ">0.01<0.02
16 40 F Euthyroid - + + 1.60 >0.01-0 .02
17 45 F Hypothyroid + ++ 1.22 >2.
IB 52 F Euthyroid - ++ 0.83 C.01
21 65 I! Euth-TOid + ++ 1.18 >0.5<1.0
25 50 F Equi vocal ly* 
Hypot.ayroid
+ ++ 1.42 >0.5*1.0
26 43 F Euthyroid + ++ 1.09 >0 . 5*1 .0
27 54 F Hypothyroid + ++ 0.57 >0.1*0.2
?c 45 F Hypothyroid + ++ C.9C > 0 . 0 5 *0 . 1
31 61 F Euthyroid + 0.68 >0.01*0.02
33 55 F Euthyroid + ++ 1.15 > 0 . 0 5 *0 . 1
36 50 F Equivocally^
Hypothyroid
+ ++ 1.54 0.01
42 57 F Euthyroid + ++ 1.09 }0.01<C.02 Acquired id iopath ic  Coombs 
ne a tiv e  haeao ly tio  anaemia
50 62 F Hypothyroid - + 0.60 0.01
* These j a t i e n t s  have been c la s s i f ie d  as euthyroid in  F igurel.
TABLE II.
C lin ic a l D e ta ils  and R esults cf Pirimary Immunisation 
to  Tetanus Toxoid in  Primary Hypothyroid! am
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Table I I .
Clinical Details and Results of Primary Immunisation to Tetanus Toxoid in Primary Hypothyroidism
Case
Ho.
Age Sex Clinical
Status
Thyroid 
Auto-antibody Tests 
Prec. CP
Gamma-globulin Tetanus Antitoxin 
titres (units/ml)
Comments
1 52 H Hypothyroid + ++ 0.97 =>01 4.02
4 56 F Hypothyroid + ++ 0.84 >0 .05 < 0 .1 Rheumatoid Arthritis
9 64 F Hypothyroid + - 0.68 C.01
19 56 F Euthyroid - ++ 0.78 0.01
22 39 F Euthyroid - ++ 1.14 > 1 4  2
23 59 F Euthyroid - 4+ 0.89 * 1 4  2
24 59 F Hypothyroid - ++ O.56 > 0.140.2
25 38 F Euthyro-id - ++ 1.25 >0 .1 < 0 .2
27 56 F Hypothyroid - + O.56 0 .2
31 65 F Euthyroid - + O.65 >0 .2 < 0 .5
32 67 F Hypothyroid - + 0.94 > 0.01
33 53 F Euthyroid - + 0.41 > 0 .5 < 1 .0
41 56 F Hypothyroid - - 0.68 > 0 .5 4  1 .0
44 44 F Euthyroid - - 1.00 0 .01
51 61 M Hypothyroid - - 1.40 >0.0140.02
69 40 F Euthyroid - - 1.15 > 0.05 < 0 .1
70 65 F Euthyroid - 1.25 >0.2 40.5
TABLE III.
C lin ic a l D e ta ils  and R esu lts o f Primary Inuaxnisation 
to  Tetanus Toxoid in  C irrhosis of L iver.
T a b le  I I I ,
C lin ic a l D e ta ils  and R esu lts o f Primary Immunisation to  Tetanus 
Toxoid in  Female P a tien ts  w ith C irrhosis  .of th e  L iver.
Case
No.
Age
(Yrs)
Sex Aetiology 
of C irrhosis
Thyroid Auto- 
Antibody Tests
Prec CFT
Gamma­
g lobu lin
(U nits/m l)
Tetanus A nti- 
Toxin te tn e s  
(U n its / ml)
Comments
1 58 F Id iopath ic + ++ 2.67 *.0.01
2 71 F Id io p a th ic + 1.25 > 0 .2  £ 0.5
5 63 F Id io p ath ic ++ 1.69 > 0 .2  C 0 .5
4 45 F Chronic H ep a titis  -  ++ 1.29 > 1  < 2
5 59 F Alcoholic ++ 2.58 > 0.5  <  1 .0
6 57 F Alcoholic - 1.04 ? 0.5  < 1 .0
7 62 F Id iopath ic -  Anti com-1*48 > 0 .2  < 0.5
plemeutary
8 58 F Id io p ath ic - 1.26 < 0.01
9 64 F Id io p a th ic - 1.58 < 0.01
10 61 F Id io p ath ic - 1.94 0.01
11 54 F Id io p ath ic Anticom-1.07 > 1  <  2
plementary
12 39 F Chronic H e p a titis  - 0 .92 0.01
13 61 F Chronic H e p a titis  - 1.78 > 0 .1  <  0 .2
14 67 F Id io p a th ic - 1.06 > 0 .1  <  0 .2
15 51 F Id io p ath ic ++ 1.37 > 0.05  < 0 .1 Rheumatoid
(non sp e c if ic ) A r th r i t i s
16 54 F Chronic H e p a titis  -  
1
1.84 < 0.01
i-r*t5.Pmy y&i*rr* ' i"*---■*
TABLE IV.
C lin ic a l D e ta ils  and R esu lts c£ Primary Iminunisation
to  Tetanus Toxoid in  Connective T issue D isease.
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T a b le  IV .
C lin ic a l  D e ta ils  and R e su lts  o f  Prim ary Im m unisation to  
T etanus Toxoid in  C onnective T issue  D isea se .
T h esis
No.
C l in ic a l  Age Sex T hyroid A uto- Gamma T etanus
C o n d itio n  an tib o d y  T e s ts  G lobu lin  A n tito x in
P rec . CF. ( T e tre s
 ______  (U nits/m l.)
Comments
1 System ic lupus 
erjrth em ato s is
53 F - 1.10 > 1 .0  < 2 .0
2 h 56 F - 1 .1 2 > 0 .01  <0.02 On s te ro id therapy
5 ii 32 F - 2.10 >0.01<0.02
6 tl 36 F — ++
(n o n s p e c if ic ) l .81 >0.01<0.02 On s te ro id th erap y
8 »t 22 F — ++
(non soec i f  ic )  0.92 > 0 .2  < 0 .5 On s te ro id therapy
12 Scleroderm a 43 i: - 0.56 > 0 .2  < 0 .5 On s te ro id therapy
15 II 49 F - ++ 1 .12 > 0 .2  <0.5
15 D erm atom yositis 
P rim ary  Hypothy­
ro id ism
64 F ++ 1.30 < 0 .0 1
1 Rheumatoid a r t h ­
r i t i s
55 F - ++
(non 3 'le c i f ic ) l .0 0 7 0 . 01C0.02
5 Rheumatoid a r t h ­
r i t i s
56 F - 0.96 >0 . 05< p .l
45 Rheumatoid a r t h ­
r i t i s
57 F 0.84 > 0 .1  <0.2
TABLE V.
C lin ic a l D e ta ils  and R esu lts of Primary Immunisation 
to  Tetanus Toxoid in  Controls.
Table V.
Clinical Details and Results of Primary Immunisation to Tetanus Toxoid in Controls
Case No. Age Sex
JB.S.R. 
(nm/first hr.)
Ganma-Globulin 
(mg..£)
Tetanus Toxoid 
(Units/ml.)
1 59 F 4 0.79 > 0 . 0 5 < 0.1
2 56 F 7 0.62 >0.02 < 0.05
3 63 F 9 0.56 >2.0 5.0
4 69 F 11 0.62 >0.1 < 0.2
5 40 F 7 0.61 >0.05 < 0.1
6 38 F 10 0.82 >0.1 < 0.2
7 57 F 3 0.42 >0.05 < 0.1
8 58 F 2 0.53 >0.05 < 0.1
9 35 F 5 0.74 >0.05 C 0.1
10 58 F 3 0.96 >0.1 < 0.2
11 38 F 8 0.83 >0.1 <* 0.2
12 68 F 11 0.86 >0.1 <* 0.2
13 58 F 2 0,65 >2.0 < 5.0
5M3.
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This th es is  deals with a c l in ic a l  study o f auto-immune 
th y r o id it is .
Chapter I i s  concerned with the background o f the present study. 
The h is to r ic a l a sp ects , morbid anatomy, and past views regarding 
a e tio lo g y , are reviewed, and an account o f the recent inmunologioal 
developments i s  a lso  given .
Chapter II  deals with my observations in 50 p a tien ts  with the 
disease and advantage has been taken o f modem methods o f in v estig a tio n  
to study the c l in ic a l  fea tu res. The ro le  o f the c ircu la tin g  thyroid  
auto-antibodies in  the pathogenesis o f the disease has been in vestiga ted  
in  a study o f the nature o f skin reactions follow ing the intradermal 
in jec tio n  of s t e r i le  extracts o f human thyroid t is su e  in  p atien ts  
with auto-immune th y r o id it is . The biochemical changes in  th is  
condition a lso  form part of the contents of th is  chapter and include 
observations o f the serum p rote in s, serum floccu la tio n  t e s t s ,  and 
erythrocyte sedimentation ra te . The mechanism o f these changes i s  
discussed and th e ir  d iagnostic s ig n ifica n ce  evaluated. A d eta iled  
in v estig a tio n  o f iodine metabolism has been undertaken and the 
abnorm alities in  the handling o f both stab le  iodine and radioiodine i s  
discussed . F in a lly , the d if fe r e n t ia l diagnosis and treatment o f  the 
disease are considered in  the l ig h t  o f these in v estig a tio n s.
-  2 -
Chapter I I I  o f the th e s is  i s  concerned with the re la tio n sh ip  o f  
auto-immune th y r o id it is  to  primary hypothyroidism and to  th y ro to x ico s is . 
Evidence i s -presented that primary hypothyroidism is  a pathologies' 
variant o f auto-immune th y r o id it is . Thyroid auto-antibodies :;ave 
been studied in  th yrotox icosis  in  r e la t io n  to the c lin ic a l features, 
to the outcome o f antithyroid  therapy, and to the foca l le s io n s  o f  
auto-immune th y ro id it is  in  the thyroid gland a fte r  operation. The 
resu lts  o f these in v estiga tion s help to elucidate  the nature o f the 
auto-immune reaction in  th y ro to x ico sis , and a lso  have important 
p ractica l im plications in  the management o f the thyrotoxic p a tien t.
Chapter IV deals with the wider im plications o f auto-immune 
disease resu ltin g  from a study o f the c l in ic a l  a sso c ia tio n s of auto­
immune th y ro id itis  with the connective t is su e  d isorders, in  p articu lar  
rheumatoid a r th r it is ,  the haemolytic anaemias, and c irrh osis  o f the l iv e r .  
An experiment designed to measure the antibody-forming p o ten tia l in  
p atien ts with 'auto-immune disease i s  a lso  reported in  th is  chapter.
F in a lly , the im plications o f these stud ies are discussed in  re la tio n  to  
the clonal s e le c tio n  theoiy  of antibody formation and to the concept of 
aoquired immunological to lerance.
The th es is  i s  presented in  three volumes. Chapters I and II are 
presented in  Volume I ,  Chapters III  and XV in  Volume I I ,  and the 
Appendices and References in  Volume I I I .  Separate summaries are presented  
at the conclusion o f  each section  and have been indexed in  the tab le o f  
contents. In order to f a c i l i t a t e  the reading o f the th es is  I have 
enclosed a separate tab le of contents for  each o f » Glumes
